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Discovery of the third domain of life
In the early 20th century, bacterial classification and taxonomy were based on metabolic, 
physiological and morphological features. Newly discovered microbes were grouped 
into the domain of prokaryotes depending on the absence of a cell nucleus, presence of 
cell walls and the absence of organelles. Species and genus were then chosen based on 
biochemical and physiological characteristics. In 1977, Carl R. Woese and George E. Fox 
performed a phylogenetic analysis on prokaryotic and eukaryotic lineages in an attempt 
to develop an unbiased method for phylogenetic classification [1]. They recognized that 
genomes are the footprint of evolutionary descent and thus a more reliable proxy for 
phylogenetic classification than metabolic, physiological and morphological characteristics. 
The broadly distributed and highly conserved 16S ribosomal RNA sequences were therefore 
used to develop a general classification of all prokaryotes. Within this comparative analysis 
they discovered that the previously classified order of the ‘archaebacteria’ (methanogens) 
should be grouped to a separate domain because of their sequence dissimilarity with other 
bacteria. Following research then confirmed the existence of a third domain/kingdom of 
life which were termed ‘Archaea’ in 1990 [2]. Soon after this revelation, the multitude of 
novel archaea was shown to have more differences with the bacterial domain and more 
resemblance to the eukarya. Characteristic differences with bacteria are the pseudo-
peptidoglycan, a transcription and translation machinery more similar to that of eukaryotes, 
a series of unique metabolic pathways and a plasma-membrane lipid composition that is 
fundamentally different in chemical architecture.
The ‘lipid divide’ and the pre-cell hypothesis
The earliest identified archaea were isolated from environments that were previously 
considered too extreme to support microbial life viz. high acidity/alkalinity, high 
temperatures, salinity etc. The newly discovered domain of life was therefore termed 
‘archaea’ after the ancient Greek word (αρχαία = ancient) to reflect these organisms extreme 
habitats comparable to earths primordial conditions. In addition to their habitats, archaeal 
physiology is equally diverse as they include autotrophs, methanogens, phototrophs 
and sulphur reducers. Although archaea are indeed dominating the extremes of earths 
physicochemical challenges, we now know that milder habitats are also copiously colonized. 
Archaea are e.g. highly abundant in oceans as a main participant of plankton [3]. Due to their 
oftentimes extremophilic nature, archaea were extensively studied for the development of 
potential biotechnological applications. Research into their robustness then soon revealed 
that archaeal phospholipids display a chemical architecture that is completely distinct from 
bacterial and eukaryal phospholipids (Fig. 1A and B). The fundamental differences are found 
in the core lipids that serve as the framework for the fully maturated polar phospholipids. 
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These are represented by ‘archaetidic acid’ in archaea and ‘phosphatidic acid’ in bacteria 
and eukarya. The bacterial phosphatidic acid is composed of two fatty acid hydrocarbon 
chains esterified to the sn-1 and sn-2 position of a glycerol-3-phosphate (G-3-P) moiety. The 
archaeal archaetidic acid (DGGGP di-O-geranylgeranylglyceryl phosphate) on the other hand 
consists of two highly methyl-branched isoprenoids (termed ‘phytanyls’ in their saturated 
state) connected by ether-bonds to the sn-2 and sn-3 position of glycerol-1-phosphate 
(G-1-P). Although few exceptions to these rules apply for the hydrocarbon chains and ester/
ether bonds [4-6], the stereochemical opposites of the glycerol-phosphates are an exclusive 
feature that separates the domains. The chemical differences have been termed “the lipid 
divide” and serve as a hallmark between the three domains [7]. Most interesting here is 
that although the core lipids are dissimilar, the polar head groups (ethanolamine, glycerol, 
serine, choline and glycerol) that are ultimately linked to the phosphate groups are shared 
by the three domains (Fig. 2). In addition to this, the archaea, and especially thermophilic 
species, use glycolipids with multiple hexoses as a main constituent of their membrane [8]. 
Another common theme of archaeal membranes is the formation of macrocyclic (Fig. 1B, 
left) and C80 tetraether lipids (also known as glycerol-dialkyl-glycerol tetraethers (GDGTs)) 
(Fig. 1C). Tetraether lipids are bipolar due to a putative condensation event that takes place 
between the isoprenoid ω20 carbon atoms of two diether lipids [9, 10]. Tetraether lipids are 
broadly distributed throughout archaea and display a high variability by the incorporation 
of cyclopentane rings in the phytanyl chains up to a maximum of 8 rings per GDGT (Fig. 1D)
[11, 12].
The revealed separation and uniformity between bacterial, eukaryal and archaeal lipids 
ultimately raised the question how and why all life on earth was differentiated into these 
three domains. Currently, one of the most accepted hypothesis partitions the evolution 
of the domains into three evolutionary stages [13, 14]. The first stage envisions the origin 
of life into a multi-phenotypical population of pre-cells with membranes composed of a 
racemic or heterochiral glycerol-phosphate lipid mixture (i.e. a mixture of G-1-P and G-3-P 
lipids) [15]. The second stage was postulated in 2003 and hypothesizes the differentiation of 
this heterogeneous population of pre-cells (cenancestor or last universal common ancestor 
(LUCA)) into two lineages [14]. In the third and last stage the parallel specialization of all species 
known today is hypothesized. During this stage the eukaryotic lineage also appeared by a 
putative endosymbiosis event of bacteria and archaea that explains the mosaic distribution 
of both bacterial and archaeal features [13]. The foundation of bacteria and archaea 
however lies in the second stage in which a racemic membrane is thought to play a major 
role in a segregation event into homochiral membranes and the subsequent development of 
the bacterial and archaeal ancestors thereafter [14]. Contradictory, during the evolution of 
the eukaryotic lineage, a fused membrane is envisioned that also led to a racemic membrane. 
It is postulated that an inferior stability of mixed membranes was the main driving force 
behind this segregation [7]. Phylogenomic comparisons indeed strongly suggest that the
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Figure 1. Bacterial and archaeal lipid variations and the lipid divide. The bacterial phosphatidic acid is represented 
by panel A right. In the left panel monounsaturated branched chain anteiso (top) and iso-fatty acid (bottom) 
variations are shown. The archaeal archaetidic acid or DGGGP (panel B right) core lipids are depicted, left lipid shows 
macrocyclic archaeol. The lipid divide describes the three chemical differences that are fundamentally different 
between the three domains of life. Grey: the hydrocarbon chains are fatty acids in bacteria and isoprenoid chains 
in archaea. Red: Ester-bonds link the hydrocarbon chains to the glycerol backbone in bacteria and ether-bonds in 
archaea. Yellow: The backbone moiety in phosphatidic acid is represented by glycerol-1-phosphate. In archaetidic 
acid the stereo-conformer or enantiomeric glycerol-1-phosphate is present in archaea. Archaeal bipolar glycerol 
dialkyl glycerol tetraether (GDGT-0) is depicted in (panel C) which spans the membrane to form monolayers. Panel 
D shows GDGT-1, the bipolar lipid containing 1 cyclopentane ring in the phytanyl chain.
cenancestor was equipped with genetic components of both lipid synthesis pathways [13]. 
Currently however there is only little data available that supports the heterochiral membrane 
hypothesis of pre-cells. One in vitro study indeed suggests that heterochiral vesicles of fatty 
acids are less stable than homochiral vesicles of the same compounds and exhibit reduced 
self-reproduction [16]. Although this data supports facilitated segregation, this study was 
done on fatty acids rather than glycero-phospholipids. This issue was addressed in another 
in vitro study on mixed vesicles of bacterial and archaeal lipids in which an increased 
temperature dependent stability was observed which proved to be highly dependent on 
the length of the fatty acid chains [17]. Here, both the archaeal lipid component C40 diether 
lipids and C80 bipolar tetraether lipids (GDGT’s) showed stable vesicles with bacterial 
phospholipids. Although this study proofs chemical stability of mixed membranes, which is a 
strong argument that disputes the facilitated segregation, in vitro vesicles are not a correct 
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representation of the last universal common ancestors membrane. Experimental evidence 
that supports the mixed membrane of pre-cells should ideally show that heterochirality 
supports a sustainable situation in vivo as well.
Archaeal and bacterial lipid synthesis 
Archaeal and bacterial lipid synthesis follows a sequence of reactions that resemble each other 
in analogous steps (Fig. 2). Synthesis of bacterial fatty acid ester-lipids starts from primary 
metabolites acetyl-CoA and malonyl-ACP. Fatty acid synthesis is a sequence of successive 
repetitive reactions that result in the formation of C14-C22 fatty acids (acyl-ACP). This acid 
then becomes esterified to glycerol-3-phosphate by glycerol-3-phosphate acyltransferase 
to form lysophosphatidic acid. A secondary acyl-ACP is attached at the sn-2 position of 
glycerol-3-phosphate and catalysed by sn1-acyl-glycerol-3-phosphate-acyltransferase 
which forms phosphatidic acid. For polar head group attachments, the newly synthesized 
phosphatidic acid first becomes activated by CDP-diacylglycerol synthase. From this point, 
the phospholipid synthesis bifurcates to either the synthesis of phosphatidylserine and 
phosphatidylethanolamine or phosphatidylglycerol. Unlike the bacterial fatty acid synthesis 
cycle, the isoprenoid hydrocarbon chains of archaeal lipids are not synthesized by a cyclic 
reaction event. The lipid precursors geranylgeranyl-diphosphate (GGPP) are synthesized 
by 3 condensation steps of isopentenyl-diphosphate (IPP) with dimethylallyl-diphosphate 
(DMAPP). The resulting geranylgeranyl diphosphate (GGPP) is attached to the sn-3 position 
of glycerol-1-phosphate by geranylgeranylglyceryl-phosphate-synthase by forming an 
ether-bond. A second GGPP is attached to the sn-2 position by di-O-geranylgeranylglyceryl-
phosphate synthase to form archaetidic acid (DGGGP). CDP-archaeol synthase activates 
DGGGP for the attachments of polar headgroups in a sequence of reactions that resembles 
bacterial polar head group attachments. The biochemistry that results in GDGT synthesis is 
currently still unknown. Some studies previously suggested that two diether molecules are 
the precursors of a single tetraether lipid. Here a putative tetraether synthase fuses two 
diether lipids by a condensation that forms two carbon-carbon bonds [10].
Natural and artificial membrane modifications
Bacteria and archaea evolved the ability to extensively remodel their membrane lipid 
composition in response to changing environmental conditions. The theory of homeoviscous 
adaptation was inspired by the observation that fluidity of the E.coli membrane remains 
relatively constant at various temperatures while the lipid composition changes [18]. 
These changes occur mostly on the core lipids and are implemented to tune the fluidity 
and permeability of the membrane to retain homeostasis. A commonly described fluidity 
adaptation example is the incorporation of methyl branches in the fatty acids of bacterial 
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phospholipids in response to lowering temperature (Fig. 1A left)[19]. In addition to 
natural environments, homeoviscous adaptation has also been reported in various applied 
industrial settings. Kanno and Kamagata showed that several firmicutes and actinobacteria 
exposed to 2.0% butanol increase their cyclopropane fatty acid (CFA) content [20]. CFA 
synthesis has also been recognized as main fortification adaptation against acid and alcohol 
exposure in Escherichia coli [21]. High levels of propionic acid induces an increase in long-
chain saturated fatty acids and a decrease in unsaturated fatty acids in Propionibacterium 
acidipropionici [22]. These various recognized homeoviscous modifications have recently 
also been exploited for the improvement of industrially applied production hosts. These 
modifications were implemented by membrane engineering strategies to increase the 
yield of industrial chemicals, or improve the tolerance of the production strain against 
demanding processing conditions. The introduction of the desaturase DesA from 
Synechocystis to Anacystis nidulans transformed the cold sensitive strain more tolerant to 
cold temperatures [23]. Another successful effort is illustrated by Escherichia coli in which 
cis-trans isomerase was introduced to convert cis-unsaturated fatty acids to the conical 
shaped trans-unsaturated fatty acids. As a result a more rigid and less fluid membrane 
was formed with reduced permeability. As such, this modification provides the cells with 
increased tolerance to alcohols, organic acids and aromatic compounds and enhances 
viability to adverse physicochemical conditions [24]. Another noteworthy example of 
membrane engineering was shown in Clostridium acetobutylicum where overproduction 
of CFAs caused an increased butanol tolerance [25].These examples illustrate the high gain 
that lies in rational design of biological membranes. Despite this, membrane engineering is 
a relatively novel discipline for which the full potential is yet to be explored. 
Heterochiral membrane engineering in Escherichia coli
Studies on extremophiles show that both bacteria and archaea tolerate comparable 
impeding conditions, which suggests an equal flexibility of these domains. Both archaea 
and bacteria are known to thrive at extreme habitats like hydrothermal vents, hypersaline 
or boiling acid lakes, or high temperature deep sea oil reservoirs. Nonetheless, subtle 
differences are recognized. Archaea are dominating the upper extreme temperatures, a 
trait which they might owe to their unique lipid compositions. Biophysical studies indeed 
show that archaeal ether-lipids are more robust against hydrolysis than ester-lipids due 
to their phytanyl hydrocarbon chains and ether bonds [26-30]. E.g. upon boiling acid 
hydrolysis, the archaeal ether-bonds generally remain intact, whereas ester-bonds are 
fully disintegrated [31]. These and other findings support that archaea are more resistant 
to challenging physicochemical conditions than bacteria. It is however unclear, whether 
extremophilic habitation of archaea is facilitated because of their distinct membranes, 
providing them precedence to certain niches. This would imply that a fatty acid-ester lipid 
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composition determines the boundaries of bacterial extremophile habitation. If true, the 
archaeal lipids form an interesting tool in industry that can potentially provide a protection 
for industrially applied bacterial organisms. The synthesis of archaeal lipids in E.coli has 
previously been accomplished in a few studies [32-34]. These studies however never 
exceeded 1% of total lipid content nor did they introduce both the main archaeal polar 
lipids archaetidylethanolamine (AE) and archaetidylglycerol (AG). These examples thus do 
not allow the analysis of heterochirality of a membrane as a contiguous organelle. 
The aim of this thesis is therefore to metabolically engineer a complete ether lipid 
synthesis pathway in Escherichia coli, thereby evolving a bacterium with a heterochiral 
mixed membrane. This engineering will additionally lead to a novel bacterial organism 
whose membrane characteristics might partly or completely resemble the membrane 
composition of the putative last universal common ancestor. The strain will be analysed 
for in vivo heterochiral properties and the gained knowledge will contribute significantly 
to the development of robust membrane engineering approaches. Moreover can this 
endeavour provide insight in the membrane properties of the postulated LUCA. Based on 
the homeoviscous adaptation strategies observed in various physicochemical constraints, 
the presence of saturated diether lipids and GDGTs are correlated with thermal resistance 
and acid tolerance to the host strain. Conversely, unsaturated diether lipids are correlated 
with psychrophilicity, but also found in hyperthermophiles. The newly developed strain will 
be fully characterized and tested for various robustness properties. The overall synthetic 
biology of the strain is composed of a series of engineering targets that are described in 
more detail in the thesis outline section.
Thesis outline
Chapter 2: Adaptations of archaeal and bacterial membranes to variations 
in temperature, pH and pressure
Here we aimed to provide insight into the question whether archaea are profiting from 
lipids with more robust characteristics compared to bacterial lipids. The bacterial and 
archaeal lipid compositions and homeoviscous adaptation strategies of extremophiles 
are reviewed, and placed in context with the physicochemical constraint from which the 
extremophilic organisms were isolated. We performed a comparative analysis to uncover 
the regularities of lipid modifications in extreme adaptations. The distilled information was 
condensed and serves as a tool to predict the outcome of the implemented membrane 
engineering strategy.
General introduction and thesis outline
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Chapter 3: Metabolic engineering of Escherichia coli for high production of 
isoprenoids 
The isoprenoid hydrocarbon chains geranylgeranyl-diphosphate make up the bulk of the 
archaeal lipids and is assembled from the building blocks IPP and DMAPP. For archaeal 
lipid production in quantities that suffice appreciable mixed membrane formation, the 
amount of IPP and DMAPP forms the main limitation. To address this issue, the pathway 
responsible for synthesis of these building blocks requires extensive upregulation. In most 
bacteria, the IPP and DMAPP pool are supplied by the MEP-DOXP pathway. Natively, 
these metabolites are essential for processing of lipopolysaccharide and peptidoglycan 
constituents, and synthesis of quinones required for the respiration chain. Despite these 
vital purposes, the available pool of IPP and DMAPP is relatively low. To deal with this 
shortage we metabolically engineered E.coli with a stable upregulation of the MEP-DOXP 
pathway. To accomplish elevated levels of IPP and DMAPP, a variety of synthetic operons 
were constructed and integrated into the chromosome. The isolated strains were then 
characterized for isoprenoid production.
Chapter 4: Modulated gene expression of fatty acid and phospholipid 
metabolism by PlsB and apo-ACP
Fatty acid and phospholipid synthesis in E.coli involve tightly regulated metabolic pathways 
for which exact details on their regulation is largely unknown. Here we describe the 
generation of a conditional knock-down of the endogenous pathway with the ultimate 
goal to further increase the ratio of the introduced archaeal lipids. The downregulation 
was accomplished by the incorporation of an inducible and repressible rhaPBAD-promoter 
to stimulate expression of the plsB gene. The encoded enzyme (sn-glycerol-3-phosphate 
acyltransferase) is responsible for the esterification of acyl-ACP to the glycerol-3-phosphate 
backbone molecule. Characterization of the mutant revealed that additional inhibition was 
required by overexpression of acyl carrier protein (ACP) to completely abolish growth. The 
regulatory actions of PlsB and ACP were then further explored by proteome analysis and 
lipid complementation assays to obtain insight into the inhibitory mechanism. 
Chapter 5: Formation of the ether lipids archaetidylglycerol and archaetidyl-
ethanolamine in Escherichia coli 
CDP-archaeol is the central precursor for polar head group attachment. Here we describe the 
in vitro production of the archaeal lipids archaetidylglycerol and archaetidylethanolamine 
from nine purified enzymes. Various bacterial enzymes involved in the attachment of 
L-serine and glycerol as polar head groups were examined for substrate promiscuity for CDP-
archaeol. The ether-lipid pathway constituted by a set of archaeal and bacterial enzymes 
was introduced in E.coli, which resulted in biosynthesis of AE and AG. 
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Chapter 6: Generation of a hybrid heterochiral membrane in Escherichia coli
This study describes the assembly and optimization of the archaeal lipid synthesis machinery 
in the upregulated MEP-DOXP strains. A variety of introduced genes was evaluated 
for their efficacy of archaeal lipid synthesis. This resulted in the generation of a mixed 
membrane and optimization of the archaeal lipid quantity. The strain was then extensively 
characterized for growth characteristics, cell morphology, endogenous lipid composition 
and its tolerance against physicochemical stressors. In the engineered strain we observed 
severe morphological changes by scanning electron microscopy and transmission electron 
microscopy. The engineered bacteria showed a high number of externally bulging lobular 
bodies. In addition, many cells also show the formation of intracellular vesicles. The high 
production of archaetidylglycerol caused a concomitant decrease in phosphatidylglycerol 
that suggests the functional incorporation of the foreign species. Most interestingly, the 
GGGPs and DGGGPs were also found to have glycerol-3-phosphate promiscuity for archaeal 
lipid synthesis. When analysing the resistance to physicochemical stressors, we observed 
a trend towards lower heat stability, but an increased cold-stability as well which confirms 
the expected hypothesis of mixed membranes with unsaturated archaeol. Altogether, we 
conclude that the incorporation of mixed membranes leads to viable cells, but with dramatic 
effects on their morphology and physicochemical stability. 
Chapter 7: Identification of Thermococcus kodakarensis genes involved in 
GDGT synthesis
The hypothesized robustness against heat, low pH and solvents by archaeal lipids has mainly 
been attributed to tetraether lipids. These lipids form a dense monolayer structure which 
is highly impermeable to protons and solutes and therefore of main interest in membrane 
engineering strategies. Unfortunately, the biochemical pathway that results in tetraether 
lipids and the involved genes has not yet been elucidated. In this study we initiated a search for 
genes that are potentially involved in tetraether synthesis. A list of potential candidate genes 
was composed by bioinformatics analyses and the most likely candidates were subjected to 
disruption and overexpression in the hyperthermophilic platform archaeon Thermococcus 
kodakarensis. The implications of these genetic modifications on the membrane lipid 
compositions were studied by mass spectrometry. Here we demonstrate that mutants of the 
TK1548, TK1836, TK1324 and TK1957 genes greatly affect the quantity of the tetraether pool. 
Lipidome analysis of these mutants allowed the prediction of the most likely substrate for 
GDGT synthesis.
Chapter 8: Thesis summary and general discussion
Finally, the main findings of all chapters will be recapitulated in Chapter 8. The conclusions 
will be placed in context to the hypotheses presented in Chapter 1. The overall impact of 
successful and unsuccessful strategies on archaeal and bacterial membrane engineering are 
discussed. To conclude, a proposal for further research will be presented. 
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Adaptations of Archaeal and 
Bacterial Membranes to Variations 
in Temperature, pH and Pressure
Melvin F. Siliakus1, John van der Oost1, Servé W. M. Kengen1
1 Laboratory of Microbiology, Wageningen University, Stippeneng 4, 6708 WE, 
Wageningen, the Netherlands
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2The cytoplasmic membrane of a prokaryotic cell is a lipid bilayer that shields its cellular content from the environment. In addition, the membrane contains proteins that are responsible for transport of proteins and metabolites as well as for signalling and energy transduction. Maintenance of the functionality of the membrane during changing environmental conditions (pH, temperature, pressure) relies on the cell’s potential to rapidly adjust the lipid composition of its membrane. Despite fundamental chemical differences between bacterial ester lipids and archaeal ether lipids, both types are functional under a wide range of environmental conditions. We here provide an overview of archaeal and bacterial strategies to modulate the lipid composition of their membranes. Some molecular adjustments are unique for archaea or bacteria, whereas others are shared between the two domains. Strikingly, shared adjustments are predominantly observed near the growth boundaries of bacteria. Here we discuss the apparent relationship between lipid composition and growth boundaries that are strikingly different between archaea and bacteria.Keywords: archaea, bacteria, membranes, adaptation, lipidsAbbreviations: AA: arachidonic acid; BCFA: branched chain fatty acid; BMP: bis-mono-acylglycero-phosphate; CL: cardiolipin; DE: diether; DHA: docosahexaenoic acid; DGGGP: di-O-geranylgeranylglycerylphosphate; EPA: eicosapentaenoic acid; GDGT: glyceroldialkyl-glycerol-tetraether; G-1-P: 
glycerol-1-phosphate; G-3-P: glycerol-3-phosphate; MUFA: monounsaturated 
fatty acid; PMF: proton motive force; PUFA: polyunsaturated fatty acid; SCFA: 
short chain fatty acid; TE: tetraether; UFA: unsaturated fatty acidAb
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Introduction 
The core lipids that serve as the framework for fully mature phospholipids are fundamentally 
different in bacteria and archaea. These differences are the basis of the so-called ‘lipid divide’ 
and are represented by ‘phosphatidic acid’ for bacteria and eukarya and ‘archaetidic acid’ 
for archaea. Phosphatidic acid is composed of two fatty acid hydrocarbon chains esterified 
to the sn-1 and sn-2 position of glycerol-3-phosphate (G-3-P) (Fig. 1A, left). Archaetidic acid 
(also known as di-O-geranylgeranylglyceryl phosphate; DGGGP) on the other hand consists 
of two methyl-branched isoprenoids (phytanyls once saturated) connected by ether-bonds 
to the sn-2 and sn-3 position of glycerol-1-phosphate (G-1-P) (Fig. 1A, right). Besides the 
latter ‘archaetidic acid based’ diether lipids, some archaea also contain glycerol-dialkyl-
glycerol-tetraether (GDGT) lipids in their membranes (Fig. 1C). These lipids are bipolar 
and believed to be the product of a tail-to-tail condensation between two diether lipids 
and they form a monolayer instead of a bilayer membrane. Because of these chemical 
differences, bacteria and archaea also evolved domain specific adaptation mechanisms to 
effectively respond to different physicochemical conditions of their habitats. The common 
physicochemical parameters that breach the integrity of membranes are temperature, pH 
and hydrostatic pressure. Typical membrane characteristics that are adversely affected by 
these environmental changes are their permeability and fluidity. These parameters have 
for example a large effect on the function and mobility of membrane proteins, diffusion of 
nutrients and proper separation during cell division. To maintain physiological homeostasis, 
membrane integrity is continuously secured through a mechanism called ‘homeoviscous 
adaptation’. This process was first demonstrated in Escherichia coli by the observation 
that fluidity of the membrane remains relatively constant at various temperatures while 
the lipid composition changes [18]. Cells thus actively modify their lipid composition to 
maintain membrane functionality at different temperatures. These modifications often 
cause shifts in ratios of lipid types and/or their hydrocarbon moieties, rather than complete 
replacement of certain species. Although the core lipids were once thought to form a sharp 
distinction between the two domains, recent analyses have revealed that a certain extent 
of overlap exists between some lipid features which in certain cases can be regarded as a 
form of homeoviscous adaptation. 
We here provide an overview of adaptations of the core-lipids of bacterial and archaeal 
cells in response to changes in their physicochemical conditions. Additionally, we present a 
comparative analysis of the reported growth ranges of archaeal and bacterial extremophiles 
to reveal the boundaries of their growth. We further discuss these boundaries in relation 
to the encountered lipid compositions and their adaptation in the archaea and bacteria. 
Adaptation of cell physiology to physicochemical conditions occurs at two levels, long-
term (genome evolution, defines the range within which a cell can survive) and short-
term (reversible regulation of gene expression and enzyme activity to achieve optimal 
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functionality). A membrane adaptation can thus refer to the generally encountered lipid 
composition that enables a species to thrive at a particular challenging habitat within its 
optimum. This kind of adaptation is regarded as a native phenotype that contributes to the 
robustness against a particular challenge/parameter and is therefore termed ‘physiological 
membrane adaptation’. Alternatively, an adaptation can also involve 
bacteria
bacteria
archaea
archaea
archaea
archaea
Figure 1. Common bacterial and archaeal lipid variations and the lipid divide. The bacterial ‘phosphatidic acid’ is 
represented by panel A left. On the right panel the archaeal ‘archeatidic acid’ or DGGGP core lipid is depicted. The 
lipid divide is presented in colours. Grey: the hydrocarbon chains represent fatty acids in bacteria and isoprenoid 
chains in archaea. Red: Ester-bonds link the hydrocarbon chains to the glycerol backbone in bacteria. In archaea, 
hydrocarbon chains are attached to the glycerol backbone by ether-bonds. Yellow: The backbone moiety in 
phosphatidic acid is represented by glycerol-3-phosphate. In archaetidic acid the backbone moiety is represented by 
the enantiomeric glycerol-1-phosphate. On panel B left, iso-branched chain fatty acid (top) and monounsaturated 
anteiso-branched chain fatty acid (bottom) variations are shown. Panel B right shows macrocyclic archaeol. Archaeal 
bipolar glycerol dialkyl glycerol tetraether (GDGT-0) is depicted in panel C and spans the membrane to form lipid 
monolayers. Panel D shows GDGT-1, the bipolar lipid containing 1 cyclopentane ring in the phytanyl chain. 
the changes in the lipid composition when conditions of the natural habitat change. This 
kind of adaptation is regarded as a stress response to the physicochemical change beyond 
the organism’s optimum that aids in the survival of the cell. This change will be termed here 
as ‘membrane stress adaptation’ and generally resembles the permanent physiological 
membrane adaptations to some extent.
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Low temperature adaptation
The temperatures of environments from which microbes are isolated roughly span from 
the freezing point of water and below for psychrophiles to the boiling point of water, 
for extreme hyperthermophiles. The challenges that microbes face below or above their 
optimal temperature is to retain optimal functionality of their macromolecules (nucleic 
acids, proteins, lipids), aiming for a balance between stability (robustness) and flexibility 
(activity, transition states). As to membranes, the fluidity is dependent on the membrane’s 
phase-transition temperature (Tm or transition midpoint) that expresses the temperature 
at which a membrane shifts from the preferred liquid crystalline phase into the rigid gel 
phase when the temperature drops. More specifically, at the midpoint temperature, 50% 
of hydrocarbon chains melt and a fluid and gel phase coincide. At temperatures below Tm, 
lipids are ‘frozen’ by alignment of the hydrocarbon chains perpendicular to the plain of the 
bilayer [35]. This is a result of the close ordering and side by side packing of the immobilized 
hydrocarbon chains and gives rise to highly impermeable membranes. Not only is the barrier 
function affected, but many membrane proteins only function in the liquid crystalline phase 
[36]. Above Tm, the phospholipid hydrocarbon chains are motile with a gradual increase of 
motility towards the core of the bilayer. The preferred liquid crystalline phase therefore 
provides a functional matrix for the many biochemical processes while being permeable to 
neutral molecules like H
2
O, CO
2
 and O
2, 
but impermeable to ions and solutes [37, 38].
To maintain sufficient membrane fluidity below their optimal growth temperatures, 
bacteria adopt a large variety of modifications to lower the Tm (reviewed in [39-42]). The 
molecular mechanisms are directed at increasing the fluidity by forming a more disordered 
gel phase or by prevention of the gel phase. Distinct targets of bacterial cold adaptations 
(stress and physiological) have been identified: (i) unsaturated fatty acids (UFAs), (ii) short 
chain fatty acids (SCFAs), (iii) branched chain fatty acids (BCFAs), (iv) carotenoids, and (v) 
glycolipids and uncommon polar lipids. The most prevalent cold-stress modification is the 
incorporation of mono-unsaturated fatty acids (MUFAs) [40, 42]. Bacteria actively introduce 
cis- or trans-double bonds (Fig. 2) by desaturases or synthesize UFAs de novo [43]. 
The main advantage of desaturases is the rapid response they elicit. The cis-unsaturated 
fatty acids, however, increase fluidity more efficiently than trans-unsaturated fatty acids. 
This is due to the immobile 30o kink in the acyl chain that increases the cross-sectional area 
of the lipid (Fig. 2) [45]. The incorporation of cis-unsaturations is a well described mechanism 
of cold-stress in the mesophilic Escherichia coli [19]. Correspondingly, the opposite 
conversion of cis- to trans-unsaturation fatty acids is correlated with adaptation to higher 
temperatures in Pseudomonas syringae [46]. The presence of poly-unsaturated fatty acids 
(PUFAs) in response to low temperatures is uncommon in mesophilic bacteria and far less 
effective in fluidization compared to mono-unsaturations. Nonetheless, omega-3 (ω3; EPA 
and DHA) and omega-6 (ω6; AA) PUFAs are abundantly detected in marine psychrophiles 
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-hydroxy 
ω-cyclohexyl 
cyclopropane 
iso-branched 
chain  
anteiso-
branched chain  
straight chain 
saturated  
trans-
unsaturated  
cis-unsaturated  
Figure 2. Variations in fatty acid chain conformation The following common fatty acid modifications are depicted 
from top to bottom: β-hydroxy fatty acid, ω-cyclohexyl fatty acid, cyclopropane fatty acid, iso-branched chain 
fatty acid, anteiso-branched chain fatty acid, saturated straight chain fatty acid, trans unsaturated fatty acid, cis 
unsaturated fatty acid.  (adapted from [40, 44])
and cyanobacteria as an adaptation to low temperatures [39, 42, 47]. Fluidization can 
also be achieved by incorporation of SCFAs (<12 carbons), but can only be implemented 
in growing cells and are not employed as an abrupt stress adaptation [44]. It is therefore 
commonly accepted that SCFA formation is not a universal way of fluidity modification 
during cold stress. Additional membrane adaptation strategies to sub-optimal temperatures 
have been observed in gram-positive mesophiles (Bacillus subtilis, Bacillus T1) but also the 
gram-negative thermophile Thermus thermophilus, in that they exchange iso- for anteiso-
BCFA (Fig. 1B, left and Fig. 2)[40, 48]. This is because anteiso-positioned methyl groups 
cause greater fluidity of the membrane due to a greater disturbance of the packing order 
of the hydrocarbon chains. As with incorporation of SCFAs, BCFAs are synthesized de novo, 
and do not allow a swift response to sudden temperature drops. In the psychrotolerant 
Sphingobacterium antarcticus (Topt=25
o) a combination of cold-specific modifications was 
detected [49, 50]. When cultivated at 5oC, the amount of UFAs is increased as well as 
the amount of BCFAs. In addition, polar and non-polar carotenoids (C40) were found to 
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be incorporated into the membrane like also shown for the psychrotolerant Micrococcus 
roseus (Topt=20
oC)[51]. These pigments are believed to insert their hydrophilic groups 
mainly at opposite sides of the polar regions of the bilayer and as such adopt a membrane 
spanning orientation [52]. Ironically, polar carotenoids like zeaxanthins are believed to 
decrease membrane fluidity in the liquid crystalline phase, but increase fluidity in the gel 
phase. Polar carotenoids are therefore assumed to balance the fluidizing effect of the fatty 
acid modifications while simultaneously enhancing the barrier function to ions and oxygen 
[50, 52, 53]. 
With respect to long-term physiological membrane adaptations to cold, many studies 
reporting on the membrane lipid composition of psychrophilic bacteria (Topt < 15
oC) have 
been performed (Table 1). Membrane characterization of Clostridium psychrophilum 
(Topt=4
oC) [54, 55], Colwellia psychrerythraea (Topt=8.5
oC) [56, 57], and Psychromonas 
ingrahamii (Topt=5
oC) [58, 59] revealed comparable adaptations to short-term cold stress 
responses. These adaptations also involve high levels of SCFAs, UFAs, polar carotenoids 
and glycolipids. Interestingly, although iso-BCFAs are detected in psychrophilic membranes, 
branching does not play a prominent role. Comparative analysis of BCFA percentages in 
psychrophiles shows a negative relationship with their growth temperature optima (Fig. 
3 and Table S1A). In Psychromonas ingrahamii, BCFAs levels of only 4.5% of the total fatty 
acid content are detected and in Colwellia psychrerythraea or Desulfotalea psychrophila 
BCFAs are present at trace amounts or completely absent. This suggests that BCFAs 
confer no benefit and may even be disadvantageous at low temperatures (Topt≤15
oC). 
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Figure 3. Bacterial temperature optima 
versus percentage BCFAs Documented 
temperature optima of 48 bacteria plotted 
against the percentage of BCFAs of the 
respective bacterium. The trend shows that at 
low growth temperatures, BCFA percentages 
are generally low, while at moderate and 
high growth temperatures, percentages are 
variable.
This trend is not only restricted to psychrophiles but also observed as stress response in 
psychrotolerant species like Planococcus halocryophilus [60]. When the psychrophilic 
Clostridium psychrophilum is cultivated below 0oC, a combination of cold-specific 
modifications is detected like in Sphingobacterium antarcticus. These bacteria use a high 
degree of unsaturated, cyclopropane containing fatty acids and SCFAs. Additionally, polar lipid 
changes are represented by a high degree of glycolipids, sn1-ether fatty acid plasmalogens 
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and cardiolipins (CLs). These comparisons indicate that long-term physiological adaptations 
comprise highly similar mechanisms compared to the short-term stress adaptations, except 
for the contribution of BCFAs. 
Membrane adaptation to cold has not been studied as extensively in archaea as in bacteria. 
Cold-adaption in archaea was long time overlooked probably due to the late recognition 
of their abundance in oceans and a main interest for hyperthermophilic archaea instead. 
Nonetheless, it appears that bacterial psychrophiles outnumber archaea in diversity and 
dominate subfreezing ecosystems (Fig. 4 and Fig. S1B)[61]. According to the standard 
terminology of psychrophilicity, (Topt<15
oC, i.e. growth optimum at or below 15oC), there are 
at present only 2 confirmed species of archaeal psychrophiles (Cenarchaeum symbiosum 
Topt=10oC [62] and Methanogenium frigidum Topt=15oC [63]). Here we will therefore apply 
an adjusted terminology for archaeal psychrophilicity (Tmin<15
oC, i.e. capable of growth 
below 15oC). Methanosarcinaceae and Methanomicrobiales are thus far the most studied 
archaeal psychrophiles, but in-depth analyses of their membrane composition are scarce. 
The few reported lipid adaptation studies, demonstrate a couple of mechanisms to increase 
membrane fluidity with only one mechanism analogous to bacteria. The documented stress 
and physiological membrane adaptations to cold are grouped as follows: (i) unsaturated 
diethers, (ii) isoprenoid hydroxylation, (iii) tetraether:diether ratio, and (iv) number of 
pentacycli. In Methanococcoides burtonii (Topt=23oC) [64] and Halorubrum lacusprofundi 
(Topt=33
oC) [65], membranes are found that completely lack GDGTs and have an increased 
level of unsaturated diether lipids. The physiological adaptation of unsaturation is probably a 
passive event in which the fully unsaturated precursor DGGGP is selectively or incompletely 
saturated by reductases, unlike the active introduction of double bonds by desaturases 
typical for bacteria. Unsaturated archaeol, however, was also found in the hyperthermophile 
Methanopyrus kandleri [66], currently the record-holder of highest growth temperature. This 
discrepancy seriously questions both the fluidizing effect and the absolute requirement of 
unsaturated diethers as psychrophilic adaptation mechanism in archaea. In addition to high 
levels of unsaturated archaeol, a significant amount of hydroxyarchaeol was also observed 
in Methanococcoides burtonii [64]. This modification involves the hydroxylation at the C-3 
position of the sn-1 isoprenoid chain. The authors suggest that this modification results in 
an extension of the polarity of the head group, thereby shortening the core of the lipid. It 
is however not certain whether this type of adaptation is really cold-specific. Although 
archaea are also known to intercalate non-polar poly-isoprenoids like lycopene and squalene 
between their membrane lipids, it is not demonstrated to result in fluidity buffering like polar 
carotenoids do in bacterial membranes. In the extreme halophile Halobacterium salinarum, 
squalene is detected at high quantities and shown to play a major role in packing and lateral 
organization of the polar lipids [67]. A role of squalene in fluidity adaptation, comparable 
to carotenoids in bacteria, is therefore also expected in psychrophilic archaea. Squalene is 
probably implemented to rigidify and reduce permeability to protons and solutes. 
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Archaeal cold stress adaptation studies are mostly done on thermophiles grown below 
their optima. From these archaeal below-optimum adaptation studies a recurring theme 
is an increase in diether content and decrease of membrane spanning GDGTs (Fig. 1C). In 
Thermococcus kodakarensis (Topt=85
oC), a temperature drop from 85 to 60oC causes archaeol 
(DE) to increase from 17.7% to 49.1% at the expense of GDGTs (82.3 to 50.9% ) [68]. 
Correspondingly, for Archaeoglobus fulgidus (Topt=78oC) the diether content shifts from 60% 
to 70% when grown at a relatively lower temperature of 70oC [69]. One of the most recently 
described below-optimum-stress adaptation in archaea concerns a decrease in pentacycle 
number. Archaeal pentacyclization is a modification often encountered in hyperthermophiles. 
This feature involves the incorporation of cyclopentane rings along the biphytanyl chains up 
to 4 rings per chain (Fig. 1D). These rings are believed to stabilize the chain packaging and 
to decrease the permeability of the membrane. In Thermoplasma acidophilum (Topt=59oC), 
lowering the growth temperature to 40oC results in a decrease in the average number of 
pentacycles per lipid. Here a change in cyclization degree from 2.1 to 1.6 cycles per lipid was 
observed [70]. A decrease in tetraether and pentacycle number, however, should not be 
regarded as universal cold-shock response. This is because membranes that are exclusively 
composed of tetraethers with high numbers of pentacycles per lipid have also been reported 
to be common in mesophilic archaea [71]. Drawing general conclusions from these changes 
are thus hampered by the fact that most of these studies are based on hyperthermophiles. 
Moreover, the observed temperature effects should be corrected for growth phase by 
normalizing to Optical Density, which has not always been done.
Due to the lack of reported archaea growing below -2oC, it is tempting to suggest that 
bacteria are better equipped to grow in extremely cold habitats. This hypothesis is 
supported by the difference in lowest reported temperature optimum between archaea 
and bacteria (Fig. S1B). The lowest confirmed growth optimum for archaea lies at 15oC 
for Methanogenium frigidum [72]. This is notably higher than the optimum of 5oC for the 
bacterium Psychromonas ingrahamii and whose lowest demonstrated growth temperature 
lies at a startling -12oC [58]. In case there is a growth temperature boundary for archaea 
around the freezing point of water, a plausible explanation for this threshold may lay in 
the methyl branched hydrocarbon chains. In the comparative analysis of BCFA percentages 
we showed that psychrophilic bacteria have less methyl branched lipids compared to 
mesophiles and thermophiles suggesting a disadvantage during cold adaptation. The 
methyl branched phytanyls on the other hand, are an imperative feature of archaeol. The 
phytanyl constituent of archaeal membranes may therefore restrict efficient adaptation 
mechanisms required to maintain fluidity at subfreezing temperatures. This apparent 
difference observed in growth temperature minima between archaea and bacteria also 
leads to a paradox, because the Tm of some archaeal membranes is established at -15
o
 
/-20oC [30, 73]. This average Tm thus suggests that archaeal membranes can maintain a 
liquid crystalline phase below 0oC without the requirement of extensive fluidity enhancing 
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modifications. Apparently, the isolated psychrophilic archaea and their established growth 
minima do not support this which may be explained by too low permeability of archaeal 
membranes instead.
-20 0 20 40 60 80 100 120 140
Growth Temperature  oC
Archaea 
Bacteria 
Figure 4. Growth temperature ranges of 
currently known archaea and bacteria The 
table depicts the minimum and maximum 
growth temperatures of well characterized 
psychrophilic and hyperthermophilic archaea 
and bacteria. Archaea survive between -2oC 
and 122oC, whereas bacteria survive between 
-12oC and 100oC.
High temperature adaptation
At higher temperatures, microbes endure increased fluidity and permeability of the membrane 
up to a point that lipids are too disordered to maintain a liquid crystalline phase. When the 
temperature rises beyond the optimum of the liquid-crystalline phase, lipids adopt a fluid 
phase and ultimately also a non-lamellar phase like the cubic and hexagonal structure [74]. It is 
therefore not surprising to find adaptation strategies which are opposite to cold adaptations, 
like those that induce stiffening and promote ordering of the hydrocarbon chains. Mesophilic 
and thermophilic bacteria mainly adjust fluidity by increasing the amount of (i) branched chain 
iso-fatty acids [18, 75, 76], (ii) saturated fatty acids [48], (iii). long-chain fatty acids and (iv) polar 
carotenoid content [77, 78]. Counterintuitively, the membranes of thermophilic bacteria are 
not devoid of cis-monounsaturated and anteiso-BCFAs [76] which are typically implemented 
as cold stress adaptation. What appears more important is the ratio between these fatty 
acids. In the highest temperature window of bacterial hyperthermophiles, some bacteria 
amend high amounts of BCFAs, which occasionally approach 100% of the fatty acids (Fig. 
3). These BCFAs are for the greatest part composed of iso-BCFAs. Interestingly, thermophilic 
bacteria that are able to grow above 70oC, implement lipid species that more or less remind 
of typical archaeal lipids (tetraethers, diether and tetraesters). A key question that comes up 
here is whether these lipids are typical physiological adaptations to heat, or whether they are 
remnants of these bacteria’s phylogenetically deeply rooted position. In Thermotogales species 
e.g. (T
max
=90oC) diabolic-acid derived membrane spanning tetraether-lipids are detected [4]. 
Diether fatty acid lipids are found in Thermodesulfotobacterium commune T
max
=85oC [79] 
and Aquifex pyrophilus T
max
=95oC [5, 80]. Lastly, long chain dicarboxylic fatty acid dimethyl-
esters or tetraester-lipids are found in Thermoanaerobacter ethanolicus Tmax=78
oC [81, 82], 
Thermoanaerobacter thermosulfurigenes T
max
=75oC [83], Thermosipho africanus T
max
=77oC 
[84], Fervidobacterium pennivorans T
max
=80oC [4] and more. Analogous to the archaeal 
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tetraether lipids, these bacterial tetraether and tetraester lipids are believed to result from 
a tail-to-tail condensation between the regular iso-branched chain fatty acids that extend 
from opposite sides of the membrane. Contrary to the earlier dogma, these species show that 
membrane spanning hydrocarbon chains are not an absolute requirement for survival beyond 
80oC. This became especially apparent by analysis of Aquifex pyrophilus (T
max
=95oC) that does 
not contain membrane spanning lipids but does have ether bonds. It must be emphasized 
here that in this species a minority of ester-lipids was isolated, which also shows the ability 
of ester lipids to tolerate these temperatures in vivo. Nonetheless, our analysis points at a 
temperature-dependent boundary at ~80oC for bacterial membranes composed exclusively 
of ester-lipids. This is in line with the postulation of Robert Huber and Karl Stetter that 
ether bonds are essential for hyperthermophilic growth [5]. The highest reported bacterial 
growth optimum so far is demonstrated for Geothermobacterium ferrireducens (T
max
=100oC)
[85] as opposed to the archaeal record holder Methanopyrus kandleri (T
max
=122oC) [86] 
(Fig. S2). For thermophilic archaea, membrane spanning tetraether lipids are the most 
abundant and frequently the only core lipid. Besides this, not much variability is observed in 
hyperthermophilic membranes. Tetraether lipids form monolayers that are highly stable due 
to a restricted motility of the hydrocarbon chains. Raising the growth temperature, therefore, 
elicits an increased tetraether/diether ratio like shown for Thermococci [68, 87]. Presence of 
tetraethers thus appears to be highly supportive for hyperthermophilic growth, a rule that is 
also followed by extreme hyperthermophilic bacteria which sometimes also use tetraether 
lipids. A tetraether-containing membrane, however, is not a prerequisite for heat tolerance, 
as Methanopyrus kandleri, Thermococcus barophilus, Thermococcus celer and Aeropyrum 
pernix all have no or only trace amounts of tetraethers but grow optimally between 85-105oC 
[88-90]. The already high stability of tetraether membranes can be further increased by the 
incorporation of pentacycli that cause an up-shift of the Tm. In line with this, an increase in the 
number of pentacycli per lipid is frequently observed, like in Thermoplasma acidophilum and 
Sulfolobus solfataricus [70, 91]. Finally, heat adapted membranes may involve macrocyclic 
archaeols. In these archaeols the isoprenoid chains are cross-linked at their tail-ends, and 
like tetraethers dramatically restricted in their motion, causing a reduced proton and solute 
permeability (Fig. 1B, right) [92]. 
Although the various reported lipid modifications suggest certain overall trends in 
membrane adaptations to high temperature, several exceptions to these rules have been 
reported as well. By far the most invalidating finding was the observed lack of GDGTs in the 
hyperthermophile Methanopyrus kandleri (T
max
=122oC). Conflicting data were also observed 
for glycolipids, that were found at high levels, but also low levels under high temperature 
conditions [88]. The implementation of ether-bonds seems to form a high correlation with 
thermal adaptation in bacteria that generally do not use ether-bonds. Despite the exceptions, 
the boundary of survival for bacteria appears to be around 100oC (Fig. S2). Altogether, these 
exceptions to the general trends indicate that bacterial and archaeal membrane adaptations 
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to temperature are complex and make use of different strategies (Table 1). However, the 
question then remains what differentiates the bacteria from the archaea with respect to 
adaptations to low and high temperatures. Bacteria maintain a proper level of permeability 
and acceptable fluidity at temperatures only just above their phase transition temperatures. 
Permeability and fluidity of archaeal membranes on the other hand generally stay optimal 
throughout the entire biological temperature span between 0 and 100oC. Oftentimes, it is 
therefore hypothesized that the archaeal biphytanyl hydrocarbon bonds linked to glycerol by 
ether bonds confer higher thermal stability, increased rigidity and reduced permeability to 
the archaeal membranes [30, 93]. This may explain why archaeal membranes do not require 
extensive thermal adaptation mechanisms like bacteria do. Despite the mentioned exceptions, 
comparison of the lipid compositions show that a lower number of ether bonds and level 
of branching highly determines the lower growth temperature boundary of thermophilic 
bacteria compared to archaea.
High pressure adaptation
In deep-sea marine environments, microorganisms are exposed to high hydrostatic 
pressure. These pressures also affect the membrane fluidity, and membranes are even 
labelled as the most pressure-sensitive biological structures [94]. At increasing pressures, 
lipids become compressed and membranes consequently loose fluidity, permeability and 
enter gel phase similar to cold conditions [95]. Deep-sea piezophiles/barophiles are found to 
grow and even require pressures up to maximally 120 MPa [96, 97] (Fig. S3). For piezophilic 
bacteria and archaea, no obvious difference is observed between their survival boundaries, 
although this is only based on studies of the bacterium Colwellia sp. MT-41(pressureopt=103 
MPa)[98] and of the archaeon Pyrococcus yayanosii CH1 (pressure
max
=120 MPa) [99]. The 
main difference of piezophilic from psychrophilic adaptation in bacteria is the prominent 
presence of PUFAs [100] in addition to MUFAs. In Alteromonas sp. the amount of long chain 
PUFA 20:5 has been shown to increase with pressure [101]. In contrast, it was shown in 
Photobacterium profundum that the MUFAs and not the PUFAs are correlated with survival 
at high pressure in bacteria [102]. The accumulation of the polar lipids phosphatidylglycerol 
and phosphatidylcholine instead of phosphatidylethanolamine is also a frequently 
observed adaptation [103-105]. It is generally accepted that larger head groups lead to 
greater disruption of membrane packing and hence to enhance membrane fluidity [104, 
105]. Studies in archaea on the homeoviscous adaptation to pressure are scarce and likely 
hampered by the fact that the identified piezophilic archaea were frequently also (hyper)
thermophiles. Currently, only two studies elaborately studied the effect of increased 
pressure on the membrane composition of archaea. In Methanococcus jannaschii, an 
increase in the macrocyclic archaeol and concomitant decrease in archaeol and GDGTs 
has been observed [106]. The difficulty of studying the sole effect of pressure on archaeal 
membranes is exemplified in a study on the piezophilic hyperthermophilic Thermococcus 
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barophilus. Here a similar decrease of GDGTs was found, but an increase in archaeol which 
completely resembles cold adaptation. Interestingly, these cocci show an upregulated 
production of lycopene derivatives [87], but it is left unclear whether this is a temperature 
or pressure induced effect. The common feature however with bacteria is that increased 
pressure leads to adaptations that result in more fluid membranes. 
Low pH adaptation
Like the discovery of microorganisms thriving at extreme temperatures, also bacteria and 
archaea have been found in ecosystems with extreme pH values. Bacteria and archaea 
have evolved various ways to cope with extreme acidity (<pH 2) or alkalinity (>pH 10). The 
challenge both acidophiles and alkaliphiles are facing is to retain a near neutral intracellular 
pH. The ∆pH (pHin – pHout) across the membrane is a major component of the proton motive 
force (PMF), and as such important for the energy supply of the cell. The cells actively 
pump out protons by means of a respiratory chain or photosystem. This outflux generates a 
proton motive force (PMF) that is used by ATPases to generate chemical energy in the form 
of ATP. Upon external down-shifts in pH, the PMF needs to be adjusted by a higher activity 
of the respiratory chain or other proton-pumping systems. Acidophiles evolved several 
mechanisms to maintain near neutral intracellular pH. They e.g. reverse their membrane 
potential (∆ψ) to deflect intrusion of protons. A higher expression of proton exporters and 
secondary transporters is therefore a common strategy. Often, enzymes and chemicals 
are produced that bind or buffer protons [107]. The most effective strategy however lies 
in reduction of proton permeability by the plasmamembrane. The neutrophilic bacterium 
Escherichia coli, remodels its membrane, based on only three strategies: (i) an increase in 
straight short-chain fatty acids content, (ii) a decrease in the amount of unsaturations and 
(iii) lowering the amount of cyclopropane-fatty acids [108] (Fig. 2). These modifications, 
however, do not follow a consistent pattern with other pH stress studies on neutrophiles. 
A decrease in short-chain fatty acids was observed in Streptococcus mutans instead [109]. 
In this species, another opposite effect was also observed for the number of unsaturations, 
which showed an increase to acid stress. Another quite contrasting finding was the fact that 
a cyclopropane fatty acid knockout in Salmonella enterica typhimurium showed a sensitivity 
to low pH, suggesting a positive relation with these fatty acids instead [110]. As a fourth 
adaptation to low pH values an overall increase of anteiso- and concomitant decrease in 
iso-BCFAs was observed in Listeria monocytogenes [111]. 
Obligate acidophiles synthesize a membrane that is highly impermeable to protons 
[112]. More consistent membrane adaptations are described in extreme acidophilic 
bacteria of which Bacillus acidocaldarius [113], Acidiphilium sp. [114, 115], Alicyclobacillus 
acidiphilus [116] and Acidithiobacillus ferrooxidans [117] are most thoroughly studied. 
These membranes are composed of high levels of iso- and anteiso-BCFAs, both saturated 
and mono-unsaturated fatty acids and uncommon β-hydroxy-, ω-cyclohexyl (Fig. 2) and 
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cyclopropane fatty acids. These permanent modifications were detected in the membranes 
of acidophilic bacteria which tolerate growth at ≤ pH 2.5. In peat bogs (pH 3-5) GDGT-like 
lipids with branched dicarboxylic fatty acids (iso-diabolic acid) bound by ether-bonds to 
G-3-P have been detected [118]. These lipids, that highly resemble the archaeal membrane 
spanning lipids, are clearly of bacterial origin and seem to correlate with the low pH of 
the habitat from which they were isolated. A widespread presence of the iso-diabolic 
acid lipids was also detected in various species of the phylum Acidobacteria, but do not 
grow below pH 3 [119]. Here we find another example for the usage of archaeal-like lipids 
implemented by bacteria, possibly to deal with the environmental stress. Despite their 
numerous adaptation strategies, bacteria have not been demonstrated to grow at pH<1 as 
opposed to archaea (Fig. 5 and Fig. S4). As with temperature adaptations, the three typical 
homeoviscous adaptation strategies of archaea are also observed in acidic environments. 
0 1 2 3 4 5 6 7 8 9 10 11 12
Growth pH
Archaea 
Bacteria 
Figure 5. Growth pH range of currently known 
archaea and bacteria The table depicts the 
minimum and maximum growth pH of well 
characterized acidophilic and alkaliphilic 
archaea and bacteria. Archaea survive 
between pH 0 and pH 11, whereas bacteria 
survive between pH 1 and pH 11.4.
A key characteristic of acidophilic archaea is the presence of a membrane monolayer 
typically composed of nearly 100% GDGTs [71, 120]. Biophysical studies on liposomes 
composed of GDGTs showed that monolayer membranes are extremely impermeable to 
protons [121]. A common acid stress response observed in archaea is, not surprisingly, also 
an increase of GDGT content. Extreme acidophilic archaea, able to thrive at pH<1, are also 
shown to incorporate multiple cyclopentane rings, to enhance lipid packing, compressibility 
and membrane rigidity even more [70, 91, 120, 122]. Whether the number of cyclopentane 
rings is really correlated with acidophilicity, however, is still a matter of debate. Nonetheless 
is it highly supported by a molecular modelling study that showed a tighter packed 
structure compared to GDGTs without rings [123]. The relation of cyclopentane rings with 
thermophilicity is shown multiple times, but in the case of acidophiles hampered by the fact 
that they are often also thermophiles. The number of cyclopentane rings e.g. was shown to 
decrease in Thermoplasma acidophilum when grown at lower pH values [124]. In contrast, 
Acidilobus sulfurireducens exhibits an increase in the cyclopentane rings at low pH values 
[125]. Apparently, the pH stress response shows a species- or temperature-dependent 
variation in terms of the number of cyclopentane rings. Because bacteria are also known to 
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generate membrane spanning lipids, the lower pH boundary of archaea can be attributed 
to cyclopentane rings and the abundant methyl-branches. Although it is evident that the 
membrane-spanning lipids exhibit lower permeability compared to standard bacterial 
lipids, the membrane spanning lipids in bacteria do not enable them to survive equally 
low pH levels as archaea. In a molecular dynamics study, Chugunov et al. simulated the 
effect of methyl-groups and cyclopentane rings on membrane permeability and fluidity. 
A prominent finding was that the presence of methyl groups confers greater fluidization 
and higher permeability to the membrane than membrane spanning lipids without methyl 
groups. It is very likely that the inability of bacteria to include multiple methyl chains in their 
hydrocarbon chains explains why membrane spanning lipids are not detected in the most 
extreme acidophilic bacteria (pHmin<3). 
High pH adaptation
On the other side of the pH scale, we encounter the obligate alkaliphiles. In sharp contrast 
to acidophiles, alkaliphilic bacteria survive comparable and even slightly higher pH values 
than alkaliphilic archaea, with ~pH=11.4 being the upper limit for bacteria (Fig. 5 and Fig. 
S5). This suggests that the adaptation mechanisms of archaea and bacteria are nearly 
equivalent in efficiency. Although studies on the membrane composition in alkaliphilic 
bacteria are scarce, a few general trends can be observed. The first striking observation is 
the high variability of lipids present in alkaliphilic bacteria. Often, specific species like bis-
mono-acylglycero-phosphate (BMP) lipids and CLs are detected in high quantities [126]. 
The alkaliphilic membranes are also copiously enriched in BCFAs (both iso as anteiso), 
and oftentimes MUFAs are very abundant [127-130]. The actual upper pH limit for life 
was described for a bacterium, Bacillus pseudofirmus (pH
max
=11.4) [131]. In this species, 
high levels of CL, BMP, squalenes, and carotenoids were detected. Furthermore, the fatty 
acids were mainly composed of MUFAs and 92% BCFAs [132]. Altogether, it is concluded 
that enrichment of BCFAs is a recurring theme in extremophilic bacteria in general, except 
for the psychrophiles. Another alkaliphilic characteristic is the presence of squalenes, 
tetrahydrosqualenes or other polyisoprenes in the membrane. Hauß et al. showed that these 
neutral lipids specifically position in the center of the lipid bilayer, parallel to the plane of the 
membrane, thereby reducing lipid motility and thus proton leakiness [133]. Furthermore, 
water permeability is reduced and membrane rigidity increased which is an adaptation 
mechanism also suitable for low pH or high temperature. Squalene incorporation is also one 
of few adaptation mechanisms that are shared by both archaea and bacteria. In alkaliphilic 
archaea one can recognize a very distinct pattern from other archaea in which tetraethers 
and its derivatives are completely absent. Alkaliphilic archaeal membranes are dominated 
by diether lipids composed of C20:C20 or C20:C25 core lipids [71] and a complete absence 
of GDGTs. The same holds true for glycolipids which are found only in trace amounts or 
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which are completely absent. The diether C20:25 lipids unmistakeably result in more fluid 
and more permeable membranes, which is also reflected in the mesophilic nature of all 
identified alkaliphilic archaea.
Table 1. Physiological membrane adaptations by core lipid modifications typically found in bacterial and archaeal 
extremophiles
Temperature pH Pressure
BACTERIA Tmin<15oC Tmax>75oC pHmin<3 pHmax>10 > 70 MPa
Level of chain length ref ref ref ref ref
   shorter chain   ≤C14 + [54, 57] + [115, 117] +
   longer chain  ≥C18
Level of unsaturation
   PUFA + [39, 42, 47] + [134]
   MUFA-cis + [54, 57, 135] + [80] + [117] +
   MUFA-trans + [57]
Level of branching 
   BCFA-iso + [48, 76, 136] + [113] + [130, 137-139]
   BCFA-anteiso + [48] + [113, 116] + [139]
   diabolic acid + [4, 140] + [119]
   (β)-hydroxy FA + [57] + [114, 117]
Level of cyclization
   Ω- cyclohexyl + [113, 116]
   cyclopropyl + [54] + [80] + [114, 117]
Level of Tetraester 
and etherlipids
   tetraesters + [84, 141]
   mono- di-  tetraethers + [4, 5, 79, 80] + [118, 119]
Level of terpenes
     polar carotenoid + [50, 51] + [77, 78]
    non-polar terpenes + [139]
Other modifications 
    cardiolipins + [54] + [139]
    glycolipids + [54] + [77]
    BMP + [139]
Archaeal and bacterial membrane adaptations 
2
33
Temperature pH Pressure
ARCHAEA Tmin<15oC Tmax> 75oC pHmin <3 pHmax>10 >70 MPa
Level of chain length ref ref ref ref ref
   shorter chain C20 + [64] + [88-90] + [142-148] + [106, 149-151]
    longer chain C25 + [152] + [142-148]
Level of saturation
    unsaturated diethers + [64, 65] + [66]
Level of branching
  hydroxyarchaeol + [64]
Level of cyclization
    pentacyclic TE + [70, 91] + [70, 91, 120, 122]
    macrocyclic + [153] + [106, 153]
Level of Tetraether lipids
    tetraethers - [64] + [68, 87] + [71, 120] - -[71] - [106]
Other modifications
    glycolipids + [66] + [91, 122] -
[143, 145, 
148, 154, 
155]
Abbreviations: PUFA: polyunsaturated fatty acids; MUFA-cis: cis-monounsaturated fatty acids; MUFA-trans: trans-
monounsaturated fatty acids; BCFA-iso: iso-branched chain fatty acids; BCFA-anteiso: anteiso-branched chain fatty 
acids; BMP: bis-mono-acylglycero-phosphate; TE: tetraethers
Concluding remarks on extremophile membrane adaptations
Various studies have shown that archaeal membranes have more robust properties 
compared to bacterial membranes [31, 93, 156, 157]. Nevertheless, both archaea and 
bacteria inhabit extreme environments as extensively as they do in mild environments. 
To provide insight into the occurrence of both domains in extreme environments we 
made an inventory of maximal and minimal growth temperatures of well characterized 
hyperthermophiles, psychrophiles and barophiles. This analysis demonstrates an equally 
broad temperature growth range of ~120 degrees for both archaea and bacteria. An 
important difference however lies in the domination at the temperature extremes. Bacteria 
were found to dominate lower temperature ecosystems, whereas archaea dominate the 
higher temperature ecosystems. A comparable pattern also appeared when we analysed 
the pH scale where archaea dominate the bacteria <pH 1, and bacteria show a slight benefit 
at high alkalinity >pH 11. Regardless of the basal core lipid composition, both domains 
extensively modify their membrane composition to overcome the inhospitable conditions. 
Here we discussed the efficiency of homeoviscous adaptations which may correlate with the 
different growth boundaries. At the observed boundaries it appears that bacterial core lipids 
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are better accommodated to modify the membrane fluidity whereas archaeal core lipids are 
more efficient in rigidifying modifications. When looking into the membrane composition 
of the most extreme representatives of the domains, a consistent pattern appears at low 
pH and high temperature. Archaea form tetraether monolayer membranes that constitute 
an adaptation mechanism of highly efficient rigidification and reduction of permeability. 
Interestingly, some of these typical archaeal features are also being implemented in 
bacterial hyperthermophiles and acidophiles. Examples are an increased level of ether-
bonds, membrane spanning lipids, and a high level of methyl-branched BCFAs. It appears 
that these features contribute to the fact that e.g. both Thermotogales and Aquificales 
can survive higher growth temperatures than other bacterial hyperthermophiles. Typical 
membrane spanning lipids are also found in bacteria that thrive in acidic ecosystems. 
However, these traits don’t seem to increase their survival boundary at low pH. Despite 
this, it is conceivable that the cyclopentane rings do show correlation with the lowest pH 
survival range as comparable cyclization’s are also found in bacterial lipids. In this case, it 
would support the hypothesized lower survival boundaries to high temperature and low pH 
from implementing standard bacterial lipids (fatty acid-diester-lipids). On the other hand, 
bacterial lipids do seem more beneficial for growth at low temperatures. It is observed that 
psychrophilic bacteria reduce their BCFA load as one of the main lipid modifications. This 
implies that at sub-freezing temperatures the effect of disturbed packing order near the 
interface of the bilayer caused by BCFAs, is no longer sufficient to maintain fluidity. Hence, 
facultative psychrophiles mainly implement unsaturations, which cause a greater cross-
sectional area of the lipids and less tight packing of the hydrocarbon chains than BCFAs. 
The isoprenoid hydrocarbon chains of archaeol which have an imperatively high number 
of methyl branches may thus be a disadvantageous characteristic at low temperatures. 
The methyl branches maintain a too dense packing which apparently cannot easily be 
compensated. In sharp contrast to bacteria, imitation of bacterial lipid features by archaea 
is thus far not observed in psychrophilic or alkaliphilic ecosystems. Despite this, both ester- 
and ether-bound fatty acid lipids are also detected in archaea, but there does not seem to 
be a correlation with either growth temperatures or pH from the analysed archaea thus 
far [6]. Altogether, the deductions presented here are in line with the hypothesis that 
cytoplasmic membrane compositions are one of the main determining factors behind 
survival boundaries at low pH and high temperature. 
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Supplemental information 
Figure S1A. Bacterial temperature optima versus branched chain fatty acid compositions
# BCFA % Topt (oC) Species BCFA ref Temp ref
1 0 15 Psychrobacter frigidicola [158] [158]
2 0 10 Desulfotalea psychrophila [135] [135]
3 1 10 Colwellia psychrerythraea [159] [159]
4 4,5 5 Psychromonas ingrahamii [160] [161]
5 11 30 Micrococcus roseus [162] [163]
6 17 25 Sphingobacterium antarcticus [164] [49]
7 19 37 Streptococcus faecalis [165] [166]
8 26 37 Clostridium Difficile [167] [168]
9 28 27 Pseudomonas rubescens [169] [170]
10 31 37 Flavobacterium thalpophilum [171] [172]
11 32 28 Streptosporangium album [173] [174]
12 32 35 Streptosporangium vulgare [173] [174]
13 33 55 Desulfotomaculum nigrificans [175] [176]
14 38 37 Streptococcus salivarius [165] [177]
15 40 65 Bacillus stearothermophilus [178] [178]
16 41 37 Streptococcus agalactiae [165] ATCC
17 45 37 Clostridium sordellii [167] Dsmz
18 49 37 Staphylococcus capitis [179] [180]
19 51 27 Actinoplanes philippinensis [173] ATCC
20 52 34 Desulfovibrio africanus [175] [181]
21 53 37 Desulfovibrio vulgaris [175] ATCC
22 55 37 Bacteroides vulgatus [173] Dsmz
23 55 37 Streptococcus pyogenes [165] Dsmz
24 57 37 Propionibacterium acnes [182] ATCC
25 59 62.5 Bacillus acidocaldarius [113] [183]
26 62 60 Thermus ruber [184] [184]
27 72 62 Thermomonospora curvata [173] [185, 186]
28 73 30 Bacillus pumilus [187] Dsmz
29 73 60 Clostridium thermocellum [188] [189]
30 75 30 Desulfovibrio desulfuricans [190] [190]
31 75 32 Staphylococcus simulans [179] [180]
32 75 34 Staphylococcus hominis [179] [180]
33 79 30 Bacillus cereus [191] ATCC
34 80 37 Bacillus anthracis [191] [192]
35 81 37 Staphylococcus aureus [179] Dsmz
36 81 32 Staphylococcus epidermidis [179] Dsmz
37 82 47 Arthrobacter radiotolerans [193] [194]
38 84 35 Staphylococcus haemolyticus [179] Bergey’s
39 84 70 Thermodesulfotobacterium commune [195] [195]
40 87 30 Micrococcus luteus [196] [197]
41 89 52.5 Bacillus coagulans [173] [198]
42 89 30 Bacillus megaterium [173] Bergey’s
43 91 71 Thermus aquaticus [199] [200]
44 92 25 Bacillus psychrophilus [201] [202]
45 95 33,5 Bacillus subtilis [187] Dsmz
46 98 70 Thermoanaerobacter thermohydrosulfuricus subsp. 
Carboxydovorans
[203] [203]
47 99 72 Thermus thermophilus [204] [205]
48 99 28 Micrococcus conglomeratus [196] Dsmz
Abbreviations: ATCC (American type culture collection) bacteriology collection, DSMZ; Deutsche Sammlung von 
Microorganismen und Zellkulturen, Bergey’s; Bergey’s manual of systematic bacteriology.
Chapter 2 Archaeal and bacterial membrane adaptations 
2
36
-20
-10
0
10
20
30
40
Te
m
pe
ra
tu
re
  (
o C
) 
Archaea temperature minima 
Tmin
Topt
Tmax
-20
-10
0
10
20
30
40
Te
m
pe
ra
tu
re
 (o
C)
 Bacteria temperature minima 
Tmin
Topt
Tmax
-20
-10
0
10
20
30
40
Te
m
pe
ra
tu
re
  (
o C
) 
Archaea temperature minima 
Tmin
Topt
Tmax
-20
-10
0
10
20
30
40
Te
m
pe
ra
tu
re
 (o
C)
 Bacteria temperature minima 
Tmin
Topt
Tmax
Figure S1B. Reported minimal, optimal and maximal growth temperatures of psychrophiles. Psychrophilic 
organisms are grouped according to the bacterial and archaeal domain.   
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Figure S2. Reported maximal, optimal and minimal growth temperatures of hyperthermophiles. 
Hyperthermophilic organisms are grouped according to the bacterial and archaeal domain. 
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Figure S3. Reported maximal, optimal and minimal pressure-values of piezophiles/barophiles. Barophilic 
organisms are grouped according to the bacterial and archaeal domain. 
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3Heterologous expression of isoprenoid pathways has resulted in successful industrial applications. However, widespread usage of isoprenoids is still hampered by sub-optimal productivity of currently used platform organisms. A bottleneck is the intracellular supply of the two isoprenoid precursors isopentenyl-diphosphate (IPP) and dimethylallyl-diphosphate (DMAPP). In E. coli, these building blocks are synthesized by the MEP-DOXP pathway. To accomplish elevated levels of IPP and DMAPP, we overexpressed different combinations of genes encoding the key enzymes of the pathway (IDI, IspDF and DXS), both from plasmids and after integration from the host chromosome. By systematically screening of the ori-macrodomain of the E.coli chromosome, we identified a convenient insertion site at the aceB/aceA locus that tolerates controlled induction and repression of the integrated operons. Unlike the plasmid-encoded variants, the integrated operon resulted in significantly enhanced production of lycopene, used as a reporter of the isoprenoid production. At optimal IPTG induction, our strains increased isoprenoid production upto 5.34-fold compared to the wild-type strain. Overall, we engineered an E.coli strain that can serve as a platform for the balanced expression of the isoprenoid building blocks and an isoprenoid biosynthesis pathway of interest. Abbreviations: DCW: dry cell weight; DMAPP: dimethylallyldiphosphate; DXP: 1-deoxy-D-xylulose-5-phosphate; EPOD: extensive protein occupancy domain; Fis: Factor for Inversion Stimulation; FPP: farnesyl diphosphate; GFP: 
green fluorescent protein; GPP: geranyl diphosphate; G3P: glyceraldehyde 
3-phosphate; H-NS: histone-like nucleoid structural protein; IHF: Integration 
host-factor; IPP, isopentenyl diphosphate; MEP, 2C-methyl-D-erythritol; PEP, 
phosphoenolpyruvate; UndP: undecaprenylphosphateAb
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Introduction
The demand for isoprenoids in industry has grown rapidly over the last years, with 
applications ranging from plastics and rubbers to therapeutics and solutes. Isoprenoid 
biosynthetic pathways from various organisms have been characterized and heterologously 
expressed in production strains for biotechnological applications. Oftentimes the resulting 
compounds are then chemically processed to a final product of interest. Successful examples 
are the production of the anti-malarial agent artimisinic acid in yeast [206], and the anti-
cancer agent taxol by introduction of the biosynthesis pathway of taxadiene in Escherichia 
coli [207]. Although several studies aimed to optimize production levels of interesting 
isoprenoids in different microbial production hosts [208-213], there is still room for 
improvement. Generally, isoprenoid biosynthesis can be divided into two partial metabolic 
pathways [214]. The upstream part concerns the synthesis of the precursor’s isopentenyl 
pyrophosphate (IPP) and dimethylallyl pyrophosphate (DMAPP), whereas the downstream 
part is a collection of variable pathways for the biosynthesis of the actual isoprenoid variant. 
The resulting compounds are then utilized in processes as diverse as respiration, protein 
prenylation, cell membrane maintenance, hormones or protein anchors [215].
Both archaea and bacteria have the capacity to produce isoprenoids, but they differ 
considerably with respect to the generation of the IPP/DMAPP building blocks. The first 
identified pathway is the classical ‘mevalonate’ or ‘HMG-CoA reductase’ pathway. This 
pathway is present in all higher eukaryotes and most archaea. In this route three acetyl-
CoA molecules are joined and converted to IPP and DMAPP, with mevalonate as a key 
intermediate. In bacteria, an alternative pathway (non-mevalonate or MEP-DOXP) has been 
identified as the dominant pathway [216]. The unexpected finding that 14C-labelled acetate 
was not directly incorporated into isoprenoids with concomitant scrambling of the label 
led to the identification of the alternative ‘MEP-DOXP’ route in bacteria. Instead of acetyl-
CoA, initiation appeared to depend on the condensation of pyruvate and glyceraldehyde-
3-phosphate. By now, the pathway is fully elucidated and all eight reactions are well 
characterized [217] (Fig. 1). 
In bacteria, the MEP-DOXP pathway is mainly used for production of farnesyl-diphosphate 
(C
15
 FPP) and the subsequent production of respiratory election carriers (ubiquinone, 
menaquinone) and sugar carrier-lipid undecaprenylphosphate (C
55
 UndP) for processing of 
the cell wall [218]. The essential UndP translocates O-antigen and peptidoglycan constituents 
from the cytoplasmic face into the periplasmic face of the inner membrane [219, 220]. 
Because of this usage, the basal IPP and DMAPP production level is relatively low. Instead, 
archaea use the mevalonate pathway also for the synthesis of the plasma membrane 
lipids, and the IPP and DMAPP supply is therefore considerably higher. Despite its lower 
production potential, E. coli still remains the production organism of first choice for industrial 
isoprenoid production. This is mainly due to the versatility of the available genetic toolbox. 
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To establish a platform E.coli strain for isoprenoid production, we embarked on the construction 
of a strain that complies with the following characteristics. (i) The strain overproduces the 
isoprenoid precursors IPP and DMAPP. Overexpression studies of various MEP-DOXP genes 
and the resulting synthesis of the building blocks IPP and DMAPP have previously been 
performed to determine the individual rate limits [209]. However, more information is required 
on the different combinations of MEP-DOXP steps, which may optimize the established 
overproductions even further. (ii) The overproduction needs to be tunable to adjust to the 
requirements of the downstream pathway of interest. To this end, a series of artificial plasmid-
borne operons with a variable combination of MEP-DOXP genes were positioned under control 
of an inducible lac-promoter. (iii) The overproduction of IPP and DMAPP needs to be stable 
without the requirement of an antibiotic resistance marker to retain the trait [206]. This is 
achieved by integration of the MEP-DOXP operon into the chromosome, which consequently 
also lowers a potential vector burden. Such a strain has previously been obtained, with a MEP-
DOXP operon integrated into the arabinose operon region [207]. The locus of integration 
however (see below, iv), has never been considered as a variable that influences transcription 
of the construct and consequently also the production levels of IPP and DMAPP. (iv) Besides 
promoters and transcription factors, transcription is also dependent on the spatial chromosomal 
location [221]. Moreover, it has been shown that these subdomains display regions with highly 
heterogeneous transcription rates [221, 226, 227]. Vora et al. further studied these regions and 
revealed that highly expressed regions correlate well with high protein occupancy referred to 
as “heEPODs” (highly expressed Extensive Protein Occupancy Domains) [228]. These heEPODs 
generally show a high enrichment of RNA polymerases and Fis (Factor for Inversion Stimulation) 
proteins. Additionally, it was shown that distinct transcriptionally silent regions also correlate 
well with high protein loading and were therefore termed “tsEPODs” (transcriptionally silent 
Extensive Protein Occupancy Domains). These tsEPODs are especially enriched with H-NS, IHF 
and Fis proteins instead, and therefore thought to anchor subdomains to the central region 
with the multiple structural proteins that are highly loaded on these positions. Hence, tsEPODs 
are assumed to hold the structural function in chromosome organization. Here, we studied a 
putative subdomain based on EPOD coordinates for the integration of a set of characterized 
operons. The yields of these integrated operons were then compared with the plasmid-borne 
operons.
Results
Construction and analysis of engineered MEP-DOXP operons
To increase carbon flux through the MEP-DOXP pathway of E.coli, a set of synthetic plasmid-
encoded operons were designed. For this purpose, we cloned 4 MEP-DOXP genes interspaced by 
a ribosome binding site (AGGAGAT). From the 8 catalytic steps (Fig. 1), the enzymes isopentenyl-
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diphosphate isomerase (IDI), 2C-methyl-D-erythritol 4-phosphate cytidylyltransferase (IspD), 
2C-methyl-D-erythritol-2,4-cyclodiphosphate synthase (IspF) and 1-Deoxy-D-Xylulose-5-
phosphate synthase (DXS) were targeted for overproduction as these four steps have been 
demonstrated to be limiting the flux of the pathway [209]. The pGFPuv plasmid was chosen as a 
cloning vector because it encompasses a strong lac-promoter, a high copy origin of replication 
and the gene encoding the Green Fluorescent Protein (gfp). Native MEP-DOXP genes were 
cloned at the 5’-end of gfp. This position includes gfp at the C-terminus of the operon which 
then serves as a phenotypic marker for expression of the synthetic operons. Operon assembly 
was initiated by cloning of idi (Fig. 2B). This enzyme is responsible for the final catalytic step of 
the MEP-DOXP pathway and has been found to play an important role in controlling isoprenoid 
flux [209]. The next cloning concerned the ispD and ispF genes (Fig. 2C). A complete operon 
‘idi-ispDF-dxs’ was made by cloning of the dxs gene (Fig. 2D)[208, 209]. In a recent study, in 
vitro inhibition on the IspF enzyme was described requiring both the metabolites farnesyl-
diphosphate (FPP), and 2C-methyl-D-erythritol 4-phosphate (MEP) [211]. This observation that 
suggests a regulatory role, prompted us to make two additional variations on the complete 
operon to study a potential inhibitory effect during upregulations of the pathway (Fig. 2E and 
F). First, a variant was made that lacks both intermediate steps catalyzed by IspD and IspF. By 
omitting both the ispD and ispF genes from the overexpression operon, a proportionally higher 
MEP accumulation is anticipated compared to the complete operon.
gfp 
gfp 
gfp 
ispD 
ispD 
ispF 
ispF dxs 
Plac 
gfp idi 
Plac 
Plac 
Plac 
A 
B 
C 
E 
ispD 
Plac 
D 
gfp dxs 
Plac 
F gfp dxs 
idi 
idi 
idi 
idi 
Figure 2. Artificial MEP-DOXP operons constructed in this study, A represents the unmodified pGFPuv vector. B 
represents the first operon with the insertion of idi. C represents the secondary modification to which the bicistronic 
genes ispD and ispF were introduced. D represents the complete operon in which the dxs gene was added. E and 
F represent constructs to test the effect of the addition of ispF and ispD specifically by the consecutive deletion of 
ispDF and introduction of ispD. Each operon is controlled by the inducible lac-promoter and ends with gfp. Dotted 
lines indicate the positions of the successive cloning steps.
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In case of feedback-inhibition of native IspF, this is expected to result in significantly lower 
up-regulated production of the building blocks IPP and DMAPP. This mechanism should then 
be confirmed by an additional operon variant that overexpresses ispD but not ispF. Here, 
ispD overexpression might result in a lower MEP pool, comparable to the complete operon. 
As a consequence, this operon should in potential alleviate the inhibition. Altogether, these 
operons allow an estimation of the relative and cumulative contribution of the targeted 
MEP-DOXP enzymes on the carbon flux.
The plasmids harboring the operon variants were transformed to E.coli JM109 cells and 
induced with IPTG. These cells were then analyzed in a series of preliminary assays to 
first test the operon design. Observed fluorescence upon ultraviolet light exposure of cell 
pellets first confirmed expression of the gene encoding GFPuv, hence indicating complete 
expression of all the operons (S1). Here we also noticed a difference in cell pellet volume 
which is most likely reflecting a variable metabolic burden by the operon variants. We 
subsequently performed an IPP-isomerase activity assay of two operons and the empty 
plasmid control, as this could give some insight in the expression of the different operons. 
We observed a 32-fold and 11-fold increase of IPP-isomerase activity upon induction of 
the idi and idi-ispDF operons respectively compared to the induced empty plasmid control 
that represents native expression of idi (Fig. S2). In the operon where ispDF was included, a 
notably lower increase in IDI activity was thus detected. This relative decrease is probably 
caused by lower idi expression and suggested a ribosome competition between the operon 
genes. Moreover, it is shown that induction of the operons results in expression of functional 
IDI regardless of the addition of multiple genes. To further study expression of all genes 
from the complete set of operons, protein profiles were analyzed on SDS-PAGE. The gels 
(Fig. 3 and Fig. S3) unambiguously confirmed expression of all four genes upon induction. 
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M           -           +          -           +            -           +           -           +         IPTG   
250 
150 
100 
75 
50 
37 
25 
20 
GFP 
IDI 
IspD 
IspF 
DXS 
Figure 3. SDS PAGE analysis of cell-free extracts of E.coli with different plasmid-borne operon constructs, after 
IPTG (0.5 mM) induction. A: pGFPuv control B: idi-operon, C: idi-ispDF-operon, D: idi-ispDF-dxs-operon. –sign: non 
induced, +sign: induced at 0.5 mM IPTG. GFP; 26.8 kDa, IDI; 20.5 kDa, IspD; 25.7 kDa, IspF; 16.9 kDa, DXS 67.6 kDa.
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Comparison of intensities, however, also suggests a differential gene expression between 
the operons. The intensity of the IDI protein for instance, gradually decreases as more 
genes are included in the operon. Here, the level of expression is in good agreement with 
the detected IPP-isomerase (IDI) activity. In the idi-ispDF operon, the ispD gene seems to 
result in the highest expression. And lastly, unequal gene expression is even more apparent 
from the idi-ispDF-dxs and idi-dxs operons (Fig. 3D and Fig. S3). Here the DXS protein 
forms the majority of the overexpressed products. Altogether this analysis suggests that 
the differential expression is determined by high translation of the bulkiest gene in the 
transcript. 
Construction and characterization of a lycopene reporter plasmid
To establish controllable isoprenoid production, a tunable IPP and DMAPP pool is 
required. This not only enables broad applicability of the strain but also adjustment to 
a downstream pathway of interest. To enable such flexibility, the operons were placed 
under control of an inducible lac-promoter. Primarily to confirm increased MEP-DOXP 
flux, but also to detect its sensitivity to the lac-promoter, we needed a rapid and sensitive 
method to detect IPP and DMAPP levels. A direct quantification of IPP and DMAPP, 
however, is hampered by the short-life span due to conversion to FPP by endogenous 
farnesyl-diphosphate synthase (IspA). Conversion to an alternative stable end-product is 
thus required. Estimating IPP and DMAPP levels has previously been done by means of 
a reporter construct assembled from the carotenoid genes crtE, crtB, and crtI [212, 229-
231]. This method enables a semi-quantitative determination of IPP and DMAPP levels 
by production of lycopene [229]. This compound is a red carotenoid pigment with an 
absorption optimum at 472 nm, which is readily quantified on a spectrophotometer. We 
have assembled a comparable inducible reporter plasmid from the crtE, crtB and crtI genes 
from the bacterium Pantoea ananatis in the compatible T7-promoter controlled pACYCduet 
vector. The newly obtained reporter plasmid was then transformed to JM109(DE3) cells to 
obtain strain WUR17.2. Induction of the reporter plasmid and the empty control plasmid 
was first done to test the functionality of the lycopene synthesis genes. The induced cells 
were pelleted and visually compared to check for red pigment development (Fig. 4).
            pACYC                                 pACYC - crtEBI                             
IPTG (mM)       0                     0.1                        0                     0.1                        0.5 
Figure 4. E.coli JM109(DE3) cell pellets showing lycopene production at various IPTG concentrations. JM109 
(DE3) cells transformed with pACYCduet or pACYC–crtEBI (WUR17.2) were induced with 0, 0.1 and 0.5 mM 
isopropyl β-D-1-thiogalactopyranoside (IPTG) and pelleted for lycopene visualization.
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Here we established a functional reporter with only mild leaky expression and an intense 
color development without notable difference between 0.1 and 0.5 mM IPTG addition. It 
was therefore concluded that an induction >0.1 mM IPTG does not further increase the 
levels of lycopene and likely demarcates an optimal expression of the reporter or maximum 
depletion of the endogenous IPP and DMAPP pool. 
Relative contributions of IDI, IspD, IspF and DXS to MEP-DOXP carbon flux.
Overproduction of IPP and DMAPP pools and the relative contribution of MEP-DOXP 
enzymes to carbon flux were determined by comparing the different operons. The plasmid-
encoded operons were transformed to the previously generated WUR17.2 strain, and the 
obtained transformants were grown on LB supplemented with glycerol as carbon source. 
Preliminary data revealed variable growth performances in the presence of different 
operons. The successive addition of genes to the operons correlated with an increase in 
the specific growth rate (µ) for, reporter only, idi, idi-ispDF, idi-ispDF-dxs operons at 0.08, 
0.011, 0.011, 0.016 minute-1, respectively. This apparent improvement of growth rate caused 
by the addition of MEP-DOXP genes may suggest that overexpression of crtE, crtB and crtI 
may cause a growth limiting depletion of FPP. This effect was clearly restored during co-
expression of MEP-DOXP genes which may have compensated for this depletion. After 
IPTG induction, the mutant strains were cultured for an additional 4 h. Total lycopene was 
extracted and measured along with the corresponding dry cell weights from three biological 
replicates as an additional preliminary test of operon functionality (Fig. 5 and Fig. S4). 
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Figure 5. Average lycopene production per plasmid-encoded operon upon induction (0.1 mM IPTG). The relative 
lycopene production assay shows the cumulative contribution of the overexpressed MEP-DOXP genes to the 
carbon flux. Lane 1: reporter only, 2 idi, 3: idi-ispDF, 4: idi-ispDF-dxs, 5: idi-ispD-dxs, 6: idi-dxs
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Here a 2.44-fold increase in lycopene by IDI alone was observed (from 0.54 to 1.32 µg 
lycopene /mg DCW) suggesting that the bottleneck of the MEP-DOXP flux is caused by the 
IPP/DMAPP isomerization [206]. Contrary to our expectations, overproduction of MEP-DOXP 
enzymes catalyzing earlier steps in the pathway (IspD, IspF and DXS) added to IDI did not 
significantly increase the production of lycopene. 
Selection of EPOD dependent loci for operon integration
To generate stable strains with inducible up-regulations of IPP and DMAPP, the synthetic 
operons were integrated into the E.coli chromosome. We first exchanged the redundant 
gfp gene at the 3’-end of the plasmid operons for a selection marker. We used a kanamycin 
resistance gene (kanR) which is flanked with lox-sites (lox66 and lox71) for its eventual 
replacement. These lox recognition sites allow for a Cre-recombinase dependent removal 
of the marker after integration. Recombination of the lox66 with lox71 sites results in 
formation of a desirable lox72 scar sequence [233]. In contrast to an frt scar [234], the lox72 
scar tolerates a subsequent cycle of gene disruption or integration event without incidental 
recombination from a previously formed scar. This may become important when additional 
genome engineering of the here described strains is required. Downstream attachment of 
the lox66-kanR-lox71 sequence yielded the plasmids pMS51, pMS52 and pMS53 (Table 2) 
which also includes the aforementioned operons idi, idi-ispDF and idi-ispDF-dxs respectively. 
These plasmids were then used as template for PCR-amplification of the integration 
cassettes. Amplifications were performed using primers elongated with ~50 bp extensions 
(homologous regions). These extensions were complementary to the sequences adjacent 
to the insertion-site at the target locus, in such a way that the orientation of the inserted 
operons is different from that of the neighboring chromosomal genes. Such positioning 
minimizes transcriptional read-through from upstream promoters. 
To select integration sites which allow for IPTG induced transcription of the synthetic operons, 
we have used recently gained insights in the protein occupancy landscape of the E.coli 
chromosome [228]. Compelling evidence has revealed that packaging of the chromosome 
can significantly influence the local gene expression, meaning that the selected integration 
site of heterologous genes/operons has major consequences for their expression [223]. For 
selecting an appropriate, high expression insertion site, the key feature of this Extensive 
Protein Occupancy Domains (EPODs) analysis concerned the accessibility of the RNA 
Polymerase [228]. The EPOD analysis discriminates transcriptionally silent tsEPODs, probably 
corresponding to the core regions of the chromosome, and highly expressed heEPODs that 
have been proposed to be more accessible chromosomal loops. Based on the previously 
identified tsEPOD and heEPOD coordinates of the E.coli chromosome, we have selected 
potential domains as operon integration sites [228]. Fig. 6 shows the plotted coordinates 
of EPODs in the selected segment of the ori-domain between nucleotides 4.000.000 and 
4.500.000. The observation of two heEPOD regions between two tsEPODs from coordinates 
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Figure 6. EPOD coordinates of a segment 
of the ori-macrodomain plotted on scale. 
Extensive protein occupancy domains 
between E.coli nucleotides 4.000.000 and 
4.500.000 are shown. Within the box, two 
tsEPODs flanking two heEPODS are depicted 
that are hypothesized to form a putative 
subdomain. In blue: tsEPODs are plotted which 
supposedly anchor the genome subdomains to 
the centromere. In red, heEPODs. the regions 
localized in the subdomain loops that extend 
from the centromere.
4.084.552 to 4.220.964 highly suggested the presence of a relatively large loop. Here we 
also noticed that the heEPOD112 domain includes many essential genes as established by 
the KEIO collection [235] (e.g. the rpl operon encoding ribosomal proteins). In contrast, 
tsEPOD130 is exclusively composed of nonessential genes (Fig. S5). As these observations 
are in line with an expected higher accessibility of the heEPOD112 region and to a lower 
accessibility of tsEPOD130, we decided to integrate the synthetic operons within and 
between these two domains. The tsEPOD130 is expected to result in lower transcriptional 
levels and serves as a control. Additionally, a region outside an EPOD was selected between 
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these domains; this region (from here on referred to as ‘EPOD-independent’) was expected 
to provide a more strict control over gene expression and is included to compare the effects 
of the allocated EPOD regions. 
A set of exclusion criteria assisting in the designation of appropriate integration sites was 
adopted from Bryant et al. [223]. To this end, promoter sequences, transcription factors, 
repeat sequences and possible nucleoid associated protein sequences (H-NS, Fis and IHF) 
were deliberately avoided (Fig. S6). This screen ultimately led to the selection of three loci 
between nonessential genes (Fig. S5). One locus was targeted inside heEPOD112 between 
the rplK and rplA genes. The EPOD-independent locus was selected between the genes aceA 
and aceB. And lastly, a locus was selected inside tsEPOD130, between the genes iclR and 
arpA. Despite several recombination attempts and screening rounds, however, integration 
at both the tsEPOD130 and heEPOD112 did not result in the isolation of the desired mutants. 
In contrast, the EPOD-independent aceB/aceA locus showed 71% integration efficiency for 
the idi operon from 84 screened colonies at the first recombination attempt. This sharp 
contrast led us to conclude that the selected EPOD-loci are highly unfavorable as target for 
integrations. This prompted us to continue integration of the idi-ispDF and idi-ispDF-dxs 
operons only at the EPOD-independent locus. For these constructs integration efficiencies 
of 20% and 6.6%, respectively, were observed. 
Characterization of MEP-DOXP upregulation by genome integrated operons. 
To estimate IPP and DMAPP pools from the integrated constructs we analyzed the mutants 
for their lycopene productions. The mutants were transformed with the reporter plasmid 
and induced with different amounts of IPTG while grown on glycerol or repressed by glucose. 
Glycerol serves as a readily used carbon source which does not induce catabolite repression 
like glucose. Moreover, as a convenient practical feature, glycerol has been reported to 
stimulate the heterologous production of carotenoids [213, 236]. The exact mechanism of 
the glycerol stimulation is unknown, but it probably relies on some control network that 
influences the glycerol-3P and pyruvate pools as precursor substrates of the MEP-DOXP 
pathway (Fig. 1) [213]. Comparison of lycopene color development first showed that glucose 
indeed establishes a very efficient repression, as no lycopene seems to be produced in these 
controls (Fig. S7). Although also without induction, the negative control with glycerol showed 
high levels of lycopene instead. Despite a stimulation of the isoprenoid production, glycerol 
thus inadvertently also promotes leaky expression of our constructs and reporter. Secondly, 
the initial screening indicates that the integrated single copy operons produce lycopene levels 
with comparable variability as their respective multicopy plasmid variants. It is therefore 
concluded that there is sufficient expression from the integrated constructs, and that the 
aceB/aceA insertion site provides a convenient locus for the inducible expression of synthetic 
gene cassettes.
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Quantification of lycopene then confirmed that statistically significant variable levels were 
indeed produced by the strains with the different operons (Fig. 7). Here, the idi-ispDF-dxs 
operon, as was shown for the plasmid assay, also resulted in the highest production of lycopene. 
A main difference with the multi-copy plasmid constructs, however, is that all integrated 
single copy constructs led to higher up-regulations (Fig. 7, grey bars). The idi-ispDF-dxs mutant 
for instance produced 2.99 instead of 1.52 µg lycopene/mg DCW when induced with 0.01 mM 
IPTG. This is roughly a doubling of the initially determined level from the plasmid variant and 
an overall 5.34-fold increase compared to the wild-type control strain (WUR17.2). It must be 
emphasized here that for testing of the plasmid-borne constructs 0.1 mM IPTG was used, also 
in the presence of glycerol. For the integrated operons, however, this IPTG concentration 
led to a dramatic decrease in lycopene productions (Fig. 7, black bars). On the basis of these 
observations it is suggested that the operon copy number modulates the response to IPTG 
either directly by the operon, or indirectly due to the reporter. Overexpression of ispDF in 
addition to idi (Fig. 7, lanes 2 and 3) was shown to contribute a little to the MEP-DOXP flux, 
as reflected by slightly higher lycopene levels (p=0.06). This suggests that the previously 
presumed inhibition (Fig. 5, lane 3) is most likely an artefact of the excessive overexpression 
[207, 237]. 
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Figure 7. Lycopene production by the mutant strains with integrated MEP-DOXP operons after variable IPTG 
induction. White bars represent the non-induced cells. Grey bars represent 0.01 mM IPTG induced cells, and black 
bars represent 0.1 mM IPTG induced cells. Negative control (lane 1) represents WUR17.2 strain without operon 
integration. Statistical significance of the 0.01 mM inductions; * p<0.1; ** p<0.01; *** p<0.001 
Like with all integrated strains, a comparable IPTG variability was observed within the control 
strain (WUR17.2) (Fig. 7, lane 1). Because of this conformity, it is more likely that the IPTG 
dependent variation is mainly due to induction of the lycopene reporter pathway rather than 
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to induction of the tested operons. To test this hypothesis, we analyzed the protein profiles 
of the induced cells on SDS-PAGE. The gel indeed showed a variation of expressed lycopene 
reporter genes crtEBI that corresponds with the lycopene levels (Fig. 8). The CrtE, CrtB and 
CrtI proteins which expression was controlled by T7 RNA-polymerase are abundantly present 
at 0.01 mM IPTG, but not visible at 0 and 0.1 mM IPTG induction. Moreover, the excessive 
production of the MEP-DOXP proteins, like shown for the plasmid operon variants (Fig. 3), is 
no longer observed. Because of this, it remains unclear whether the IPTG variation was really 
due to expression of the lycopene reporter pathway or whether the MEP-DOXP genes show a 
comparable variation in expression albeit below the detection limit. 
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Figure 8. SDS PAGE of the differentially induced mutants. An expression optimum is shown for the lycopene 
reporter plasmid by the excessive presence of the CrtE: 32.6 kDa; CrtB: 34.5 kDa and CrtI: 55.0 kDa proteins. 
Operon gene products IDI: 20.51 kDa; IspF: 16.9 kDa; IspD: 25.7 kDa and DXS: 67.6 kDa are not distinguishable. 
Discussion
The main objective of this study was to obtain a platform Escherichia coli strain with a 
stable upregulation of the MEP-DOXP pathway for isoprenoid productions. This was done 
by assembly of a series of synthetic operons to overexpress the crucial MEP-DOXP (idi, ispD, 
ispF and dxs) genes. In the course of the operon characterization we additionally studied 
whether these rate limiting or rate-controlling steps demonstrate a cumulative enhancing or 
silencing effect. This influence on carbon flux was estimated by quantification of synthesized 
lycopene as a representation of the available pool of IPP and DMAPP. As shown by earlier 
studies, we confirm that the isopentenyl-diphosphate isomerase forms a high rate-limiting 
step [209, 238]. High overexpression of the idi gene caused a 2.54-fold increase in lycopene 
production compared to native idi expression from the wild-type strain. Because of this, 
the idi gene was compared for IPP and DMAPP production upon co-expression with ispD 
and ispF or in a complete operon idi-ispDF-dxs. Here the complete operon resulted in the 
highest levels of lycopene of the plasmid-encoded operons at an average 2.8-fold increase. 
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Interestingly, in the plasmid-encoded operons, no significant differences were observed by 
the co-expression of ispD, ispF or dxs gene in any of the combinations. 
To generate strains with a stable upregulation of IPP and DMAPP, we embarked on 
the integration of the characterized operons (idi, idi-ispDF and idi-ispDF-dxs) in the 
E.coli chromosome. Three targeted loci for integrations were chosen such to allow 
variable expression dependent on EPOD types: highly expressed, EPOD independent 
and transcriptionally silent. Here we observed highly efficient integrations in the EPOD 
independent locus as opposed to the heEPOD and tsEPOD loci that did not yield any of 
the desired mutant colonies. The molecular basis of these failed recombinations remains 
unclear, but may reflect the compact folding of the chromatin in the tsEPODs and the highly 
dense protein occupancy of EPODs in general. Because of this experimental result, we only 
compared the operon variants integrated from the EPOD-independent locus. Interestingly, 
expression from these chromosomal ‘duplication variants’ resulted in optimal levels of IPP 
and DMAPP with a fold-change of 1.07, 1.32 and 1.97 (µg lycopene/mg DCW) for the idi, idi-
ispDF and idi-ispDF-dxs operons respectively compared to the plasmid-encoded operons. 
This assay confirmed that excessive expression of the targeted genes was deleterious to 
isoprenoid production [207]. Here the duplication of dxs led to the highest additional fold-
change and indicates that the excessive overexpression of this enzyme was probably the 
cause of the low isoprenoid flux in the plasmid-assays. Likely because of this the complete 
idi-ispDF-dxs operon thus resulted in the highest detected upregulation at an 5.34-fold 
increase compared to a wild-type MEP-DOXP control. In addition to the single copy number 
improvements, a presumed inhibitory effect of the idi-ispDF operon in the plasmid-borne 
assay was no longer observed in the integrated mutant. Although a significant improvement 
was observed, no high upregulation was obtained. This finding led us to conclude that 
ispDF overexpression is only beneficial to the flux during co-expression with dxs. Despite 
the observed improvements it remains unclear whether duplication variants resulted in 
higher lycopene levels due to lower but more efficient expression levels, or because of a 
more beneficial expression of the reporter. Either way it seemed that much profit can be 
gained by IPTG calibration. In this assay we therefore also tested the influence of variable 
induction levels to further explore the system. Here we found that a high concentration of 
IPTG (i.e. 0.1 mM) severely diminishes the production of lycopene. These low levels were 
not observed for the plasmid-encoded operons at the same concentration of IPTG. An SDS-
PAGE analysis showed that the highest levels of lycopene corresponded with high expression 
of the reporter enzymes and levels below detection with high IPTG concentration. Because 
high expression levels of the reporter did not show any correlation with lower lycopene 
levels, it can be concluded that excessive expression of crtEBI was not deleterious to the 
isoprenoid flux. 
Regardless of the observed variabilities by IPTG, we demonstrate the construction of a 
series of platform strains, enabling controllable levels of isoprenoid production. Our data 
Chapter 3 Metabolic engineering for isoprenoid production
3
56
show that the available IPP and DMAPP pool which is the main determining factor of the 
production level of isoprenoids can be further optimized. In addition to this, our data 
also suggests that more efficient isoprenoid production can be obtained by balancing the 
expression between upstream and downstream pathways which in the first place can be 
achieved by IPTG calibrations, but possibly even more by tuning individual expression levels 
of the downstream pathway. 
Materials and Methods
Construction of MEP-DOXP operons
The idi, ispDF, and dxs genes were PCR-amplified using E.coli MG1655 genomic DNA as 
template. Cells from a 7-ml overnight culture were harvested and the chromosomal DNA was 
isolated according to the manufacturer’s procedures “Qiagen DNeasy Blood & Tissue Kit”. 
PCR amplifications were performed according to the standard protocol of Phusion DNA 
polymerase (Thermo Fisher Scientific). Each PCR reaction contained 0.2 mM forward and 
reverse primer (Table 1), 0.2 mM dNTPs, 1x Phusion buffer, and 1U Phusion polymerase 
(Thermo Fisher Scientific). Each PCR cycle initiated with a 5 min incubation at 95oC. This was 
followed by 30-35 cycles consisting each of: 1) 30 s at 98oC, 2) 30 s annealing at variable 
temperatures, and 3) variable elongation at 72oC at variable duration. The cycles were 
finalized by an additional extension of 5 min at 72oC. The resulting DNA fragments were 
analyzed on a 1% agarose gel. All PCR fragments were first ligated into pCR2.1 topo vector 
by TOPO TA cloning according to the manufacturer’s procedures. This ligation enabled 
sequence analysis of the isolated fragments (BaseClear and GATC). MEP-DOXP genes 
were cloned in consecutive steps according to standard molecular biological procedures. 
Restriction enzymes, ligases and gel extraction kit were provided by Thermo Fisher Scientific. 
The idi insert and pGFPuv vector (Clontech) were double digested with SphI and PstI. The 
digested insert and vector were excised from gel and extracted by a DNA gel extraction kit. 
The insert was subsequently ligated into linearized pGFPuv by T4 DNA ligase. The resulting 
construct pGFPuv-idi was transformed to competent E.coli DH5α cells. The subsequent 
fragment ispDF, was amplified at an annealing temperature of 58oC and an extension time of 
3 min. The insert was screened for mutations in pCR2.1topo and after confirmation cloned 
into pGFPuv-idi. Cloning yielded pGFPuv-idi-ispDF using the XbaI and PstI restriction sites. 
The subsequent fragment dxs was amplified at an annealing temperature of 60oC and an 
extension time of 4 min. The screened insert was cloned into pGFPuv-idi-ispDF to yield the 
final construct pGFPuv-idi-ispDF-dxs. For this final cloning the XbaI and the KpnI restriction 
sites were used. Two variants of the pGFPuv-idi-ispDF-dxs construct were made by removal 
of the ispF gene. To compose the first plasmid, the ispDF genes were both removed by 
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digestion with PstI and XbaI and the single ispD gene put in place to yield pMS31. The ispD 
insert was amplified at an annealing temperature of 58oC and an extension time of 30 s. 
The PCR fragments were cloned into the pCR2.1 cloning vector and screened for mutations. 
Both insert and pGFPuv-idi-ispDF-dxs were double digested with PstI and XbaI. The resulting 
insert was ligated into the linearized vector to yield pGFPuv-idi-ispD-dxs. To yield the second 
variant, the linearized plasmid after removal of ispDF was treated with klenow fragment 
(ThermoFisher Scientific). The resulting blunt-ends were self-ligated to yield the pGFPuv-
idi-dxs (pMS33) construct. 
Transformation and screening
All transformations were done by heat shock as following. Frozen chemically competent 
E.coli cells were thawed 10 min on ice. Either DH5α cells, made competent by a calcium 
rubidium treatment, or commercial TOP10 cells were used (Invitrogen). Ligation mixtures (2 
µl) containing 20 ng DNA or 1 ng plasmid DNA were added to the cells and gently mixed. The 
cells were incubated on ice for 30 min. The cells were heat shocked by an incubation of 45 s 
at 42oC and then immediately cooled on ice to incubate 5 min for recovery. After recovery, 
250 µl SOC medium was added at ambient temperature and the cells were incubated 1 
h at 37oC while aerated at 170 rpm. Finally, the cells were plated on lysogeny broth (LB)-
agar supplemented with appropriate antibiotics to select for transformants. The resulting 
colonies were screened for inserts by colony PCR and the plasmids subsequently sent for 
sequencing. The resulting operon constructs were then re-transformed to competent E.coli 
JM109 for expression analysis.
Assembly of a lycopene reporter construct
The crtE gene was PCR-amplified using Pantoea ananatis genomic DNA as template. 
Purified DNA isolate was provided by DSMZ GmbH (DSM30080). PCR amplifications were 
performed as described previously. Amplification of crtE was performed at an annealing 
temperature of 55oC and an extension time of 35 s. The fragment was first cloned into the 
pCR2.1topo vector and inserts selected by blue/white screening on LB-agar Amp100 X-gal 
plates. The T7-promoter controlled pACYCduet vector (Novagen) and the crtE insert were 
digested with EcoRI and AflII (BspTI). The vector was treated with antarctic phosphatase 
(NEB) to prevent self-circularization. The crtE insert was ligated into linearized pACYCduet 
by T4 ligase. The ligation mixture (2µl) was subsequently transformed to E.coli TOP10 cells 
according to the heat shock protocol. The bicistronic crtB and crtI genes were PCR-amplified 
as a single fragment using Pantoea ananatis genomic DNA as template. PCR amplifications 
were performed as described previously. The crtBI fragment was amplified at an annealing 
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temperature of 58oC and an extension time of 80 s. The fragment was cloned into the 
pCR2.1topo vector for screening. The screened insert was digested with BglII and XhoI as 
well as the previously constructed pACYC-crtE plasmid. The linearized plasmid was treated 
with antarctic phosphatase (NEB) to prevent self-circularization. Ligation by T4 ligase yielded 
the completed lycopene reporter pACYC-crtEBI (pMS17) (Table 2). After confirmation of 
correct mutation-free inserts, the reporter plasmid was transformed to E.coli JM109(DE3) 
cells for further processing to yield strain WUR17.2.
Table 2. Escherichia coli strains and plasmids used in this study
Parent strain Annotation Inserts Plasmid(s)
JM109 WUR06 (-) pGFPuv ctrl
JM109 WUR04.2 idi pMS03
JM109 WUR08.2 idi–ispDF pMS08
JM109 WUR11.2 idi–ispDF-dxs pMS11
DH5α WUR17 crtEBI pMS17
JM109 WUR31 idi–ispD-dxs pMS31
JM109 WUR33 idi–dxs pMS33
JM109(DE3) WUR17.2 crtE-B-I pMS17
JM109(DE3) WUR17.3 crtE-B-I (-) pMS17 and  pMS01
JM109(DE3) WUR17.4 crtE-B-I (idi) pMS17 and  pMS03
JM109(DE3) WUR17.5 crtE-B-I (idi-ispDF) pMS17 and  pMS08
JM109(DE3) WUR17.6 crtE-B-I (idi-ispDF-dxs) pMS17 and  pMS11
JM109(DE3) WUR31.3 crtE-B-I (idi-ispD-dxs) pMS17 and  pMS31
JM109(DE3) WUR33.3 crtE-B-I (idi-dxs) pMS17 and  pMS33
TOP10 WUR46 BsiWI - lox71-kanR–lox66 - AflII pMS46
TOP10 WUR51 idi–lox71-kanR-lox66 pMS51
TOP10 WUR52 idi–ispDF - lox71-kanR-lox66 pMS52
TOP10 WUR53 idi–ispDF–dxs – lox71-kanR-lox66 pMS53
JM109(DE3) WUR61 lambda RED (exo, bet, gam) pKD46
Genome modifications
JM109(DE3) WUR63 idi - lox71-kanR-lox66 EI -
JM109(DE3) WUR70 idi-ispDF - lox71-kanR-lox66 EI -
JM109(DE3) WUR71 Idi-ispDF-dxs- lox71-kanR-lox66 EI -
JM109(DE3) WUR89 idi EI -
JM109(DE3) WUR90 idi-ispDF EI -
JM109(DE3) WUR91 idi-ispDF-dxs EI -
JM109(DE3) WUR92 idi EI pMS17
JM109(DE3) WUR93 idi-ispDF EI pMS17
JM109(DE3) WUR94 idi-ispDF-dxs EI pMS17
Abbreviations: EI: EPOD Independent
Strains and induction assay
The newly obtained E.coli JM109(DE3) strain carrying the lycopene reporter construct 
(WUR17.2) was used to analyze the various plasmid-borne MEP-DOXP operons. This strain 
was transformed with constructs: pMS01, pMS03, pMS08, pMS11, pMS31 and pMS33 to 
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yield WUR17.3, WUR17.4, WUR17.5, WUR17.6, WUR31.3 and WUR33.3 by electrophoresis 
respectively. LB-agar plates supplemented with 34µg/ml chloramphenicol (Cm34) and 
100µg/ml ampicillin (Amp100) were inoculated from glycerol stocks. Antibiotics were used as 
selection marker to retain both the reporter pMS17 and MEP-DOXP operons, respectively. 
The plates were incubated overnight at 37oC. Ten ml LB Cm34 Amp100 was supplemented 
with 10 mM MgSO
4
 and 0.4% glycerol and inoculated with a fresh single colony to start 
a pre-culture. The pre-cultures were incubated overnight at 37oC and stirring at 180 rpm. 
Three biological replicates per strain were inoculated in 25 ml LB media with 1/50 volume 
pre-culture. The cells were grown to logarithmic phase by incubating the culture at 37oC 
and stirring at 180 rpm. IPTG was added to the cultures to a final concentration of 0.1 mM 
or 0.01 mM at an OD
600
 of 0.55. The cultures were than incubated for an additional 4 h. 
Samples were cooled on ice for 15 min. Two 10-ml aliquots were transferred consecutively 
to pre-cooled 15-ml Greiner tubes. One aliquot was destined for lycopene extraction and 1 
aliquot was destined for dry cell weight (DCM) determination.
Sample preparation and SDS-PAGE 
To analyze protein profiles, pelleted cells from 4 ml culture were resuspended in 1 ml cold 
lysis buffer (Tris-HCl 50 mM, pH=8, 1 mM EDTA, 150 mM NaCl, 1 mM DTT and 0.1 mM PMSF) 
The cells were lysed by four consecutive sonication rounds (20 s pulse and 30 s on ice). To 
obtain cleared lysates, the crude extracts were centrifuged 10 min at 10,000 xg at 4oC. A 
12% or 13.5% running gel and a 4% stacking gel were made to visualize protein profiles. 
Per sample 15 µg protein was applied and a “BioRad Precision plus Protein standard” 
was included as a reference. To visualize the proteins, the gel was stained overnight with 
coomassie brilliant blue according to standard procedures of Sambrook and Maniatis [239].
 IDI activity assay 
Isopentenyl-diphosphate isomerase (IDI) activity from cleared lysate was determined by 
measuring the formation of DMAPP according to Satterwhite et al. [240]. The reaction 
mixture contained: 10 mM Tris-HCl, 0.1 mM DTT, 2 mM MgCl
2
, 0.04 mM 14C-isopentenyl 
diphosphate (10 Ci/mol) (Perkin Elmer). The reaction was initiated by addition of 3 µg 
cleared lysate protein to 50 µl reaction mixture. The reaction was incubated for 10 min at 
37oC and stopped by the addition of 200 µl HCl/methanol (3/1 v/v) followed by 0.5 ml MQ. 
Samples were vortexed, and incubated 10 min at 37oC. This incubation was followed by the 
addition of 20 µl saturated NaCl solution. Acidified DMAPP was extracted by addition of 10 
ml toluene, vortexed, centrifuged (5 min, 1,000 xg), and the toluene phase removed twice. 
The extracts were pooled, MgSO
4
 added until complete desiccation, and 1 ml from the 
toluene and the water phase transferred to scintillation vials. Radioactivity was measured 
in both aqueous and organic phases by scintillation counting to quantify the percentage of 
substrate conversion.
Metabolic engineering for isoprenoid production
3
61
Lycopene quantification
Aliquots (10 ml) from biological triplicates were centrifuged at 4,700 xg for 10 min. The 
cell pellet was resuspended in 1 ml MQ, and transferred to a clean 2-ml screw-cap vial and 
centrifuged (12,000 xg, 5 min). The resulting cell pellet was suspended in 500 µl acetone 
and incubated 30 min at 55oC to promote extraction and centrifuged again (20 min, 16,000 
xg, 4oC). The supernatant containing lycopene was transferred to a clean screw-cap vial. 
The extracts were kept in the dark to prevent light induced break-down of lycopene. This 
extraction procedure was repeated twice and the three lycopene extracts pooled to a final 
volume of 1.5 ml. The extract was centrifuged additionally at 16,000 xg for 2 min to pellet 
incidental cell-debris. A 250-µl sample was removed and diluted with 750 µl acetone from 
which the absorbance was measured at 472 nm in an acetone-resistant cuvette (Brand).The 
lycopene concentration was determined by interpolation of the measured absorbance to 
a standard calibration curve of lycopene (Sigma-Aldrich). The calibration curve of lycopene 
dissolved in acetone resulted in the following equation (y=0.2254x-0.0077) established at 
an R2 =0.9998. The total lycopene concentration was normalized to the dry cell weights 
(DCW) per 10 ml induced culture. For DCW determinations, a 10-ml culture aliquot was 
centrifuged (4,700 xg, 2 min), and the pellet was resuspended in 1 ml MQ and transferred 
to a pre-weighed aluminum dish. The cells were dried for 24 h at 105oC and weighed. The 
lycopene production was expressed as “µg lycopene/mg DCW”. All values are derived from 
biological triplicates. 
Chromosome integration of MEP-DOXP operons 
A lox71-kanR-lox66 gene cassette as a selection marker was cloned to pCR2.1 topo by Topo-
TA cloning to yield pMS46. The purpose of the cloning was to extend the cassette with an 
N-terminal BsiWI and a C-terminal AflII restriction site. These sites allow the insertion of the 
lox71-kanR-lox66 cassette downstream of the previously constructed MEP-DOXP operons. 
The lox71-KanR-lox66 insert was amplified with Phusion polymerase. The PCR reaction 
contained: 1 µl lox71-kanR-lox66 template, 0.2 uM forward primer (BG4429), 02 µM reverse 
primer (BG4430), 0.2 mM dNTPs, 1x Phusion buffer, and 1U Phusion polymerase. The PCR 
cycle initiated with a 5 min incubation at 98oC. This was followed by 30 cycles consisting 
each of: 1) 30 s denaturation at 98oC, 2) 30 s annealing at 52oC, and 3) 40 s elongation at 
72oC. The cycles were finalized by an additional extension of 5 min at 72oC. The lox71-kanR-
lox66 PCR fragment was cloned in pCR2.1 topo vector and transformed to E.coli TOP10 cells 
according to the manufacturer’s procedures. Correct insertion was verified by sequence 
analysis. The main purpose of the following cloning procedure was the exchange of the gfp 
gene from the previously cloned constructs pMS03, pMS08, pMS11 with the lox71-kanR-
lox66 selection marker. A BsiWI compatible Acc65I and BspTI (AflII) double digestion on 
2 µg pMS03, pMS08 and pMS11 plasmid DNA was performed to generate linear vector. 
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To generate a lox71-kanR-lox66 insert, 4 µg pMS46 was similarly digested. Digests were 
applied on 1% agarose gel and separated for 30 min at 100V. Correct fragments were 
excised from gel and purified on a DNA clean and concentrator-5 column (ZYMO Research). 
The lox71-kanR-lox66 inserts were ligated to linearized vectors to generate pMS51, pMS52 
and pMS53 (Table 2).
To identify appropriate sites for integration, heEPOD112, tsEPOD130 and the region between 
these EPODs ‘EPOD independent’ were screened for cis-regulatory elements. Promoter 
sequences, transcription factors and repeat sequences were identified by means of the 
regulonDB database (http://regulondb.ccg.unam.mx/). We used (anti)sense consensus 
sequences to screen for Histone-like Nucleoid Structural proteins (H-NS), TCGWTWAATT 
[241, 242], Factor for Inversion Stimulation (Fis) GNNNRNNWNNYNNNC[243], Integration 
host-factor (IHF), WATCAANNNNTTR[244, 245], sites. Sequences with less than 20, 10 and 
0% deviation from the consensus sequences respectively depending on their abundance 
were deliberately avoided for integration. Interestingly, we observed a relatively high 
abundance of possible H-NS sites within tsEPOD130 (19 sites / 2717 nt’s) comparison to 
the heEPOD (4 sites / 6317 nt’s). This comes down to an average H-NS-site frequency of 1 
per 1579 nt’s in heEPOD112 and 1 site per 143 nt’s in tsEPOD130. This 11-fold difference 
strongly supports the hypothesis of a structural role for tsEPOD130 and the presence of a 
putative subdomain.
Homologous end extension PCR was performed by Phusion polymerase PCR (ThermoFisher 
Scientific). The following primers were used to extend the operons with homologous ends 
(Table 1). For heEPOD locus insertion BG4883 and BG4884 primers were used and annealed 
at 55oC. For the EPOD-independent locus insertion BG4885 and BG4886 primers were used 
and annealed at 56oC. For the tsEPOD locus insertion BG4887 and BG4888 primers were 
used and annealed at 59oC. A standard PCR protocol was performed to amplify the knock-in 
cassettes for the idi, idi-ispDF and idi-ispDF-dxs operons using pMS51, pMS52 and pMS53 
as template DNA, respectively. The resulting PCR-fragments were purified on a clean and 
concentrator 5 column (ZYMO research).
The integration and clearing of the selection marker was performed as described 
previously in the gene disruption strategy by Datsenko and Wanner [234]. Briefly, 
competent JM109(DE3) cells with induced pKD46 for phage λ Red-recombinase (WUR61) 
were electroporated with 375 ng purified cassette DNA at 2500V, 200Ω, 25 µF and 5 ms. 
After 1.5 h recovery on SOC medium at 37oC, cells were plated on LB-agar supplemented 
with 50 µg/ml kanamycin. Mutant colonies were screened by colony PCR using primers 
BG5004 and BG5005 complementary to the aceB and aceA gene respectively at the EPOD-
independent locus according to standard PCR conditions. Positive clones were annotated 
as WUR63, WUR70 and WUR71 for the idi, idi-ispDF and idi-ispDF-dxs operons in the 
EPOD-independent region, respectively. Correct mutation-free insertions were confirmed 
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by sequence analysis of the amplified knock-in region with primers BG4476 and BG4886. 
Novel strains were transformed with pJW168 harboring the Cre-recombinase to remove 
the kanamycin resistance gene leaving a lox72 scar sequence. The cells were spread on 
LB-agar plates supplemented with 100 µg/ml ampicillin and 0.5 mM IPTG to induce Cre-
recombinase and grown at 30oC. To finalize the recombination, purification of the cells 
and clearance of the plasmids, the colonies were re-streaked on LB-agar plates without 
additives and kept overnight at 37oC to grow. The novel strains were annotated as WUR89, 
WUR90 and WUR91 for the integrated operons idi, idi-ispDF and idi-ispDF-dxs, respectively. 
The mutant strains were transformed with the lycopene reporter construct pMS17 to yield 
strains WUR92, WUR93 and WUR94.
Acknowledgements
This project was carried out within the BE-Basic R&D Program, which was granted a FES 
(Fonds Economische Structuurversterking) subsidy from the Dutch Ministry of Economic 
affairs, agriculture and innovation (EL&I).
Supplemental Information 
idi - + + + + 
ispD - + + + - 
ispF - + - + - 
dxs - - + + + 
Figure S1. GFP fluorescence of cell pellets of upon ultraviolet light exposure GFPuv fluorescence of harvested 
cultures (10 ml) confirms complete transcription of the entire operons. A steady decrease in the pellet volume is 
observed by the successive addition of MEP-DOXP genes. Negative control contains the unmodified pGFPuv plasmid.
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Figure S2. IDI activity assay of cell-free 
extracts of E.coli with different operon 
constructs after IPTG (0.1 mM) induction 
Assays show an efficient upregulation of IDI 
activity compared to wild type (-). A decrease 
in activity is observed when IspDF genes are 
included in the operon. Negative controls: (-) 
contains unmodified pGFPuv plasmid only; 
(buffer) control without cell-free extract.
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Figure S3. SDS-PAGE of cell-free extracts of 
E.coli with different operon constructs, after 
IPTG (0.1 mM) induction. Lane 1: pGFPuv 
control; 2: idi-ispDF-operon; 3: idi-ispD-dxs-
operon; 4: idi-ispDF-dxs, 5: idi-dxs. Operon 
gene products GFP: 26.8 kDa; IDI: 20.51 kDa; 
IspD: 25.7 kDa; IspF: 16.9 kDa; DXS 67.6 kDa.
Figure S4. Relative lycopene production 
comparison per plasmid-encoded operon 
Induced vs. non induced   lycopene yields.
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Figure S5. Integration loci according to identified EPOD regions In red: heEPOD112, In blanc: EPOD independent, 
In blue tsEPOD130. For all three chosen loci the integration strategies are depicted for the complete operon. For 
the heEPOD112 region, a locus between the rplK and rplA genes encoding nonessential: 50S ribosomal subunit 
protein L1 and L11 respectively was selected for integration. For the EPOD independent region, a locus between 
the aceB and aceA genes encoding nonessential malate synthase A and isocitrate lyase respectively was selected 
for integration. For the tsEPOD130 region, a locus between the nonessential arpA and iclR genes encoding ankyrin 
repeat protein and DNA-binding transcriptional repressor respectively was selected for integration. (Adapted from 
Bryant et al.[223]).
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Figure S5. Continued
0 2000 4000 6000 8000 10000 12000 14000 16000 18000 20000
Fis 
IHF 
H-NS 
heEPOD112 EPOD independent tsEPOD130 
0 2000 4000 6000 8000 10000 12000 14000 16000 18000 20000
Figure S6. Relative positioning and abundance of nucleoid associated proteins dispersed in heEPOD112, 
tsEPOD130 and the EPOD-independent region between the EPODS, Fis, Factor for inversion stimulation; IHF, 
integration host factor; H-NS, Histone-like Nucleoid Structural proteins. Relatively high predicted abundance of 
H-NS sites are detected in tsEPOD130. 
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Figure S7. Lycopene production assay in 
E.coli JM109(DE3) Three different MEP-DOXP 
operons were integrated encompassing (i) idi, 
(ii) idi-ispDF and (iii) idi-ispDF-dxs. The mutants 
were grown on LB supplemented with glucose 
(Glu) or glycerol (Gly) to show the effect of 
catabolite repression. Cultures were induced 
with Isopropyl β-D-1-thiogalactopyranoside 
(IPTG) at variable concentrations to promote 
expression of the integrated operons and 
lycopene reporter
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4Fatty acid metabolism and phospholipid synthesis in Escherichia coli have previously been studied in detail. However, the balanced regulation between fatty acid biosynthesis (FAB), fatty acid degradation (FAD) and phospholipid (PL) synthesis is still not fully understood. Glycerol-3-phosphate acyltransferase (PlsB) is the key enzyme that is responsible for the coupling between the biosynthesis of fatty acids and phospholipids. To specifically study FAB and FAD expression, PlsB transcription and activity was varied, and the alternative phospholipid synthesis route via the PlsX disrupted. The level of PlsB was manipulated by exchanging its native promoters by a repressible and inducible promoter. Down-regulation of the expression of plsB indeed resulted in decreased growth. As reported previously, additional inhibition of PlsB activity was obtained at the enzyme level by overexpression of the acyl carrier protein (ACP), causing partial growth arrest in wild-type plsB cells. Unexpectedly, when plsB was overexpressed in the engineered strain this further intensified the apo-ACP-induced growth inhibition. To explain these differences and study the balanced regulation between FAD, FAB and PL synthesis, proteome analysis was performed. This revealed that ACP overproduction induces PlsB-dependent responses on the fatty acid biosynthesis and degradation pathways. Not only does apo-ACP inhibit PlsB activity, it also results in decreased concentrations of PlsB and an increase of 1-acyl-sn-glycerol-3-phosphate acyltransferase (PlsC). Furthermore we show that a simultaneous increase of both apo-ACP and PlsB results in down-regulation of fatty acid and phospholipid biosynthesis but 
stimulates expression of FAD. 
Keywords: Beta-oxidation, Fatty acid/metabolism, Lycophopholipid, 
Membranes, phospholipids/phosphatidic acidAb
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Introduction
The membrane of Escherichia coli is probably the most extensively studied membrane 
of any biological system [246, 247]. The gained insights have been instrumental in 
understanding the lipid synthesis pathways in both prokaryotes and eukaryotes. 
Biochemical research has elucidated each step in the phospholipid biosynthesis pathways. 
Based on this knowledge, efforts are on-going that aim at efficient synthesis of lipids and 
fatty acids as potential sources of biofuels. Fatty acids (acyl chains) are hydrocarbon chains 
with a terminal carboxylate group, that vary in length from short chains (C4-C6), medium 
chains (C7-C11), to long chains (C12-C22). Multiple enzymes involved in distinct fatty acid-
dependent pathways have previously been reconstructed by demonstrating fatty acid 
delivery through the interaction of the acyl-carrier-protein (ACP) and partner proteins [248-
253]. This has revealed that fatty acids contribute to four different physiological functions. 
Firstly, fatty acids are the biggest constituent of glycero-phospholipids, sphingolipids and 
lipopolysaccharides, and as such the main components of biological membranes. Secondly, 
some proteins are post-translationally modified by acylation or lipidation. In that case, the 
covalent attachment of acyl chains to membrane proteins act as anchor to the membrane 
like shown for lipoprotein Lpp[254] and hemolysin HlyA[255]. Thirdly, fatty acids may be 
fuel molecules that are stored as triglycerides in eukaryotes. Bacteria can also internalize 
and utilize exogenous fatty acids either as carbon source or as membrane constituent. 
Upon uptake of the fatty acid by FadL and FadD, the acyl chain is oxidized to acetyl-CoA 
units by beta-oxidative fatty acid degradation (FAD) enzymes FadA, FadB and FadE (Fig. 1). 
The fourth function of fatty acids is that of precursor molecules for cofactors. Fatty acid 
octanoic acid serves as a building block of lipoic acid, a cofactor essential for the functioning 
of several key enzymes in oxidative decarboxylation reactions [256]. The fatty acid pimelic 
acid serves as the precursor of biotin, another important co-factor involved in metabolic 
fixation of carbon dioxide [257].
Fatty acid biosynthesis
The bacterial fatty acid biosynthesis (FAB) cycle starts with the carboxylation of 2 acetyl-
CoA to malonyl-CoA by the multi-subunit complex accABCD [258] (Fig. 1). The malonyl 
moiety is subsequently attached as thio-ester to the phosphopantetheine prosthetic 
group of holo-ACP by FabD to form malonyl-ACP [259]. Three 3-ketoacyl-ACP synthases 
then catalyse the condensation of acetyl-CoA to the growing acyl-ACP. FabH initiates 
the first elongation by condensing acetyl-CoA to malonyl-ACP [260-262]. Subsequent 
elongations are catalysed either by FabF or FabB [263]. Each successive condensation 
is followed by a reduction to 3-hydroxyacyl-ACP by  FabG [264], a dehydration to 
enoyl-ACP by FabA or FabZ [265-267] and a final reduction to acyl-ACP by FabI. The 
latter enzyme has a key role in the completion of each elongation cycle [268, 269].
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Phospholipid biosynthesis
The first step in the biosynthesis of phospholipids is the esterification of a fatty acid to 
glycerol-3-phosphate (G3P) to form lysophosphatidic acid (LPA). The incorporated 
fatty acids can be utilized either as acyl-ACP or acyl-CoA. The reaction is catalysed by 
acyltransferases of either the PlsX-PlsY pathway or the PlsB pathway (Fig. 1). The PlsX-
PlsY pathway is the most abundant system encountered in bacteria. First, the membrane-
associated phosphate acyltransferase (PlsX) phosphorylates the fatty acid from acyl-ACP 
to form the intermediate acyl-phosphate. This activated acyl-chain is then transferred to 
the sn-1 position of G3P by glycerol-3-phosphate acyltransferase (PlsY). LPA synthesis may 
also proceed via the alternative PlsB pathway. The PlsB pathway, however, is essential to 
E. coli and cannot be substituted by the dispensable PlsX-PlsY pathway [270]. Glycerol-
3-phosphate acyltransferase (PlsB) is restricted to mycobacteria, alpha- and gamma-
proteobacteria like E. coli, and requires no phosphorylated intermediate [271]. In contrast 
to PlsX, PlsB is an integral membrane protein which acylates G3P by utilizing either acyl-ACP 
or acyl-CoA as substrate. For this esterification there is a clear distinction between acyl-ACP 
from the cytosol and acyl-CoA imported from the environment. The 1-acyl-sn-glycerol-3-
phosphate acyltransferase (PlsC) subsequently transfers a secondary fatty acid to LPA at 
the sn-2 position to form phosphatidic acid (PA). Analogous to PlsB, PlsC can also utilize 
either acyl-CoA or acyl-ACP as the fatty acid donor. Prior to polar head group attachment 
CdsA activates PA to form CDP-diacylglycerol (CDP-DAG). Finally, functional phospholipids 
are being formed, from which CDP-DAG bifurcates to two routes; either phosphatidyl-L-
serine and phosphatidyl-ethanolamine or phosphatidyl-glycerol and cardiolipin which are 
synthesized by PssA and Psd, or by PgsA, Pgp and ClsA respectively. 
Regulation of FAB and PL synthesis
Although a coordinated regulation between FAB, PL synthesis and FAD is evident, this 
process is still not fully understood. The fact that the phospholipid content of the cell 
remains constant regardless of the growth phase, suggests a coordinated regulation 
between all three pathways. A better understanding of this regulation might aid in designing 
metabolic engineering strategies for lipid biofuel productions. According to Zhang and 
Rock [246], the long-chain acyl-ACP end-products of FAB are the key regulators of the PL 
biosynthetic pathway. Cellular acyl-ACP levels in turn are controlled by the glycerol-3P sn-
1-acyltransferase (PlsB) activity. Additionally, acyl-ACP levels also rely on ACP availability 
and the rate of the FAB cycle. Acyl-ACP has been shown to regulate Acc, FabH and FabI 
activity, which are responsible for the rate of FA synthesis [272, 273]. Heath and Rock et 
al. revealed that an acyl-ACP accumulation inhibits fatty acid biosynthesis. This regulation 
was especially evident during the stringent response. Following amino acid depletion, the 
(pppGpp synthetase (RelA) causes the alarmone (p)ppGpp to accumulate, which effectively 
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silences PlsB activity and concomitantly causes acyl-ACP to accumulate resulting in FAB inhibition 
[274]. Although these studies indeed show a feed-back inhibition, it is not clear whether this 
is the only mechanism that silences phospholipid synthesis when resources are depleting. In 
addition, there is only partial understanding of the responses triggered on a transcriptional level. 
To shed more light on this regulation, we induced an inhibition of phospholipid synthesis. A barrier 
was established at the first committed step of phospholipid synthesis (PlsB) and the effects on 
growth and the proteome analysed. Because plsB is essential to E.coli [270], we exchanged the 
plsB promoter region for a tuneable and repressible promoter to generate a conditional plsB 
knock-down strain. To effectively control the rate of LPA formation, a plsB knock-down requires 
an additional knock-out of the classical PlsX-PlsY route. Complete abolishment of LPA formation 
was further explored by modulating the critical pool of ACP which allowed us to study cellular 
responses to the ACP isoforms: apo-ACP and acyl-ACP. The inactive apo-ACP, which is devoid in 
the attachment of the prosthetic phosphopantetheine group by holo-ACP synthase [275, 276], is 
shown to inhibit PlsB and PlsC in vitro [277]. The introduced modifications to inhibit PL synthesis 
were followed by analysis of the proteome to get more insight into the regulation of FAB, FAD 
and PL synthesis. This analysis revealed a modulated gene expression between FAB and FAD 
during induced silencing of membrane synthesis.
Results
Overproduction of PlsB and ACP causes growth arrest
To gain more insight in control mechanisms of phospholipid synthesis we constructed mutant 
strains that allowed for analysis of the first step of the main phospholipid synthesis route, i.e. 
the step catalysed by PlsB (Fig. 1). Because we were specifically interested in the effects of ACP 
and acyl-ACP on PlsB functionality, we used an E.coli JM109(DE3) plsX knockout strain as basis 
(Fig. S1). To enable modulation of plsB expression, we replaced the native promoters plsBp2 
and plsBp with the rhamnose promoter based on the sequence of a pRham–plsB-Chis plasmid, 
the functionality of which was demonstrated beforehand by anti-His Western blotting (Fig. S2). 
Instead of using this plasmid-based plsB system, a chromosomal promoter exchange of native 
plsB was generated (strain rhaPBAD-plsB) as it was anticipated to provide a more accurate control. 
The growth characteristics of the plsB-promoter mutant strain rhaPBAD-plsB was analysed upon 
induction and repression of plsB expression. Unexpectedly, growth was not blocked in the 
absence of rhamnose, but continued up to an OD of ~2.5. Even in the presence of glucose, 
which further represses plsB expression, this initial growth was observed, suggesting that the 
LB-medium contains available phospholipids or that cells can cope with a minimal amount of 
leaky expression of plsB. As expected, addition of rhamnose (0.1 % (w/v)) caused a continuation 
of growth albeit at rhamnose concentrations of >0.1% (w/v) (Fig. 2, panel 3). These findings 
prompted us to determine PlsB activity in the repressed and induced cultures. The PlsB activity 
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assays confirmed that rhamnose induces expression of plsB, and that glucose efficiently silences 
expression of plsB by catabolite repression (Fig. 3). These findings proof that the constructed 
mutants allow a controllable expression of plsB, but that (unexpectedly) growth does not 
correlate well with different PlsB levels, indicating some compensatory mechanism.
We subsequently transformed wild-type plsB and the rhaPBAD-plsB mutant strain with a pACYC-
acpP plasmid to study the effects of Acyl Carrier Protein (ACP). The inactive apo-ACP is known 
to competitively inhibit PlsB activity in vitro [277], and therefore is also expected to inhibit PlsB 
activity in vivo. We compared the growth characteristics of the wild-type (plsB under control of 
its native promoters) and the rhaPBAD-plsB mutant at a fixed level of PlsB expression (0.5% (w/v) 
rhamnose). Here we found that variable induction of acpP by different IPTG concentrations had 
clear effects (Fig. S3). The fact that overexpressed ACP co-localizes with an S36T-ACP mutant 
with disabled pantetheinylation on urea-PAGE (Fig. S4C) confirms that apo-ACP is responsible 
for this inhibition. Although growth in the ACP-overexpressed cells was reduced severely (Fig. 2, 
panel 2), growth was never reduced completely. The rhaPBAD-plsB strain, on the other hand, was 
expected to overcome the in vivo inhibition by apo-ACP by compensation with the overexpressed 
PlsB pool; although a 6-fold increase in PlsB activity was detected in the rhaPBAD-plsB strain (Fig. 
3), this situation did not counteract the growth inhibition, but instead it further enhanced the 
inhibition and led to almost complete growth arrest (Fig. 2, panel 4). Remarkably, introduction 
of the pACYC-acpP plasmid to the rhaPBAD-plsB strain (Fig. S3, panel 1) also reduces cell growth 
significantly. This growth reduction by apparent leaky expression of acpP highly contrasts 
growth of the mutant before transformation with pACYC-acpP. In this strain growth was only 
mildly affected by the increased PlsB pool (Fig. 2, panel 3). Based on the in vitro inhibition of PlsB 
by apo-ACP [277] and on the growth arrest during simultaneous overexpression of ACP and PlsB, 
it is concluded that growth inhibition by apo-ACP can not only be explained by PlsB inactivation.
Figure 2. Growth curves of acpP and plsB overexpressed cells AcpP overexpression is elicited by induction of the 
pACYC-acpP plasmid (50 µM IPTG) and plsB overexpression by induction of the rhaPBAD-plsB strain (0.5% (w/v) 
L-rhamnose). Lower panel shows induction (+) and no induction (-) of acpP and plsB expression. 
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Figure 3. Activity assay upon overexpression and repression of plsB The rhaPBAD-plsB strain shows induction, 
repression, and no stimulation of plsB by the rhamnose promoter substitution on the addition of respectively 
0.5% (w/v) rhamnose, 20 mM glucose, and LB only. The mutant strain is compared to an E.cloni strain transformed 
with empty vector and pRham-plsB-Chis plasmid as positive control. Additionally, the mutant is compared to an 
unmodified E.coli JM109(DE3) strain (WT). All error bars are based on 4 biological replicates.
FAB and PL synthesis are regulated by ACP and PlsB
plsB overexpression
To assess the expression profile during inhibited membrane synthesis and understand 
the observed changes in growth behaviour, we further analysed ACP and ACP - PlsB 
overexpressed cells. To obtain milder growth inhibitions, we resigned from using the 
pACYC-acpP plasmid which relies on T7 RNAP expression. Instead, wild-type plsB and 
rhaPBAD-plsB cells were transformed with the pCA24N–acpP plasmid that relies on the T5-lac 
promoter from the ASKA collection (strain JW1080) [278]. The novel strains were cultured 
on LB medium supplemented with 0.5% (w/v) rhamnose and 0, 0.1 and 0.5 mM IPTG. 
We performed a proteome analysis on cleared lysates and membrane fractions to obtain 
insight into changed levels of proteins involved in fatty acid and phospholipid synthesis or 
degradation (raw data in supplementary excel file S12). We first looked into the changes 
elicited by plsB overexpression alone (Fig. S5) to distinguish between effects of plsB and 
acpP overexpression. Overproduction of PlsB (28-fold, Fig. S6) promotes expression of fatty 
acid synthesis cycle proteins FabB, FabG, FabI and a repression of FadD whose peptides were 
no longer detected. These changes correspond with transcriptionally regulated responses 
by FadR and (p)ppGpp by RelA [247]. As FadR was only sparingly detected during PlsB 
overproduction (Fig. S7, 0 mM IPTG), (p)ppGpp is a plausible regulator responsible for these 
collateral changes in an attempt to silence PlsB activity. We also observed a large reduction 
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of phospholipid head group enzymes PssA, Psd, which suggests an overproduction of 
phosphatidylglycerol and reduction of phosphatidylethanolamine. Together these changes 
may contribute to the formation of elongated cells observed during plsB overexpression 
(Fig. S8).
acpP overexpression in wild-type plsB cells
We then looked into proteome changes caused by enhanced levels of ACP. The effect of 
acpP induction was analysed in both the wild-type and mutant plsB strain. In contrast to 
an expected activity increase, the increased ACP pool causes a down-regulation of PlsB in 
wild-type plsB cells (Fig. 4 and Fig. S9). Furthermore, no major changes were observed for 
the proteins involved in fatty acid synthesis and beta-oxidation cycle that could explain the 
toxicity of apo-ACP. Instead, the reduced PlsB pool is accompanied by an up-regulation of 
the fatty-acid synthesis genes, FabA, FabF, FabG, FabH and FabI. In contrast, proteins of 
the beta-oxidation cycle did not change markedly. The FadD protein (acyl-CoA synthetase) 
however showed a down-regulation at low IPTG induction. Interestingly, at high induction, 
the FadD pool increased, which facilitates coupled import and activation of fatty acids. The 
increased apo-ACP pool also causes an up-regulation of PlsC. Taken together, the inhibition 
and down-regulation of PlsB is accompanied by higher expression at the level of both acyl-
ACP and phosphatidic acid synthesis. Therefore, we speculate that growth continuation is 
facilitated by expediting flux through PlsB by increasing the acyl-ACP pool or by increasing 
the internalization of acyl-CoA. These observed responses correspond with a FadR-mediated 
control [279, 280] for which an up-regulation was indeed detected at high induction of acpP. 
Altogether these findings support an accumulation of acyl-ACP due to reduced PlsB activity.
Overproduction of ACP and PlsB in rhaPBAD–plsB cells
The shapes of the aforementioned growth curves (Fig. 2 and Fig. S3) indicate that an 
inhibitory mechanism takes place that (directly or indirectly) depends on the size of both 
the ACP and the PlsB pool. Our proteome analysis shows that large ACP and PlsB pools 
affect several of the involved enzymes, and that this appears to be the opposite after 
overexpression of ACP alone (Fig. 4, right panel). Our earlier discussed responses elicited 
by plsB overexpression alone also appear to differ markedly. During acpP and plsB co-
expression, we observed a down-regulation of the FAB cycle enzymes FabB, FabG and FabI 
(Fig. 4, and Fig. S10). Conversely, 3 proteins that make up the FAD pathway (FadB, FadD 
and FadE) are highly induced. In strain rhaPBAD-plsB, the level of FadE was already increased 
2-fold in response to plsB overexpression. Additional ACP however causes even higher titres 
of FadE (2.6 and 3.2-fold). This is in sharp contrast to the wild-type plsB strain in which acpP 
overexpression alone does not change the FadE pool. A simultaneous increase in PlsB and 
ACP levels apparently stimulates a shift in expression of fatty acid metabolism from anabolic 
(FAB) to catabolic (FAD) (Fig. 4). In contrast to wild-type plsB cells where sufficient acyl-ACP 
is expected, a reduced synthesis of acyl-ACP causing LPA shortage is a likely explanation 
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for the growth arrest. Based on these observations we hypothesize a shortage of de novo 
synthesized fatty acids in the rhaPBAD-plsB strain but not in the wild-type plsB strain. Both 
strains were therefore expected to allow growth rescue by free lysophosphatidic acid (LPA) 
addition, but only growth rescue by free fatty acid addition in the wild-type plsB strain.
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Figure 4. Summarized proteome changes Proteome changes are shown between ACP overproduction (wild-
type plsB) in the left panel and ACP/PlsB overproduction (rhaPBAD-plsB) in the right panel. Arrow thicknesses are 
not provided on absolute scale, but illustrated in Fig. S9 and Fig. S10. Blue arrows: up-regulations; black arrows: 
unchanged; red arrows: down-regulations in reference to non-induced cells of the respective strain. 
Transcription factors do not correlate with observed changes
We further analysed the transcriptional regulators involved in the expression of the analysed 
pathways[247] to find trends that may explain the observed differences in the proteome. In 
both wild-type plsB and rhaPBAD-plsB cells a down-regulation of FabR and an up-regulation 
of FadR were observed compared to non-induced cells (Fig. S7). The FabR and FadR changes 
correlate well with a stimulation of the FAB cycle. Although this relation is evident in the 
wild-type plsB cells, the changes observed in the rhaPBAD-plsB strain cannot be attributed to 
these transcription factors. In addition to FadR and FabR we therefore also looked at the 
transcription factors RpoS, CRP, (p)ppGpp by RelA and RpoE. During overexpression of plsB, 
we observed accompanied FAD up-regulations that were only observed at simultaneous 
acpP induction. The stimulation of FAD proteins in these cells is most likely regulated by 
the observed increase in RpoS. This finding however highly contrasts the increased FadR 
up-regulation which is known to cause a down-regulation of this pathway. Likewise did 
we observe an increased pool of RelA that can account for the changes in the FAB cycle. 
Conversely, the changes in FadR and FabR highly contradict this outcome. Hence, this data 
clearly shows that the transcriptional regulation profile does not allow a prediction of the 
metabolic status of the rhaPBAD-plsB cells. This suggests that ACP apparently exerts effects 
both by allosteric and (in)direct transcriptional control.
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PlsB and apo-ACP overproduction diminishes availability of fatty acids for PL synthesis
Based on the proteome analysis, we predicted an inhibition of membrane synthesis in wild-
type plsB cells upon acpP induction as a result of decreased lysophosphatidic acid (LPA) 
synthesis. For the rhaPBAD-plsB cells, overexpression of plsB and acpP was expected to cause 
a depletion of LPA by acyl-ACP shortage instead. These expectations were based on the 
down-regulation of FAB and up-regulation of FAD, which were not observed in the wild-
type plsB cells. To test this hypothesis, we attempted to restore growth by the addition of 
LPA or free fatty acids to the growth medium during acpP induction.
Our rescue assays demonstrate that diminished growth by acpP overexpression in the 
wild-type plsB strain can indeed be fully restored by the addition of LPA (Fig. 5, left panel). 
This observation thus confirms that apo-ACP inhibits acyl-ACP utilization by PlsB in vivo. 
This, however, also entails that sufficient acyl-ACP was present for PlsC to synthesize 
PA, indicating that the FAB cycle is not fully inhibited by the accumulating acyl-ACP. This 
finding also agrees well with the proteome data that demonstrates an up-regulation of FAB 
proteins. Growth recovery also occurs upon addition of fatty acids, which suggests that the 
inhibition of PlsB by apo-ACP can be overcome by competing with imported acyl-CoA. 
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Figure 5. LPA and FA growth rescue assays. Effect 
of LPA and fatty acid addition on cell growth in 
wild-type plsB and rhaPBAD-plsB cells during acpP or 
acpP and plsB overexpression respectively. Grey: 
oleic and palmitic acid administration, dark grey: 
LPA (14:0 and 18:1) administration, white, no IPTG 
control.*significantly different from 0 µg/ml control 
P<0.05, **significantly different from 0 µg/ml control 
P<0.01. 
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A similar LPA administration however, could not fully restore the growth arrest in the 
rhaPBAD-plsB mutant (Fig. 5, right panel). This suggests that unlike the wild-type situation, the 
level of acyl-ACP is now insufficient for PlsC to give complete recovery. This apparent lower 
acyl-ACP level agrees well with the down-regulation of FAB proteins in the mutant strain. 
Thus, the observed aggravated growth inhibition in rhaPBAD-plsB cells can be attributed to a 
reduced availability of acyl-ACP rather than a reduced activity of PlsB alone. In contrast to 
wild-type plsB, internalization of fatty acids showed only minor growth restoration despite 
a down-regulation of FAB that suggests a high need for fatty acids. This difference might be 
explained by activity of the increased beta-oxidation cycle that competes with PlsB for the 
internalized fatty acids. Altogether, a high level of PlsB and apo-ACP is shown to result in the 
silencing of FAB and PL synthesis by a combination of transcriptional and allosteric control.
Discussion
Only few studies have explored the balanced regulation between fatty acid and phospholipid 
synthesis. Previous studies report that long-chain acyl-ACP is the main regulator of membrane 
synthesis by feedback inhibition on FAB and requires proper balancing [246]. Here, we set 
out to further investigate the regulatory mechanisms of acyl-ACP on membrane synthesis, 
underlying the observed growth inhibition. An acyl-ACP accumulation implies that formation 
by FAB and consumption by PlsB, PlsX and PlsC are unbalanced. Additionally, long chain acyl-
ACP can only accumulate upon obstruction of PlsB, PlsX and PlsC activity or a G3P shortage. 
To provide clarity in this mechanism, we investigated whether there are other regulatory 
systems involved that change expression of FAB, PL synthesis and FAD upon induced inhibition 
of membrane synthesis. 
Wild-type plsB
To study changes in expression levels of the FAB cycle and PL synthesis pathway, we inhibited 
phospholipid synthesis by overexpression of ACP in wild-type plsB cells. As apo-ACP did not 
abolish growth completely, these cells were expected to respond by up-regulating their PlsB 
level. Proteome analysis in these cells however demonstrated a down-regulation of PlsB 
instead. To explain this down-regulation, we also analysed changes in transcription factors. 
Our data suggests that the observed down-regulation is likely elicited by the alarmone (p)
ppGpp caused by RelA up-regulation. A PlsB down-regulation and blocked activity by apo-
ACP should lead to an accumulation of long-chain-acyl-ACPs and the concomitant cessation 
of fatty acid synthesis [272-274, 281-283]. This, however, does not agree with the observed 
up-regulated expression of fatty acid synthesis proteins FabH, FabG, FabF, FabB, FabI, as well 
as of PlsC shown in this study. Feedback inhibition of FabH and FabI by acyl-ACP (allosteric) is 
apparently compensated by up-regulation of these genes. This questions the main role of acyl-
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ACP as a controller of the rate of fatty acid synthesis. To further study the mechanism of the 
growth inhibition, we performed a FA and LPA rescue assay. Here we observed that growth 
was fully restored by the addition of LPA, which confirms that PlsB inhibition by apo-ACP was 
indeed the causative obstruction. In addition, this restored growth implies that sufficient FAB 
activity is maintained, as for PA formation from LPA, acyl-ACP is also required. Apparently, LPA 
addition relieves the acyl-ACP accumulation by activity of PlsC which utilizes acyl-ACP as well. 
Fatty acid addition to the medium also led to growth rescue which implies that PlsB inhibition 
by apo-ACP tolerates acyl-CoA utilization in contrast to earlier observations [277].
In the absence of exogenously added fatty acids or LPA, PlsB inhibition is evidently accompanied 
by increased acyl-ACP and PA synthesis as shown by the up-regulated expression of FAB and 
PlsC enzymes. Altogether, it is shown that an accumulation of acyl-ACP is not an exclusive 
condition for silencing of phospholipid synthesis, and not necessarily accompanied by down-
regulation of FAB proteins. 
rhaPBAD-plsB mutant
By replacing the native promoters of plsB with a rhamnose promoter we showed that 
repression of plsB inhibits growth, but did not suffice to cause a complete growth arrest. 
Therefore we attempted to enhance the inhibition of membrane synthesis by also 
increasing the apo-ACP pool. Overexpression of ACP in combination with a repressed 
plsB expression proved successful in abolishing growth. We expected that the inhibitory 
effect of apo-ACP could be relieved by causing an overexpression of plsB as was already 
demonstrated for ppGpp induced growth inhibition [274]. However, overexpression of PlsB 
(28-fold) failed to rescue growth at increased ACP pools. In contrast, growth inhibition was 
even aggravated. This finding is a first indication that apo-ACP has additional inhibitory 
effects on growth, apart from merely PlsB inhibition. During simultaneously high PlsB and 
ACP pools, proteome data showed notable changes which were not observed when either 
PlsB or ACP are overexpressed separately. Here we observed a down-regulation of fatty 
acid synthesis proteins FabI and FabB in contrast to an up-regulation which was observed 
when ACP alone was overexpressed. Concomitantly, a significant increase in fatty acid 
degradation enzymes FadB, FadE, FadD and FadL was induced. Altogether these changes 
suggest a decreased acyl-ACP pool and an increased beta-oxidation activity. Therefore, 
we hypothesized that a shortage of available fatty acids for membrane synthesis was the 
detrimental deficiency instead of an inhibition of PlsB alone. To test this, a rescue assay by 
FA and LPA supplementation to the medium was also performed on these cells. This assay 
demonstrated that growth inhibition in this strain is not recovered by fatty acid uptake and 
only poorly by LPA which validates the hypothesis. This data shows that high apo-ACP and 
PlsB pools induces a metabolic shift towards degradation of fatty acids. Another contributing 
player is (p)ppGpp, that is expected to accumulate by the observed up-regulation of RelA. 
This alarmone plays a crucial role in the stringent response which modulates transcription 
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of many genes under conditions of amino acid limitation. Thus, (p)ppGpp may have been 
formed in response to high PlsB expression in an attempt to suppress the activity and 
gene transcription. An additional effect of the stringent response might therefore also be 
found by the down-regulation of FAB and increase of FAD. The accumulation of (p)ppGpp, 
however, cannot explain all differences between the strains, as RelA was also found to be 
highly expressed in the wild-type plsB cells. 
In conclusion, our data shows that a model in which acyl-ACP accumulation always triggers 
silenced membrane synthesis is too simple. We postulate that FAB down-regulation and FAD 
up-regulation are transcriptionally-controlled phenomena in response to simultaneously 
elevated pools of both PlsB and apo-ACP. 
Materials and Methods
Generation of a plsX knock-out strain
A plsX knock-out was obtained according to a modified gene disruption protocol by 
Datsenko and Wanner [234]. Briefly, E.coli JM109(DE3) cells were transformed with 
pKD46 by heat shock. Electrocompetent cells were made by growing a culture on 2x Yeast 
Peptone ampicillin 100µg/ml supplemented with 10 mM L-arabinose to induce the λ Red 
recombinase. Primers to amplify the gene disruption cassette are listed in Table 1. The 
5’-end of For-H1-plsX-P1 contains a 39 nucleotides homologous end, corresponding to the 
upstream region of plsX. The 5’-end of Rev-H2-plsX-P2 contains a 40 nucleotides homologous 
end that corresponds to the upstream region of fabHp which is located at the 3’-end of plsX. 
A new disruption cassette was developed based on the cassette of Westra E.R. et al.[284], 
but with lox71(left)/lox66(right) sites [285] instead of frt sites flanking kanR (synthesized 
and cloned SfiI/SfiI in pMA-RQ by Geneart AG, see supplementary information (S11) for 
description and sequence). The primers For-H1-plsX-P1 and Rev-H2-plsX-P2 were used to 
amplify the plsX knockout cassette from the plasmid template pMA-RQ lox71-kanR-lox66. 
The amplified fragments were applied on agarose gel and extracted. The purified knockout 
cassettes were transformed at 100 ng DNA by electroporation 2.5 kV, 200Ω, 25 µF at 5 ms. 
Cells were plated at 37oC on lysogeny broth (LB)-agar plates with 50 µg/ml kanamycin. For 
subsequent elimination of kanR by Cre-recombinase, parts of the protocol from Datsenko 
and Wanner [234] were replaced by components of the protocol from Palmeros et al. [286]. 
The integrated kanamycin resistance gene was cleared by transformation with pJW168 
and subsequent IPTG induction of Cre-recombination of the flanking lox-sites by plating 
on LB-agar Amp100 plates supplemented with 0.5 mM IPTG. Recombination events were 
confirmed by colony-PCR amplification using primers plsX-k.o-For and plsX-k.o-Rev specific 
for the flanking rpmF and fabH genes respectively. The newly obtained plsX knock-out strain 
was cleared from plasmids by growth at 37oC and designated WUR45.
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Cloning and characterization of the pRham-plsB plasmid
The plsB gene was amplified from E. coli MG1655 genomic DNA by using the primer pair 
For-prham-plsB and Rev-prham-plsB-Chis. E.cloni cells (Lucigen corp.) were co-transformed 
with 75 ng plsB insert and 25 ng linear pRhamTM vector according to the manufacturer’s 
procedure. The obtained colonies were screened by colony PCR using the pRham forward 
and pETite reversed primer. The newly obtained plasmid was designated pMS32 (pRham 
plsB-Chis). A single colony of E.cloni pRham-plsB-Chis was used to inoculate fresh LB medium 
supplemented with 50 µg/ml kanamycin to obtain a pre-culture. Fresh LB-Kan50 medium 
(9x10ml) was inoculated with a 100x diluted pre-culture and supplemented with glucose or 
rhamnose at an OD
600
=0.8. The induced cultures were grown an additional 4h at 37oC. Cells 
were subsequently harvested by centrifugation. The cell pellets were resuspended in 1.5 ml 
ice cold lysis buffer: 50 mM Tris HCl, pH=8, EDTA 1 mM, NaCl 150 mM, DTT 1 mM, PMSF 0.1 
mM. Induced E.cloni cells were homogenized by 4 pulses of 20 s ultrasonication. Cleared 
lysates were obtained by 10 min centrifugation of the crude extracts at 10,500 xg at 4oC. The 
protein content of cleared lysates was quantified by the Roti Nanoquant method according 
to Bio-RAD. Twenty µg protein per sample was applied on 8.5% SDS-PAGE. Proteins were 
transferred to nitrocellulose membrane for 1.5 h at 130 mA. The nitrocellulose membrane 
was blocked with bovine serum albumin (BSA). PlsB was visualized with primary antibody 
mouse anti-His6 IgG and secondary antibody Alexa Fluor488 goat anti-mouse IgG.
Table 1. Oligonucleotides, strains and plasmids used in this study
Primer Oligo Sequence (5’ 3’)
Construction of mutants
For-H1-plsX-P1 GGCAACTGGGGAAAGACCAAACCGGGCGGCGACGATACCGGTGTCTTTTTTACCTGTTTGACC
Rev-H2-plsX-P2 CCCTTCACCCTGAGATTTCAGCAGAGAAAGGAACATCCTGCTACCTCTGGTGAAGGAGTTG
plsX-k.o.-For TCCATGGCCGTACAACAG
plsX-k.o.-Rev AAAGCGTGCGTAGCAGAAGTC
For-plsB-KI-S3 ATTTCCAGCGGCTCTAACG
For-plsB-exch-Nter     TTCAGGCGCTTAACGGTAAC
Construction of plasmids
For-prham-plsB GAAGGAGATATACATATGTCCGGCTGGCCACGAATTTAC
Rev-prham-plsB-Chis     GTGATGGTGGTGATGATGCCCTTCGCCCTGCGTCGCACT
pRHam forward GCTTTTTAGACTGGTCGTAGGGAG
pETite reversed CTCAAGACCCGTTTAGAGGC
For-NcoI-acpP GCGCCATGGGCACTATCGAAGAACGCGTTAAG
Rev-BamHI-acpP GCCGGATCCTTACGCCTGGTGGCCGTTGATGTA
ACYCDuetUP1 GGATCTCGACGCTCTCCCT
DuetDOWN1 GATTATGCGGCCGTGTACAA
For-SDM-ACP-S36T      CGTTGAAGACCTGGGCGCGGATACTCTTGACACCGTTGAGCTGG
Rev-SDM-ACP-S36T     CCAGCTCAACGGTGTCAAGAGTATCCGCGCCCAGGTCTTCAACG
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Homologous ends and restriction sites are underlined
Strains Plasmids Genes / Characteristics
WUR45 JM109(DE3) ∆plsX
WUR46 pMS46 pCR2.1topo lox71-kanR-lox66
WUR61 pKD46 JM109(DE3) ∆plsX, pKD46
WUR102 JM109(DE3) ∆plsX, ∆dgkA, rhaPBAD-plsB
WUR32 pMS32 pRham plsB-Chis
WUR57 pMS57 pRham -
WUR132 pMS132 pACYCduet – acpP
WUR133 pMS133 pACYCduet – acpP (S36T)
WUR105 pUC18 JM109(DE3) ∆plsX, ∆dgkA, rhaPBAD-plsB, pUC18
WUR106 pCA24N acpP JM109(DE3) ∆plsX, ∆dgkA, rhaPBAD-plsB, pCA24N acpP
WUR113 pUC18 JM109(DE3) pUC18
WUR115 pCA24N acpP acpP
WUR139 pMS132 JM109(DE3) ∆plsX, pACYCduet – acpP
WUR140 pMS133 JM109(DE3) ∆plsX, pACYCduet – acpP (S36T)
WUR141 pMS132 JM109(DE3) ∆plsX, ∆dgkA, rhaPBAD-plsB, pACYCduet – acpP
WUR142 pMS133 JM109(DE3) ∆plsX, ∆dgkA, rhaPBAD-plsB, pACYCduet – acpP (S36T)
plsB promoter exchange with rhaPBAD and strain characterization
The sequence of the rhaPBAD -promoter exchange cassette was designed according to the 
sequence of the rhaPBAD-plsB promoter-gene sequence of the previously characterized 
pMS32 plasmid. A stretch of 288 nucleotides upstream of the plsB startcodon which entails 
the rhaPBAD promoter, was attached to the 5’-end of the lox71-kanR-lox66 cassette. This 
resulting construct was additionally flanked at the 5’-end with 227 nucleotides of the plsB 
gene which represents the 5’-homologous region H1. At the 3’-end of the lox71-kanR-lox66 
cassette, 292 nucleotides of the lexA gene including the upstream lexA repressor binding 
sites 1, 2, 3 and lexAp promoter sequence were attached and represent the 3’-homologous 
region H2. The 5’-terminus of the homologous region H1 was extended with nucleotides 
5’-GGC to form a unique SfoI site which upon digestion leaves a native blunt-end terminus. 
The 3’-termini of the homologous region H2 was likewise extended with nucleotides 5’-
GCC to form a secondary SfoI site which upon digestion also leaves another native blunt-
end terminus. The cassette was artificially synthesized by GeneArt (Life Technologies) and 
subcloned in a pMA-RQ plasmid. To obtain linear promoter exchange cassettes, 13 µg of 
pMA-RQ entailing the synthesized construct was double digested with AvaII (Eco47I) and 
SfoI (EheI) Thermo Fisher Scientific Inc. The digest was subsequently applied on a 1% (w/v) 
agarose gel and the 1887 bp fragment excised from gel. Competent WUR61 (JM109(DE3) 
∆plsX, pKD46) cells were transformed with 300 ng gel-extracted and purified cassette DNA 
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by electroporation. The transformed cells were subsequently plated on LB-agar plates 
supplemented with 50 µg/ml kanamycin and 0.2% (w/v) rhamnose. The newly obtained 
colonies were screened for insert by colony PCR using the primer pair: For-plsB-KI-S3 and For-
plsB-exch-Nter. An integration efficiency of 40% was established for the screened colonies. 
The kanR gene was cleared from the genome by Cre-recombinase as described previously. 
The newly obtained plsB mutant strain was designated as WUR102 (JM109(DE3) ∆plsX, 
∆dgkA, rhaPBAD-plsB). The plsB mutant and wild-type were additionally transformed with 
pUC18 plasmid to include an independent antibiotic selection marker and are designated 
as WUR105 and WUR113 respectively. A single colony was used to inoculate 25 ml LB 
100 µg/ml ampicillin, rhamnose 0.05% (w/v) as a pre-culture. Second pre-cultures were 
started in 10 ml LB-Amp100 from 1/1000 volume pre-culture 1. Secondary pre-cultures were 
supplemented with 20 mM glucose, and 0, 0.01, 0.02, 0.05, 0.1, 0.2, 0.5, 1 and 2% (w/v) 
rhamnose and grown o/n at 37oC. Twenty-five ml LB Amp100 supplemented with appropriate 
substrates were inoculated at 1/1000 volume from the secondary pre-cultures in triplicates 
and grown at 37oC. Growth curves were obtained by measuring turbidity at 600 nm. Cells 
were subsequently checked under a light microscope at a 1000x magnification to examine 
their morphology. 
G3P acyltransferase (PlsB) activity assay
WUR57 (empty vector) WUR32 (pRham-plsB-Chis plasmid) and WUR102 (rhaPBAD-plsB) 
were grown in 100 ml LB supplemented with 20 mM glucose or 0.5% (w/v) rhamnose and 
appropriate antibiotics. Likewise, WUR115 (rhaPBAD-plsB with pCA24N-acpP) cells were 
grown at 0.5% (w/v) rhamnose and 1 mM IPTG to test PlsB activity upon acpP induction. 
The cells were harvested after 16 and 42 h growth resp. at 37oC by a 10 min centrifugation 
at 4,700 rpm and 4oC. Cell pellets were subsequently resuspended in 8 ml cold lysis buffer 
(Tris HCl 50 mM pH=8, 1 mM EDTA, 150 mM NaCl, 1 mM DTT and 0.1 mM PMSF). The cells 
were lysed by two passages through a french press cell at 16,000 psi. To obtain cleared 
lysates, the crude extracts were centrifuged 10 min at 10,000 xg at 4oC. The cleared lysates 
were then ultracentrifuged at 120,000 xg at 4oC for 70 min to obtain membrane fractions. 
The pelleted membranes were covered with 200 µl lysis buffer and resided at 4oC >48 h. The 
membranes were resuspended in the lysis buffer by gently pipetting. The protein content 
was quantified by Roti nanoquant (Roth). The G3P acyltransferase reaction mixture was 
composed of: 100 mM Tris-HCl (pH=8.4), 0.3 M NaCl, 1 mg/ml BSA, 3.5 mM MgCl2, 1 mM 
14C-glycerol-3P ( 10 mCi/mmol) (Perkin Elmer), 50 µM palmitoyl-CoA (Sigma-Aldrich) in a 
final volume of 200 µl. The reaction was initiated by addition of 10 µg membrane fraction 
to the reaction mixture and incubated at 24oC for 10 min. The reaction was stopped by 
addition of 0.6 ml of 1% HClO
4
. Lysophosphatidic acid product was extracted by addition of 
3 ml CHCl
3
:MeOH (1:2 v/v) and vortexing. This was followed by addition of 1 ml CHCl
3
 and 
1 ml 1% HClO
4
. Two phases were reconstituted by centrifugation (5 min at 1,000 xg). The 
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upper aqueous phase was removed by aspiration, and the organic phase was washed twice 
with 2 ml 1% HClO
4 
to remove residual substrate. The product was measured by counting 
disintegrations on a scintillation counter. 
Cloning of acpP and acpP S36T in pACYCduet
The acpP gene was amplified by PCR using the primer pair For-NcoI-acpP and Rev-BamHI-
acpP from E.coli MG1655 genomic DNA template. The resulting PCR product was digested 
with NcoI and BamHI, and then ligated into the corresponding restriction sites of pACYC-duet 
(Novagen). This construct was designated pMS132 and transformed to competent NEB5α 
cells (New England Biolabs Inc.) by heat shock according to the manufacturer’s procedure. 
The newly obtained colonies were screened for insert by colony PCR using the provided 
ACYCDuetUP1 and DuetDOWN1 primers. To mutate the serine at amino acid position 36 
to a threonine, a single nucleotide mutation thymine109 was exchanged for an adenine. 
Quikchange site directed mutagenesis was performed on the newly obtained pMS132 plasmid 
using the primer pair For-SDM-ACP-S36T and Rev-SDM-ACP-S36T according to Stratagene. 
The mutated plasmid pMS133 was obtained by performing a Phusion polymerase (Life 
Technologies) reaction followed by a DpnI reaction. The resulting plasmid was transformed 
to NEB5α cells and screened by sequence analysis. 
Strain and ACP pool characterization
The newly obtained plasmids pMS132 and pMS133 were transformed by electroporation to 
the previously generated WUR45 and WUR102. The newly obtained strains were designated 
WUR139 and WUR140 from WUR45 respectively and WUR141 and WUR142 from WUR102 
respectively. A single colony was used to inoculate 10 ml LB supplemented with 34 µg/ml 
chloramphenicol and grown overnight at 37oC to obtain a pre-culture. For each induction, 
25 ml LB-Cm34 supplemented with 0.5% (w/v) rhamnose with appropriate IPTG addition was 
inoculated at 1/100 volume from the obtained pre-culture. Each induction was performed in 
triplicate. Growth curves were obtained by measuring turbidity at 600 nm. For ACP detection 
on urea-PAGE, fresh cultures were obtained and incubated on ice after 28.5 h. of growth. The 
cells were harvested by centrifugation for 10 min at 4700 rpm on a Sorvall centrifuge at 4oC. 
The obtained cell pellets were resuspended in 1 ml cold lysis buffer. Cells were homogenized 
by 4 pulses of 20 sec ultrasonication. Cleared lysates were obtained by centrifugation of the 
crude extracts (10 min at 10,500 xg at 4oC). The protein content was subsequently quantified 
by the Roti-Nanoquant method (Roth). ACP species were analysed on a 13% PAGE containing 
2.5M urea. Twenty µg of protein per sample was diluted in sample buffer (3x) (150 mM 
Tris-HCL pH=6.8, DTT 300 mM, 0.3% bromophenol blue, 30% glycerol, urea 2.5M). Samples 
were boiled 10 min at 95oC and loaded on 13% PAGE containing 2.5 M urea. Proteins were 
subsequently stained by PAGE-blue (Bio-RAD) according to the manufacturers procedures. 
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Proteome analysis of ACP overproduction
WUR102 and WUR45 were transformed with pCA24N-acpP isolated from the ASKA 
collection strain JW1080 to obtain strains WUR106 and WUR115 respectively. A pre-culture 
was obtained by inoculation of 10 ml LB Cm34 from a single colony and growing overnight 
at 37oC. 100 ml LB Cm34 supplemented with 0.5% (w/v) rhamnose was inoculated at 1/1000 
volume from the pre-culture. The samples were induced at 0, 0.1 and 0.5 mM IPTG and 
grown approximately 42 h at 37oC to obtain a stable growth plateau. Cleared lysates and 
membrane fractions were generated as described previously. Membrane fractions were 
resuspended in a solution containing 0.5 M 6-aminocaproic acid and 5 g/L n-dodecyl-beta-
D-maltoside to solubilize membrane proteins. Membrane fractions were solubilized for 
1 h. at 20oC at vigorous stirring. After 15 min sonication in a sonicator bath, the fractions 
were centrifuged at 14,000 rpm for 30 min to pellet insolubilized aggregates. Protein 
content of the obtained cleared lysate samples and solubilized membrane proteins was 
subsequently quantified by Roti-nanoquant. Twenty-five µg protein from both cleared lysate 
and membrane fraction was loaded on a pre-cast 10% acrylamide gel Mini-PROTEAN® TGX 
(BioRad) and electrophoresed 12-15 min at 15 mA to migrate 1-1.5 cm. The gel was washed 
with demiwater and stained with PAGEblue (Thermo Fisher Scientific). The stained proteins 
were excised from gel. Trypsin digestion and peptide clean-up were performed according 
to the standard procedures of the Radboud UMC Centre for Proteomics, Metabolomics and 
Glycomics, (Nijmegen, the Netherlands). LC-MS/MS profiling of the peptides was performed 
by nanoflow C18 reversed phase liquid chromatography coupled to a Maxis 4G +ETD Q-TOF 
instrument (Bruker Daltonics) The samples were measured with CID (Collision Induced 
Dissociation) as fragmentation technique and chromatographic separation was achieved via 
a linear gradient of 7 to 35% acetonitrile using 0.1% formic acid as ion pair reagent. Data 
analysis was performed using the MaxQuant software package. 
FA and LPA growth rescue assay
Induced cultures of WUR139 and WUR140 were obtained as described previously for the 
strain characterization. Both strains were induced with 25 µM IPTG. Three stock solutions 
of fatty acids and LPA were prepared at 2, 5 and 10 mg/ml in LB Tween-20 5%. Fatty acid 
stock solutions were prepared from palmitic acid and oleic acid (Sigma Aldrich) at a (1.63 
: 1.00) ratio as shown for E.coli W3110 fatty acid composition at 30oC [287, 288]. The LPA 
stock solutions were prepared from 1-myristoyl-2-hydroxy-sn-glycero-3-phosphate (14:0) 
and 1-oleoyl-2-hydroxy-sn-glycero-3-phosphate (18:1) provided by Avanti Polar Lipids Inc. 
by solubilizing in a (1 : 4.26) ratio as determined at physiological compositions at 30oC [287, 
288] in LB Tween-20 5%. Fatty acid and LPA mixtures were added directly after induction 
and inoculation. Triplicate cultures were grown in 10 ml LB from each FA and LPA containing 
medium at 0, 100, 250 and 500 µg/ml. Control cultures were subjected to similar volumes 
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of LB Tween-20 5% without fatty acids or LPA. Growth performance was determined by 
measuring turbidity at 600 nm after 20 h. incubation at 37oC. 
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Figure S1. Generation of a plsX knock-out. A: Fab gene cluster plsX-fabHDG showing the fabHp promoter at the 
3’-end of plsX. The knock-out cassette shows the corresponding homologous regions positioned on the rpmF 
and plsX gene. Although the fabHp-promoter is compensated by the upstream YceDp1 and YceDp2 promoters, 
transcriptional alteration of the fatty acid synthesis cycle was avoided by excluding this region from the disruption. 
Fig. S1B: 1% agarose gel showing PCR amplification of the knock-out strain plsX region at 1011 bp, wild-type plsX 
at 1655 bp and the gene disruption harbouring the lox flanked kanamycin resistance gene (LKL) at 1999 bp.
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kDa 
A 
Figure S2. Exchanging the native promoters plsBp2 and plsBp with a rhaPBAD promoter. A: Inducible control 
of plsB was tested in a pRham-plsB-Chis plasmid. Western Blot analysis on the C-terminal His-tagged PlsB was 
performed by mouse-anti-His IgG, and visualised with Alexa-fluor 488. Effective catabolite repression by glucose 
and induction by rhamnose addition is confirmed. In the absence of glucose and rhamnose ‘LB’, leaky production of 
PlsB (91.4 kDa) is visible. Tuneable control of plsB expression was shown by adding different amounts of rhamnose 
(%). EV: empty vector S2B: A knockout cassette was employed that replaces plsBp2 and plsBp with the rhamnose 
promoter based on the acquired plasmid sequence of pRham-plsB-Chis. Because of partial overlap of plsBp and 
some putative transcription factor sites with the 5’-end of dgkA, it was decided to disrupt dgkA simultaneously 
with the promoter exchange. The dgkA gene is shown essential only during hypo-osmotic circumstances, and 
therefore assumed to be of no relevant influence in further analyses.
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Figure S4. Urea-PAGE analysis of the ACP pool A: Urea PAGE showing cleared lysate fractions from WUR139 
(∆plsX, pACYC - acpP) and WUR140 (∆plsX, pACYC – acpP S36T) at various IPTG concentrations. acpP S36T is a 
mutant in which the serine-36 pantetheinylation is disabled causing an apo-ACP accumulation. S4B: Urea PAGE 
showing WUR140 inclusion body aggregates resolubilized in lysis buffer and by sonication. ACP aggregates are 
abundant at concentrations of 0.025 and 0.05 mM IPTG. Less ACP fragments (soluble and insoluble) are present 
at concentrations >0.1 mM IPTG indicating a correlation between growth inhibition and ACP overexpression. S4C: 
Urea-PAGE showing overexpression of ACP and ACP-S36T at 0, 0.025 and 0.05 mM IPTG induction. Protein samples 
were normalized to 20 µg. An increased production of apo-ACP is shown. Holo-ACP is likely caused by endogenous 
expression. The asterisk indicates the position of a partially (un)-folded or variant of undescribed nature. 
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Figure S5. Proteome changes upon PlsB overproduction. A 28-fold increase 
in PlsB by 0.5% (w/v) rhamnose induction, stimulates overexpression of FAB 
enzymes FabB, FabG and FabI and a down-regulation of FadD. A PssA and Psd 
down-regulation suggests an accumulation of phosphatidylglycerol. Legend 
shows log values of fold changes compared to wild-type plsB cells. (adapted 
from Janβen and Steinbüchel 2014 [247]).
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Figure S6. Proteome values (LFQ peptide intensities) of ACP and PlsB. PlsB overexpression is shown by rhamnose 
addition at a maximum of 28-fold increase. Conversely, PlsB pools are decreased by the presence of high ACP pools 
despite equal rhamnose induction. ACP levels are produced in higher quantities in the rhaPBAD- plsB strain at 0.5 
mM IPTG induction. Grey bars: rhaPBAD - plsB, black bars: wild-type plsB.
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Figure S7. Proteome values of transcription factors FabR, FadR, RpoS, CRP, RelA and RpoE. In grey: rhaPBAD-plsB, 
in black: wild-type plsB.
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plsX, DgkA, rhaPBAD- plsB, at 0.5% rhamnose 
plsX, DgkA, rhaPBAD- plsB, at 20 mM Glucose  
Figure S8. Light microscopy pictures of E.coli cultures. PlsB overexpression by 0.5% (w/v) rhamnose addition 
changes the cell morphology to elongated cells. PlsB repression by 20 mM glucose addition changes cell morphology 
to coccoid shaped cells. Cells shown were taken from the same magnification of 1000 x.
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Figure S9. Wild-type plsB strain proteome Representation of fatty acid and phospholipid synthesis and degradation 
pathways at 0.1 mM (upper panel) and 0.5 mM (lower panel) IPTG induction of acpP. Legend shows log values of 
fold changes compared to non-induced sample. Blue: upregulation, Red: downregulation. (adapted from Janβen 
and Steinbüchel 2014 [247])
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Figure S10. RhaPBAD - plsB strain proteome. Representation of fatty acid and phospholipid synthesis and degradation 
pathways at 0.1 mM (upper panel) and 0.5 mM (lower panel) IPTG induction of acpP. PlsB overproduction by 
0.5% (w/v) rhamnose induction. Legend shows log values of fold changes compared to non-induced sample. Blue: 
upregulation, Red: downregulation. (adapted from Janβen and Steinbüchel 2014 [247])
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S11: Disruption cassette sequence and design. 
 
GGCCGTCAAGGCCGCATAAGCTTGGTGTCTTTTTTACCTGTTTGACCCTGCAGTACCGTTC
GTATAATGTATGCTATACGAAGTTATAGATCTCTATTTGTTTATTTTTCTAAATACATTCAAAT
ATGTATCCGCTCATGAGACAATAACCCTGATAAATGCTTCAATAATATTGAAAAAGGAAG
AGTATGAGCCATATTCAACGGGAAACGTCTTGCTCTAGGCCGCGATTAAATTCCAACATG
GATGCTGATTTATATGGGTATAAATGGGCTCGCGATAATGTCGGGCAATCAGGTGCGACA
ATCTATCGATTGTATGGGAAGCCCGATGCGCCAGAGTTGTTTCTGAAACATGGCAAAGGT
AGCGTTGCCAATGATGTTACAGATGAGATGGTCAGACTAAACTGGCTGACGGAATTTATG
CCTCTTCCGACCATCAAGCATTTTATCCGTACTCCTGATGACGCATGGTTACTCACCACTG
CGATCCCCGGGAAAACAGCATTCCAGGTATTAGAAGAATATCCTGATTCAGGTGAAAATA
TTGTTGATGCGCTGGCAGTGTTCCTGCGCCGGTTGCATTCGATTCCTGTTTGTAATTGTCCT
TTTAACAGCGACCGCGTATTTCGTCTCGCTCAGGCGCAATCACGAATGAATAACGGTTTG
GTTGATGCGAGTGATTTTGATGACGAGCGTAATGGCTGGCCTGTTGAACAAGTCTGGAAA
GAAATGCACAAACTTTTGCCATTCTCACCGGATTCAGTCGTCACTCATGGTGATTTCTCAC
TTGATAACCTTATTTTTGACGAGGGGAAATTAATAGGTTGTATTGATGTTGGACGAGTCG
GAATCGCAGACCGATACCAGGATCTTGCCATCCTATGGAACTGCCTCGGTGAGTTTTCTC
CTTCATTACAGAAACGGCTTTTTCAAAAATATGGTATTGATAATCCTGATATGAATAAATT
GCAGTTTCATTTGATGCTCGATGAGTTTTTCTAAGTCGACATAACTTCGTATAATGTATGCTA
TACGAACGGTAGCGGCCGCCAACTCCTTCACCAGAGGTAGGAATTCCTGGGCCTCATGGGC
C 
Figure S11. Disruption cassette sequence and design. lox71-kanR-lox66 disruption cassette. Underlined and italic 
nucleotides indicate restriction sites and lox sites, respectively. The cassette contains from 5’ to 3’ a SfiI site (used 
for cloning by Geneart), a HindIII site, a site for primer annealing, a PstI site, lox71, a BglII site, kanR, a SalI site, 
lox66, a NotI site, a site for primer annealing, an EcoRI site, and a SfiI site (used for cloning by Geneart).
Figure S12. Proteomics raw data excel file. Quantification of 1255 proteins in reference to E.coli K12 proteome by 
Maxquant version 1.5.0.0. software package
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5In Archaea, the membrane phospholipids consist of isoprenoid hydrocarbon chains that are ether-linked to a sn-glycerol-1-phosphate backbone. This unique structure is believed to be vital for the adaptation of these microorganisms to extreme environmental conditions, but it also reflects an evolutionary marker that distinguishes archaea from bacteria and eukaryotes. CDP-archaeol is the central precursor for polar head group attachment. We examined various bacterial enzymes involved in the attachment of L-serine and glycerol as polar head groups for their promiscuity in recognizing CDP-archaeol as a substrate. Using a combination of mutated bacterial and archaeal enzymes, archaetidylethanolamine (AE) and archaetidylglycerol (AG) could be produced in vitro using nine purified enzymes and starting from simple building blocks. The ether lipid pathway constituted by a set of archaeal and bacterial enzymes was introduced into E. coli, which resulted in the biosynthesis of AE and AG. This is a further step in the reprogramming of E. coli for ether lipid biosynthesis.
Keywords: archaea; ether lipid biosynthesis; membrane proteins; Liquid 
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Introduction
The cytoplasmic membrane is an essential constituent of cells. It forms a barrier that 
separates the cytosol from the external milieu. In conjunction with energy transducing 
complexes and transporter proteins, the phospholipid bilayer allows a homeostasis of the 
intracellular concentration of nutrients and other metabolites within the cell[289, 290]. The 
lipid composition of the cytoplasmic membrane differs between organisms, and is one of 
the elements that distinguishes Archaea from Bacteria and Eukarya. This marked diversion 
of the lipid composition is also termed “the lipid divide” that may finds its origin in the early 
stages of the evolution of life[14, 17, 291, 292].
Archaeal lipids are composed of highly branched isoprenoid chains ether-linked to a 
glycerol-1-phosphate (G1P) backbone, compared to fatty acid chains ester-linked to a 
glycerol-3-phosphate (G3P) backbone as typically found in bacteria and eukarya. Besides 
these main characteristics, archaeal membranes display a further diversity in their lipid 
composition consisting of different modifications of the two major structures: sn-2,3-
diphytanylglycerol diether, called archaeol and sn-2,3-diphytanylglycerol tetraether lipid, 
known as caldarchaeol [292-294]. The biosynthetic pathway leading to the formation 
of archaeal lipids has been studied in some detail [9, 33, 215, 295-297] and most of the 
enzymes involved in the biosynthesis have been identified and characterized. However, 
the entire pathway is not completely understood, nor is it clear how caldarchaeol is 
formed. The isoprenoid building blocks isopentenyl pyrophosphate (IPP) and dimethyallyl 
pyrophosphate (DMAPP) are synthesized via the mevalonate pathway in Archaea [215] 
and are combined through sequential condensation reactions catalyzed by geranylgeranyl 
diphosphate (GGPP) synthase and farnesylgeranyl diphosphate (FGPP) synthase, depending 
on the length of the isoprenoid chain product [298, 299]. Glycerol-1-phosphate (G1P) in 
archaea and glycerol-3-phosphate (G3P) in Bacteria and Eukarya are synthesized by similar 
reactions although the enzymes involved, i.e., glycerol-1-phosphate dehydrogenase 
(G1PDH)[300, 301] and glycerol-3-phosphate dehydrogenase (G3PDH), are not evolutionary 
related and belong to different protein families [295]. The elongated isoprenoid chain and 
G1P are subsequently linked together through ether linkages by two prenyltransferases. A 
cytosolic protein geranylgeranylglyceryl phosphate synthase (GGGP synthase) selectively 
attaches the isoprenoid chain to the G1P[302, 303] leading to the first ether bond formation. 
Next, the di-O-geranylgeranylglyceryl phosphate synthase (DGGGP synthase)[304-306] 
catalyzes the second ether bond formation step linking another isoprenoid chain to the lipid 
precursor yielding DGGGP. The following step concerns the activation of DGGGP via a CTP-
transferring reaction by CDP-archaeol synthase (CarS) that was recently discovered[306]. 
CDP-archaeol is an important intermediate for the successive steps in lipid biosynthesis 
where the CDP group is replaced by a polar head group. Serine, ethanolamine, glycerol and 
myo-inositol are common polar head groups found throughout the three domains of life. 
Chapter 5 Archaetidylglycerol and archaetidylethanolamine in E.coli 
5
100
The enzymes involved in the initial replacement of CMP from a CDP-alcohol with different 
types of polar head groups share mostly a common mode of action among Eukarya, Bacteria 
and Archaea (Fig. 1).  A different mechanism to produce phosphatidylethanolamine (PE) 
has been described for Eukarya that involves a direct replacement of the CDP group with 
ethanolamine[307, 308]. 
The E. coli membrane is composed by 70-80% of phosphatidylethanolamine (PE), 20-
25% of phosphatidylglycerol (PG) and 5% or less of cardiolipin as the major phospholipid 
components[289, 290, 309]. PG represent the main anionic phospholipid and is important for 
various cellular processes such as the initiation of DNA synthesis[290, 310-312] and protein 
translocation[313-315], whereas PE is the main non-bilayer lipid. In order to re-program 
E. coli for the synthesis of archaeal ether lipids, it will be essential to produce the two 
archaeal lipids archaetidylethanolamine (AE) and archaetidylglycerol (AG) to accommodate 
at least the polar head group composition. For polar head group modification, the branch 
point in bacteria lies with CDP-diacylglycerol (CDP-DAG), produced by CDP-diacylglycerol 
synthase encoded by the cdsA gene[316]. CDP-DAG acts as a substrate for two sets of 
enzymes. For the formation of PE, the CDP group of CDP-DAG is replaced with L-serine 
by phosphatidylserine synthase (Pss) leading to the production of phosphatidylserine (PS). 
Next, PS is decarboxylated by phosphatidylserine decarboxylase (Psd) converting it into PE. In 
the other biosynthetic pathway the CDP group of CDP-DAG is initially replaced by a glycerol-
3-phosphate (G3P) moiety by phosphatidylglycerol synthase (Pgs) leading to the formation 
of phosphatidylglycerol phosphate (PGP). The enzyme phosphatidylglycerol phosphatase 
(Pgp) removes the phosphate resulting in the formation of PG[246, 289, 290, 309]. In 
Archaea, the formation of the corresponding archaeal lipids, archaetidylethanolamine (AE) 
and archaetidylglycerol (AG) seems to take place via very similar mechanisms (Fig. 1). The 
two biosynthetic branches diverge from the CDP-archaeol towards the formation of AE or 
AG. The former is produced by the sequential action of two enzymes, archaetidylserine 
synthase (Ass)[317] and archaetidylserine decarboxylase (Asd) which replace the CDP group 
with L-serine whereupon a decarboxylation reaction yields the AE. Likewise, AG synthesis 
involves the enzyme archaetidylglycerol phosphate synthase (Ags) which attaches a G3P 
to CDP-archaeol with the consequent formation of archaetidylglycerol phosphate (AGP) 
which is subsequently dephosphorylated into archaetidyglycerol (AG) by the action of 
archaetidylglycerol phosphatase (Agp)[318, 319]. 
The bacterial and archaeal synthase enzymes involved in polar head group attachment all 
contain a well conserved domain, identified as D-G-x(3)-D-x(3)-D in the PROSITE database 
that classify these proteins as members of CDP-alcohol phosphatidyltransferase family [7, 
318]. Previous bioinformatics analysis [7, 318, 320] revealed a wide distribution of these 
enzymes in Bacteria and Archaea suggesting the existence of an ancestral enzyme in the last 
universal common ancestor (LUCA)[7] able to produce both archaeal- and bacterial-like lipids.
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Therefore, this could indicate substrates promiscuity among these enzymes and possibly 
bacterial enzymes are able to catalyze polar head group attachment to the CDP-archaeol. In 
this study, we have tested various bacterial enzymes for the formation of AE and AG from 
CDP-archaeol and in vitro reconstituted the entire pathways employing simple building 
blocks and up to nine purified enzymes from archaeal and bacterial origin. In addition, we 
have introduced the archaeal ether lipid biosynthetic pathway for AE and AG synthesis into 
E. coli making use of the substrate promiscuity of bacterial enzymes catalyzing the final 
polar head group conversion steps. 
Results
Archaetidylglycerol formation by bacterial PgsA and PgpA enzymes 
PG synthesis in E. coli proceeds via two enzymatic steps. The first reaction is catalyzed 
by phosphatidylglycerophosphate synthase. E. coli contains two individual genes that 
encode this activity [321, 322]. The pgsA gene exclusively functions in phosphatidylglycerol 
formation [323], whereas the pgsB gene is also involved in the synthesis of the Lipid A 
core of Lipopolysaccharide (LPS)[324]. The resulting phosphatidylglycerol phosphate (PGP) 
is dephosphorylated to phosphatidylglycerol. In E. coli three main phosphatidylglycerol 
phosphatases are found, encoded by the pgpA, pgpB and pgpC genes [325]. PgpA exhibits 
a narrow substrate specificity dephosphorylating only PGP[326] while PgpB also shows 
phosphatase activity towards diacylglycerol pyrophosphate [327], phosphatidic acid and 
lysophosphatidic acid [328, 329] revealed the occurrence of Pgs homologs in Archaea 
that belong to CDP-alcohol phosphatidyltransferase family, suggesting functional and 
structural conservation of these enzymes among bacteria and archaea. The same analysis 
revealed a weak sequence conservation of Pgp in Archaea, limited to PgpA and PgpB only. 
To investigate the ability of bacterial enzymes to accept CDP-archaeol as a substrate for 
archaetidylglycerol (AG) formation, the pgsA and pgpA genes of E. coli, were cloned and 
overexpressed in E. coli BL21. Both overexpressed proteins localized to the membrane 
fraction after cell fractionation. Upon membrane solubilization with the detergent 
n-dodecyl-β-D-maltopyranoside (DDM), PgsA and PgpA could be purified by Ni-NTA affinity 
chromatography (Fig. 2A). The activity of the enzymes was analyzed in in vitro coupled 
reactions in detergent solution using LC-MS for detection (Fig. 2D). The activity of the E. coli 
PgsA towards the archaeal substrates CDP-archaeol (CDP-ol) was tested using chemically 
synthesized DGGGP as a substrate that was converted into CDP-ol in the presence of the 
A. fulgidus CarS and CTP as described previously [306] (Fig. 2B, lane 2). Upon the addition 
of the E. coli PgsA and G3P, the formation of AGP could be demonstrated (m/z= 869.51 
[M-H]-) (Fig. 2B, lane 3). In the subsequent reaction the conversion of AGP into AG (m/z= 
789.55 [M-H]-) was observed when also the E. coli PgpA was included in the reaction (Fig. 
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2B, lane 4). The E. coli PgsA was unable to use archaeal DGGGP as substrate (Fig. 2B, lane 
5). As control, the activity of PgsA and PgpA was also tested towards the bacterial substrate 
CDP-diacylglycerol (CDP-DAG). The latter was produced by incubating the purified E. coli 
CdsA protein with its substrates phosphatidic acid (PA, 18:1) and CTP (Fig. 2C, lane 2). The 
formation of PGP (m/z= 853.50 [M-H]-) was detected only in presence of the E. coli PgsA and 
G3P (Fig. 2C, lane3), which was further converted into the final product PG (m/z= 773.54 
[M-H]-) upon the addition of the E. coli PgpA (Fig. 2C, lane 4). These results demonstrate 
that the E. coli PgsA and PgpA recognize and convert the archaeal substrate CDP-archaeol 
into archaetidylglycerol phosphate and archaetidylglycerol, respectively. 
Figure 2. In vitro demonstration of AG biosynthesis involving the E. coli PgsA and PgpA. (A) Coomassie stained 
SDS-PAGE gels showing the Ni-NTA purified proteins PgsA (21 kDa) and PgpA (20.5 kDa) from the bacteria E. 
coli. In vitro reactions using (B) DGGGP or (C) PA (C18:1,C18:1) and the purified proteins as specified, to test the 
substrate specificity of the E. coli PgsA and PgpA. Total ions counts from LC-MS data were normalized using DDM as 
internal standard. The data are the average of three experiments ± SE. (D) Schematic representation of the in vitro 
reactions. The purified enzymes used in the experiments are highlighted in blue and the mass spectra from the 
LC-MS runs of the corresponding products are depicted in the red boxes: DGGGP (m/z= 715.51 [M-H]-), CDP_ol (m/
z= 1020.54 [M-H]-), AGP (m/z= 869.51 [M-H]-) and AG (m/z= 789.55 [M-H]-) in panel B and PA 18:1 (m/z= 699.50 
[M-H]-), CDP_DAG (m/z= 1004.54 [M-H]-), PGP (m/z= 853.50 [M-H]-) and PG (m/z= 773.54 [M-H]-) in figure C. 
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Archaetidylethanolamine formation by bacterial PssA and Psd enzymes
Like PG synthesis, phosphatidylethanolamine (PE) synthesis also requires the action of two 
enzymes: phosphatidylserine synthase (Pss) for the synthesis of phosphatidylserine (PS) 
which is further decarboxylated to PE by phosphatidylserine decarboxylase (Psd)[330]. 
Two different subclasses of phosphatidylserine synthases exist: Pss-I, a cytoplasmic protein 
present mainly in Gram-negative bacteria such as E. coli, and Pss-II, a membrane protein 
that is found in Gram-positive bacteria,  yeast[331] and archaea[332]. The Pss-II enzymes 
contain a highly conserved domain present in CDP- alcohol phosphatidyltranferases[332]. 
Previously, archaetidylserine synthase (Ass) activity was identified in the membrane 
fraction of Methanothermobacter thermautotrophicus[317]. Secondary structure analysis 
of the archaeal members of the CDP-alcohol phosphatidyltransferase family indicates 
the presence of eight conserved transmembrane domains (TMDs) comparable to the 
corresponding bacterial protein family (Fig. 3A).  
Interestingly, the PssA sequence of B. subtilis is substantially smaller than the other members 
of this family  (only 177 amino acids instead of 451 amino acids of the E. coli Pss-II), but it 
shows the core of five TMDs (Fig. 3B) but lacking two C- terminal TMDs. A membrane fraction 
of B. subtilis incubated with the different archaeal-like substrates showed archaetidylserine 
(AS) formation whereas such activity could not be demonstrated in E. coli [317] suggesting a 
more narrow substrate specificity of the E. coli Pss-I and Pss-II enzymes. Therefore, the PssA 
gene of B. subtilis was cloned and overexpressed in E. coli BL21 strain under the control of T7 
promoter. The protein was solubilized from the membrane with DDM and purified by Ni-NTA 
affinity chromatography (Fig. 3C). Coupled in vitro reactions were performed using DGGGP 
as initial substrate along with the A. fulgidus CarS and CTP. Products were isolated through 
n-butanol extraction and analyzed by LC-MS (Fig. 3F). In the presence of the B. subtilis PssA, 
AS (m/z= 802.53 [M-H]-) formation was observed in the presence of L-serine and Mg2+ (Fig. 
3D, lane 3). PssA showed no activity towards DGGGP indicating the strict requirement of a 
CDP-activated intermediate for the reaction (Fig. 3D, lane 4). Moreover, no AS was formed in 
presence of EDTA (Fig. 3D, lane 5) which chelates divalent ions, consistent with a requirement 
of Mg2+ for enzymatic activity[333]. As a control, formation of phosphatidylserine by B. 
subtilis PssA was demonstrated in the presence of phosphatidic acid (PA, 18:1), CTP and the 
E. coli CdsA (Fig. 3D, lane 6). To examine the activity of the E. coli PssA towards CDP-archaeol, 
the enzyme was also overexpressed and purified (Fig. 3C). In the presence of CDP-archaeol 
as substrate, no AS formation was observed demonstrating that the E. coli PssA (the Pss-II 
enzyme) indeed does not recognize the archaeal precursor (Fig. 3E, lane 1). The enzyme, 
however, converted CDP-DAG to phosphatidylserine (m/z= 786.53 [M-H]-) in a coupled 
enzyme assay using phosphatidic acid as substrate (Fig. 3E, lane 4). 
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Figure 3. In vitro AS synthesis by the B. subtilis PssA. (A) Averaged hydropathy profile of the bacterial Pss proteins 
(blue line) and archaeal ones (red line) is aligned highlighting their conservations in the two kingdoms. The 
membrane topology prediction is depicted above the plot. (B) Hydropathy profile alignment of B. subtilis PssA 
(purple line) and the averaged hydropathy profile of the bacterial Pss protein family (blue line). The conserved 
transmembrane domains (TMDs) are indicated by Roman numbers. (C) Coomassie stained SDS-PAGE gels showing 
the Ni-NTA purified proteins B. subtilis PssA (21 kDa) and E. coli PssA (53.6 kDa). Specificity of the bacterial B. 
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subtilis PssA (D) and E. coli PssA (E) towards DGGGP and PA (C18:1,C18:1) as assessed by means of an in vitro 
assay using the purified enzymes. Total ions counts from LC-MS data were normalized using DDM as internal 
standard. The data are the average of three experiments ± SE. (F) Schematic representation of the performed in 
vitro reactions. The mass spectra from the LC-MS runs of the two products AS (m/z= 802.54 [M-H]-) and PS (m/z= 
786.53 [M-H]-) are indicated in the boxes.
Figure 4. In vitro AE formation involving 
the E. coli Psd. (A) Coomassie stained 
SDS-PAGE gel showing the Ni-NTA purified 
protein E. coli Psd. The α-subunit with 
a molecular weight of 14.4 kDa and the 
β-subunit of 28.6 kDa. (B) In vitro reactions 
using the chemically synthesized substrate 
DGGGP, and the purified proteins as 
specified. Total ions counts from LC-
MS data were normalized using DDM 
as internal standard. The data are the 
average of three experiments ± SE. (C) 
The mass spectra from the LC-MS runs of 
the products AE (m/z= 758,55 [M-H]-) is 
indicated. 
 In Archaea and Bacteria, AE and PE are produced by a decarboxylation reaction that removes 
the carboxylic acid group of L-serine. In E. coli, the phosphatidylserine decarboxylase 
is encoded by the psd gene that specifies a membrane-associated pro-enzyme which 
undergoes an autocatalytic internal cleavage [334] leading to two subunits – the α subunit 
containing a pyruvoyl prosthetic group and a β subunit [335, 336]. Previous bioinformatics 
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analysis [318]. However, the archaeal Asd has not been biochemically characterized. 
Because of the general mechanism of the decarboxylation reaction [307], the possibility 
exists that the endogenous phosphatidylserine decarboxylase of E. coli is able to recognize 
AS. Therefore, the E. coli psd gene was overexpressed in E. coli BL21 strain under the control 
of T7 promoter. Membranes bearing overexpressed levels of Psd were solubilized with DDM 
and the enzyme was purified by Ni-NTA affinity chromatography (Fig. 4A).  
Τhe  α-subunit showed a slower migration on SDS-PAGE, as expected on the basis of its 
predicted molecular mass. This is likely due to the presence of the pyruvoyl prosthetic 
group attached. [335] The enzymatic activity of the E. coli Psd was tested by in vitro coupled 
reactions as described above and product formation was detected by LC-MS (Fig. 4C). 
Conversion of AS to AE (m/z= 758.55 [M-H]-) by the E. coli Psd was observed in the presence 
of Mg2+, L-serine, B. subtilis PssA, A. fulgidus CarS, CTP and DGGGP (Fig. 4B, lane 4). 
In vitro reconstitution of archaetidylethanolamine and archaetidylglycerol 
formation
Previously, we have described the in vitro reconstitution of CDP-archaeol formation 
starting from the precursors IPP and DMAPP/FPP [306] using two bacterial enzymes and 
three archaeal enzymes that were overexpressed and purified from E. coli upon codon 
optimization. Due to the wider substrate 
specificity described above, the extension of this pathway for the reconstitution of 
the formation of AE and AG requires four additional bacterial enzymes described in the 
previous section. The ether lipid biosynthetic pathway reconstitution [306] starts from the 
two isoprenoid building blocks IPP and FPP which undergo several cycles of condensation 
leading to isoprenoid chains with the required C
20
 length [337]. GGPP (m/z= 449.19 [M-H]-) 
formation was detected by LC-MS with an E. coli farnesyl diphosphate synthase (IspA) [338] 
mutant as described previously (Fig. 5, lane 2).[306] Despite the unique feature of archaeal 
G1P dehydrogenases to synthesize the G1P, some bacterial enzymes are also able to 
perform this reaction [339]. The enzyme AraM (G1PDH) from B. subtilis [340] produces the 
required glycerophosphate backbone which can be attached to the GGPP via the first ether 
bond leading to the synthesis of GGGP (m/z= 443.26 [M-H]-). This latter reaction is catalyzed 
by the M. maripaludis GGGP synthase (MmarC7_1004) [302] which in combination with 
IspA and G1PDH and the substrates IPP, FPP, DHAP and NADH leads to the conversion of 
GGPP into GGGP (Fig. 5, lane 3). DGGGP production (m/z= 715.51 [M-H]-) was observed in 
a subsequent reaction with the A. fulgidus DGGGP synthase (AF0404) [304] (Fig. 5, lane 4). 
Next, DGGGP is converted into CDP-archaeol (m/z= 1020.54 [M-H]-) by the A. fulgidus CarS 
(AF1740) in the presence of CTP [306] (Fig. 5, lane 5). CDP-archaeol is the precursor for the 
formation of AS (m/z= 802.51 [M-H]-) in the presence of the B. subtilis PssA and L-serine 
(Fig. 5, lane 6), which is further converted into AE (m/z= 758.54 [M-H]-) (Fig. 5, lane 7) by the 
E. coli Psd. In another reaction, the CDP-archaeol is converted into AGP (m/z= 869.51 [M-H]-
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) by the E. coli PgsA in the presence of G3P (Fig. 5, lane 8). AGP is then converted into AG (m/
z= 789.54 [M-H]-) by the addition of the E. coli PgpA to the in vitro reactions (Fig. 5, lane 9). 
Taken together, the reactions described here employing purified enzymes represent the in 
vitro reconstitution of the entire archaeal lipid pathway using a set of archaeal and bacterial 
enzymes.
Figure 5. In vitro reconstitution of the archaeal ether lipid pathway. In vitro reactions were performed using a 
combination of purified enzymes as specified and the substrates IPP, FPP, DHAP and NADH in the presence of 
Mg2+ and 0.2% of DDM. Each product was detected by LC-MS: FPP (m/z= 381 [M-H]-), GGPP (m/z= 449.19 [M-H]-), 
GGGP (m/z= 443.26 [M-H]-), DGGGP (m/z= 715.51 [M-H]-), CDP-archaeol (m/z= 1020.54 [M-H]-), AS (m/z= 802.51 
[M-H]-), AE (m/z= 758.54 [M-H]-), AGP (m/z= 869.51 [M-H]-) and AG (m/z= 789.54 [M-H]-). The total ion counts were 
normalized using DDM as internal standard. The graph represents averages of two experiments ± SE.
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Archaetidylglycerol and archaetidylethanolamine formation in E. coli
To reconstruct the entire archaeal ether lipid biosynthetic pathway into E. coli, a system of 
four compatible expression vectors was used to co-express seven ether lipid genes into E. 
coli. In this system, the vectors containing one or two genes each, as listed in the Table 1, 
allowed the simultaneous expression of three archaeal enzymes (M. maripaludis GGGPS, A. 
fulgidus DGGGPS and A. fulgidus CarS) and four bacterial enzymes (E. coli IDI, E. coli mutant 
IspA, B. subtilis AraM and  
Table 1. Expression vectors used in this study.
Plasmid Description Reference
pRSF-Duet-1 Cloning and expression vector (KanR), T7 promoter Novagen
pET-Duet-1 Cloning and expression vector (AmpR), T7 promoter Novagen
pCDF-Duet-1 Cloning and expression vector (StrR), T7 promoter Novagen
pACYC-Duet-1 Cloning and expression vector (CmR), T7 promoter Novagen
pSJ122 Synthetic gene encoding codon optimized DGGGP synthase from A. 
fulgidus with N-terminal His-tag and redesigned ribosome binding site 
AGGACGTTAACAT cloned into pRSF-Duet vector using the primers 41 and 42
Jain et al.[306] 
pSJ135 PCR product of ispA gene with N-terminal His-tag from E. coli K12 genomic 
DNA containing a double mutation Y79H and S140T. PCR product of idi gene 
with His-tag at the N-terminus from E. coli K12 genomic DNA. Both genes 
were cloned into pCDF-Duet vector using the primers 62, 63, 24 and 57
This study
pSJ138 Synthetic gene encoding codon optimized GGGP synthase from M. 
maripaludis with N-terminal His-tag. PCR product of araM with C-terminal 
His-tag from B. subtilis genomic DNA. Both genes were cloned into pET-Duet 
vector using the primers 70, 71, 11 and 12
This study
pSJ140 Synthetic gene encoding codon optimized DGGGP synthase from A. 
fulgidus with N-terminal His-tag and redesigned ribosome binding site 
AGGACGTTAACAT. Synthetic gene encoding codon optimized CDP-archaeol 
synthase from A. fulgidus with C-terminal His-tag. Both synthetic genes are 
cloned into pRSF-Duet vector using the primers 32, 20, 84 and 86
This study
pSJ148 PCR product of cdsA with N-terminal His-tag from E. coli genomic DNA 
cloned into pACYC-Duet vector using the primers 103 and 106
This study
pAC004 PCR product of pss with C-terminus His-tag from B. subtilis genomic DNA 
cloned into pACYC-Duet vector using the primers 89 and 90
This study
pAC008 PCR product of psd with C-terminus His-tag from E. coli genomic DNA cloned 
into pACYC-Duet vector using the primers 533 and 534
This study
pAC011 PCR product of pss with C-terminus His-tag from E. coli genomic DNA cloned 
into pET-Duet vector using the primers 542 and 543
This study
pAC015 PCR product of pgsA with C-terminus His-tag from E. coli genomic DNA 
cloned into pRSF-Duet vector using the primers 551 and 552
This study
pAC017 PCR product of pgpA with C-terminus His-tag from E. coli genomic DNA 
cloned into pET-Duet vector using the primers 562and 563
This study
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B. subtilis PssA). All genes were expressed under the control of the T7 promoter and induced 
with 0.25 mM of IPTG for 3.5 h. Total lipids were extracted from the E. coli membrane 
fraction using the Bligh and Dyer method [341] and analyzed by LC-MS. Four different 
engineered E. coli strains were compared, containing a different combination of archaeal 
lipid enzymes: (i) control harboring only the empty vectors; (ii) five ether lipid enzymes 
(E. coli IDI, E. coli mutant IspA, B. subtilis AraM, M. maripaludis GGGPS and A. fulgidus 
DGGGPS); (iii) six ether lipid enzymes (E. coli IDI, E. coli mutant IspA, B. subtilis AraM, M. 
maripaludis GGGPS, A. fulgidus DGGGPS and A. fulgidus CarS) and (iv) seven ether lipid 
enzymes (E. coli IDI, E. coli mutant IspA, B. subtilis AraM, M. maripaludis GGGPS, A. fulgidus 
DGGGPS, A. fulgidus CarS and B. subtilis PssA). When the total phospholipid composition of 
E. coli was compared for the different strains, no major differences were observed for the 
four differently engineered E. coli strains (Fig. 6A). However, a detailed analysis shows the 
presence of a peak corresponding to AE in E. coli strain 4 (Fig. 6B, lane 4) which contains all 
the ether lipid genes required for synthesis compared to the other strains that lack the B. 
subtilis PssA (Fig. 6B, lane 3) or both the A. fulgidus CarS and B. subtilis PssA (Fig. 6B, lane 2) 
or the control (Fig. 6B, lane 1). Another archaeal specific product DGGGP-Gro was detected 
in the engineered E. coli strains, which is absent in the control strain (Fig. 6B, lane 1). This 
compound was also detected in a previous study [32]. The formation of DGGGP-Gro, that 
hereafter is termed unsaturated AG, was observed in the E. coli strains that contain the 
basic set of five ether lipid genes up to the genes required for the formation of DGGGP (Fig. 
6B, lane 2). However, there is an enhanced production of AG when the strain also contains 
the A. fulgidus CarS (Fig. 6B, lane 3). Upon the introduction of the AS producing B. subtilis 
PssA enzyme (strain 4), the amount of AG decreased and instead AE is produced (Fig. 6B, 
lane 4).
Formation of unsaturated AG has been attributed to an endogenous reaction in E. coli 
which directly attaches the glycerol moiety to DGGGP [32], as it was assumed that the 
E. coli PgsA and PgpA enzymes are not able to accept the archaeal intermediated as 
a substrate. As shown in the previous section, these two enzymes do recognize CDP-
archaeol and convert it into AG. Therefore, the presence of unsaturated AG in the E. coli 
strain expressing the ether lipid genes is due to the low, but significant activity of the 
endogenous CDP-diacylglycerol synthase towards DGGGP. To confirm this hypothesis an 
in vitro reaction was performed where DGGGP was incubated in presence of the purified 
CDP-diacylglycerol synthase (E. coli CdsA) in presence of CTP. Under those conditions, 
a significant fraction of the DGGGP was converted into CDP-archaeol (Fig. 6C, lane 2) 
demonstrating that CdsA is active with the archaeal substrate. When the E. coli PgsA and 
PgpA and the substrate G3P were added to the reaction, the CDP-archaeol was converted 
into AG (Fig. 6C, lane 3). Taken together, these data demonstrate that the low activity 
of the endogenous E. coli CdsA (in vitro less than 1% compared to CarS in our previous 
work [306]) towards DGGGP results in substantial AG production in vivo. It is concluded 
that with a limited set of genes the archaeal lipids AG and AE can be produced in E. coli.
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Figure 6. Archaeal lipid production in E. coli. (A) Total lipid analysis of four different engineered E. coli strains 
containing a different combination of ether lipid enzymes. The lipids were extracted from the membrane fraction and 
analyzed by LC-MS. The total ion counts of the several PE and PG species and of the archaeal lipids were normalized 
using eicosane as internal standard. The species depicted as classified according to the number of carbon atoms 
and number of unsaturated bonds in the acyl chains at the sn-1 and sn-2 positions. (B) Archaeal lipids production 
by different strains of E. coli upon the expression of the ether lipid biosynthetic genes. Both the graph represents 
the average of three biological replicates ± SE. (C) In vitro reactions using DGGGP and the purified E. coli CdsA, PgsA 
and PgpA protein to determine the ability of CdsA to convert DGGGP into CDP-archaeol. Total ions counts from 
LC-MS data were normalized using DDM as internal standard. The data are the average of three experiments ± SE.
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Discussion
Since several decades E. coli has been used for metabolic engineering such as the improvement 
of isoprenoids or carotenoids production [208, 237, 238, 342]. Several attempts have 
been made to reconstruct the archaeal ether lipid biosynthetic pathway into E. coli. Lai et 
al. [33] demonstrated production of DGGGP upon the overproduction of the endogenous 
E. coli IDI and production of four enzymes (G1PDH, GGPPS, GGGPS and DGGGPS) from the 
hyperthermophilic archaeon Archaeoglobus fulgidus. Likewise,Yokoi et al. [32] employed ether 
lipid genes from the mesophilic archaeon Methanosarcina acetivorans to produce DGGGP and 
another compound that was identified as the phosphatidylglycerol-type derivate of DGGGP, 
named DGGGP-Gro. Isobe et al. [34] In addition expressed the M. acetivorans geranylgeranyl 
reductase for double bonds reduction in conjunction with the four aforementioned archaeal 
enzymes [32]. They observed the in vivo production of archaeal lipids with a fully saturated 
isoprenoid chain only when the cofactor M. acetivorans ferredoxin was co-expressed. 
In the present study we aimed to produce the two major archaeal-like lipids 
archaetidylethanolamine (AE) and archaetidylglycerol (AG) in E. coli as these lipids have 
the same polar head group as the major phospholipids phosphatidylethanolamine (PE) 
and phosphatidylglycerol (PG) present in the E. coli membrane. However, this required a 
further understanding of the enzymatic steps required for polar head group attachment. 
Importantly, we have previously shown the production of CDP-archaeol in vitro by also 
including the CDP-archaeol synthase (CarS) into the pathway that yielded DGGGP. Expression of 
CarS provides a means to substantially increase the production of the endogenously produced 
DGGGP-Gro that corresponds to archaetidylglycerol (Fig. 6B). During polar head group 
attachment, the CDP group from the CDP-activated precursor is replaced by a different polar 
head group. In Bacteria and in Archaea, the reactions involved in this process are very similar 
and mediated by enzymes belonging to the CDP-alcohol phosphatidyltransferase superfamily. 
Given the high sequence homology among archaeal and bacterial phosphatidyltransferase 
[318, 320], we investigated the substrate promiscuity of the enzymes PgsA and PgpA that are 
involved in PG formation, and their ability to recognize CDP-archaeol. Using in vitro reactions, 
purified E. coli PgsA was able to produce AGP from CDP-archaeol which in turn was produced 
by the A. fulgidus CarS from DGGGP, CTP and G3P. By means of the E. coli phosphatase PgpA, 
the AGP was readily converted into AG. This demonstrates a high substrate promiscuity of 
these bacterial enzymes and alleviates the need to introduce archaeal enzymes into E. coli 
to perform these reactions steps. Indeed, when the ether lipid biosynthesis pathway up to 
the formation of CDP-archaeol is introduced into E. coli, AG formation is observed. However, 
CarS is not essential, as even in its absence, some AG can be formed. The origin of this AG was 
previously unknown, but we now show that this is due to a low activity of the endogenous E. 
coli CdsA for DGGGP resulting in the formation of CDP-archaeol that is further converted by E. 
coli PgsA and PgpA into AG. 
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In contrast to AG formation, AE formation has not yet been observed previously in E. coli which 
must imply that the E. coli phosphatidylserine synthases are unable to recognize CDP-archaeol 
in order to produce the intermediate AS that by decarboxylation should be further converted 
into AE. Indeed, the purified E. coli PssA was inactive with this substrate. Structural analysis of 
the bacterial and archaeal members of CDP-alcohol phosphatidyltransferase family indicated 
a high level of secondary structure conservation of these enzymes with eight transmembrane 
segments. The B. subtilis PssA is a truncated version of these enzymes, being significantly 
shorter but still containing the highly conserved protein core. Importantly, this enzyme was 
previously shown to be active with the archaeal-like substrates [343]. Indeed, the purified B. 
subtilis PssA catalyzed the production of AS from CDP-archaeol and L-serine. The next step, the 
decarboxylation of the serine moiety seems less specific, as purified E. coli Psd mediated the 
decarboxylation of AS with the concomitant formation of AE. Thus, for the production of AE in 
E. coli cells only the B. subtilis PssA needs to be introduced (Fig. 6B).
Having established the exact sequence of reactions needed for the archaeal ether lipid 
biosynthetic pathway [306] including the polar head group attachment, the reconstitution of 
AE and AG formation in vitro could be realized. Using a combination of archaeal and bacterial 
enzymes and a breakdown in individual reactions, the synthesis of the unsaturated archaeal 
lipids AE and AG from the initial building blocks IPP, FPP and DHAP was achieved with nine 
purified enzymes. This defined the conditions needed for the reconstitution of AE and AG 
formation in vivo, using E. coli as a host. Since three endogenous E. coli enzymes (Psd, PgsA and 
PgpA) recognize the archaeal precursors, the in vivo reconstitution depends on the expression 
of seven ether lipid genes. This includes overexpression of the E. coli idi to boost IPP formation, 
and expression of a mutant IspA to generate GGPP; the B. subtilis AraM for G1P formation, and 
B. subtilis PssA for AS formation, the key ether lipid biosynthetic proteins, the M. maripaludis 
GGGPS, the A. fulgidus DGGGPS and the A. fulgidus CarS. Although the conversion reactions 
appear efficient in vitro, the amounts of AE and AG produced in vivo are still low and compared 
to the total E. coli lipid content, they are probably less than 1%. However, the expression of 
CarS elevated the levels three-fold as compared to a previous report on AG formation [32]. 
The work described here represents a unique strategy to synthesize archaeal ether lipids 
in bacteria. Although the levels are still low, it is important to realize that the production 
of AE and AG as reported in this study, is performed in the presence of a fully functional 
phospholipid biosynthetic pathway. High-level AE and AG production likely also requires 
the upregulation of the entire pathway leading to IPP production. In addition, the pathway 
resulting in the reduction of the isoprenoid chains needs to be introduced to produce the 
saturated archaeatidyl compounds. Future studies should be directed towards a gradual 
down-regulation of the endogenous ester-bonded phospholipid biosynthetic pathway so that 
the endogenous lipids can be replaced by ether lipids. Such a bacterial strain could be used 
as an experimental model to examine the impact of the ‘lipid divide’ on the physiology and 
robustness of bacteria.
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Materials and Methods
Bacterial strain and cloning procedures
Escherichia coli and Bacillus subtilis genomic DNA was used as template for the amplification 
of genes encoding the bacterial enzymes. Escherichia coli DH5α (Invitrogen) was used for 
the cloning steps. The plasmids and the primers used in this study are listed in Table 1 
and 2. Escherichia coli BL21 (DE3) or Lemo21 (DE3) [344] was used as protein over-
expression host strain and grown in aerobic condition at 37°C in Luria-Bertani (LB) medium 
supplemented with the required antibiotics. Kanamycin (50 μg/ml), chloramphenicol (34 
μg/ml), streptomycin (50 μg/ml) and ampicillin (50 μg/ml) in conjunction with 0.2% glucose 
were added to the medium when necessary. 
Table 2. Oligonucleotide primers used in the study.
Primers 
name Primer sequence 5’3’
Restriction 
enzyme site
11 GCGCGAATTCATGCATCACCACCACC EcoRI
12 GCGCAAGCTTTCATTTTTTGGACAGC HindIII
20 GCGCCTCGAGGACAGGTTTCCCGACTGGAAAG XhoI
24 GATATACCATGGGCAGCCATCACCATC NcoI
32 GGCGCCATATGCTGGATCTGATTCTGAA NdeI
41 GACCAAGCTTGCGGCCGCATAATGC HindIII
42 GATGCTCGAGTTAGAATGCACCGGCG XhoI
57 GCGCGAATTCTTATTTATTACGCTGGATGATGTAG EcoRI
62 CACTCATTAATTCATGATGATTTACCGGCAATGG blunt
63 AGCGTGGATACACTCAACGGC blunt
70 GCGCCATATGAATCGTATCGCAGCTGAC NdeI
71 GCGCCTCGAGTTAGTGATGATGGTGGTGATGTTCATATAGACCATGGTTGATCAGCG XhoI
84 GCCGCCATGGGTAGTCATCATCACCACCATC NcoI
86 GCGCGAATTCTTAGAATGCACCGGCGA EcoRI
89 GCGCCATATGAATTACATCCCCTGTATGATTACG NdeI
90 GCGCCTCGAGTTAGTGATGGTGATGGTGGTGATGATGATTCCATCTCCCAGACTCCAG XhoI
103 GCGCCTCGAGTTAGTGATGGTGATGGTGGTGATGATGAAGCGTCCTGAATACCAGTAAC XhoI
106 GCCGCCATGGGCAGCCATCACCATCATCACCACAGCCTGAAGTATCGCCTGATATCTGC NcoI
533 GCGCCTCGAGAAAACAATGGCCTGGAGGCTACCTTGTTAAATTCATTTAAACTTTCGCTAC XhoI
534 GCGCTTAATTAATTAGTGATGGTGATGGTGGTGATGATGGACCTGGTCTTTTTTGTCGTCAAC PacI
542 CGGCCATATGCTGTCAAAATTTAAGCGTAATAAAC NdeI
543 GCGCCTCGAGTTAGTGATGATGGTGGTGATGCAGGATGCGGCTAATTAATC XhoI
551 GCGCCATATGCAATTTAATATCCCTACGTTGC NdeI
552 CGCGCTCGAGTCAGTGATGGTGATGGTGGTGATGATGCTGATCAAGCAAATCTGCACGC XhoI
562 CGCGGAATTCATGACCATTTTGCCACGCCATAAAG EcoRI
563 CGGCGCGGCCGCCTAGTGATGGTGATGGTGGTGATGATGCGACAGAATACCCAGCG NotI
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Expressions and purification of ether lipid enzymes
The bacterial proteins B. subtilis PssA and E. coli Psd were expressed in E. coli BL21 strain 
and induced with 1 mM of isopropyl β-D-1-thiogalactopyranoside (IPTG). E. coli PssA was 
induced with 0.5 mM of IPTG in the same over-expression strain E. coli BL21, whereas E. coli 
PgsA and PgpA were expressed in E. coli Lemo strain and induced with 0.4 mM of IPTG and 
0.5 mM of L-rhamnose. After 2,5 h of induction the cytoplasmic and membrane fractions 
were separated as described in a previous study [306]. The inner membrane vesicles (IMVs) 
of E. coli expressing the membrane proteins (B. subtilis PssA and E. coli Psd, PgsA and PgpA) 
were isolated as previously described [345]. The E. coli IMVs harboring the B. subtilis PssA 
and E. coli Psd were resuspended in buffer A (50 mM Tris-HCl pH 7.5, 300 mM NaCl and 
10% glycerol) and 0.5 mg/ml of IMVs were solubilized in 2% of DDM detergent for 1 h at 
4°C. A centrifugation (173,400xg) step of 30 min at 4°C removed the insolubilized materials 
and the supernatant was incubated with Ni-NTA beads (Sigma) for 1 h at 4°C. The Ni-NTA 
beads were washed ten times with 40 column volumes (CV) of buffer B (50 mM Tris-HCl pH 
7.5, 300 mM NaCl, 10% glycerol and 0.2% DDM) supplemented with 20 mM Imidazole and 
the proteins were eluted three times with 0.5 CV of buffer B supplemented with 250 mM 
Imidazole. The E. coli IMVs (1 mg/ml) containing the E. coli PgsA and PgpA were resuspended 
in buffer C (50 mM Tris-HCl pH 7.5, 150 mM NaCl and 10% glycerol). The solubilization, 
the removal of the insolubilized materials and the Ni-NTA beads incubation was performed 
in the same manner as described above. The E. coli PgsA-bound beads were washed five 
times with 40 CV of buffer D (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 10% glycerol and 0.2% 
DDM) supplemented with 10 mM Imidazole and eluted three times with 0.5 CV of buffer 
D supplemented with 250 mM Imidazole. The Ni-NTA beads containing E. coli PgpA were 
washed ten times with 40 CV of buffer D supplemented with 10 mM Imidazole and the 
protein was eluted in one single wash of 0.5 CV of buffer D supplemented with 300 mM 
Imidazole.
For the purification of the soluble protein E. coli PssA, the cytoplasmic fraction was 
incubated with Ni-NTA beads in buffer C overnight at 4°C. The beads were washed three 
times with 40 CV of buffer C supplemented with 10 mM Imidazole, one times with 40 CV of 
buffer C supplemented with 60 mM Imidazole end eluted with one wash of 2 CV of buffer 
C supplemented with 300 mM Imidazole. The purified proteins purity was assessed on SDS-
PAGE (12%) stained with Coomassie Brilliant Blue and the purified protein concentration was 
determined by measurement of the absorbance at 280 nm. The other cytosolic proteins (E. 
coli IDI, E. coli mutant IspA, B. subtilis AraM and M. maripaludis GGGPS) and the membranes 
proteins ( A. fulgidus DGGGPS, A. fulgidus CarS and E. coli CdsA) used in this study were 
expressed and purified as described previously [306]. 
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In vitro assays for archaeal lipids production
In vitro reactions were performed in 100 μl of assay buffer containing a final concentration 
of 50 mM Tris-HCl pH7.5, 10 mM MgCl
2
, 52.5 mM NaCl, 87.5 mM Imidazole, 0.07% DDM 
and 3.5% glycerol. Where specified 100 μM synthetic DGGGP, 100 μM PA (18:1), 2 mM CTP, 
10 mM G3P, 10 mM L-serine 20 mM EDTA and the indicated amount of purified enzymes 
were added to the reaction mixture. For the in vitro AE and AG reconstitution, 100 μl of 
reaction volume was used containing the following assay buffer: 50 mM Tris-HCl pH 7.5, 10 
mM MgCl
2
, 15 mM NaCl, 25 mM Imidazole, 0.02% DDM, 1% glycerol, 0.5 mM dithiothreitol 
(DTT), 0.1 mM FPP, 0.1 mM IPP, 2 mM NADH and 2 mM DHAP in. Reactions were incubated 
at 37°C for 1 h as described previously [306], and the products were extracted with two 
times 0.3 ml of n-butanol. Extracted lipids were evaporated under a stream of nitrogen gas 
and resuspended in 50 μl of methanol for the LC-MS analysis.
In vivo archaeal lipids synthesis
Engineered E. coli strains were aerobically grown at 37°C in 200ml of LB medium 
supplemented with half antibiotic concentration (kanamycin (25 μg/ml), chloramphenicol 
(17 μg/ml), streptomycin (25 μg/ml) and ampicillin (25 μg/ml), 0.2% of glucose and 1 mM 
NiCl
2
. The cells were induced with 0.25 mM IPTG and after 3.5 h, the total membrane 
fractions were isolated as previously described [306]. The internal standard eicosane (20 
μM) was added to the total membrane fractions (8 mg/ml) and lipids were extracted by 
means of the Bligh and Dyer method [341]. The chloroform extractable lipid fraction was 
washed with the aqueous phase from a blank Bligh and Dyer extraction and evaporated 
under a stream of nitrogen gas. The evaporated samples were resuspended with 0.3 ml 1:2 
chloroform:MeOH, evaporated and finally resuspended in 100 μl MeOH to be analyzed in 
LC-MS. 
LC-MS analysis
The in vitro reaction samples were analyzed using an Accela1250 high-performance liquid 
chromatography system coupled with an electrospray ionization mass spectrometry (ESI-
MS) Orbitrap Exactive (Thermo Fisher Scientific). A volume of 5μl of each sample was used 
for the analysis. The column, the LC method and the MS parameters used in this study have 
been already described in details in our previous work [306]. The capillary and in the tube 
lens voltage were set to -75V and -190V, respectively. For the in vivo experiment samples 
different method was used for the analysis. A volume sample of 5μl was injected into a 
Shim-pack XR-ODS/C8/Phenyl column with dimension 3.0 mm I.D. x 75 mm (Shimadzu) 
operating at 55°C with a flow rate of 400 μl/min. Mobile phase A (10mM ammonium 
formate with 0.1% formic acid in water:acetonitrile 40:60 v/v) and mobile phase B (10 mM 
ammonium formate with 0.1% formic acid in acetonitrile:isopropanol 10:90 v/v) were used 
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as follows: initial condition started with 40% B, a linear gradient was started in 2 min from 
40% to 43% B, gradient from 43% to 50% B in 0.1 min, 54% B isocratic for the next 9.9 min, 
linear gradient from 54% to 70% B in 0.1 min, 99% B isocratic for the following 5.9 min, 
gradient from 99% to 40% B in 0.1 min and 40% B isocratic for the last 1.9 min [346]. The 
MS settings used for this analysis were the same as described above. The thermo XCalibur 
processing software was used for the data analysis and Genesis algorithm for automated 
peak detection and integration was applied to this analysis. 
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Archaea and Bacteria share many genetic and biochemical features, yet 
their phospholipids are fundamentally different. Whereas bacterial lipids are 
composed of glycerol-3-phosphate (G3P) with ester-linked fatty acid side 
chains, archaeal lipids consist of glycerol-1-phosphate (G1P) with ether-linked 
isoprenoids with distinct chirality. This phenomenon is referred to as ‘the 
lipid divide’. It has been speculated that the last universal common ancestor 
(LUCA) cell could have possessed a mixed membrane that at some stage has 
segregated, resulting in the bacterial and archaeal lineages. However, a mixed 
membrane has never been found, possibly because it would not tolerate 
a viable situation due to instability. In the present study, we tested this 
hypothesis by constructing and characterizing a mixed membrane in Escherichia 
coli. By combining metabolic engineering of the MEP-DOXP pathway with an 
isoprenoid-based lipid synthesis pathway we engineered a mixed membrane 
consisting of up to 28% archaeal lipids. G1P-based archaeal lipids were formed 
both in the presence and in the absence of a heterologous G1P-dehydrogenase, 
showing that E.coli can synthesize G1P endogenously. Despite normal growth 
of the engineered cells, it was observed that the production of archaeal lipids 
resulted in marked changes in their endogenous lipid composition as well as 
in dramatic morphological deformities. Remarkably, robustness assays also 
demonstrated an elevated cell survival when exposed to a cryo-treatment and 
to butanol exposure. From these results, we conclude that mixed membranes 
are readily tolerated in vivo, which would agree with the existence of natural 
cells with hybrid bacterial/archaeal membranes. 
Keywords: LUCA, heterochirality, archaetidylglycerol, archaetidylethanol-
amine, di-O-geranylgeranylglyceryl-phosphate, metabolic engineering, glycer-
ol-1-phosphate, glycerol-3-phosphateAb
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Introduction
Archaeal lipids are fundamentally different from those of bacteria. Archaeal lipids are 
composed of isoprenoid chains attached to sn-glycerol-1-phosphate by ether bonds, 
whereas bacterial lipids are composed of fatty acid chains esterified to sn-glycerol-3-
phosphate. Although this intrinsic difference is commonly used to distinguish bacteria 
and archaea (‘Lipid Divide’), there are bacterial lipids that contain fatty acids attached by 
diether- or tetraether-bonds [4, 5, 79, 81, 84, 119], as well as archaeal lipids containing fatty 
acid based ester-lipids [6]; in addition, polar head groups are shared between archaeal and 
bacterial lipids. Despite these few discrepancies, there are, as yet, no examples of exchange 
of the glycerophosphate enantiomers between lipids of the two domains. Over the years, 
this lipid divide, has given rise to a range of different scenarios for the evolution of the 
domain-specific lipid types [7, 13-15, 347]. 
In 1994, Kandler postulated the pre-cell hypothesis to explain the distinct and uniform 
features across the three domains of life [15]. A heterogeneous population of pre-cells or 
last universal common ancestor (LUCA) cells was proposed which ultimately diverged into 
the bacterial and archaeal lineages. These pre-cells must have had some basic features 
shared by all descending lineages, including the systems responsible for processing of the 
genetic information (transcription, translation and replication). In case a reproducing pre-
cell with complete inheritable characteristics existed, the genetic material must have been 
confined within a closed membrane. At this point however, the pre-cell hypothesis fails 
to explain the lipid divide. According to Wächtershäuser [14] there are two possibilities to 
account for the evolution of extant membrane compositions. A pre-cell may have existed 
with a uniform membrane based on either ether-G1P or on ester-G3P lipids. From this 
ancestor, separate lineages evolved with the concomitant emergence of new lipids and 
subsequent loss of the original lipid. In a more widely accepted alternative scenario, a 
pre-cell membrane evolved with mixed ether-G1P/ester-G3P lipids, and through selection 
of one lipid over the other segregated when the domain divergence occurred [14]. Both 
scenarios, however, inevitably lead to an hypothesized appearance and disappearance of 
hybrid membranes from which also cross-hybridized diasteriomers and enantiomer lipids 
(isoprenoid-G1P/isoprenoid-G3P vs. fatty acyl-G1P/fatty acyl-G3P resp.) were proposed to 
drive the segregation [7]. The mixed membrane theory has caused heated debates over the 
last years. In his review [7], Koga shows that a wide range of specificities of CDP-alcohol 
phosphatidyltransferases on unnatural lipid substrates (isoprenoid-G3P and fatty acyl-G1P) 
occur [317]. This observation supports the idea that the four mentioned lipid types already 
existed in pre-cells. Besides that, it was emphasized that lipids with different hydrocarbon 
chains tend to segregate, but not because of the different glycerophosphate backbones. 
The biochemical pathways for synthesis of the core lipids phosphatidic acid and archaetidic 
acid are not related, but do show a high degree of analogy (Fig. S1). In line with this, shared 
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enzyme families and substrate promiscuities of polar head-group specific enzymes may, to 
some extent, support the mixed membrane hypothesis. In vitro biophysical and modelling 
studies in turn report some contradictory findings on mixed membranes. On the one 
hand, it has been demonstrated that heterochiral vesicles of fatty acids are unstable and 
exhibit reduced self-reproduction compared to homochiral vesicles [16]. This claim found 
some support in a mathematical model on membrane bioenergetics that postulated that 
the LUCA membrane required a highly impermeable membrane made of fatty acids and 
isoprenes only [347]. On the other hand, arguments have been put forward that would be 
in favour of the existence of mixed membranes. The enzyme families of polar head group 
attachment (phospholipid synthases) are all homologs, which would agree with the model 
that LUCA contained mixed lipid membranes. This is supported by an in vitro study in which 
mixed membranes from bacterial and archaeal lipids exhibited a decreased permeability at 
elevated temperatures and were therefore postulated to be highly stable [17]. However, 
there is as yet no consensus on the early-evolution mixed-membrane hypothesis.
The pathway for diether lipid synthesis is completely elucidated (Fig. S1) [100]. The 
reconstruction of the archaeal core lipid di-O-geranylgeranylglyceryl-phosphate (DGGGP) 
was first successfully demonstrated in Escherichia coli [33]. For the biosynthesis of DGGGP 
four genes are required. Firstly, the isoprenoid geranylgeranyldiphosphate is assembled from 
its building blocks isopentenyl-diphosphate (IPP) and dimethylallyl-diphosphate (DMAPP) 
by geranylgeranyl diphosphate synthase (GGPPs). Secondly, the other lipid building block 
concerns the backbone molecule sn-glycerol-1-phosphate (G1P) that is being generated by 
G1P-dehydrogenase. Thirdly, two enzymes subsequently attach two GGGP isoprenoid chains 
to G1P by formation of ether bonds: sn-3-O-geranylgeranylglyceryl phosphate synthase 
(GGGPs) attaches GGPP to G1P at the sn-3 position to form GGGP, after which attachment 
of the second GGPP to the sn-2 position is catalysed by a membrane protein called sn-2,3 di-
O-geranylgeranyl-glyceryl phosphate synthase (DGGGPs). For the final stage of polar head 
group attachment, the required enzymes of archaea and bacteria are orthologs. Yokoi et 
al. have demonstrated that in E.coli DGGGP is converted to archaetidylglycerol (AG). The 
promiscuous activity of E.coli’s native phosphatidylglycerol phosphate synthase (PgsA) and 
phosphatidylglycerol phosphatase (PgpA) have recently been shown to be responsible for 
these conversions [348]. The final synthesis step to the full diether has been described by 
Isobe et al. who established a complete reduction of the lipid isoprenoid chains to phytanyls 
by identification of a geranylgeranyl reductase (GGr) along with its accompanying ferredoxin 
[34]. The increase in biochemical knowledge on both lipid synthesis routes has stimulated 
researchers to construct a mixed membrane in vivo, however, with limited success as the 
contribution of archaeal lipids never exceeded 1% [32-34, 348].
In the present study we engineered an upregulation of the genes involved in the synthesis of 
the building blocks IPP and DMAPP, and co-expressed a composite archaeal lipid synthesis 
pathway in E. coli. The main objective of this endeavour was to evaluate whether a hybrid 
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heterochiral membrane is tolerated in vivo and what the implications are on growth, cell 
morphology and membrane biochemistry. This is the first report of a mixed archaeal/
bacterial membrane in a biological system and the first characterization of a hybrid 
glycerophosphate heterochiral membrane in vivo. 
Results
Metabolic engineering of a hybrid membrane in Escherichia coli
1. Enhanced supply of IPP and DMAPP
To screen for higher in vivo diether-lipid production different variants of the archaeal lipid 
synthesis pathway were constructed in E.coli JM109(DE3) (Table 1). The main limitation to 
the production of isoprenoid compounds and thus also for archaeal lipids in bacteria is the 
supply of its building blocks isopentenyl-diphosphate (IPP) and dimethylallyl-diphosphate 
(DMAPP). To construct a hybrid membrane, the MEP-DOXP pathway which is responsible 
for synthesis of IPP and DMAPP in E.coli must be upregulated. We addressed this constraint 
by the chromosomal integration of two synthetic fragments composed of the native idi 
gene or a combination of the idi, ispD, ispF and dxs genes. These constructs were integrated 
by a modified gene disruption protocol from Datsenko and Wanner [234] (Fig. S2). The 
aceA-aceB locus was chosen for integration (Chapter 3). The two obtained mutant strains 
WUR89 and WUR91 were tested for inducible MEP-DOXP upregulation by means of a 
reporter plasmid that encodes enzymes that catalyse the conversion of IPP and DMAPP 
to the red carotenoid lycopene. Here we observed a 2.5- and 5.3-fold increase in lycopene 
production, respectively, confirming that upon induction the pool of IPP and DMAPP had 
increased (Fig. S3). 
2. Production of DGGGP and archaetidylglycerol
To enable di-O-geranylgeranylglyceryl-phosphate (DGGGP) production, the MEP-DOXP 
integrated strains were complemented with 2 compatible plasmids. The first plasmid 
(pMS148) harbours the previously characterized crtE (GGPP synthase) gene from Pantoea 
ananatis [229] and araM (sn-glycerol-1-phosphate dehydrogenase, G1PDH) gene from 
Bacillus subtilis [340] for synthesis of lipid precursors geranylgeranyl-diphosphate (GGPP) 
and sn-glycerol-1-phosphate (G1P), respectively. The initial purpose of the secondary plasmid 
was to test for optimal heterologous functionality and coupled activity of Methanococcus 
maripaludis GGGP-synthase with DGGGP-synthases.
We first compared two different DGGGP synthase genes, either from Archaeoglobus fulgidus 
(AF0404) to yield pSJ139 or from M. maripaludis to yield pSP001. Introduction of these 
plasmids provided the following 5 mutant strains (Table 1): (i) Wild type JM109(DE3) strain 
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harbouring pMS148 and pSJ139 annotated as WUR150; (ii) integrated idi gene, pMS148 and 
pSJ139 annotated as WUR151; (iii) integrated idi-ispDF-dxs operon, pMS148 and pSJ139 
annotated as WUR152; (iv) integrated idi-ispDF-dxs operon, pMS148 and pSP001 annotated 
as WUR153; v) and lastly a negative control strain harbouring idi-ispDF-dxs, complemented 
with pSJ139 only, and annotated as WUR168. As a final variable during the lipid production 
assays, the mutant strains were grown either on LB medium or defined minimal medium 
(OPT1) which was optimized for isoprenoid production [213]. This OPT1 medium was modified 
to our specific requirements by decreasing the MgSO
4
 content to 0,012 mg/L and glycerol to 
1%, addition of 1 mM NiCl
2
 as a co-factor for G1PDH, and replacing the composed vitamins 
for a combined MEM-vitamin mixture. Total lipid extracts from isolated membrane fractions 
were obtained using the Bligh and Dyer method [341] and analysed on LC-MS for production 
of DGGGP (m/z=715.51 [M-H+]), archaetidylglycerol (AG) (m/z=789.54 [M-H+]), and the native 
E.coli lipids phosphatidylglycerol (PG) (m/z=773.54 [M-H+]) and phosphatidylethanolamine (PE) 
(m/z=775.61 [M-H+]) which together account for 95% of E.coli’s lipids [309]. Comparison of the 
strains having both introduced plasmids showed variable levels of AG in the membrane fractions 
(Fig. 1A, lanes A-D). In accordance with previous reports [32, 348], heterologous production of 
AG was obtained without the special requirement for specific CDP-archaeol synthase (CarS), 
archaetidyl glycerophosphate synthase (Ags) and phosphatase (Agp) activity. The CdsA, PgsA 
and PgpA enzymes native to E.coli recognize and convert the archaeal DGGGP substrate to AG; 
these enzymes are promiscuous in that they accept substrates derived from both G1P and G3P, 
and with fatty acid and isoprenoids [348]. The metabolic engineering of the MEP-DOXP pathway 
caused an overall increased production of DGGGP and AG compared to the control strain with 
native IPP and DMAPP pools. This upregulation was especially apparent for the WUR153 strain 
(Fig 1A, lane D) which contains the complete idi-ispDF-dxs operon and the M. maripaludis 
DGGGPs. Here we observed a 1.7-fold upregulation of DGGGP leading to 6.1% diether lipids 
of the cumulative lipid areas. The most radical improvement, however, was observed when 
WUR152 was grown on the statistically optimized OPT1 medium which resulted in diether ratios 
up to 15.6% (Fig. 1B). This finding suggested possibly even higher upregulations for WUR153 
where the M. maripaludis DGGGP-synthase seemed to be more efficient than the A. fulgidus 
DGGGP-synthase.
Table 1 Strains, integrations and plasmids used for DGGGP and AG production.
Strain Integrated operon Plasmid 1 Plasmid 2 DGGGPs
WUR150 - pMS148 pSJ139 A.fulg
WUR151 idi pMS148 pSJ139 A.fulg
WUR152 idi-ispDF-dxs pMS148 pSJ139 A.fulg
WUR153 idi-ispDF-dxs pMS148 pSP001 M.marp
WUR168 idi-ispDF-dxs - pSJ139 A.fulg
Abbreviations: A.fulg, Archaeoglobus fulgidus; M.marp, Methanococcus maripaludis.
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idi-int - + - - - 
idi-ispDF-dxs-int - - + + + 
P1: crtE-araM + + + + - 
P2A: GGGPs/DGGGPs Afulg + + + - + 
P2B: GGGPs/DGGGPs Marp - - - + - 
% diethers 3,7 2,9 4,5 6,1 1,0 
LB + - 
OPT1 - + 
% diethers 4,5 15,6 
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Figure 1. Level of produced DGGGP and AG in different genetic variants or different growth media. A. The 
total amount of diethers (pink bar) is expressed as a percentage of the cumulative ion counts. A: WUR150; 
B: WUR151; C: WUR152; D: WUR153; E: WUR168. B. Level of DGGGP and AG in WUR152 on different 
growth medium, LB and OPT1. DGGGP = di-O-geranylgeranylglyceryl-phosphate; AG = archaetidylglycerol.
When both strains were grown on OPT1 medium, an increase in AG production was again 
observed (Fig. 2A, lanes B and C). A very high increase however was not detected without 
integration of the MEP-DOXP operon in WUR150. Like anticipated, WUR153 on OPT1 
medium showed the highest productions of AG. Cumulative ether lipid contents up to 
37.8% of the total lipid extract were found.
3. Production of archaetidylethanolamine
Archaetidylethanolamine (AE) is the main non-bilayer lipid constituent of the archaeal 
membrane which is essential for the realization of a functional membrane and the proteins 
therein [349]. Previously, production of AE was established in E.coli by the heterologous 
expression of the B. subtilis phosphatidylserine synthase gene (pssA). By in vitro coupled 
reactions, this enzyme, unlike the counterpart of E.coli, was found to display promiscuous 
activity towards CDP-archaeol (in addition to its native substrate CDP-diacylglycerol). 
This central core lipid was converted to archaetidylserine (AS) by the exchange with 
L-serine by PssA. When E.coli phosphatidylserine decarboxylase (Psd) was also added to 
the reaction, in vitro formation of AE was confirmed [348]. To also include production of 
phosphatidylethanolamine (PE) in the mixed membrane, three variations of the WUR153 
strain were constructed by the addition of A. fulgidus carS and B. subtilis pssA to the 
secondary plasmid. These additions provided 3 additional strains (Table 2): (i) WUR153 with 
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carS annotated as WUR177 (ii) WUR153 with pssA annotated as WUR178 and finally (iii) 
WUR153 with both carS and pssA annotated as WUR182. Induction and lipid analysis including 
archaetidylethanolamine (AE) (m/z=758.54 [M-H+]), on these strains confirmed production of 
AE (Fig. 2B). In accordance to our previous findings, the carS gene also significantly contributed 
to the production of AG, but only in addition to pssA. Interestingly, AE was detected in all 
strains with pssA, albeit at very low amounts. Increased expression of pssA by optimizing 
RBS sequences could not compensate for this low production (data not shown). Despite 
persistently low levels of AE, WUR182 which has the complete pathway present, showed 
reproducibly high levels of AG. Further experiments were therefore continued with this strain.
Table 2 Strains tested for archaetidylethanolamine production. Variations of the inserts in plasmid 2 are indicated 
with pSJ139 as negative control.
Strain P1 P2 Insert 1 Insert 2 Insert 3 Insert 4
WUR153 pMS148 pSJ139 DGGGPs M. marp GGGPs M.marp - -
WUR177 pMS148 pAC027 DGGGPs M. marp GGGPs M.marp carS -
WUR178 pMS148 pAC028 DGGGPs M. marp GGGPs M.marp pssA -
WUR182 pMS148 pAC029 DGGGPs M. marp GGGPs M.marp carS pssA
Abbreviations: P1, plasmid 1; P2, plasmid 2; M.marp, Methanococcus maripaludis
idi-ispDF-dxs-int + + + + 
P1: crtE-araM + + + + 
P2: GGGPs/DGGGPs Afulg + + + + 
carS - + - + 
pssA - - + + 
% diethers 11,8 8,9 13,4 14,7 
B 
idi-ispDF-dxs-int - + + + 
pMS148: crtE-araM + + + - 
pSJ139: GGGPs/DGGGPs A.fulg + + - + 
pSP001: GGGPs/DGGGPs M.marp - - + - 
% diethers 7,9 13,7 37,8 1,2 
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Figure 2. Level of produced DGGGP, AG and AE in different genetic variants A. Calculated ratio of diethers (pink 
bar) is expressed as a percentage of the cumulative ion counts. A: WUR150; B: WUR152; C: WUR153; D: WUR127; 
B. Level of produced AG and AE expressed as normalized ion counts. The total amount of diethers (pink bar) is 
expressed as a percentage of the total ion counts. A: WUR153; B: WUR177; C: WUR178; D: WUR182. DGGGP = di-
O-geranylgeranylglyceryl-phosphate; AG = archaetidylglycerol; AE = archaetidylethanol-amine
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4. Induction optimization
Heterologous isoprenoid production may benefit from a proper balancing of the expression 
between the upstream MEP-DOXP pathway, and the downstream pathway. This effect was 
also apparent when we analysed the different integrated operons by lycopene productions. 
Variable levels of lycopene were produced by varying the time of induction and the IPTG 
concentration. Here, a variable IPTG concentration was found to correlate well with the level 
of expression of the crtEBI reporter genes (data not shown). This IPTG-dependent expression 
level strongly supported a potential for improved diether production, which was also tested 
in the WUR182 strain. To this end, we looked for better induction by varying the onset of 
induction or the IPTG concentration. We observed that IPTG supplementation immediately 
before inoculation resulted in higher amounts of archaeal lipids compared to postponed 
induction (Fig. 3A, lane 1 vs. lane 2 and 3). Significantly lower levels of AG were obtained after 
late induction at OD
600
=0.3 or OD
600
=0.6. Interestingly, a high AG production was also observed 
without the addition of IPTG. These levels, attributed to leaky expression, even exceeded the 
levels obtained at postponed inductions [350]. For the early induced cells a highest average 
content of 28% archaeal lipids (consisting of AG, AE and DGGGP) was demonstrated. Together 
with the earlier obtained diether levels, this shows that E.coli cells can tolerate high levels of 
archaeal lipids in their membrane and are perfectly able grow.
5. Substrate promiscuity of archaeal enzymes 
To be able to attribute potential phenotypical changes to the presence of archaeal lipids and not 
to an overall high abundance of heterologous membrane proteins, we constructed a control 
strain (WUR187) with a disrupted araM gene. By deleting a large segment of the araM gene, 
responsible for the synthesis of sn-glycerol-1-phosphate, we aimed to disrupt archaeal lipid 
synthesis, but maintain the heterologous enzyme load. With the initial purpose to calibrate 
for optimal IPTG concentrations, we performed a serial dilution of IPTG on the WUR182 strain 
and compared it with WUR187. This analysis showed that optimal AG production occurs at 
~0.05 mM IPTG (Fig. 3B, lane 4). Unexpectedly, the WUR187 ∆araM control strain appeared 
to still contain a substantial amount of archaeal lipids (up to 10%), albeit at a lower level than 
WUR182 (Fig. 3B, lanes 6 and 7). This observation suggested that GGGPs and DGGGPs display 
substantial substrate promiscuity towards sn-glycerol-3-phosphate.
The glycerophosphate configuration, however, is traditionally recognized as one of the 
most striking differences between archaeal and bacterial lipids. The finding of AG in the 
lipidome of E. coli, a bacterium in which G1P synthesis has never been reported, thus raises 
questions about the molecular basis of this observation. The first enzyme of the ether lipid 
biosynthesis pathway committed in the recognition of G1P or G3P is GGGP-synthase. This 
enzyme typically attaches the isoprenoid GGPP to the glycerol-1-phosphate backbone by 
an ether-bond. The crystal structures of the GGPPs enzymes from A. fulgidus [302] and 
Methanothermobacter thermoautotrophicus have been elucidated, and the catalytic site 
Chapter 6 Generation of a hybrid heterochiral membrane 
6
128
and the binding site for G1P have been identified [303]. When activity of this enzyme was 
tested towards G1P or G3P it was found to have an activity of only 5% with G3P as substrate 
compared to the activity with G1P [351]. We therefore also investigated the activity of M. 
maripaludis GGGP-synthase towards G1P and G3P in an in vitro reaction using GGPP as 
initial substrate. Surprisingly, GGGP formation was observed both in the presence of G1P 
and G3P at equal levels (Fig. 4A, lanes 2 and 3) compared to the negative control where 
no glycerophosphate was added (Fig. 4A, lane 1). As a control, the specificity of purified 
PlsB from E. coli towards G3P and G1P was tested in another coupled in vitro reaction. As 
expected the synthesis of lysophosphatidic acid (LPA) was observed in the presence of 
G3P (Fig. 4B, lane 2) but not with G1P (Fig. 4B, lane 3). Kinetic analysis of GGGP-synthase 
towards G1P and G3P showed, however, an 8-fold higher affinity of the enzyme for G1P (Km 
= 5.75 ± 1.57 µM for G1P, Km = 46.67 ± 6 µM for G3P) (Fig. 4C). Consequently, substrate 
specificity of all the downstream enzymes of the ether lipid pathway were also tested for G3P 
specificity. Coupled in vitro reactions were used to test the stereoselectivity of the second 
enzyme (DGGGP-synthase) involved in the ether bonds formation towards G1P and G3P.
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Figure 3. Optimization of IPTG induction in WUR182 A. DGGGP, AG and AE production expressed as 
normalized ion counts. The total amount of diethers (pink bar) is expressed as a percentage of the total ion 
counts. WUR182 was assayed for optimal onset of induction (IPTG = 0.1 mM). B. An IPTG calibration curve was 
tested on WUR182, Additionally, the ∆araM control strain WUR187 was tested for AG and AE production.
By using purified GGGPs from M. maripaludis and DGGGPS from A. fulgidus, DGGGP synthesis 
was observed also when using G3P (Fig. 4D, lane 2 vs. Fig. 4E, lane 4 ). Remarkable, however, is 
the low amount of DGGGP produced in the presence of GGGP in G3P configuration compared 
to GGGP in G1P configuration. This result implies that DGGGPs plays a more important role in 
the selection of substrates in G1P configuration than the GGGPs does. This finding therefore 
shows that the stereoselectivity of G1P in archaea is thus not solely determined by the 
presence of the G1P-dehydrogenases but also determined by substrate specificity of the lipid 
synthesis enzymes downstream of GGGPs.
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1 2 3 
GGPP yes yes Yes 
GGGPS_M.mar yes yes Yes 
G1P no yes no 
G3P no no yes 
1 2 3 
Oleic acid yes yes yes 
CoA yes yes yes 
ATP yes yes yes 
FadD yes yes yes 
PlsB yes yes yes 
G3P no yes no 
G1P no no yes 
lipids yes yes yes 
A B 
Vmax= 3259 ± 150 nmol/min/mg 
Km= 5.75 ± 1.57 uM 
Kcat = 1.086 ± 0.05 s-1 
Vmax= 4850 ± 161 nmol/min/mg 
Km= 46.67 ± 6 uM 
Kcat= 0.8084 ± 0.027 s-1  
C 
Figure 4. Specificity of archaeal lipid synthesis enzymes towards glycerophosphate substrates A. Enantiomer 
specificity of GGGP synthase from M. maripaludis to G1P and G3P B. PlsB acitivity towards G1P and G3P C. 
Kinetics of M. maripaludis GGGP synthase dependent on glycerophosphate D. Cascade in vitro reaction using G3P 
substrate; E. Cascade in vitro reaction using G1P substrate via AraM [348].
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Figure 4. Specificity of archaeal lipid synthesis enzymes towards glycerophosphate substrates. Continued
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6. Confirming heterochirality of a hybrid membrane
After finding archaeal lipids in the ∆araM control strain and substrate promiscuity of 
GGGPs and DGGGPs, the chirality of the lipids was analysed by NMR. Via a saponification 
of the bacterial ester-lipids, the archaeal ether-lipids were purified from the lipid 
extracts. The purified lipids were then analysed to reveal the stereo configuration of their 
glycerophosphate backbone. By using lipid standards having either a G3P (Fig. 5, panel E) or 
a G1P (Fig. 5, panel D) configuration and a combination of both (Fig. 5, panel A), the chirality 
of the ether lipids was established. Strain WUR182 harbouring the MEP-DOXP operon 
and all the ether lipid required genes, clearly showed a near 100% identity with the lipid 
standard in G1P configuration (Fig. 5, panel B). Surprisingly, also the control strain WUR187 
having the deletion in araM showed the presence of lipids in the G1P configuration (Fig. 5, 
panel C), with only a trace amount of G3P-lipids. Apparently, G1P is natively present in E.coli 
and the inclusion of the araM gene thus appeared to be redundant for the formation of the 
desired G1P-diether lipids. Despite this, the level of diether lipids markedly increased by the 
presence of intact araM (Fig. 3B, lane 3 vs. lane 6).
Synthetic  G1P - 
lipid 
Synthetic  G3P - 
lipid 
Mixture synthetic G3P 
and G1P lipids 
WUR 182 lipid extract 
WUR 187 (araM) 
lipid extract 
E 
D 
C 
B 
A 
Figure 5. NMR spectra of lipid extract from WUR182 and WUR187(∆araM)
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Cellular characteristics and general responses to a hybrid 
heterochiral membrane 
Biochemical adaptations to endogenous lipid synthesis
To assess phenotypical responses of E. coli to archaeal lipids, we characterized the endogenous 
lipid composition, growth performance, cell morphology and physico-chemical adaptiveness 
of the induced WUR182 strain. As previously shown and confirmed here, conversion of 
DGGGP to AG can be catalysed by the native polar head-group machinery of E.coli [348]. 
Although introduction of B. subtilis PssA is necessary for AE formation, this product also 
relies on the additional activity of two native proteins i.e. CDP-diacylglycerol synthase (CdsA) 
and phosphatidylserine decarboxylase (Psd). This dependence on native E.coli membrane 
proteins [332, 352, 353], highly supports membrane incorporation and functionality of the 
introduced lipids. This assumed membrane integration of AG and AE might in turn trigger 
compensatory changes in the native lipid composition. Arguments in favour of this hypothesis 
are the observed sudden increase in anionic lipid content and shared substrate utilization of 
G-3-P for polar head groups. Secondly, the acquired lipids are also likely to cause an overall 
change in membrane permeability and fluidity which may elicit changes in the native lipid 
composition as a homeoviscous adaptation mechanism. To test this, we grouped all obtained 
lipidomes according to their cumulative diether lipid content (DGGGP, AG and AE). The 
phosphatidylglycerol (PG) pool, which typically accounts for 25% of the phospholipids [290, 
353] was remarkably high in the WUR168 control strain (i.e. 39.1%) (Fig. 6A, lane 1).
This increase is possibly due to an excess of glycerol added to the OPT1 medium. Associated 
with an increase in diether lipid content we observed a gradual decrease of PG in response to 
the increasing AG content (Fig. 6A, lanes 2-11). A highest overall PG decrease of 28.1% was 
observed that perfectly matched with the detected amount of diether lipids (also 28.1%). This 
phenomenon is probably best explained by competition of CDP-DAG (CDP-diacylglycerol) and 
CDP-archaeol for phosphatidylglycerophosphate synthase (PgsA), the enzyme that exchanges 
the CDP moiety for G-3-P. Despite the trade-off between PG and AG, the overall percentage 
of lipids with glycerol head groups remained stable at 37.1% of the total phospholipid content. 
Average PE levels also remain the same regardless of the AG content. 
Growth performance and genotypic changes
To evaluate potential effects of the archaeal lipids on the metabolic fitness of the WUR182 
strain during mixed membrane formation, growth was analysed. Fresh pre-cultures of 
WUR182 on LB were obtained and used to inoculate the OPT1 medium without the addition 
of IPTG. Changing from LB to OPT1 medium first resulted in a large lag-phase that lasted for 
approximately 16 h, which was also observed for the control strain. We then used this starter 
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culture to inoculate fresh OPT1 medium supplemented with IPTG. We observed, however, 
an additional lag-phase for WUR182 and WUR187 that lasted for at least 20 h (Fig. 6B, 
triangles) compared to a non-induced culture which entered log-phase already after 7 h (Fig. 
6B, circles). This growth retardation is best explained by some metabolic adaptation to the 
introduced heterologous proteins or the foreign lipid species. Alternatively, the final culture 
may represent a selective progeny of cells. In this case, incidental but beneficial mutations 
rather than a collective growth retardation of the entire population explains the growth delay.
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Figure 6. A. Lipidome composition in relation to the diether lipid content. Lipidomes of WUR182 were arranged 
according to increasing diether lipid content; the WUR168 control strain lacking pMS148 is depicted in lane 1; B. 
Growth curves obtained during mixed membrane production. Negative control WUR45 (diamonds); WUR182 
with immediate induction (triangles); WUR182 with delayed induction (circles); WUR187 with araM deletion, 
with immediate induction (squares). Growth was monitored by measuring the turbidity at 600 nm (OD
600
) using 
biological triplicates.
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Interestingly, this latency was no longer observed after subsequent culturing of the adapted 
cells on fresh OPT1 with IPTG (not shown). Late inductions at OD
600
=0.3 also caused a 
comparable but smaller growth retardation (Fig. 6B, circles). In contrast to a 20 h lag phase, 
growth was restored shortly after a transient plateau was reached at OD
600
=1. An even longer 
lag phase (>24 h) was observed for the WUR187 strain that lacks G1PDH (Fig. 6B, squares). 
Although onset of growth was severely affected in both WUR182 and WUR187, specific 
growth rate of the strains did not change, as almost equal slopes were observed compared 
to the control. In addition to this, nearly equal cell densities were obtained, indicating that 
mixed membrane production does not affect the metabolic fitness of the cells.
To detect incidental mutations that could explain the initial growth retardation, we 
performed genome sequencing on two samples of adapted cells and compared these to 
a reference genome sequence. The latter was obtained by a PacBIO sequencing on strain 
WUR182, which was grown on LB without induction. For the adapted cells (sample B and 
C), two individual cultures were grown on OPT1 with IPTG and sampled for DNA extraction 
at stationary phase. These cultures showed the same growth retardation as observed 
before. The hybrid assemblies of the induced strains were then referenced to the de novo 
annotated genome of the non-induced cells. The comparative analysis of the “pre-induction 
reference genome” and the two “post-induction” genomes revealed the occurrence of 10 
mutations (8 substitutions and 2 deletions) at 7 different loci (Table 6). 
Table 6. Single nucleotide variants detected by illumina sequencing. Samples B and C were referenced against a 
whole genome hybrid assembly (sample A). 
Ref. allele 
(A)
allele sample gene/ intergenic 
region
effect Predicted function of affected 
gene or intergenic region
C T B mhpE – mhpT None 4-hydroxy-2-oxovalerate aldolase;
3-hydroxyphenylpropionic acid transporter
A T C lysZ - lysQ None (tRNA-lys) ttt
G A C nu1_2 ( possible prophage) None possibly nohB
G C C rsxC E614Q Reducer of SoxR, SoxR iron-sulfur cluster 
reduction factor component
G C C lptB V210L LPS transport; LPS export ABC transporter 
ATPase
A T B yhhI A292A H-repeat-associated protein, RhsE-linked, 
(predicted transposase)
A G B yhhI E293E 
G A B yhhI K294K
C del C rop - lacI none non-coding C-terminal region of lacI
G del C rop - lacI none
Abbreviations: del: deletion
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Four of these mutations occurred in intergenic regions, but not in the vicinity of genes 
that had any obvious relation with the observed phenotype. In addition, 3 silent mutations 
were found in the yhhI gene of sample B (predicted transposase) and 2 substitutions in 
rsxC (E614Q)(reducer of SoxR) and lptB (V210L)(LPS transport ABC transporter ATPase) in 
sample C. None of these mutations, however, was involved in central metabolism or able to 
directly affect phospholipid synthesis, nor did the observed mutations occur in both tested 
samples or in related genes. Besides the integrated operon, the recovered plasmids were 
also left unchanged. Therefore, we conclude that the observed lag-phase was likely due to 
a metabolic adaptation rather than a small selective population of mutants. We therefore 
also conclude that the applied membrane modifications result in a stable genotype. 
Effects of the hybrid heterochiral membrane on cell morphology
WUR182 cells for which 28% diether lipid content and heterochirality was confirmed, were 
inspected by SEM and TEM to examine their cell morphology. SEM imaging first illustrated 
that the shape of the cells was radically changed (Fig. 7A-C). The most striking observation 
was the appearance of one or more lobular appendages with diameters ranging roughly 
between 100 and 500 nm. Occasionally, we observed a detachment or apparent budding 
of the appendages which resulted in separated vesicles (Fig. 7A, lower right panel). This 
phenotype appeared to affect the majority of the cells, and was only observed at a very 
low frequency for the late induced cells having lower amounts of archaeal lipids (i.e. 
5.4%). Moreover, the cells with 28% diether lipids were generally longer (up to 12 µm in 
length) with irregular surfaces. TEM analysis indicated that the appendages bud from the 
cytoplasmic membrane with a continuous outer and inner membraneand detachment likely 
occurs through a vesiculation or pinching event. Furthermore, the cells formed intracellular 
vesicles with a high diversity in diameter, that apparently originate from the cytoplasm or 
the periplasmic space (Fig. 7A, lower left panel). Dramatic effects were also observed in 
cells that were induced late at early log phase (OD
600
=0.3). Instead of forming appendages, 
thickening at the distal ends was observed that appeared to have its origin from within the 
cells (Fig. 7B, upper panel). The accumulation of a dense material was demonstrated within 
the cells, occasionally protruding the cell surface from the inside. To further analyse the 
nature of these dense bodies, the cells were fractionated by French-press and the resulting 
extract centrifuged. Here we found large cellular fragments accumulating in the insoluble 
fraction. SEM and TEM analysis showed the formation of extremely dense bodies covered 
by membrane or cell wall fragments (Fig. 7B, lower panel).
Physico-chemical robustness of a hybrid heterochiral membrane
To determine whether membrane robustness is affected by a hybrid and heterochiral lipid 
composition, cells were subjected to some physical/chemical challenges. The engineered 
strains were tested for temperature and butanol sensitivity. We were particularly interested 
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in these parameters because archaeal lipids are assumed to be responsible for cellular 
robustness [30, 121, 295, 354]. We included the WUR187 strain as a primary control to 
assess the influence of lower quantities of archaeal lipids. As a second control strain, we 
included the lycopene synthesis strain (WUR94) to assess the effect of a high isoprenoid 
level in general. Cell cultures were prepared according to the IPTG optimized protocol and 
aliquoted. Individual samples were then exposed to the different stressors and analysed 
for their survival when normalized to a condition without a stressor. A heat shock survival 
assay was performed by exposing the cells 2 min to challenging temperatures between 
42oC and 58oC and the surviving cells were normalized to control cells from each strain 
exposed to 37oC. We observed that the hybrid heterochiral membrane provides E.coli with 
A 
Figure 7. Electron microscopy pictures of engineered strains A. WUR182 cells containing 28% diether lipids: upper 
panel, SEM at 50.000 x magnification. Lower left, TEM; lower right, SEM at 250.000 x magnification. 
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B 
Figure 7. Electron microscopy pictures of engineered strains B. WUR182 cells containing 5.4% diether lipids: 
upper panel, SEM at 50.000 x magnification; Lower left, TEM; lower right, SEM at 200.000x magnification. 
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C 
Figure 7. Electron microscopy pictures of engineered strains C. WUR182 cells containing <1% diether lipids. 
WUR182 cells were grown on LB without induction: upper panel, SEM at 100.000 x magnification; Lower left, TEM.
a lower heat shock survival (Fig. 8A, black bars). We observed a dramatic decline in the 
number of recovered cells compared to the control strains. Conversely, significantly more 
cells were recovered after cryogenic treatment at -80oC compared to wild-type cells (Fig. 
8B, black vs. white bars). Using WUR182, 140% of the cells was recovered compared to 
only 75% for the wild-type cells. In sharp contrast, an incubation at -20oC for a comparable 
duration resulted in loss of viability. The presence of archaeal lipids thus seemed to have 
a protective effect against extreme cryogenic conditions (-80 oC). This finding suggests that 
the hybrid membranes are generally more robust in terms of cold stability. Interestingly, 
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enrichment of unsaturated diether lipids has been described as a psychrophilic adaptation 
in Methanococcoides burtonii [64] and Halorubrum lacusprofundi [65]. The relationship 
between the introduced archaeal lipids and cold stability may thus be based on an increased 
fluidity of the membrane. An increased fluidity, however, also implies that butanol 
resistance would be reduced. This is mainly because increasing membrane rigidity is shown 
to be effective in rationally designed tolerant bacteria [20, 24]. Since butanol concentrations 
higher than 1% are toxic to E.coli, we exposed the cells to butanol in a range of 0 to 2.5%. 
The 1% butanol exposure resulted in a 75% recovery of the lycopene control strain (Fig. 8C, 
squares). In contrast, both the WUR182 and WUR187 strains were found to survive over 
100% of CFU’s at a butanol concentration of 1%. The WUR182 strain even resisted butanol 
levels of 1.5% where still 100% of the original amount of CFU’s was recovered. Altogether, 
these assays suggest a higher stability of the membranes against cryogenic and butanol 
exposure. The lower resistance to a heat shock, however, emphasizes that the membrane 
modifications do not imply an overall improved robustness.
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Figure 8. Robustness tests A. Heat shock 
survival assay. The heat shock survival assay 
shows a decreased recovery for the ether-
lipid-containing cells (WUR182). B. Cold 
shock survival assay. At -80oC the ether-lipid-
containing cells (WUR182) show an increased 
survival. C. Butanol exposure survival assay; 
Diamonds: WUR182 mixed membrane, 
Squares: lycopene strain, Triangles: ∆araM 
negative control
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Discussion
Archaea and Bacteria are believed to have emerged from a last universal common ancestor 
[14]. The appearance at a certain point in time of a mixed membrane, composed of both 
ether- and ester lipids, is regarded as an inevitable transitional stage to reconcile the shared 
characteristics of bacteria and archaea. As this may indeed explain shared features as well 
as the lipid divide, a chimeric membrane should at least support a viable situation to support 
this event. 
To simulate a mixed membrane, we combined metabolic engineering of the MEP-DOXP 
pathway in E.coli with heterologous expression of a composite archaeal biosynthesis 
pathway. To this end, 3 bacterial genes for the synthesis of GGPP (crtE; P. ananatis), G1P 
(araM; B. subtilis), and AS (pssA; B. subtilis) were used and 3 archaeal genes for synthesis 
of GGGP (mmarc5_RS05150; M. maripaludus), DGGGP (mmarc5_RS08865; M. maripaludis) 
and CDP-archaeol (carS; A. fulgidus) (Fig. S1). An important finding of this endeavour was 
the formation of a mixed membrane with reproducible archaeal lipid levels up to 28% 
(w/w) of the total extracted lipids. Besides the choice of genes, the MEP-DOXP engineering 
and tuning of the induction protocol seemed to be of high influence on the net archaeal 
lipid production levels. The most radical improvement, however, was observed when 
the engineered strain was grown on optimized medium, consisting of glycerol and citric 
acid as basic components [213]. We conclude that the optimized medium resulted in a 
substantial stimulation of the isoprenoid flux. This finding strongly suggested that during 
overexpression of only the 4 MEP-DOXP genes, a maximum was reached in the supply of 
pyruvate and glyceraldehyde-3-phosphate as substrate for DXS. On the other hand, when 
we searched for optimal induction parameters, we also observed that the onset of induction 
can radically change the outcome. Immediate induction just before inoculation led to higher 
levels of AG compared to delayed inductions at OD
600 
≥ 0.3. The highest reproducible level 
of archaeal lipids consisted mainly of archaetidylglycerol (92.8%), and to a lower extent of 
DGGGP (6.3%) and archaetidylethanolamine (0.9%). We performed chiral-selective NMR 
on these archaeal lipids to analyse the enantiomeric backbone of the archaeal lipids. Here 
we confirmed that the lipids indeed consisted exclusively of the sn-glycerol-1-phosphate 
configuration. When synthesis of G1P was disabled by disruption of the araM gene, the cells 
unexpectedly still produced a significant amount of diether lipids (≥10.6%). We therefore 
expected to find a high substrate promiscuity of GGGP-synthase for G-3-P which was 
confirmed in an in vitro assay. This finding could explain the unexpected lipid production 
and makes the postulated existence of the presently unnatural G3P-isoprenoid-ether lipid 
in LUCA [7] more credible. Unexpectedly, NMR analysis showed that lipids from this control 
strain also consisted exclusively in G-1-P configuration. This observation leads us to two 
more interesting conclusions. Apparently, E.coli can synthesize G1P endogenously under 
these circumstances, an activity that has never been reported to occur in this bacterium 
before; as no obvious G1PDH ortholog is present in E.coli, the responsible enzyme remains 
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elusive. Secondly, although M. maripaludis GGGP-synthase can utilize both G1P and G3P 
to synthesize GGGP, selectivity for G1P (and not G3P) as the only backbone molecule for 
archaeal lipids is brought about by the higher stereo-selective substrate specificity of the 
DGGGP-synthase for G1P-lipids.
Because a mixed membrane of 28%(w/w) archaeal lipids was demonstrated to sustain a 
viable situation, we were specifically interested in the novel phenotype of the obtained 
strain (WUR182). Here we focussed on establishing growth performance, endogenous 
lipid composition, cell morphology and physicochemical robustness. We noticed that the 
cells displayed a major lag phase upon induction, but eventually started to produce mixed 
membranes at growth rates approaching that of the parent strain. Although the occurrence 
of a long lag phase may have suggested a genetic adaptation, no adaptive mutations affecting 
central metabolism or membrane synthesis could be detected. In addition, the cells did not 
display another lag phase when passed to fresh OPT1 medium with IPTG again, which is 
indicative of a metabolic adjustment during the growth retardation. When we looked into the 
endogenous lipid composition we observed a significant decrease in PG that anti-correlated 
with the level of AG production. PG levels are primarily controlled by activity of PgsA and 
its substrates [355]. The involvement of an allosteric downregulation of the endogenous 
phosphatidylglycerol production by PgsA, however, seems unlikely. Because PgsA is also 
required for AG formation its activity appears not to be inhibited. The formation of PG on 
the other hand is also indirectly controlled by a compensatory activity of endogenous PssA 
that competes for the same substrate CDP-diacylglycerol [356]. Because the overall anionic 
lipid content (39%) was fairly high, E.coli PssA may have been stimulated to overproduce PS 
as a means to compensate with more zwitterionic lipids (PE). This mechanism seems like the 
most plausible explanation to the observed lower PG contents. The change in endogenous 
lipid composition and the membrane-associated location of the polar head-group enzymes 
CdsA, PgsA and PgpA, strongly supports that nascent archaeal lipids become incorporated 
in the membrane. Despite compensatory changes in the membrane and a fairly normal 
growth, SEM and TEM images revealed a high degree of morphological malformations. 
Most strikingly are the lobular appendages with diameters ranging between 100-500 nm. 
Besides extraneous appendages, the cells also disseminated these bodies by an apparent 
budding event and formation of vesicles, intra- and extracellularly or between the inner and 
outer membrane. Because of a seemingly dose-dependent response, it is quite evident that 
the diether lipids were directly responsible for these malformations. The exact mechanism 
behind the localized dissociations remains unclear, but might very well be triggered by 
localized accumulation of archaeal lipids in patches or the immiscibility of the archaeal 
lipid species with the bacterial variants. In turn this may have resulted in locally reduced 
membrane stabilities and the formation of vesicles to expel the foreign lipids. SEM and 
TEM analysis suggested the possible formation of extremely large aggregates in cells with 
a delayed induction (Fig. 7B, lower panel). These findings show that late induction at early 
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log phase was probably disadvantageous to proper folding of the produced proteins and 
therefore resulted in dense aggregates likely consisting of the heterologous gene products 
either with or without archaeal lipids. More importantly, it supports that the many lobular 
appendages and intracellular vesicles cannot be explained by the sheer presence of the 
heterologous expression of membrane proteins. Because inclusion bodies were detected 
in high abundance in both strains, the morphological changes of lobules and intracellular 
or extracellular vesicle formation are very likely attributed to the presence of the foreign 
lipids. In addition to morphological changes, we also observed a dramatic reduction in heat 
tolerance which may support immiscibility. An increased fluidity is likely the reason behind 
this reduction as we also observed a cryo-protective effect of the mixed membrane. Here 
it is commonly accepted that psychrophiles amend a more fluid membrane as a means to 
lower the phase-transition temperature of their membrane.
In conclusion, our data provides evidence that heterochiral hybrid membranes can sustain 
a viable situation but, at least under the tested conditions, this may result in dramatic 
phenotypical alterations. Our findings also support that archaeal lipids are incorporated in 
the membranes, but the miscibility of bacterial and archaeal lipids remains questionable 
which may be related to the concentration of archaeal lipids or their unsaturation. This 
conceivable heterogeneous distribution of lipids may in fact have been the reason for the 
here reported budding, and possibly also may have contributed to the lipid-divide: the 
divergence of the archaeal and bacterial domains.
Materials and Methods
MEP-DOXP operon construction
The idi, ispDF, and dxs genes were amplified by PCR using E.coli MG1655 genomic DNA as 
template. DNA was extracted according to the manufacturer’s procedures ‘Qiagen DNeasy 
Blood & Tissue Kit’. For gene amplifications, primers were used as indicated for the idi, ispDF 
and dxs genes in Table 3. Amplified MEP-DOXP genes were cloned in consecutive steps in 
pGFPuv (Clontech). Restriction digestions, electroporation and cloning procedures were 
carried out according to standard molecular biological techniques according to Maniatis et 
al [239]. 
PCR amplifications were performed according to the standard protocol of Phusion DNA 
polymerase (Thermo Fisher Scientific). The idi gene was amplified with an annealing 
temperature of 58oC and extension time of 80 s. The idi insert and pGFPuv vector were 
double digested for 2h with SphI and PstI (Thermo Fisher Scientific). The insert was 
subsequently ligated into linearized pGFPuv by T4 DNA ligase (Thermo Fisher Scientific) 
to yield pGFPuv-idi (Table 4, pMS03). The subsequent ispDF fragment was amplified at an 
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annealing temperature of 58oC and an extension time of 3 min. The insert was subsequently 
cloned into pMS03 using the XbaI and PstI restriction sites to yield pGFPuv- idi-ispDF (pMS08) 
using the XbaI and PstI restriction sites. The subsequent dxs fragment was amplified at an 
annealing temperature of 60oC and an extension time of 4 min. The insert was cloned into 
(pMS08) to yield the final construct pGFPuv-idi-ispDF-dxs (pMS11). For this final cloning the 
XbaI and the KpnI restriction sites were used.
Table 3: Oligonucleotide sequences. Restriction sites are underlined. For MEP-DOXP operon integrations, 
homologous regions are underlined. 
Primer TG Sequence (5’3’) RS Primer name
Cloning primers
BG3606 idi GGCATGCCATGCAAACGGAACACG SphI For-a1.1 SphI_Idi
BG3599 idi GCTGCAGTTATTTAAGCTGGGTAAATGCA PstI Rev-a1.1 idi_PstI
BG3600 ispDF GCTGCAGAGGAGATATACATATGGCAACCA
CTCATTTGG
PstI For-a1.2Pst_RBS_
IspDF
BG3601 ispDF GTCTAGATCATTTTGTTGCCTTAATGAGTAGCG XbaI Rev-a1.2 IspDF_XbaI
BG3602 dxs GTCTAGAGGAGATATACTGATGAGTTTTG
ATATTGCCAAATAC
XbaI For-a1.3XbaI_rbs_dxs
BG3603 dxs GCGGTACCTTATGCCAGCCAGGCC KpnI Rev_a1.3dxs_KpnI
BG3899 crtE GAACGAATTCAGCCCGAATGACGGTCTGC EcoRI For_EcoRI_CrtE
BG3900 crtE GAATCTTAAGGCGCGACCAGTTCCTGAG AflII Rev_AflII_CrtE
BG3901 crtBI GCTGAGATCTGATGAAACCAACTACGGTAATTGG BglII For_BglII_CrtBI
BG3902 crtBI CTTACTCGAGAAAGACATGGCGCTAGAG XhoI Rev_XhoI_CrtBI
BG4429 BB GACGCGTACGGTGTCTTTTTTACCTGTTTGACC BsiWI For-BsiWI-PI-BB
BG4430 BB GACGCTTAAGCTACCTCTGGTGAAGGAGTTGG AflII Rev-AflII-PII-BB
BG4476 kanR TTCCGTCAGCCAGTTTAGTC - Rev-Kan1-BB
BG5004 aceB TACATCGAAGCGTGGATCTCTGG - For EI–scr UP
BG5005 aceA ATCTGATCGGCACGACGGAAGG - Rev EI–scr DOWN
Knock-in primers
BG4885 MEP-
DOXP 
operons
CTGACCCTGCCAGGCTACCGCCTGTTAGCGTAAACCACCA-
CATAACTATG GCTACCTCTGGTGAAGGAGTTG
- For-H1B-P2
BG4886 MEP-
DOXP 
operons
CTGTAATTCTTCAATTTGTTGTGTACGGGTTTTCATGTGCAGAT-
GCTCGGCAGTGAGCGCAACGCAATT
- Rev-H2B-Lac O3
Abbreviations: TG: Target gene; RS: restriction enzymes; BB: backbone, represents the lox71-kanR-lox66 knock-in 
cassette
A lox71-kanR-lox66 gene cassette as selection marker was cloned to pCR2.1 topo by topo-
TA cloning to yield pMS46. The purpose of the cloning was to extend the cassette with 
an N-terminal BsiWI and a C-terminal AflII restriction site. These sites allow the insertion 
of the lox71-kanR-lox66 cassette downstream of the previously constructed MEP-DOXP 
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operons. The lox71-kanR-lox66 gene template (provided by T. van Rossum) was amplified 
with Phusion polymerase. The PCR reaction contained: 1 µl lox71-kanR-lox66 template, 0.2 
µM forward primer (BG4429), 02 µM reverse primer (BG4430), 0.2 mM dNTPs, 1x Phusion 
buffer, and 1U Phusion polymerase. The amplification of lox71-kanR-lox66 was done at 
an annealing temperature of 52oC and an extension time of 40s. Correct insertion was 
verified by sequence analysis. The main purpose of the following cloning procedure was the 
exchange of the gfp gene from the previously cloned constructs pMS03, pMS11 with the 
lox71-kanR-lox66 selection marker. An Acc65I (BsiWI) and BspTI (AflII) double digestion on 2 
µg pMS03 and pMS11 plasmid DNA was performed to generate a linear vector. To generate 
a lox71-kanR-lox66 insert, 4 µg pMS46 was similarly digested. Digests were applied on 1% 
agarose gel and separated for 30 min at 100V. Correct fragments were excised from gel 
and purified on a DNA clean and concentrator-5 column (ZYMO Research). The lox71-kanR-
lox66 inserts were ligated with linearized vectors to generate pMS51 and pMS53 (Table 4).
Table 4: Plasmids and inserts used in this study
Annotation vector Insert 1 Insert 2 Insert 3 Insert 4
pMS03 pGFPuv idi
pMS08 pGFPuv idi ispDF
pMS11 pGFPuv idi ispDF dxs
pMS17 pACYCduet crtE crtBI
pMS46 pCR2.1 topo lox71-kanR-lox66
pMS51 pGFPuv idi lox71-kanR-lox66
pMS53 pGFPuv idi-IspDF-dxs lox71-KanR-lox66
pMS148 pETduet crtE araM
pMS184 pETduet crtE ∆araM*
pSP001 pRSF GGGPs M.marp DGGGPs M.marp
pSJ139 GGGPs M.marp DGGGPs A.fulg
pAC027 pRSF GGGPs M.marp DGGGPs M.marp carS
pAC028 pRSF GGGPs M.marp DGGGPs M.marp pssA
pAC029 pRSF GGGPs M.marp DGGGPs M.marp carS pssA
*∆-sign denotes deletion, 
Operon integration
Homologous end extension PCR was performed by Phusion polymerase PCR (ThermoFisher 
Scientific) to generate integration cassettes. The following primers were used to extend 
the operons with homologous ends (Table 3). For the EPOD-independent locus insertion, 
BG4885 and BG4886 primers were used and annealed at 56oC. A standard PCR protocol 
was performed to amplify the knock-in cassettes for the idi, and idi-ispDF-dxs operons using 
pMS51, and pMS53 template DNA, respectively. The resulting PCR-fragments were purified 
on a clean and concentrator 5 column (ZYMO research).The integration and clearing of the 
selection marker was performed as described previously in the gene disruption strategy 
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by Datsenko and Wanner [234]. Briefly, competent JM109(DE3) cells with induced pKD46 
for Red-recombinase (WUR61) were electroporated with 375 ng purified cassette DNA at 
2500V, 200Ω, 25 µF and 5 ms. After 1.5 h recovery on SOC medium at 37oC, cells were plated 
on LB-agar supplemented with 50 µg/ml kanamycin. Mutant colonies were screened by 
colony PCR using primers BG5004 and BG5005 for the EPOD-independent locus according 
to standard PCR conditions. Positive clones were annotated WUR63, and WUR71 for the 
idi-lox71-kanR-lox66 and idi-ispDF-dxs-lox71-kanR-lox66 operons in the EPOD-independent 
region, respectively. Correct insertion was confirmed by sequence analysis of the amplified 
knock-in region with primers BG4476 and BG4886. Novel strains were transformed with 
pJW168 harbouring the Cre-recombinase to remove the kanamycin resistance gene leaving 
a lox72 scar sequence. The cells were spread on LB-agar plates supplemented with 100 µg/
ml ampicillin and 0.5 mM IPTG to induce cre-recombinase and grown at 30oC. To finalize 
recombination, purification of the cells and clearance of the plasmids, the colonies were 
re-streaked on LB-agar plates without additives and grown at 37oC. The novel strains were 
annotated WUR89, and WUR91 for the integrated operons idi, and idi-ispDF-dxs, respectively. 
The mutant strains were retransformed with the lycopene reporter construct pMS17 to yield 
strains WUR92 and WUR94.
Table 5: Strains and respective genotypes used in this study
strain Genome integrations Plasmid 1 Plasmid 2 
WUR45 - (Wild type JM109(DE3)) - -
WUR61 - pKD46 -
WUR63 idi- lox71-kanR-lox66 - -
WUR71 idi-ispDF-dxs-lox71-kanR-lox66 - -
WUR89 idi - -
WUR91 idi-ispDF-dxs - -
WUR92 idi pMS17 -
WUR94 idi-ispDF-dxs pMS17 -
WUR150 - pMS148 pSJ139
WUR151 idi pMS148 pSJ139
WUR152 idi-ispDF-dxs pMS148 pSJ139
WUR153 idi-ispDF-dxs pMS148 pSP001
WUR168 idi-ispDF-dxs pETduet pSJ139
WUR177 idi-ispDF-dxs pMS48 pAC027
WUR178 idi-ispDF-dxs pMS48 pAC028
WUR182 idi-ispDF-dxs pMS48 pAC029
WUR187 idi-ispDF-dxs pMS84 pAC029
Assembly of a lycopene reporter construct pMS17
The crtE, crtB and crtI genes were PCR-amplified using Pantoea ananatis genomic DNA as 
template DSMZ (DSM30080) Amplifications were performed at an annealing temperature of 
55oC and an extension time of 35 s with the primers indicated in Table 3. pACYCduet vector 
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(Novagen) as well as the amplified crtE fragments were digested with EcoRI and AflII (BspTI). 
The vector was treated with antarctic phosphatase (NEB) to prevent self-circularization. 
The crtE insert was ligated into linearized pACYCduet by T4 ligase to obtain pACYC-crtE. 
The crtB and crtI genes constitute a bicistronic mRNA and were PCR-amplified as a single 
fragment. The amplified crtBI fragment was amplified at an annealing temperature of 58oC 
and an extension time of 80 s. The insert as well as the previously constructed pACYC-crtE 
plasmid were digested with BglII and XhoI. The linearized plasmid was treated with antarctic 
phosphatase (NEB) to prevent self-circularization. Ligation by T4 ligase yielded the completed 
lycopene reporter pACYC-crtEBI. From this point on this construct was referred to as pMS17 
(Table 4). 
Lycopene quantification 
An aliquot (10 ml) from each culture was centrifuged at 4,700 xg for 10 min. The cell pellet 
was resuspended in 1 ml MQ, and transferred to a clean 2-ml screw-cap vial and centrifuged 
(12,000 xg, 5 min). The residual cell pellet was suspended in 500 µl acetone and incubated 
30 min at 55oC to promote extraction and centrifuged again (20 min, 16,000 xg, 4oC). The 
supernatant containing lycopene was transferred to a clean screw-cap vial. The extracts were 
kept in the dark to prevent light induced break-down of lycopene. This extraction procedure 
was repeated two times and the three lycopene extracts pooled to a final volume of 1.5 
ml. The extract was centrifuged additionally at 16,000 xg for 2 min to pellet incidental cell-
debris. A 250-µl sample was diluted with 750 µl acetone and the absorbance was measured 
at 472 nm in a chemical-resistant cuvette (Brand GmbH). The lycopene concentration was 
determined by interpolation of the measured absorbance to a standard calibration curve of 
lycopene (Sigma-Aldrich). The calibration curve of lycopene dissolved in acetone resulted in 
the following equation (y=0.2254x-0.0077) established at an R2 =0.9998. The total lycopene 
concentration was normalized to the dry cell weights (DCW) per 10 ml induced culture. For 
DCW determinations, a 10-ml culture aliquot was centrifuged (4,700 xg, 2 min), and the 
pellet was resuspended in 1 ml MQ and transferred to a pre-weighed aluminium dish. The 
cells were dried for 24 h at 105oC and weighed. The lycopene production was expressed as 
“µg lycopene/mg DCW”. All obtained values were derived from biological triplicates.
Plasmid 1, pMS148 and pMS184 construction 
Plasmid pSJ130 (pETduet-araM) harbouring the Bacillus subtilis G1P-dehydrogenase was 
used as vector for cloning of pMS148. The crtE gene of Pantoea ananatis was excised from 
the cloning vehicle pMS14 (pCR2.1-crtE) which was already used to construct pMS17. The crtE 
gene and pSJ130 were both digested with EcoRI and ligated to obtain pMS148. A negative 
control plasmid with a deleted section of the araM gene was made by EcoRV and BmgBI 
double digestion of pMS148 and a subsequent blunt ligation from the linearized plasmid to 
obtain pMS184.
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Plasmid 2, pSP001 and pAC series construction
The mmarc7_RS05150 gene encoding the Methanococcus maripaludis geranylgeranyl-
glyceryl-phosphate synthase was cloned to the EcoRI and HindIII sites of the pRSF-duet 
vector. The obtained plasmid was complemented with the mmarc5_RS08865 gene encoding 
the Methanococcus maripaludis 2,3-di-O-geranylgeranylglycerol phosphate synthase at the 
NdeI and XhoI site to yield pSP001. To construct pAC027, the codon optimized AF1749 gene 
encoding the CarS enzyme from Archaeoglobus fulgidus was cloned to the NcoI and HindIII 
sites of pSP001 vector. To obtain pAC028, the pssA gene encoding the phosphatidylserine 
synthase enzyme from Bacillus subtilis was cloned to the NotI and AflII sites of pSP001 vector. 
Finally, to construct pAC029, the pssA gene encoding the phosphatidylserine synthase enzyme 
from Bacillus subtilis was cloned to the NotI and AflII sites of pAC027 vector.
Growth conditions and lipid analysis
Newly obtained E.coli strains were grown aerobically on LB at 37oC, and where appropriate 
supplemented with 100 µg/ml ampicillin (Amp100) and 50 µg/ml kanamycin (Kan50) to obtain 
starter cultures. To obtain secondary starter cultures, 25 ml OPT1 medium without IPTG was 
inoculated at a 1/100 volume and grown overnight at 37oC. OPT1 medium contained (Glycerol 
1% (v/v), KH
2
PO
4
 2.4% (w/v), (NH
4
)
2
HPO
4
 0.4% (w/v), citric acid 0.17% (w/v) as adapted from 
the previous formulation [213]. After autoclaving the OPT1 medium, filter-sterilized NiCl
2
 1 
mM, MgSO
4
 0.012 mM and 1x MEM vitamin solution (Sigma-Aldrich 58970C) were added and 
where appropriate IPTG added at 0.1 mM. 
For lipid production assays, 220 ml LB or OPT1 medium was inoculated in triplicates using the 
primary or secondary starter cultures resp. from a 1/100 volume inoculum and grown aerobically 
overnight at 37oC. The obtained cells were cooled on ice and pelleted by centrifugation (15 
min at 4,700 xg, 4oC). The supernatant was removed, and the cells resuspended in 10 ml lysis 
buffer ( 50 mM Tris-HCL pH=8, 1 mM EDTA, 150 mM NaCL, 1 mM DTT, 0.1 mM PMSF). The 
cell suspensions were passed through a French press twice at 16,000 psi to lyse the cells. 
The collected crude extracts were then centrifuged (10 min at 10,000 xg, 4oC) to remove 
insoluble debris. To collect the membrane fractions, the cleared lysate was ultracentrifuged 
(80 min at 120,000 xg, 4oC). The resulting pellets were resuspended in 500-1000 µl lysis 
buffer by pipetting. To obtain lipid extracts, the rapid extraction and purification of lipids 
method by Bligh and Dyer was performed [341]. The membrane fractions were quantified 
and normalized for their protein content (Roti Nanoquant method, ROTH) and diluted to 
1 ml with lysis buffer. Prior to dissolving the membranes in 3.75 ml chloroform:methanol 
(1:2), 2 µl of 20 µM eicosane was added as internal standard. After addition of 1 ml MQ, the 
samples were vortexed and 1.25 ml chloroform added. The samples were again vortexed and 
1.25 ml MQ added. After vortexing and centrifugation (15 min at 2,000 rpm), the chloroform 
phases were transferred to a clean glass tube. To purify the extracts, 2.25 ml authentic upper 
phase was added and vigorously vortexed. The chloroform phase was again separated after 
centrifugation ( 15 min at 2,000 rpm). The chloroform was evaporated under a stream of 
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nitrogen gas. The resulting lipid pellets were dissolved in 300 µl chloroform:methanol (1:2), 
again pelleted under a stream of nitrogen and dissolved in 100 µl methanol. Finally, the lipid 
extracts were briefly centrifuged to pellet insoluble particles.
LC-MS analysis
The samples obtained by lipid extraction and in vitro reactions were analysed using an 
Accela1250 high-performance liquid chromatography system coupled with an electrospray 
ionization mass spectrometry (ESI-MS) Orbitrap Exactive (Thermo Fisher Scientific). A volume 
of 5 μl per sample was used for the analysis. The LC-MS method parameters used in this study 
were the same as described previously [22]. The capillary and the tube lens voltage were set 
to -75 V and -190 V, respectively. For the samples from in vivo experiments, a sample volume 
of 5 μl was injected into a Shim-pack XR-ODS/C8/Phenyl column with dimension 3.0 mm I.D. x 
75 mm (Shimadzu) operating at 55°C with a flow rate of 400 μl/min. Mobile phase A (10 mM 
ammonium formate with 0.1% formic acid in water:acetonitrile 40:60 (v/v) and mobile phase 
B (10 mM ammonium formate with 0.1% formic acid in acetonitrile:isopropanol 10:90 (v/v) 
were used as follows: initial condition started with 40% B, a linear gradient was started in 2 
min from 40% to 43% B, gradient from 43% to 50% B in 0.1 min, 54% B isocratic for the next 
9.9 min, linear gradient from 54% to 70% B in 0.1 min, 99% B isocratic for the following 5.9 
min, gradient from 99% to 40% B in 0.1 min and 40% B isocratic for the last 1.9 min[43]. The 
MS settings used for this analysis were the same as described above. The Thermo XCalibur 
processing software was used for data analysis and the Genesis algorithm for automated peak 
detection and integration was applied to this analysis.
PacBIo and Illumina whole genome sequencing
One ml WUR182 cell suspensions were obtained from cultures grown on LB (control) or OPT1 
medium as described in the section ‘growth conditions and lipid analysis’. Chromosomal DNA was 
isolated according to the gram positive DNA purification protocol of the EPICENTRE masterpure 
DNA purification kit (MGPO4100). Quality and quantity of DNA isolates were checked by QUBIT 
quantification (Thermo Fisher Scientific). Next Generation Sequencing was executed by Baseclear 
B.V. Leiden. A de novo hybrid assembly was done by means of PacBio sequencing on the unaltered 
isolate of WUR182 cells (sample A), and on two independent cultures after induction on OPT1 
(samples B and C) by Illumina sequencing. The de novo hybrid assembled genome was annotated 
using the Baseclear annotation pipeline based on Prokka version 1.6 Prokaryotic Genome 
Annotation System. Illumina generated sequence reads were aligned against the assembled 
hybrid genome using the ‘Map reads to reference’ option of the CLC Genomics Workbench 
version 8.5.1. Output of the variant detection was given in single nucleotide variants, multiple 
nucleotide variants and short InDels. Identified mutations were interactively analysed using the 
BaseClear online annotation browser. Intergenic regions were inspected for possible alterations 
of promoter regions and transcription factor sequences by means of the online transcriptional 
regulatory network database (http://regulondb.ccg.unam.mx/).
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Stereo-selective NMR 
The NMR spectra were recorded on a Varian Unity Inova 600 MHz spectrometer using 
deuterated chloroform. The signals are given as in parts per million (δ, ppm) and were 
determined relative to the proton resonance of chloroform at 7.26 ppm as the internal 
standard. All Mosher’s ester derivatives (synthetic and naturally derived) were isolated as 
mixtures (sn-3 synthetic, sn-1 synthetic, mixture of sn-1 and sn-3 synthetic, E. coli extracted 
and E. coli G1P deficient strain extracted lipids). The spectrum of the synthetic (R,R)-lipid (sn-
3 stereochemistry) shows a pair of sharp double doublets at 4.525 and 4.505 ppm whereas 
in the spectrum of the synthetic (S,R)-lipid we observe similar double doublets at 4.575 and 
4.555 ppm, for all naturally derived Mosher’s esters double doublets at 4.575 and 4.555 ppm 
were observed.
In vitro activity assays
GGGP synthase activity
In vitro reactions were performed in 100 μl of assay buffer containing a final concentration of 
50 mM Tris-HCl pH7.5, 10 mM MgCl
2
, 60 mM NaCl, 100 mM imidazole, 0.08% DDM and 4% 
glycerol. Where specified, 100 μM GGPP, 10 mM G3P, 10 mM G1P and the indicated amount 
of purified enzymes were added to the reaction mixture. The reactions were incubated at 
37°C for 1 h. The kinetics assays were performed using the same mixture but the reactions 
were incubated at 37 °C for 2 h. For determining the in vitro bacterial PlsB activity, 100 μl of 
reaction volume was used containing the following assay buffer: 50 mM Tris-HCl pH 8, 10 
mM MgCl
2
, 100 mM KCl, 20% glycerol, 2mM DTT, 2.8 mM lipids (DOPG:DOPE, 2:1). Where 
specified, 200 μM oleic acid, 10 mM G-3-P, 10 mM G-1-P, 1mM ATP, 40 μM CoA and the 
indicated amount of purified enzymes were added to the reaction mixture. Reactions were 
incubated at 37°C for 3 h and the products were extracted two times with 0.3 ml of n-butanol. 
Extracted lipids were evaporated under a stream of nitrogen gas and resuspended in 50 μl of 
methanol for the LC-MS analysis.
In vitro reconstruction of AE and AG
For the in vitro reconstitution of AE and AG, 100 μl of reaction volume was used containing 
the following assay buffer: 50 mM Tris-HCl pH 7.5, 10 mM MgCl
2
, 15 mM NaCl, 25 mM, 
Imidazole, 0.02% DDM, 1% glycerol, 100 ul GGPP and 10 mM G3P. The indicated amount of 
purified enzymes was added to the reaction mixture. Reactions were incubated at 37 °C for 
1 h as described previously, and the products were extracted twice with 0.3 ml of n-butanol. 
Extracted lipids were evaporated under a stream of nitrogen gas and resuspended in 50 μl of 
methanol for the LC-MS analysis.
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Scanning electron microscopy
Droplets (150 µl) of culture medium containing bacteria or isolated beads from bacteria were 
put on poly-L-lysine coated cover slips (Corning art. 354085) for 1 h to immobilize the samples 
on the surface. The glasses with the attached cells were put in 2.5% glutaraldehyde in 0.05 M 
sodium cacodylate buffer pH 7.2 at room temperature for one h, rinsed 3 times in the same 
buffer and post fixed for 1 h in 1% OsO4 (w/v) in the same buffer. Hereafter they were washed 
with water twice, dehydrated in a graded ethanol series (10, 30, 50, 70, 90, 100, 100%) and 
were critical point dried with carbon dioxide (Leica EM CPD 300). The glasses were attached 
on a sample holder by carbon adhesive tabs (EMS Washington USA), sputter coated with 
tungsten (Leica EM SCD 500) and analysed and digitally imaged with a field emission scanning 
electron microscope (FEI Magellan 400). Sample preparation, imaging and measurements 
were performed by the Wageningen Electron Microscopy Centre (WEMC) facility.   
Transmission electron microscopy of thin sections
E.coli cells in stationary phase were fixed by incubation in 2.5% glutaraldehyde in 0.05 M sodium 
cacodylate buffer pH 7.2 for 1.5 h at room temperature. After three washes in the same buffer 
a post fixation was done in 1% (w/v) OsO
4
 and 1.5% (w/v) potassium ferricyanide in the same 
buffer for 1 h at room temperature and subsequently rinsed three times in water. One volume 
of the sample suspensions were mixed with equal volumes of 3% low melting point agarose. 
Between each step the samples were centrifuged for 5 min at 8,000 rpm and the pellets were 
suspended again in the next liquid. After centrifugation the agarose was solidified at 0°C and 
the parts containing the pelleted sample were cut in very small pieces. The sample pieces were 
dehydrated for one h in 1% uranylacetate (w/v) in ethanol 50%, infiltrated with modified Spurr 
resin mixture (Serva) and polymerised for 8 h at 70°C. The samples were ultra-thin (70-80 nm) 
sectioned with an ultra-microtome (Reichert, Ultracut S), post-stained with 5 times diluted 
Reynold’s lead citrate for 5 min and analysed with a transmission electron microscope (JEOL, 
JEM 1011). Micrographs were made with a digital camera (Olympus, Veleta) and measurements 
were done with iTEM software. Sample preparation, imaging and measurements were 
performed by the Wageningen Electron Microscopy Centre (WEMC) facility.
Physicochemical survival assays
WUR182, WUR187, WUR45 and WUR94 cells were grown on OPT1 medium to stationary 
phase as described in the section ‘growth conditions and lipid analysis’. Cultures were cooled 
on ice for 15 min. Cell turbidity of the cultures was measured spectrophotometrically at 600 
nm as a reference to subsequent dilutions. An aliquote of cells was diluted to an OD
600
 = 1. A 
subsequent aliquot was again diluted 1000x in 50 ml pre-cooled OPT1 medium. At least 25 
samples were aliquoted at 20 µl per ep and snap-frozen on dry ice and stored at -80oC. As a 
reference, 20 µl cells were plated on LB-agar supplemented with appropriate antibiotics in 
triplicate in a dilution series of 10, 100 and 1000x. The cells were grown overnight at 37oC 
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and the resulting colonies counted to estimate the exact amount of cells per aliquote. For 
cold treatments, cells which were not snap-frozen were stored at -20oC or 5oC. To estimate 
the survival rate after cold treatments, the cells stored at -20oC, 5oC and -80oC were thawed 
on ice for 10 min. The cells were then diluted with pre-cooled OPT1 medium and plated 
on LB-agar at appropriate volumes. The amount of raised colonies were referenced to the 
earlier determined cell concentration without any treatment and expressed as a percentage 
of CFU recovery. For heat shock treatments, cells stored at -80oC were thawed on ice for 10 
min. The samples were exposed to a heat treatment for exactly 120 seconds at a calibrated 
41.2, 45.34, 49.6, 53.8, and 58oC in triplicate. Immediately after the heat shock, the cells 
were incubated on ice to allow recovery for at least 5 min. After recovery, the cells were 
suspended in 980 µl SOC medium and incubated at 37oC for 1 h. Appropriate volumes 
of cells were plated on LB-agar to quantify the percentage of CFU recovery. For butanol 
exposure assays, the heat shock treatment protocol was applied, with the omission of the 
heat shock. Here, the SOC medium was supplemented with the following concentrations at 
0, 0.5, 1.0, 1.5, 2.0 and 2.5% butanol (v/v). To avoid evaporation, the cells were transferred 
to screw-cap tubes during incubations.
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Figure S1. Biosynthesis routes of archaeal and bacterial phospholipids. In red, the introduced genes for archaeal 
core lipid synthesis. In blue, E.coli genes responsible for promiscuous activity in the synthesis of archaeal lipids. 
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Figure S3. Lycopene production. The integration of idi only or idi-spDF-dxs operon is compared with a wild-type 
control for production of lycopene to estimate MEP-DOXP upregulation.
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A typical feature of archaea is that their membranes are composed of ether 
lipids, unlike the ester lipid membranes of bacteria and eukarya. Apart from 
a diether state, also condensation to membrane spanning tetra-ether lipid 
occurs at least in some archaea. The enzyme that catalyzes this condensation 
reaction has not yet been identified. In this study, we set out to identify the 
enzyme(s) involved in the synthesis of tetraether lipids in Thermococcus 
kodakarensis, more specifically the one(s) responsible for the condensation of 
two C
20
 isoprenyl chains, i.e. the putative tetraether synthase(s). To do this, 
a list of genes that are potentially involved in tetraether lipid synthesis was 
composed and prioritized based on a couple of characteristics assumed to be 
important for a tetraether synthase. This resulted in the selection of 12 genes, 
which were targeted for overexpression and disruption. Subsequent diether/
tetraether lipid analysis of the mutant strains showed that at least three of 
these genes, TK1548, TK1836 and TK1957 play a role in controlling the amount 
of glycerol dialkylglycerol tetraethers (GDGTs) in the archaeal membrane. 
Whereas TK1548, annotated as serine-pyruvate aminotransferase, has no 
obvious link with lipid biosynthesis, both TK1836 and TK1957 have putative 
roles as geranylgeranyl hydrogenase and polyprenyltransferase, respectively. 
Their potential role in GDGT synthesis is discussed. Although the key enzyme 
responsible for tetraether synthase remains to be identified, our analyzed lipid 
contents strongly suggest that unsaturated diether lipids serve as substrate for 
the missing link in tetraether synthesis. 
Keywords: archaea; ether lipid biosynthesis; membrane lipids, GDGT, 
tetraether lipids, mass spectrometry (MS), Thermococcus kodakarensisAb
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Introduction
Micro-organisms are able to colonize and survive an extraordinary diversity of environments. 
Most strikingly, some not only survive, but even thrive under extreme conditions such as 
very high temperatures (thermophiles), salinities (halophiles), or extreme pH levels (acido- 
and alkaliphiles). Though the majority of the first identified extremophiles belong to the 
archaea, they are also abundant amongst the bacterial domain. Since their discovery, 
extremophiles have attracted much attention because of both their biotechnological 
potential and their remarkable physiological capabilities. Obviously, the main focus of how 
these microbes withstand the perturbations of cellular integrity has been on the cytoplasmic 
membrane, as the membrane shields the inner homeostatic conditions of the cell from the 
hostile environment. Before the discovery of extremophiles, the membrane composition 
and adaptation strategies of mesophilic bacteria were well described [246, 289, 357, 358].
The cytoplasmic membrane generally consists primarily of a phospholipid bilayer. In bacteria, 
the framework molecule of these phospholipids is phosphatidic acid. Phosphatidic acid is 
composed of two acyl-chains which are esterified to the backbone sn-glycerol-3-phosphate. 
Phosphatidic acid serves as a basis for a high variety of phospholipids, which are adjusted 
to the requirements of the membrane. The main membrane parameters that are subject to 
change in response to varying physicochemical conditions are fluidity and permeability [44, 
359]. In response to physicochemical stressors, bacteria regulate the saturation and length 
of the acyl chains to keep the membrane parameters within acceptable boundaries. Archaea 
have a different lipid architecture and thus also differ in their homeoviscous adaptation 
strategies [71]. Instead of phosphatidic acid, archaea typically use archaetidic acid as the 
framework molecule of their phospholipids. Archaetidic acid, which is also known as (S)-
2,3-di-O-geranylgeranyl-sn-1-glyceryl phosphate (DGGGP), differs from phosphatidic acid in 
several key aspects. For example, the hydrophobic moiety is composed of highly branched 
C
20
-isoprenoid chains, rather than the bacterial acyl chains. Moreover, these chains are 
bound by ether bonds (as opposed to the bacterial ester bonds) to sn-glycerol-1-phosphate, 
the stereochemical opposite of the bacterial sn-glycerol-3-phosphate [292, 295]. These key 
differences are unique to both domains and have therefore been termed “the lipid divide” 
[7]. Hence, phosphatidic acid and archaetidic acid are regarded as marker molecules between 
the prokaryotic lineages. Archaetidic acid is considered as the framework molecule of a 
broad range of archaeal membrane lipids [31]. Nevertheless, archaeal membranes typically 
consist of a variation of two main core structures: sn-2,3-diphytanyl glycerol diether, which 
in this study will simply be referred to as diether (and is also known as archaeol), and sn-2,3-
dibiphytanyl diglycerol tetraether, which in this study will be referred to as tetraether (and is 
also known as glycerol-dialkyl-glycerol tetraether (GDGT), or caldarchaeol). The diether lipids 
are generated from archaetidic acid by reducing the unsaturated isoprenoid chains, forming 
C
20
-phytanyl chains, and by subsequent addition of a polar headgroup to the glycerol moiety. 
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Tetraether lipids are bipolar, consisting of saturated C
40
-biphytanyl chains (a molecule that is 
composed of two condensed C
20
-phytanyl units) and a polar head group at each end of that 
chain. Because of their bipolarity, tetraether lipids form a monolayer membrane, whereas 
diether lipids form a bilayer structure that closely resembles the traditional double leaflet 
bilayer of bacteria [9, 292, 295]. 
The variation observed in tetraether lipids involves the incorporation of one or more 
pentacycles, the incorporation of a single hexamer, the addition of methyl groups, or the 
incorporation of bridges between the isoprenoids [68, 71, 360, 361]. Tetraether lipids are 
believed to contribute considerably to an increased stability, permeability and resistance of 
the membrane [121, 359]. Moreover, the diether:tetraether ratio appears to vary substantially 
between archaea at different conditions. And for some hyperthermophilic archaea the 
amount of tetraethers has been shown to increase gradually as the growth temperature rises 
[68, 153, 362]. This suggests that the diether:tetraether ratio might be regulated to adapt 
membrane fluidity and permeability. Additionally, for some hyperthermophilic archaea it 
has been shown that in response to increasing temperatures, the number of incorporated 
pentacycles also increases [70, 153, 359]. However, as thermal adaptation has frequently 
been studied in archaea, it soon became clear that not all archaea form tetraethers and that 
different archaeal species respond to temperature fluctuations in different ways. 
In general, tetraethers have been shown to be the dominant lipid species in Crenarchaeota 
and Thaumarchaeota, whereas members of the Euryarchaeota synthesize diethers, 
tetraethers, or both [9]. However, the exact route leading to tetraether synthesis is still 
unknown. Nevertheless, two different pathways have been postulated (Fig. 1) [9, 292, 295]. 
In the first pathway (which we will refer to as the traditional route), DGGGP is first converted 
to saturated diether lipids, after which two of these molecules are coupled via the yet 
unknown route by a tail-to-tail condensation of the isoprenoid chains to form one tetraether 
molecule [10, 292, 295]. Evidence for the traditional route comes from pulse chase and 
labelling experiments using cell extracts of the euryarchaeon Thermoplasma acidophilum 
incubated with 14C-mevalonate, which is a precursor for the synthesis of the isoprenoid 
building blocks IPP and DMAPP [10, 292]. These experiments showed that the label first 
incorporates into diethers until saturation and only then into tetraethers. Moreover, when an 
inhibitor of squalene epoxidase (known as terbinafine) was used, an inhibition of tetraether 
formation was observed. In addition, pulse labelling in the presence of terbinafine showed 
an accumulation of radioactivity in the diether fraction and a decrease in radioactivity in 
the tetraether fraction, which was reversed by removal of the inhibitor [10, 363]. These 
observations are interesting as, in the traditional route, the putative tetraether synthase is 
predicted to be an analog of squalene or phytoene epoxidase [10].  
However, no incorporation of radiolabelled diether lipids (i.e. archaeol) into tetraether lipids 
(i.e. GDGT-0) was observed in vivo in the euryarchaeon Methanospirillum hungatei [364]. 
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Moreover, from a chemical point of view, the required carbon-carbon bond formation of 
tetraethers between diethers (i.e. the condensation of two saturated phytanyl chains of 
archaeol) is considered quite unusual and some studies indeed suggest that the presence 
of unsaturations is a prerequisite for the formation of tetraethers [9, 92, 365]. These 
observations are contradicting the ones described above and suggest that saturated diether 
lipids are not the precursor of tetraether lipids. This discrepancy might, for example, be 
explained by the possibility that a diether accumulation upon terbinafine exposure is the 
result of growth retention due to toxicity rather than the inhibition of a specific enzyme. This 
alternative might very well be true as it has been demonstrated several times that the ratio 
of diether-to-tetraether is highly dependent on growth phase as well [31, 68, 360, 366].
Recently, an alternative route for the formation of tetraether lipids has been proposed in 
which the tail-to-tail condensation is thought to take place directly after the synthesis of 
various forms of isoprenoid chains (i.e. with or without pentacycle moieties) [9]. According 
to this model, the tail-to-tail condensation of two C
20
 isoprenyl molecules is thus suggested 
to occur before attachment of the hydrocarbon chains to glycerol-1-phosphate and the 
subsequent reduction of the chains (Fig. 1). The consequence of this proposal is that it 
eliminates the requirement of the unusual condensation of two saturated phytanyl chains 
present in diether lipids (i.e. archaeol). The alternative route implies that diether lipids are 
not the precursor of tetraether lipids and that the ether-bond forming enzymes, GGGP 
synthase and DGGGP synthase (responsible for the coupling of the isoprenyl chains to 
the glycerol unit), can accomodate not one but various prenyl species as substrate. These 
substrates include both C
20
 and C
40
 isoprenoid chains (for the formation of diether lipids and 
tetraether lipids, respectively) with or without ring moieties. Thus, in this alternative pathway, 
tetraether lipids are formed by creating C
40
 isoprenoid chains first, which are subsequently 
used as a substrate for the GGGP synthase and DGGGP synthase to attach both the first and 
second glycerol units. However, like the traditional route, the enzyme and the hypothetical 
intermediates responsible for the condensation of the C
20
 isoprenyl chains is still unknown. 
Despite the high interest in the biochemical mechanism, no information is available about 
the enzymes involved in the tail-to-tail condensation. This lack of knowledge might partly 
be due to the long-term absence of archaeal genetic toolboxes. Here, the anaerobic, 
sulphur reducing, hyperthermophilic Euryarchaeon Thermococcus kodakarensis was 
used as a model organism that meets a couple of important criteria that enable such a 
study: (i) T. kodakarensis has previously been confirmed to have both diether lipids and 
tetraether lipids in its cytoplasmic membrane [367],(ii) T. kodakarensis has a genetic 
toolbox available[368-371], (iii) It has a relatively small and fully sequenced genome of 
an estimated 2306 coding DNA sequences [372], many of which have been functionally 
characterized already, and (iv) T. kodakarensis is fairly easy to grow in a laboratory setting. 
By performing comparative bioinformatics analyses, we selected several candidate genes 
that might encode for enzyme(s) involved in the tail-to-tail condensation reaction.
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Moreover, we composed a list of characteristics that were expected to be possessed by a 
tetraether synthase. By scoring the candidate genes according to these characteristics, we 
ultimately selected 12 candidate genes that were targeted for overexpression and deletion. 
The generated mutant strains were analysed for their diether/tetraether lipid composition. 
Results
Selection of candidate genes
To select gene(s) that are potentially involved in tetraether synthesis, two independent 
bioinformatics approaches were performed. For both analyses, we assumed a direct 
correlation between the presence of putative genes (genotype) and the presence of 
tetraether lipids (phenotype). In addition to archaea producing both diether and tetraether 
lipids, there are also a number of archaea reported within the phylum of Euryarchaeota that 
completely lack tetraethers [71]. In the first analysis, we made use of these phenotypes by 
selecting a set of reference species that are phylogenetically closely related to T. kodakarensis 
and that have a confirmed presence or absence of tetraethers in their membranes. The 
selected reference genomes belonging to the first group (i.e. confirmed presence of 
tetraethers) include the hyperthermophiles Pyrococcus furiosus and Thermoplasma 
acidophilum [10, 373-375] and those of the second group (i.e. confirmed absence) include 
the haloalkaliphilic Natronomonas pharaonis and the hyperthermophilic Methanopyrus 
kandleri [299, 376]. The genome of T. kodakarensis was screened for homologs present 
in the first group, but absent in the second group, by performing a phylogenetic profiler 
single gene search (using the IMG system of JGI). This resulted in the identification of 57 T. 
kodakarensis genes that may potentially be involved in tetraether synthesis (Table. S1A).
In the second comparative genome analysis we attempted to correlate the presence of 
specific arCOGs (archaeal Clusters of Orthologous Genes [377] in 149 sequenced archaeal 
genomes to species with a confirmed tetraether lipid membrane. The arCOGs included in 
the analysis (Table. S2) were related to the following categories: phospholipid biosynthesis, 
isoprenoid mevalonate biosynthesis, uncharacterized proteins associated with mevalonate 
biosynthesis, terpene cyclases, fatty acid synthesis, and phytoene/squalene synthesis or 
saturases. However, none of the arCOGs analysed showed a strong correlation with species 
that have a confirmed tetraether lipid membrane. Assuming correct membrane profiling, 
this analysis suggests that tetraether synthesis is either catalysed by different enzymes 
over different archaeal lineages, or that the responsible enzyme is present in all archaea 
whose synthesis or activity is tightly regulated causing different phenotypes (e.g. by post-
translational modification, temperature activation, etc.). Alternatively, one cannot rule out 
that the reported lipid analyses (tetraether/diether presence) are correct. 
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Since no correlation was observed, it was decided to select all uncharacterized T. 
kodakarensis genes that are present in the mentioned arCOGs categories instead. This 
led to the selection of 32 additional genes. To exclude other members of the archaeal 
lipid biosynthetic pathway (e.g. IPP synthase, GGPP synthase, GGGP synthase, etc.) we 
compared the selected genes with experimentally characterized genes. Here we made use 
of homologs from various archaea that have a confirmed enzymatic activity in reactions 
leading to isoprenoid and CDP-archaeol synthesis. To do this, characterized genes from 
each individual step in lipid synthesis [34, 298, 304, 306, 348, 351, 378] were analysed by 
BLAST search against the genome of T. kodakarensis. T. kodakarensis genes that showed 
a high sequence similarity to these characterized genes were excluded from this list (Fig. 
S1). However, the candidate genes TK1324 and TK1957 both showed sequence similarity to 
known DGGGP synthases, making it, based on this information only, impossible to decide 
if both or only one (and if the latter, which one) encode for a DGGGP synthase. Moreover, 
both are annotated as 4-hydroxybenzoate polyprenyltransferase belonging to the UbiA-like 
prenyltransferase COG0382, and it was therefore decided to retain and prioritize both of 
them. This ultimately led to the selection of 27 additional genes that may be involved in 
tetraether lipid biosynthesis (Table S1B). 
To reach a final selection, it was decided to prioritize the resulting 84 genes based 
on characteristics assumed to be important for a putative tetraether synthase. These 
characteristics were (in a non-specific order): (i) predicted prenyl binding. (ii) the presence 
of an FAD or Flavin mononucleotide (FMN) binding domain, which is potentially important 
for tetraether synthases because carbon-carbon bond formations are often aided by FAD 
cofactors as dual electron acceptor [379]. (iii) the presence of aspartic acid rich DDxxD 
motifs. These motifs contribute to the substrate binding of prenyltransferases, which are 
responsible for the transfer of prenyl groups and chain elongation of isoprenoids [337, 380, 
381]. (iv) Homology to squalene epoxidase. This has been suggested by Kon et al., who, 
upon addition of a squalene epoxidase inhibiter (i.e. terbinafine) to the growth medium 
of Thermoplasma acidophilum, observed an accumulation of diether lipids at the expense 
of tetraether lipid biosynthesis [10]. (v) Transcriptional regulation by the Thermococcales 
heat shock protein Phr. Phr is a transcriptional regulator that represses transcription 
under normal growth conditions by binding to the promoters of certain genes and that is 
released from them upon heat shock [382-384]. Since previous studies showed an increase 
in tetraether lipid content upon thermal treatment, transcription of the putative tetraether 
synthase may also be Phr-dependent [68, 69, 153]. Altogether, this scoring resulted in a 
ranking of the candidate genes (Table S1). In case the candidate genes had an equal score, 
priority was given to the presence of prenyl binding or -transferase domains. By doing 
this, we selected 10 priority genes (in addition to TK1324 & TK1957) that were targeted 
for overexpression and disruption (Table 1). These genes were: TK1088, TK0929, TK2159, 
TK1836, TK0509, TK0513, TK1173, TK1477, TK1548 and TK1732. 
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Moreover, an additional column was included in Table 1 showing the presence or absence 
of transmembrane spanning helices. This information may become valuable as it can 
demonstrate the validity of either the classical or alternative synthesis pathway. This is 
because in the traditional biosynthesis pathway, the tetraether lipid biosynthesis is proposed 
to occur by condensing two diether lipids, the synthesis of which already takes place in 
the membrane[295]. In contrast, however, in the alternative pathway, the condensation 
reaction leading to the C
40
 isoprenoid chains takes place in the early steps of the ether lipid 
biosynthesis and is therefore more likely to be catalyzed by a cytosolic enzyme [9].
Construction of mutant strains
To screen for enzymes involved in tetraether lipid formation, 12 genes of interest (GOIs) 
were selected. For each of these genes, we attempted to create a disruption strain and a 
strain overexpressing the GOI. T. kodakarensis strain TS559 was chosen as a parent strain to 
utilize the previously developed selection and counter-selection procedure in rich medium 
(Fig. S2A) [368, 369, 385]. Disruption strains were created as described previously [368]. 
Transformation of the disruption vectors (Table 2) resulted in agmatine prototrophs for 11 
out of the 12 GOIs. TK2159 was the only GOI for which no transformants were obtained, 
not even after 3 independent transformation attempts. Transformants of the remaining 
11 GOIs were confirmed to be 6-methyl purine sensitive (6MPs), a phenotype conferred by 
the expression of TK0664. Next, disruption of the GOIs as well as precise and markerless 
deletion of the selection and counter-selection cassette was stimulated by plating the 
transformants on plates containing 6MP and agmatine. For each of  the remaining GOIs, 
genomic DNA of 30 spontaneous 6MP resistant (6MPR) colonies was analyzed by diagnostic 
PCR. In this analysis, we screened for the deletion of both the GOIs and of the selection 
and counter-selection cassette. Ultimately, 6 of the 12 selected GOIs were successfully 
deleted. For the remaining 5 (TK2159 did not result in transformants), only revertants 
(i.e. parental) were obtained. For the 6 successful GOI disruptions, representative 
clones having the desired final genome configurations were designated T. kodakarensis 
strain ∆TK0513, ∆TK1324, ∆TK1477, ∆TK1548, ∆TK1732, and ∆TK1836, in which the ∆ 
denotes disruption and the number indicates which TK-gene has been deleted (Table 2).
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Table 2. T. kodakarensis strains and plasmids used in this study
Strain or plasmid Relevant characteristics Source or reference
Strains
TS559 ΔpyrF; ΔtrpE::pyrF; ΔTK0664; ΔTK0149 [385]
Disruption strains
ΔTK0513 TS559 derivative, ΔTK0513 This study
ΔTK1324 TS559 derivative, ΔTK1324 This study
ΔTK1477 TS559 derivative, ΔTK1477 This study
ΔTK1548 TS559 derivative, ΔTK1548 This study
ΔTK1732 TS559 derivative, ΔTK1732 This study
ΔTK1836 TS559 derivative, ΔTK1836 This study
Overexpression strains
OE0509 TS559 derivative, ΔTK1765::TK0509, TK0149 This study
OE0513 TS559 derivative, ΔTK1765::TK0513, TK0149 This study
OE0929 TS559 derivative, ΔTK1765::TK0929, TK0149 This study
OE1088 TS559 derivative, ΔTK1765::TK1088, TK0149 This study
OE1173 TS559 derivative, ΔTK1765::TK1173, TK0149 This study
OE1324 TS559 derivative, ΔTK1765::TK1324, TK0149 This study
OE1477 TS559 derivative, ΔTK1765::TK1477, TK0149 This study
OE1548 TS559 derivative, ΔTK1765::TK1548, TK0149 This study
OE1732 TS559 derivative, ΔTK1765::TK1732, TK0149 This study
OE1836 TS559 derivative, ΔTK1765::TK1836, TK0149 This study
OE1957 TS559 derivative, ΔTK1765::TK1957, TK0149 This study
OE2159 TS559 derivative, ΔTK1765::TK2159, TK0149 This study
Plasmids
pTS700 Basis for the creation of “A”-plasmids,
Harboring TK0664; TK0149
[368]
pSKS022 Derivative of pSecPyrF [386], enabling integration 
at TK1765 locus. Basis for the creation of vector 
backbone of OE plasmids, harboring TK0149
[387] and [386]
Disruption vectors*
p∆”GOI” (12x) TK0664; TK0149; Δ”GOI” This study
Integration vectors*
pOE”GOI” (12x) TK0149; ΔTK1765::”GOI” This study
* = for each gene of interest (GOI) a disruption (∆) vector and integration (or overexpression; OE) vector was 
created. The GOIs were TK0509, TK0513, TK0929, TK1088, TK1173, TK1324, TK1477, TK1548, TK1732, TK1836, 
TK1957, and TK2159. 
Overexpression strains were obtained by the following procedure. First, a universal vector 
backbone was created to accommodate the integration of an additional copy of the GOIs into 
the chromosome of T. kodakarensis. Next, the 12 selected GOIs were individually cloned into 
this vector backbone, placing them under control of the strong constitutive hmtB-promoter 
[385], resulting in 12 unique overexpression vectors (Table 2). Subsequent transformation 
of these vectors in T. kodakarensis TS559 ultimately resulted in agmatine prototrophs for 
all GOIs. For each GOI, genomic DNA of 5 agmatine prototrophic clones was analyzed by 
diagnostic PCR to confirm integration of the various overexpression vectors. Moreover, the 
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diagnostic PCR was also used to discriminate between transformants that were the result of 
a single homologous recombination (resulting in the integration of the entire donor plasmid 
DNA integrated into the genome of T. kodakarensis) and transformants that were the result 
of two crossover events (resulting in the integration of only the GOI and selection marker 
(TK0149)). This discrimination was done since only the transformants resulting from two 
crossover events can be considered stable (and are thus preferred), while the transformants 
resulting from a single homologous recombination may ultimately revert to the original 
genome. Nevertheless, are both variants considered sufficient for this study as long as the 
agmatine prototrophy selection pressure is maintained. The diagnostic PCRs showed that 
preferred double crossover mutants were obtained for TK1324, TK1477, TK1548, TK1732, 
TK1088, TK1957 and TK2159, but not for TK0509, TK0513, TK1836, TK1173 and TK0929. 
Next, the entire integration locus was PCR amplified and subsequent sequencing confirmed 
that the integrated additional copy of the GOIs did not contain any undesired mutations. 
Representative clones, containing correct sequences of the additional copies of the GOIs 
were designated T. kodakarensis strains: OE0509, OE0513, OE0929, OE1088, OE1173, 
OE1324, OE1468, OE1477, OE1548, OE1732, OE1836, OE1957 and OE2159, in which the 
OE denotes ‘overexpression’ and the number specifies the introduced TK gene (Table 2). 
Finally, we aimed to confirm enhanced transcription or loss of transcription of the 
overexpressed and knock-out strains respectively. To this end, we isolated total RNA from 
all OE- and ∆-strains to use in a semi-quantitative Reverse Transcriptase-PCR (RT-PCR) to 
detect the level of transcription of the respective GOI’s. The primers used for the diagnostic 
PCRs were designed such that amplification of a particular GOI resulted in a PCR product of 
~250 bp in case of expression. The results shown in Fig. 2 confirm increased transcription 
levels of the GOIs in their corresponding OE-strain and the absence of transcription in their 
corresponding ∆-strains. The housekeeping gene puf (TK0308) [388], encoding the α-subunit 
of the elongation factor-1 complex, was used for normalization and as positive control in 
the RT-PCRs for the OE- and ∆-strains, respectively.
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A                                                                B 
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Figure 2. Semi quantitative Reverse Transcriptase-PCR (RT-PCR) 
analysis Total RNA was isolated from the parental and mutant strains 
and subjected to a DNase I treatment to degrade traces of isolated 
chromosomal DNA. cDNA was created via a reverse transcriptase 
reaction and subsequently used as template in a diagnostic PCR to 
confirm (A) loss of expression or (B) overexpression of the genes of 
interest in the disruption and overexpression strains, respectively. 
All RT-PCR products had the appropriate size on SYBR safe stained 
agarose gels. The housekeeping gene elongation factor 1-α was 
used for normalization. Abbreviations: D-strain, disruption strain; P, 
parent strain TS559; M, marker; EF1a, elongation factor 1-α; GOI, 
gene of interest; NTC, no template control; RT, Reverse transcriptase; 
TS559, parent strain; OES, overexpression strain; TK#, gene locus of 
GOI. “+”, RT present; “-“, RT absent
A                                                                B 
    
Phenotypical changes elicited by the OE- and ∆-strains
To assess the involvement of the corresponding GOIs in tetraether lipid biosynthesis, the 
total diether and tetraether lipid content of the OE- and ∆-strains was determined and 
compared with the lipid content of the parental strain TS559. To do this, we prepared 
overnight cultures (>16 h) for each strain in triplicate and harvested the cells. The membrane 
lipids were then hydrolysed to cleave off polar head groups and subjected to a total lipid 
extraction to isolate core lipids. These isolates were subsequently characterized for their 
diether and tetraether lipid content by UHPLC-API/MS by monitoring their ions at (m/
z=653.6 [M-H]+) and (m/z=1302.3 [M-H]+), respectively. Here, the total amounts of diether 
and tetraether lipids (in µg) turned out to be highly variable between the different strains, 
even after normalization per mg dry cell weight (DCW) (Fig. 3, in (w/w)%). For example, the 
total amount of diether and tetraether lipids obtained for strain OE0929 was nearly twice as 
high as that obtained for the parental strain TS559, while hardly any diether and tetraether 
lipids were obtained from strain OE1324.
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Figure 3. Average diether and tetraether lipid content per strain. orange: average tetraether lipid content (i.e. 
GDGT-0), blue: average diether lipid content (i.e. archaeol).
To allow a more accurate and realistic comparison of the membrane composition of the 
different strains, the average diether and tetraether lipid contents per strain was expressed 
as a percentage of their cumulative amount (Fig. 4). For this analysis we also included the 
detection of unsaturated diether lipids which were missing in the preliminary analysis, 
by performing HPLC/ESI-MS to detect intact polar lipids (IPLs). This showed that the 
parental strain TS559 has a tetraether lipid content of 80% ± 3.9, which roughly agrees 
with the results obtained by Matsuno et al. [68]. Concerning the possible involvement 
of the GOIs in tetraether lipid biosynthesis, the most striking effects were observed for 
the strains OE1957 and ∆TK1548, for which a tetraether lipid content of 96.1% ± 1.1 and 
15.1% ± 2.8 (w/w) was detected, respectively. Moreover, an increased but insignificant 
(p=0.06) tetraether lipid content was also observed for the OE-strain of TK0509, having 
a tetraether lipid content of 91.7% ± 2.3 (w/w). In addition, a significant decrease in the 
tetraether lipid content of the OE-strain of TK1836 and TK1324 was shown. Interestingly, 
though disruption of TK1548 led to a dramatic decrease in the tetraether lipid content, 
no notable increase was observed upon its overexpression. With the exception of the 
disruption of TK1548, no significant changes in the tetraether lipid content (TE:DE ratio) 
of the other disruption strains were observed. In previous studies, it was established that 
the tetraether lipid content may vary markedly dependent on the growth phase [68, 366]. 
As this may have contributed to the different levels of diether and tetraether lipids as 
well, we determined the dependence of the lipid composition on turbidity in the parental 
strain TS559. Here we observed that the tetraether content reaches a near stable plateau 
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Figure 4. Average % of tetraether and diether lipids per strain The tetraether lipid content (in orange) and diether 
lipid content (in blue) of three biological replicates was normalized to the total amount of lipids measured per 
strain (i.e. to the sum of GDGT-0 and archaeol). The vertical numbers (in white) show the average fraction (in %) 
of tetraether lipids per strain.
after 11 h of growth (stationary phase) (Fig. S3). This finding reinforces our postulation 
that the TK1548, TK1836, TK1324 and TK1957 genes are involved in determining the 
tetraether content. To obtain more insight in the mechanism that causes these shifts in 
diether:tetraether lipid (DE:TE) ratios, we performed a total ion monitoring on the lipid 
extracts (without acid hydrolysis), to selectively detect both saturated and unsaturated 
intact polar lipids species (Table S4, IPLs with head groups, hexose, phosphohexose and 
aminohexose phosphohexose). Interestingly, intact tetraether polar lipids were not 
detected, probably due to insufficient solubilisation during the extraction procedure. 
When the diether IPLs were analysed instead, we noticed a marked variation in the level of 
unsaturated diether lipids (3 unsaturations per lipid) between the mutant strains (Fig. 5). 
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Figure 5. Representation of the cumulative saturated and unsaturated diether lipids per strains The saturated 
diether levels (in blue) and unsaturated diether lipids (in grey) of three biological replicates were normalized to 
the total amounts of intact polar diether lipids (IPLs) measured per strain (i.e. the sum of all intact polar lipids of 
archaeols). As such, the blue bars are representative of the total diether lipid peaks depicted in Fig. 3.
Moreover, the previous variations in tetraether content specifically correlates with either a 
decrease or increase of unsaturated or saturated diether levels. More specifically, mutants 
with both a low tetraether levels (OE1836 and ∆TK1548) and a high tetraether levels (as 
observed for OE1957) show a marked decrease in unsaturated diether lipids (summarized 
in Table S5, marked). This finding highly suggests that unsaturated diethers may serve as 
shared substrate for the formation of both tetraether lipids and fully saturated diether 
lipids. Additionally, the unsaturated lipids (which were not included in the preliminary test) 
explain the overall low amounts of lipids obtained for OE1324 and ∆TK1477 (Fig. 3, lanes 6 
& 16).
To investigate whether the altered membrane composition (diether:tetraether lipid ratio) 
has a detrimental effect on the morphology of T. kodakarensis, samples of the parental 
strain and mutant strains showing the biggest extremes in their membrane lipid composition 
(strain OE1957 and ∆TK1548) were studied by transmission electron microscopy (TEM). In 
addition, samples of the mutant strain OE1324 were included to check for its cellular integrity 
as this strain showed low overall lipid content consisting of high levels of unsaturation (Fig. 
3, lane 6). The obtained images showed neither a difference on the morphology of the cells, 
nor on the physical appearance of the membranes of T. kodakarensis (Fig. 6, upper and 
lower right panel).
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Discussion
In this study, we set out to identify genes involved in the synthesis of tetraether lipids. 
More particularly, we focused on the enzyme(s) responsible for the condensation of two 
C
20
 isoprenyl chains. To do this, we composed a list of genes that are potentially involved in 
tetraether synthesis, and prioritized these based on characteristics assumed to be important 
for a tetraether synthase. This resulted in the selection of 12 genes, which were targeted for 
overexpression and disruption. A subsequent lipid analyses on the mutant strains, strongly 
suggests that at least four of these genes (TK1548, TK1836, TK1324 and TK1957) indeed 
play an intimate role in the synthesis of tetraether lipids. In addition, the genes that appear 
to be non-viable upon disruption may be interesting in this respect as well. Especially, the 
candidates that did not yield a disruption strain but instead showed a slight increase in the 
tetraether lipid content upon its overexpression, such as TK0509 and TK1088 may be of 
significance. This is because the membrane of T. kodakarensis exists primarily of tetraether 
lipids (i.e. 80.0%). Losing the ability to synthesize tetraether lipids, may possibly result in a 
lethal phenotype.
One of the genes that seems to affect the synthesis of tetraether lipids is TK1548. 
Interestingly, this gene is annotated to encode a serine-glyoxylate aminotransferase. This 
gene was selected from the list of candidate genes as a priority gene since it encompasses 
a degenerate DDxxD motif, is associated with substrate binding of prenyltransferases, and 
it has been shown to be slightly upregulated during heat shock (Table 1). Disruption of 
TK1548 resulted in a strain (∆TK1548) with significantly lower tetraether lipid contents 
(Fig. 3 and 4, lanes 17), which is a strong indication that the enzyme encoded by this 
gene plays an important role in tetraether synthesis. However, despite the disruption of 
TK1548, a considerable amount of tetraethers could still be detected (15.1% ± 2.8). This 
either suggests there is not just one encoding gene responsible for tetraether synthase 
and hence there may be multiple isozymes involved as well, or that TK1548 encodes for 
an enzyme that indirectly influences tetraether synthesis. Moreover, since this gene has 
been annotated as an aminotransferase it is also possible that the annotation about amino 
substrate specificity is wrong, meaning that it could be involved in lipid synthesis and that 
the observed effect may be elicited directly. Interestingly, overexpression of TK1548 did 
not result in a significant effect (Fig. 4, lane 8), which would agree with the conclusion that 
it is not a tetraether synthase, but might also simply imply it is not a rate controlling step 
in the pathway. Furthermore the IPL analyses showed that ∆TK1548 results in membranes 
with very low levels of unsaturated diether lipids. This suggests that unsaturated diether 
lipids may act as a substrate for tetraether synthesis and hence correlates with the shortage 
of tetraether lipids. A second gene that has an influence on the tetraether lipid content is 
TK1836. This gene has been annotated as a geranylgeranyl hydrogenase and was selected 
as a priority gene for its predicted prenyl binding, and the presence of a FAD/FMN binding 
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domain and DDxxD motif (Table 1). Though disruption of TK1836 does not seem to have 
a detrimental effect on the tetraether lipid content of the membrane, overexpression 
does (Fig. 4, lanes 19 and 10 resp.). These results imply that TK1836 is involved in lipid 
biosynthesis, but make it very unlikely to be a tetraether synthase. Instead, phylogenetic 
analysis suggests that TK1836 probably belongs to a dehydrogenase family that has been 
shown to be a homolog of prenyl reductases [389, 390]. In case of a true reductase, the 
results obtained for this mutant again suggest that the presence of unsaturations in the 
precursor molecule of tetraether lipids is a prerequisite to the formation of tetraether 
lipids. This would be an interesting finding, as the absence or presence of double bonds 
in the C
20
 isoprenyl chains (i.e. before the condensation reaction) is a major difference 
between the traditional and alternative tetraether biosynthesis hypothesis, respectively 
[9]. Correspondingly, the diether IPL analysis also showed a significant decrease in the 
amount of unsaturated diethers which agrees with the suggestion that TK1836 encodes for 
a reductase. Equivalent to TK1548, a low level of unsaturated diether may imply a shortage 
of substrate for tetraether synthesis that caused the low tetraether levels. 
A third gene that seems to be involved in tetraether lipid synthesis is TK1957, which has 
been annotated as a 4-hydroxybenzoate polyprenyltransferase. Though this gene shows 
sequence similarity to experimentally characterized DGGGP synthases [304, 348] (which 
should have led to the exclusion of this gene from the list of candidate genes), it was decided 
to retain it and to select it as a priority gene for further analysis. The reason for this was that 
another candidate gene, also annotated as a 4-hydroxybenzoate polyprenyltransferase, 
i.e. TK1324, showed sequence similarity to DGGGP synthases as well. This fact makes it 
difficult to decide which of these two genes encodes a DGGGP synthase or which may in 
potential be a tetraether synthase. It was therefore decided to retain both and to select 
them as priority genes for further analysis. Surprisingly, overexpression of TK1957 resulted 
in a strain with a membrane that almost exclusively consists of tetraether lipids (96.1% SD 
± 1.1; Fig. 4, lane 11). This is a strong indication that TK1957 is involved in the tetraether 
lipid synthesis. Moreover, the observation that disruption of TK1957 appears to be non-
viable is quite interesting in this respect as well. However, though these results imply 
that TK1957 may be a tetraether synthase, a similar reasoning as described above would 
also apply to a DGGGP-synthase. This is because, in both the traditional and alternative 
biosynthesis hypothesis, DGGGP synthases are key enzymes in the formation of archaeal 
membrane lipids (Fig. 1). However, from the small amount of detected diether lipids, the 
main share consisted of saturated IPLs only (99.9%). This, however, cannot be explained 
by an excess of DGGGP-synthase activity and strongly argues against the possibility of a 
DGGGP-synthase. Instead of a postulated shortage of unsaturated diethers (∆TK1548 and 
OE1836), an enhanced conversion to tetraether lipids may explain the observed shortage 
of unsaturated diethers. Contrary to TK1957, overexpression of TK1324 (the other gene 
annotated as a DGGGP synthase) resulted in a significant decrease in the tetraether/diether 
lipid ratio (Fig. 4). This implies that TK1324 is most likely neither a DGGGP synthase nor a 
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tetraether synthase. However, two important observations suggest that TK1324 is involved 
in the biosynthesis of lipids as well. Firstly, we obtained a significant decrease in the amount 
of total lipids (di- and tetraethers) upon its overexpression (Fig. 3), and that the unsaturated 
diether lipid level expanded dramatically. This strain however, also shows that a decrease in 
tetraether levels can also correlate with a high level of unsaturated diether lipids. 
In conclusion, we provide evidence that TK1548, TK1836, TK1324 and TK1957 seem to be 
interesting candidates to further study tetraether synthesis. In addition, our data strongly 
suggests that unsaturated diether lipids are substrate to the tail-to-tail condensation in 
tetraether synthesis and compete with geranylgeranyl-reductases that form the saturated 
diether lipids. Alltogether, these analyses could provide a better understanding of the 
tetraether lipid biosynthesis pathway and may ultimately lead to the identification of the 
tetraether synthase(s).
Materials and Methods
Selection of candidate genes
Two independent bioinformatics approaches were performed. In the first analysis, a set of 
reference species were selected that are phylogenetically closely related to T. kodakarensis, 
and that have a confirmed presence (Pyrococcus furiosus and Thermoplasma acidophilum) 
or absence (Natronomonas pharaonis and Methanopyrus kandleri) of tetraethers in their 
membranes [10, 299, 374-376]. The genome of T. kodakarensis was screened for homologs 
present in the first two, but which are absent in the latter two by performing a phylogenetic 
profiler single gene search using the IMG system of JGI (https://img.jgi.doe.gov/cgi-bin/m/
main.cgi). In the second analysis, it was attempted to correlate the presence of specific 
arCOGs (archaeal Clusters of Orthologous Genes [377] in 149 sequenced archaeal genomes 
to species with a confirmed tetraether lipid membrane. 
The list of genes resulting from two bioinformatics approaches was prioritized based on 
the following characteristics: (i) predicted prenyl binding, (ii) the presence of a FAD or 
Flavin mononucleotide (FMN) binding domain or Rosmann Fold [391], (iii) the presence 
of aspartic acid rich DDxxD motifs, (iv) homology to squalene epoxidase, and (v) 
transcriptional regulation by the Thermococcales heat shock protein Phr. Screening for 
(i) and (ii) was done by scanning the protein sequences against the InterPro collection of 
protein signature databases (http://www.ebi.ac.uk/Tools/pfa/iprscan5/). The screening for 
(iii) was done by manually checking the protein sequences for presence of a DDxxD motif. 
To identify possible homologs of squalene epoxidase (iv), the selected genes were included 
in a BLAST search using the Saccharomyces cerevisiae ERG1 squalene epoxidase sequence 
(EC1.14.99.7) as a query. The S. cerevisiae squalene epoxidase was selected, as a recently 
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created three-dimensional model of this protein allowed for the identification of crucial 
residues [392]. To determine if the transcription of the candidate genes may be influenced 
by Phr (v), we made use of the results of a previously published microarray experiment 
that was performed to identify the Phr-dependent heat shock regulon in T. kodakarensis 
[382]. The presence or absence of transmembrane spanning helices was determined by 
constructing hydrophobicity plots using the online Transmembrane Hidden Markov Model 
(TMHMM http://www.cbs.dtu.dk/services/TMHMM-2.0/) tool to predict probability of 
transmembrane spanning segments. From this analysis it was shown that the following 
gene products (TK1324, TK1732, TK1957) have high probability of being integral membrane 
proteins or membrane associated (TK2159).
Microorganisms and culture conditions
E. coli DH5α was used for general DNA manipulation, and E. coli strains were cultivated at 
37°C in LB medium supplemented with 100 µg/ml ampicillin. T. kodakarensis strains and 
plasmids used in this study are listed in Table 2. T. kodakarensis strains were cultivated 
anaerobically in stoppered serum bottles at 85°C in a nutrient-rich medium (ASW-YT) [370], 
composed of 0.8x artificial seawater (0.8x ASW), 5.0 g/L yeast extract, 5.0 g/L tryptone, 1 
ml/L KOD vitamin mixture (1000x) and 0.8 mg/L resazurine. The headspace of all cultures 
was exchanged for N
2
. Before inoculation, either 2.0 g/L sulfur (ASW-YT-S0) or 5.0 g/L 
pyruvate (ASW-YT-Pyr) was added to the medium, as well as Na
2
S.9H
2
O to reduce the 
dissolved oxygen, until the resazurin became colorless. When required, the media were 
supplemented with 500 µM agmatine and/or 75 µM 6-methyl purine (6MP) [368, 369]. 
Cultures were continuously shaken (50 rpm) during growth. In the case of plate culture, 1% 
(wt/vol) Gelrite was added to solidify the medium together with 2 ml/L polysulfide solution 
[370] instead of S0. Cells inoculated on plates were incubated at 85°C for at least 48 h in 
an air-tight anaerobic jar containing an Anaerocult A mini (Merck Millipore, Darmstadt, 
Germany) to maintain anaerobic conditions. 
Construction of plasmids and mutant strains
Plasmids incapable of autonomous replication in T. kodakarensis were constructed and 
amplified in Escherichia coli, carrying the genes of interest (GOIs) or knockout constructs 
adjacent to the previous developed selection and, in the case of the disruption vectors, 
counter-selection cassette (TK0149; TK0664) [368, 369]. The GOIs and selection cassette (in 
case of the OE vectors) and the selection/counter-selection cassette (in case of the disruption 
vectors) were flanked by a ~500-1000 bp region homologous to T. kodakarensis genome that 
are natively located immediately up- and downstream of the target locus (Fig. S2). Standard 
molecular biology procedures were used for PCR amplifications, plasmid construction, E. coli 
DH5α transformation, transformants selection, plasmid isolation, and sequence verification. 
The sequences of oligonucleotide primers used in this study are listed in Table S3.
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The vectors created to disrupt or overexpress the GOIs are shown in Table 2. The disruption 
vectors were constructed as described before [368]; first, so-called “A”-plasmids were 
created by amplifying each GOI along with ~500-700 bp of flanking DNA and cloning the 
corresponding amplicon into pTS700 in a ligation-independent mechanism. Next, the “A”-
plasmids served as a foundation plasmid from which so-called “B”-plasmids, or disruption 
vectors, were generated. This was done by a single-step PCR-based procedure wherein the 
original GOI was deleted from the plasmid, while leaving the flanking DNA that will target 
integration of the entire B-plasmid to the TS559 genome. Two separate initial integration 
events are possible for incorporation of the entire B-plasmid to the genome, and each 
generates an intermediate strain that, when 6MP-based counter-selective pressure is 
applied, can undergo an internal recombination event to either restore the original genome 
or produce a strain containing a genome with the desired, targeted deletion (Fig. S2A).
The overexpression vectors were constructed as follows. First an inverse PCR using the 
primer-pair BG4881-BG4882 and the previously constructed integration vector pSKS022 
[387] as template was performed. pSKS022 is a derivative of pSecPyrF [386] and was chosen 
as template, as integration in the genome at the ChiA locus targeted by this plasmid has 
shown to be efficient and non-disturbing. The PCR resulted in the amplification of a vector 
backbone for the overexpression vectors that contained the flanking regions needed for 
integration as well as the strong constitutive hmtB-promoter. The PCR thus removed the 
csg-promoter, the TM-gene expression cassette, the synthetic transcription terminator (T
8
), 
the 500-bp pop-out homology, and the counter-selection marker TK0664 from pSKS022. The 
linear vector backbone created by this PCR was extended with a unique AgeI restriction site, 
which was incorporated in the primer BG4882. Next, the GOIs were amplified by Phusion 
polymerase PCR (Thermo Fisher Scientific) using the corresponding primers listed in Table 
S3. The reverse primers were extended with a unique AgeI restriction site, allowing for easy 
and directional (blunt-sticky) ligation in the amplified vector backbone, creating the desired 
vectors as shown in Figure S2b. Transcription of the GOIs was designed to be controlled by 
the strong constitutive hmtB-promoter [385].
The T. kodakarensis ∆- and OE-strains shown in Table 2 were generated by transforming 
the corresponding vectors into T. kodakarensis TS559 (ΔpyrF; ΔtrpE::pyrF; ΔTK0664; 
ΔTK0149) [368, 369, 385]. Disruption strains were created as described previously [368]. 
Overexpression strains were created by a slightly adapted approach in which the counter-
selection marker (TK0664) was not involved and desired mutants were thus simply selected 
by growing colonies on medium lacking agmatine. An important difference between these 
two methods is that, as a result of excluding TK0664, the selection marker (TK0149) cannot 
be removed from the genome after obtaining initial transformants. This means that, in 
contrast to the disruption strains, the created overexpression strains do not allow another 
round of the procedure to make additional genome modifications. Diagnostic PCRs were 
performed to select and confirm genotypes of desired strains. To do this, 6MP-resistant 
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colonies growing on ASW-YT plates supplemented with agmatine (in the case of the disruption 
strains) or agmatine-prototrophic colonies growing on ASW-YT plates without agmatine (in 
the case of the overexpression strains) were picked and used to inoculate liquid ASW-YT- 
S0 cultures (with and without agmatine, respectively), which were incubated o/n at 85°C. 
Next, 1.5-ml culture was sampled using a syringe and genomic DNA was isolated according 
to the protocol for Gram-positive bacteria of the GeneJET genomic DNA purification kit 
(Thermo Scientific). Purified DNA was then used as template in three diagnostic PCRs. In 
the first PCR, the primers used were complementary to the sequence upstream of the 
desired integration locus as well as to the C-terminus of the integrated GOI (illustrated by 
primers A and B in Fig. S2). Similarly, a second PCR was included using primers that were 
complementary to the sequence downstream of the desired integration locus as well as 
to the N-terminus of the integrated GOI (illustrated by primers C and D). A third PCR was 
performed to identify double crossover mutants, using primers that were complementary 
to the sequence downstream and upstream of the integration locus (illustrated by primers 
A and D). A generated PCR product having the correct size for all three reactions suggested 
the desired double crossover genotype. In addition, fragments containing the additional 
copy of the GOI were PCR amplified from the genome of the desired clones and sent for 
sequencing to confirm the absence of undesired mutations. Sequences of the primers are 
listed in Table S3.
RNA isolation and RT-PCR
To confirm loss of transcription or increased mRNA levels of the GOIs in the disruption 
strains or overexpression strains, respectively, reverse transcriptase PCR (RT-PCR) was 
performed. To do this, the parental strain TS559 and the various mutant strains created 
in this study were cultivated in 120-ml serum bottles containing 40 ml ASW-YT-S0 medium, 
which in the case of the disruption strains were also supplemented with 500 µM agmatine 
(Sigma-aldrich) and 75 µM 6MP. Samples of 10 ml were removed and cells were harvested 
by centrifugation (4700x g, 30 min, 4°C). Total RNA was isolated by the following method. 
Cell pellets were resuspended in 1 ml Trizol and 200µl chloroform was added. The mixtures 
were shaken by hand for 15 seconds, followed by incubation at RT for 3 min. Next, the 
samples were centrifuged (13,000x g, 15 min, 4°C) and the supernatants were transferred to 
fresh Eppendorf tubes. 5 µg glycogen and 500 µl isopropanol were added and the mixtures 
were incubated at RT for 10 min. The samples were centrifuged (13,000x g, 15 min, 4°C) and 
the pellets were washed in 75% ethanol, air-dried for 10 min and resuspended in 20 µl MQ 
water. RNA concentrations were determined with a Nanodrop ND-1000 and the total RNA 
samples were stored at -20°C until further processing.
Before RT-PCR, the total RNA samples (1 µg each) were treated with DNaseI, to remove 
residual genomic DNA. cDNA was prepared by following the protocol for first strand cDNA 
synthesis of the Thermo Scientific RevertAid RT kit (20 µl reactions), using random hexamers 
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as primers. Gene-specific cDNA fragments were amplified by conventional PCR using the 
freshly prepared cDNA as template and primer pairs developed to specifically target the 
genes of interest (Table S3). The housekeeping gene TK0308 (puf), encoding the α-subunit 
of the elongation factor-1 complex (EF-1-α), was included for normalization [388]. All primer 
pairs were designed to produce a specific product of ~250 bp. All reactions were run for the 
amount of cycles needed to make the respective product in the reactions containing cDNA 
of the parental strain TS559 just visible. The only exception to this are the reactions used 
for normalization (TK0308), which were run for 18 cycles. PCR amplification products were 
analyzed by agarose gel electrophoresis. Control experiments were included by following 
the same procedure, but without addition of RevertAid Reverse Transcriptase enzyme to 
the RT reaction mixture.
Core lipid extraction and analysis by UHP-APCI/MS
Triplicate cultures of the various mutant strains and parental strain TS559 were cultured 
on ASW-YT-Pyr. When the cultures reached the stationary phase, cells were harvested by 
10 min centrifugation at 4700x g and lyophilized overnight. To extract the core lipids of the 
various strains, lyophilized cells were hydrolysed with 2ml 1.5N HCl in methanol by reflux at 
130°C for 2 h. The hydrolysate was adjusted to pH 7 with 2N KOH-methanol (MeOH) (1:1, 
vol/vol) and, after addition of water to a final 1:1 ratio of H
2
O-MeOH, extracted three times 
with dichloromethane (DCM). The DCM fractions were collected and dried over sodium 
sulfate. The resulting extract was dried under nitrogen and dissolved in hexane–2-propanol 
(99:1, vol/vol), filtered over a 0.45-µm polytetrafluoroethylene filter, and analysed by high-
performance liquid chromatography (HPLC)–atmospheric pressure chemical ionization 
(APCI) mass spectrometry (MS) for archaeol and GDGTs. The UHPLC-APCI/MS analysis was 
done according to Hopmans et al. [393], with some modifications. Briefly, analysis was 
performed on an Agilent 1260 UHPLC coupled to a 6130 quadrupole MSD in selected ion 
monitoring (SIM) mode. Separation was achieved on two UHPLC silica columns (BEH HILIC 
columns, 2.1 x 150 mm, 1.7 µm; Waters) in series, fitted with a 2.1 x 5 mm pre-column 
of the same material (Waters) and maintained at 30˚C. Archaeol and GDGTs were eluted 
isocratically for 10 min with 10% B, followed by a linear gradient to 18% B in 20 min, then a 
linear gradient to 100% B in 20 min, where A is hexane and B is hexane: isopropanol (9:1). 
Flow rate was 0.2 ml/min. Total run time is 60 min with a 20 min re-equilibration. Source 
settings were identical to Schouten et al. (2007)[394]. Typical injection volume was 5 µl of 
a 1 mg/ml solution. M/z of the protonated molecules of archaeol and isoprenoid GDGTs 
were monitored. Archaeol and GDGTs were quantified by comparing the response in the 
appropriate mass chromatogram to the response of known amounts of standards (archaeol 
obtained from Avanti Polar Lipids, Inc. Alabaster, Alabama, USA; GDGT-0 prepared according 
to Sinninghe Damste et al., 2002 [395]).
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Intact polar lipid analysis by HPLC/ ESI-MS
For analysis of the intact polar lipids, total lipids of T. kodakarensis were extracted using a 
modified Bligh–Dyer procedure (Bligh and Dyer 1959). 1-3 mg of freeze-dried cell material 
was used and dissolved in a solvent mixture of phosphate-buffer (0.05 M, pH 7.4)/MeOH/
DCM 0.8/2/1 (v/v). A 1 ml aliquot of the solvent mixture was sonicated for 10 min. The 
sample was centrifuged (2,500 xg, 1 min), and the supernatant removed. The sonication 
procedure was repeated twice after which DCM and phosphate buffer were added to a 
volume ratio of 0.9/1/1. After centrifuging (2,500 xg, 2 min) the DCM layer was collected. 
The residue was re-extracted twice following the same procedure. The combined DCM 
layers were concentrated by evaporating solvent under a stream of N2 gas. Lipid extracts 
were re-dissolved in hexane:2-propanol:water (72:27:1) at a concentration of 1 mg mL-1 
and filtered through a 0.45 µm regenerated cellulose (RC) filter (Alltech Associates Inc., 
Deerfield, IL) prior to injection.
Intact polar lipids (IPLs) were analysed according to Sturt et al. (2004) with some 
modifications. An Ultimate 3000 RS UHPLC, equipped with thermostatted auto-injector 
and column oven, coupled to a Q Exactive Orbitrap MS with Ion Max source with heated 
electrospray ionization (HESI) probe (Thermo Fisher Scientific, Waltham, MA), was used. 
Separation was achieved on a YMC-Triart Diol-HILIC column (250 x 2.0 mm, 1.9 µm 
particles, pore size 12 nm; YMC Co., Ltd, Kyoto, Japan) maintained at 30 °C. The following 
elution program was used with a flow rate of 0.2 mL min-1: 100% A for 5 min, followed by 
a linear gradient to 66% A: 34% B in 20 min, maintained for 15 min, followed by a linear 
gradient to 40% A: 60% B in 15 min, followed by a linear gradient to 30%A:70%B in 10 
min, where A = hexane/2-propanol/formic acid/14.8 M NH
3aq
 (79:20:0.12:0.04 [volume 
in volume in volume in volume, v/v/v/v]) and B = 2-propanol/water/formic acid/ 14.8 M 
NH
3aq
 (88:10:0.12:0.04 [v/v/v/v]). Total run time was 70 min with a re-equilibration period 
of 20 min in between runs. HESI settings were as follows: sheath gas (N
2
) pressure 35 
(arbitrary units), auxiliary gas (N
2
) pressure 10 (arbitrary units), auxiliary gas (N2) T 50 ˚C, 
sweep gas (N
2
) pressure 10 (arbitrary units), spray voltage 4.0 kV (positive ion ESI), capillary 
temperature 275 °C, S-Lens 70 V. Lipids were analyzed with a mass range of m/z 375 to 
2000 (resolution 70,000), followed by data dependent MS2 (resolution 17,500), in which 
the ten most abundant masses in the mass spectrum(with the exclusion of isotope peaks) 
were fragmented successively (stepped normalized collision energy 15, 22.5, 30; isolation 
window 1.0 m/z). A dynamic exclusion window, with a mass tolerance of 3 ppm, of 6 sec 
was applied. In addition an inclusion list was used with a mass tolerance of 3 ppm, targeting 
the following compounds: Table S4. The Q Exactive was calibrated within a mass accuracy 
range of 1 ppm using the Thermo Scientific Pierce LTQ Velos ESI Positive Ion Calibration 
Solution (containing a mixture of caffeine, MRFA, Ultramark 1621, and N-butylamine in an 
acetonitrilemethanol-acetic solution).
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Transmission electron microscopy (TEM) of thin sections 
Cells of T. kodakarensis strains TS559, OE1324, OE1957 and ∆TK1548 cultured in ASW-YT-
Pyr and harvested in the stationary phase were fixed by incubation in 3% glutaraldehyde in 
0.1 M sodium cacodylate buffer pH 7.2 for 1.5 h at room temperature. After three washes 
in the same buffer, a post fixation was done in 1% (w/v) OsO
4
 and 1.5% (w/v) potassium 
ferricyanide in the same buffer for 1 h at room temperature and subsequently rinsed three 
times in water. One volume of the sample suspensions were mixed with equal volumes 
of 3% low melting point agarose. Between each step the samples were centrifuged for 5 
min at 8,000 rpm (5,220 xg) and the pellets were suspended again in the next liquid. After 
centrifugation the agarose was solidified at 0°C and the parts containing the pelleted sample 
were cut in very small pieces. The sample pieces were dehydrated in a graded ethanol series 
(10, 30, 50, 70, 90, 100, 100%), infiltrated with modified Spurr resin mixture (Serva) and 
polymerized for 8 h at 70°C. The samples were ultra-thin (70-80 nm) sectioned with an 
ultra-microtome (Reichert, Ultracut S), post-stained with 5 times diluted Reynold’s lead 
citrate for 5 min and analyzed with a transmission electron microscope (JEOL, JEM 1011). 
Micrographs were made with a digital camera (Olympus, Veleta). Sample preparation and 
imaging were performed by the Wageningen Electron Microscopy Centre (WEMC) facility.
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Supplemental Information 
GGPP synthase 
GGGP synthase 
DGGGP synthase 
CDP-archaeol- synthase 
G1P dehydrogenase TK1468 
TK1026 
TK1957 or TK1324 
TK2119 
TK0789 
PPi 
Mevalonate pathway  
TK0180, TK0181, TK0914, TK1474 
TK1473 
  
Glycolysis 
GGPP 
PPi 
CTP 
PPi 
NADH + H+ 
NAD+ 
TK1088 
e-   Ferredoxin 
Geranylgeranyl 
reductase 
DPhG-CDP 
Figure S1. Hypothetical pathway responsible for the biosynthesis of CDP-archaeol in T. kodakarensis CDP-archaeol 
is the CDP-activated precursor of diether polar lipids. The pathway was reconstructed by aligning sequences of 
experimentally characterized genes, and shown to be responsible for the reactions leading to isoprenoid and CDP-
archaeol synthesis in various archaea, against the genome of T. kodakarensis [34, 298, 304, 306, 348, 351, 378]. 
Analysis of TK1957 and TK1324 overexpression in this study showed that both genes are unlikely responsible for 
DGGGP-synthesis.
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A 
GOI TK0149 TK1765
TK1763 TK1764 ChiA TK1765
TK1764
TK1766
TK1763 TK1764 TK1766GOI TK0149 TK1765
A
B D
C
PhmtB
PhmtB
C
BE
F
TS559 genome
OE genome
OE-vector
Figure S2A. Schematic representation of the disruption and overexpression procedure in T. kodakarensis Use 
of disruption vectors (B-plasmids) to generate markerless knockouts in the genome of T. kodakarensis TS559. The 
image has been reused from Hileman, T.H., and Santangelo, T.J. (2012) [368]. A hypothetical region of the genome 
of T. kodakarensis strain TS559 is shown at top, with the left and right panels depicting the two possible integration 
events yielding agmatine-prototrophic intermediate strains from the diagramed B-plasmid. Both intermediate 
strains #1 and #2 contain direct repeats flanking the target locus, and dependent on recombination responsible 
for excision upon counter-selection with 6MP, either the original TS559 genome can be restored or the desired 
deletion genome generated. Fig. S2B Use of overexpression vectors (OE-vector) to generate T. kodakarensis 
strains overexpressing the gene of interest (GOI). The GOI is integrated at the ChiA-locus of T. kodakarensis strain 
B
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TS559 via a double homologous recombination event yielding agmatine-prototrophic OE-strains. The letters A-D 
represent the binding sites of the primers used in the diagnostic PCRs. The letters E & F represent the binding sites 
of the primers used to amplify the vector backbone using pSKS022 as a template. Abbreviations: TK0149, agmatine 
selection marker; TK0664, counter-selection marker; Phmtb, strong constitutive promoter.
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Figure S3. Growth phase dependent tetraether levels Upper panel, T. kodakarensis T5559 cells grown on ASW-
YT pyr were sampled at different ODs (red dots); Lower panel, the OD dependent tetraether levels (%) were 
determined and expressed as % of the total detected amount of lipids showing near stability after 11 h of growth 
at stationary phase.
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Table S2. arCOGs included in the second comparative genome analysis.
COG0020 Undecaprenyl pyrophosphate synthase
COG0039 Malate/lactate dehydrogenases
COG0043 3-polyprenyl-4-hydroxybenzoate decarboxylase and related decarboxylases
COG0075 Serine-pyruvate aminotransferase/archaeal aspartate aminotransferase
COG0083 Homoserine kinase
COG0119 Isopropylmalate/homocitrate/citramalate synthases
COG0142 Geranylgeranyl pyrophosphate synthase
COG0153 Galactokinase
COG0163 3-polyprenyl-4-hydroxybenzoate decarboxylase
COG0167 Dihydroorotate dehydrogenase
COG0183 Acetyl-CoA acetyltransferase
COG0210 Superfamily I DNA and RNA helicases
COG0214 Pyridoxine biosynthesis enzyme
COG0240 Glycerol-3-phosphate dehydrogenase
COG0280 Phosphotransacetylase
COG0282 Acetate kinase
COG0318 Acyl-CoA synthetases (AMP-forming)/AMP-acid ligases II
COG0331 (acyl-carrier-protein) S-malonyltransferase
COG0371 Glycerol dehydrogenase and related enzymes
COG0382 4-hydroxybenzoate polyprenyltransferase and related prenyltransferases
COG0407 Uroporphyrinogen-III decarboxylase
COG0417 DNA polymerase elongation subunit (family B)
COG0439 Biotin carboxylase
COG0469 Pyruvate kinase
COG0558 Phosphatidylglycerophosphate synthase
COG0575 CDP-diglyceride synthetase
COG0578 Glycerol-3-phosphate dehydrogenase
COG0644 Dehydrogenases (flavoproteins)
COG0688 Phosphatidylserine decarboxylase
COG0761 Penicillin tolerance protein
COG1022 Long-chain acyl-CoA synthetases (AMP-forming)
COG1024 Enoyl-CoA hydratase/carnithine racemase
COG1052 Lactate dehdrogenase and related dehydrogenases
COG1154 Deoxyxylulose-5-phosphate synthase
COG1183 Phosphatidylserine synthase
COG1233 Phytoene dehydrogenase-related protein
COG1239 Mg-chelatase subunit Chll
COG1250 3-hydroxyacyl-CoA dehydrogenase
COG1257 Hydroxymethylglutaryl-CoA reductase
COG1267 Phosphatidylglycerophosphatase A and related proteins
COG1304 L-lactate dehydrogenase (FMN-dependent) and related alpha-hydroxy acid dehydrogenases
COG1331 Highly conserved protein containing a thioredoxin domain
COG1348 Nitrogenase subunit NifH (ATPase)
COG1355 Predicted dioxygenase
COG1429 Cobalamin biosynthesis protein CobN and related Mg-chelatases
COG1443 Isopentenyldiphsophate isomerase
COG1502 Phosphatidylserine/phosphatidylglycerophosphate/cardiolipin synthases and related enzymes
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COG1545 Predicted nucleic -acid-binding protein containing a Zn-ribbon
COG1562 Phytoene/squalene synthetase
COG1577 Mevalonate kinase
COG1608 Predicted archaeal kinase
COG1646 Predicted phosphate-binding enzymes, TIM-barrel fold
COG1657 Squalene cyclase
COG1689 Uncharacterized protein conserved in archaea
COG1960 Acyl-CoA dehydrogenases
COG2025 Electron transfer flavoprotein, alpha subunit
COG2057 Acyl CoA-acetate/3-ketoacid CoA transferase, beta subunit
COG2086 Electron transfer flavoprotein, alpha subunit
COG2098 Uncharacterized protein conserved in archaea
COG2227 2-polyprenyl-3-methyl-5-hdyroxy-6-metoxy-1,4-benzoquinol methylase
COG2324 Predicted membrane protein
COG2440 Ferredoxin-like protein
COG2710 Nitrogenase molybdenum-iron protein, alpha and beta chains
COG3407 Mevalonate pyrophsophate decarboxylase
COG3425 3-hydroxy-3-methylglutaryl CoA synthase
COG3890 Phosphomevalonate kinase
COG4072 Uncharacterized protein conserved in archaea
COG4851 Protein involved in sex pheromone biosynthesis
COG5190 TFIIF-interacting CTD phosphatases, including NLI-interacting factor
COG5243 HRD ubiquitin ligase complex, ER membrane component
COG5272 Ubiquitin
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Table S3. Sequences of oligonucleotide primers used in this study
Oligonucleotide Sequence (5’3’) Application
Disruption vectors
0010509 GGAGGTGAATTTCGTATGGACTTATACGTCAGAAAAGC TK0509 initial amplification
0020509 GGTGAAGGATTTCCTCCTTTATTATTTCCTTGCTCTCC TK0509 initial amplification 
0160509 AGCCCTATCAAGGTCGTCCAGCTGTACCATCCAAT
CACCTAACGTTCGCTAGGGACGCTT
TK0509 inverse PCR to construct 
B plasmids
0170509 AAGCGTCCCTAGCGAACGTTAGGTGATTGGATGGTA
CAGCTGGACGACCTTGATAGGGCT
TK0509 inverse PCR to construct 
B plasmids
0010513 GGAGGTGAATTTCAGGGGATTATCGAGTATCTTCAGG TK0513 initial amplification
0020513 GGTGAAGGATTTCCTTCTCTATCTTATGCCCCCTATCC TK0513 initial amplification
0160513 CGCCTGTTCTACTCCATAGGAGGCGGTAGAATCTT 
TTAAACAATCCATCCTTTCGAAAGC
TK0513 inverse PCR to construct 
B plasmids
0170513 GCTTTCGAAAGGATGGATTGTTTAAAAGATTCTACC
GCCTCCTATGGAGTAGAACAGGCG
TK0513 inverse PCR to construct 
B plasmids
0010929 GGAGGTGAATTTCGGCATTCATCGAAGAGGACTATCG TK0929 initial amplification
0020929 GGTGAAGGATTTCCATGTCGTTTAAAGAAAGTGTGACC TK0929 initial amplification
0160929 AGACCTTTTGGAAGTTGGTATGGTGATAGCT
CACTCCCCCATTTCCCTAATCTTCCTGAC
TK0929 inverse PCR to construct 
B plasmids
0170929 GTCAGGAAGATTAGGGAAATGGGGGAGTGAGCTA
TCACCATACCAACTTCCAAAAGGTCT
TK0929 inverse PCR to construct 
B plasmids
0011088 GGAGGTGAATTTCCAGCGAGGAAGTACTATAACATCG TK1088 initial amplification
0021088 GGTGAAGGATTTCACCCTGATCTTGATCTTCAGTTAGG TK1088 initial amplification
0161088 AGCGCTAAACCCCTGGAGGTGAGCGAATGAT
CAAGGAGCTTCTTTAACCAGTCTGAACCC
TK1088 inverse PCR to construct 
B plasmids
0171088 GGGTTCAGACTGGTTAAAGAAGCTCCTTGATCATTC
GCTCACCTCCAGGGGTTTAGCGCT
TK1088 inverse PCR to construct 
B plasmids
0011173 GGAGGTGAATTTCAGCTCAAAGACCTCATAGTGTTCC TK1173 initial amplification
0021173 GGTGAAGGATTTCAGGACTGCGAATCCTTTACTTTCG TK1173 initial amplification
0161173 TTAATAAGCTTTAGCGGAAAAATTTAAAAATTGCCCT
CACTCTATCTTCTTCCTCTTGAG
TK1173 inverse PCR to construct 
B plasmids
0171173 CTCAAGAGGAAGAAGATAGAGTGAGGGCAATTTTTA
AATTTTTCCGCTAAAGCTTATTAA
TK1173 inverse PCR to construct 
B plasmids
0011324 GGAGGTGAATTTCCTCACCAGTTCTCTCTCTTTATTGC TK1324 initial amplification
0021324 GGTGAAGGATTTCAATACGACACACCGGTTTACGTTGG TK1324 initial amplification
0161324 CTATTTTCATTTTCCTGCACCCCTAAGACAGGTATC
ACTCAATAGCTCCCAAAATAGGAC
TK1324 inverse PCR to construct 
B plasmids
0171324 GTCCTATTTTGGGAGCTATTGAGTGATACCTGTCT
TAGGGGTGCAGGAAAATGAAAATAG
TK1324 inverse PCR to construct 
B plasmids
0011477 GGAGGTGAATTTCCCTCTAACAAGTCCTTCAAATACG TK1477 initial amplification
0021477 GGTGAAGGATTTCGTTCACAAAGAGGCTATAGAGTTCG TK1477 initial amplification
0161477 AAATATGGAAAAGGGCTTATCACACTTTCGCATCT
CCATCACCCCCAATGGATTTTAGCT
TK1477 inverse PCR to construct 
B plasmids
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Oligonucleotide Sequence (5’3’) Application
0171477 AGCTAAAATCCATTGGGGGTGATGGAGATGCGAAAG
TGTGATAAGCCCTTTTCCATATTT
TK1477 inverse PCR to construct 
B plasmids
0011548 GGAGGTGAATTTCGAAAGTCCCAAATCTATTGTGTAGG TK1548 initial amplification
0021548 GGTGAAGGATTTCTATCATGGGAGTCTACATCTTTACC TK1548 initial amplification
0161548 CCTTGAGCAACTAAGGGCGAGGTGATAACTTTC
CAATTCTCCCTCTTTTCCCCTTCTTAT
TK1548 inverse PCR to construct 
B plasmids
0171548 ATAAGAAGGGGAAAAGAGGGAGAATTGGAAAGTTA
TCACCTCGCCCTTAGTTGCTCAAGG
TK1548 inverse PCR to construct 
B plasmids
0011732 GGAGGTGAATTTCAAAGAGAACAGTATTCCCATCACC TK1732 initial amplification
0021732 GGTGAAGGATTTCGGAAGGAGAGTTGAGAGACTGACC TK1732 initial amplification
0161732 AAAATAGGGAGCAACGAGCAGAACCCTCATTCAACT
GTCATCTGCGACCCTCTCGTAGAA
TK1732 inverse PCR to construct 
B plasmids
0171732 TTCTACGAGAGGGTCGCAGATGACAGTTGAAT
GAGGGTTCTGCTCGTTGCTCCCTATTTT
TK1732 inverse PCR to construct 
B plasmids
0011836 GGAGGTGAATTTCCAACGAGCTTTAATAACCTTCTCG TK1836 initial amplification
0021836 GGTGAAGGATTTCGCCAAGTAAAAGCTCTCGTTGTCC TK1836 initial amplification
0161836 TTTTAAAACCACCCCATCCGAGGGGTGAAGGGTGAG
AAGATGGCCAGATGGAAGATGGGC
TK1836 inverse PCR to construct 
B plasmids
0171836 GCCCATCTTCCATCTGGCCATCTTCT
CACCCTTCACCCCTCGGATGGGGTGGTTTTAAAA
TK1836 inverse PCR to construct 
B plasmids
0011957 GGAGGTGAATTTCAGCTGGTAAAACCTGACATTATTGC TK1957 initial amplification
0021957 GGTGAAGGATTTCAAGAAGAGGAGGAGAAAACTGAGG TK1957 initial amplification
0161957 CTTCCGACAGAATTTAGTTAGGTGCCCCTATGGATA
TGGATTTTGAGAAAGAACTGATTA
TK1957 inverse PCR to construct 
B plasmids
0171957 TAATCAGTTCTTTCTCAAAATCCATATC
CATAGGGGCACCTAACTAAATTCTGTCGGAAG
TK1957 inverse PCR to construct 
B plasmids
0012159 GGAGGTGAATTTCGTCAACTATGACCGGAGCCTCTACG TK2159 initial amplification
0022159 GGTGAAGGATTTCGAAGGTATCAAAAATCCCAAAGTGG TK2159 initial amplification
0162159 CCACTCTACAAATGTAAAGAAAAGTGCCGCTCT
ACCACCTGAAATGCCAAGGGTGAGGAA
TK2159 inverse PCR to construct 
B plasmids
0172159 TTCCTCACCCTTGGCATTTCAGGTGGTAG
AGCGGCACTTTTCTTTACATTTGTAGAGTGG
TK2159 inverse PCR to construct 
B plasmids
Overexpression vectors
BG4881 CACCTCCGTGATATTATCTATTAC vbb amplification (pSKS022)
BG4882 CGCACCGGTCCGGACAACACCCCTTGAGCTTTG vbb amplification (pSKS022)
BG4934 ATGCTATACAGATTGGTCTCCCACATCCC TK1173 amplification
BG4935 CGCACCGGTCTACCTTCCAAAGCGCCGCTGTCTC TK1173 amplification
BG4936 ATGCTGAGGGAGATACTCTCAC TK0929 amplification
BG4937 CGCACCGGTTCACACCCTCGCCCTCTCAAAC TK0929 amplification
BG4938 ATGAAGTACGATGTCCTCATAATCGGCGGC TK1836 amplification
BG4939 GCGACCGGTTACTCCTCCTGGAGGCCCATCTTCCAT TK1836 amplification
BG4940 ATGAAAGTCATTGTCGCAATAACGGGGGC TK0509 amplification
BG4941 GCGACCGGTTCAAGGTCGTCCAGCTGTAC TK0509 amplification
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Oligonucleotide Sequence (5’3’) Application
BG4942 ATGGCATCTGTTTCAGCTGTTATAAGG TK1324 amplification
BG4943 GCGACCGGTCGCTGACGAGGGCTATTTTCAT TK1324 amplification
BG5196 ATGACCTGGAAGTACGACGTCGTTG TK1088 amplification
BG5197 GCGACCGGTGAAGAAGGGGTTCAGACTGGTT TK1088 amplification
BG5200 ATGGAATTCAAGGCATTCATCGAG TK1957 amplification
BG5201 GCGACCGGTGGCGTCTTGAACGTTATGACAG TK1957 amplification
BG5202 ATGGGCTCGAAGCTTGATGAG TK0513 amplification
BG5203 GCGACCGGTTCCCGCACGTTAGTCCTACAC TK0513 amplification
BG5204 ATGGAGCTCCACTTTGACATGACC TK1548 amplification
BG5205 GCGACCGGTGGGGAAAAGAGGGAGAATTG TK1548 amplification
BG5584 ATGACAGTTGAAGTCTCCGTG TK1732 amplification
BG5585 GCGACCGGTAACGAGCAGAACCCTCATTC TK1732 amplification
BG5586 ATGGAGATGGTGGTAAGGTATCCC TK1477 amplification
BG5587 GCGACCGGTCTAGCGCCTGAAGACTATG TK1477 amplification
BG5588 ATGAGTAAAGGAGTTGTACATCC TK2159 amplification
BG5589 GCGACCGGTGCCGCTCAGAGGTACCATTCGG TK2159 amplification
Diagnostic primers
BG4871 CATCCTCACAGGGACGTTTG OExxxx diagnosis & sequencing (primer A in Figure S2b)
BG4873 ACAGACTTGAGGTGGAAAGG OExxxx diagnosis & sequencing (primer D in Figure S2b)
BG4662 GCTTGGGTCATGGACAGGCTC RT-PCR: TK0308 (F)
BG4663 TCTTAACCTGCTCGGCGACC RT-PCR: TK0308 (R)
BG5570 TAGAAGGATAACCGCAGGTG RT-PCR: TK1477 (F)
BG5571 CGATGGAGTGCTCGTATTTG RT-PCR: TK1477 (R)
BG5572 TGGAAACTACCTGGCGTCTC RT-PCR: TK1836 (F)
BG5573 AGTCGGCTCCCTTCTTTACC RT-PCR: TK1836 (R)
BG5574 CTCACTGAACCCAGATAAGG RT-PCR: TK1324 (F)
BG5575 GATTCTCCCGTCCATTGAAG RT-PCR: TK1324 (R)
BG5576 AAGACGGCGGCTACTGCTTC RT-PCR: TK0513 (F)
BG5577 CGCCAAGACCAACGGCAAAC RT-PCR: TK0513 (R)
BG5578 TGGTGAAGCCGAAGTACAAG RT-PCR: TK1548 (F)
BG5579 AACGCTCCAATAACCGTGAC RT-PCR: TK1548 (R)
BG5580 GGTTGGGCGTTTCCTATGAG RT-PCR: TK1732 (F)
BG5581 TGCACCGGGTTCGATCATTC RT-PCR: TK1732 (R)
BG5723 GCTATCTCCAGCTCGCTAAC RT-PCR: TK0929 (F)
BG5724 CTCAAGAAGCTCCCGATTCC RT-PCR: TK0929 (R)
BG5725 GGATGCGGGCATAATCACAG RT-PCR: TK0509 (F)
BG5726 GCTTGGGCATGAGGTTGTTG RT-PCR: TK0509 (R)
BG5727 CGCTGTAGGCGATCTGATAG RT-PCR: TK1173 (F)
BG5728 AACATAGCCCTCGCATACGG RT-PCR: TK1173 (R)
BG5729 GCGGAGCGTAGGTGTTTATG RT-PCR: TK1088 (F)
BG5730 ACAAGGAAGTCAGCGGAGTG RT-PCR: TK1088 (R)
BG5733 ATGAGGAACGCAGAGTACAG RT-PCR: TK1957 (F)
BG5734 ATAGCCGTTGGTGAGATTGG RT-PCR: TK1957 (R)
BG5737 TCTCCTTGATGCCGATGTTC RT-PCR: TK2159 (F)
BG5738 AGATAGGCGACAACGAGTTC RT-PCR: TK2159 (R)
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Table S4. Detected IPL-adduct masses in the HPLC / ESI-MS
m/z
Saturated H+ NH4+ Na+
PH 895,700 912,726 917,682
HPH 1057,753 1074,779 1079,735
H(NH2)PH 1056,769 1078,751
Unsaturated H+ NH4+ Na+
PH 883,606 900,632 
HPH 1045,659 1062,685 1067,641
H(NH2)PH 1044,675 1066,657
Fragmentation indicated the presence of unsaturated diether lipids 
with 3 unsaturations per lipid on one chain only. Abbreviations: PH: 
phosphohexose; HPH: hexose-phophohexose; H(NH2)PH: aminohexose 
phosphohexose, 
Table S5. Summarized Tetraether levels and diether compositions for knockout strains (∆) and overexpression 
strains (OE) with altered tetraether levels 
Gene ∆ (TE:DE)% DE (sat) DE (unsat) OE (TE:DE)% DE (sat) DE (unsat)
TK1548 15.1 99.6 0.4 82.5 91.8 1.2
TK1836 79.8 99.8 0.2 27.3 52.4 19.8
TK1957 † † † 96.1 99.9 0.1
TK1324 80.9 73.4 26.6 38.1 16.1 83.9
wildtype wildtype
T.k. TS559 80.0 55.2 44.8 80 55.2 44.8
The data indicate that both low obtained tetraether levels (∆TK1548 and OE1836) and high tetraether levels 
(OE1957) correlate with decreased unsaturated diether levels compared to the wild type TS559 strain. †: lethality; 
(TE:DE%): percentage of tetraethers over total amount of core lipids (tetraethers and diethers)
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As a means to improve Escherichia coli robustness, one of the pillars of synthetic biological 
approaches is dedicated to membrane engineering. As described in Chapter 1, rational 
design of membranes already proved to be a promising technique with few applications 
already being implemented. Alternatively, much can be learned from nature. As archaea 
are labelled as naturally robust microbes, the membrane properties of these organisms 
may in fact be the key to many of the biological constraints encountered in industry. This 
thesis describes the metabolic engineering of a hybrid membrane of archaeal and bacterial 
lipids in E.coli, and the characterization of the accompanying properties of this engineered 
strain. The main objective of this venture was to investigate whether mixed membranes can 
support a biologically viable cell, and to determine what phenotypical changes are elicited. 
Chapter 2 provides an overview of membrane adaptations to temperature, pH and pressure 
for both bacterial and archaeal extremophiles. The main focus of this study lies on how 
nature deals with extreme habitats and thus what to expect from a mixed membrane. Here 
we made an inventory of the encountered membrane lipid compositions near the survival 
boundaries at physico-chemical constraints. To do this, the most robust extremophiles 
known to date were first subjected to a comparative analysis. We then looked into the 
encountered lipid compositions and searched for correlations within the respective survival 
limits. This overview showed that archaea are generally dominating eco-systems with high 
temperatures and low pH. On the other hand, bacteria seem to dominate habitats with low 
temperature and slightly but insignificantly also to high pH. As the adaptation mechanisms 
to low and high temperature and low and high pH are fundamentally different, we conclude 
that bacterial ‘phosphatidic acid’ based lipids are better customized to fluidizing 
modifications of the membrane. Archaetidic acid based lipids on the other hand seem to be 
better equipped for rigidifying modifications of the membrane most likely due to the methyl 
branches of the isoprenoids. On the basis of these observations, it is therefore tempting to 
suggest that a mixed membrane will gain heat and pH dependent stability. Here we stress 
that these rigidifying adaptations are probably the most useful for industry. In Chapter 3, 
we embarked on the construction of a platform strain of E.coli with a stable but inducible 
upregulation of the MEP-DOXP pathway. A successful strategy was shown to be the directed 
integration of an artificial MEP-DOXP operon composed of four rate controlling steps. 
Although flux was never actually measured, the accumulation of a carotenoid end-product 
‘lycopene’ showed that a ~5-fold flux increase was accomplished. Here, a maximal amount 
of roughly 3 µg/mg dry cell weight (DCW) was measured. This finding however also implied 
it would not suffice to generate a mixed membrane with an appreciable amount of archaeal 
lipids. The average amount of lipids in E.coli is estimated to be roughly 10% of the DCW. This 
implies that a maximum of 3% archaeal lipids of the total membrane content could be 
reached. This finding underlined the need for further MEP-DOXP engineering or a 
downregulation of the endogenous lipid synthesis pathway. A down-regulation of bacterial 
lipids would in the first place increase the ratio to archaeal lipids, but perhaps also 
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redistribute carbon flux to the introduced archaeal lipid pathway. In Chapter 4 we generated 
a conditional knock-down of lysophosphatidic acid biosynthesis. To accomplish this, we 
generated a plsX knock-out strain and provided the alternative plsB gene with a repressible 
and inducible promoter. Here we observed that despite a successful engineering, the 
system fails to repress the synthesis of phospholipids. Because of this insufficiency, we 
complemented the system with an overproduction of apo-ACP, which is a potent competitive 
inhibitor of PlsB. This complementation demonstrated that cell growth was severely 
impaired, suggesting that the desired silenced membrane synthesis was obtained. To 
understand the true nature of the retarded growth, we performed a proteomics analysis on 
the mutant cells during induction and without induction. A reversal of expression in enzymes 
involved in fatty acid metabolism was shown from anabolic to catabolic. Instead of a 
compensatory expression of the fatty acid synthesis pathway, a relatively high expression of 
the fatty acid degradation pathway was observed. These findings showed that this system 
is suitable to combine with the archaeal biosynthesis pathway. In Chapter 5, the in vitro and 
in vivo assembly of the archaeal lipids archaetidylglycerol and archaetidylethanolamine was 
tested. Here, the aim of the study was to identify candidate genes from bacterial origin 
suitable for mixed membrane synthesis. This led to the successful reconstruction of 
archaetidylglycerol and archaetidyl-ethanolamine both in vitro as in vivo. Besides a selection 
of archaeal enzymes that show heterologous activity in Escherichia coli, a promiscuous 
activity of endogenous lipid synthesis enzymes PgsA, PgpA and Psd and the Bacillus subtilis 
PssA was shown towards the archaeal lipid precursor CDP-archaeol. With the combined 
products and knowledge gained from the MEP-DOXP upregulation, phosphatidic acid 
downregulation and archaeal lipid reconstruction, we embarked on the assembly of a mixed 
membrane as described in Chapter 6. From preliminary assays of combining the three 
systems it soon became clear that neither the combination of the MEP-DOXP upregulation 
and lipid synthesis nor a joint system including a downregulation of phosphatidic acid 
synthesis would lead to the desired level of archaeal lipids. We attempted to boost these 
levels by tuning the down-regulatory system or alternatively by providing cerulenin, a fatty 
acid synthesis inhibitor, without significant improvement. A successful strategy however 
proved to be the usage of a statistically optimized medium (OPT1). A combination of MEP-
DOXP engineering and OPT1 proved to be a vital combination to boost archaeal lipid levels 
to a reproducible average of 28%. It was shown here that these levels of archaeal lipid 
production do not lead to loss of viability or affect growth of E.coli besides an extensive 
delay upon induction. A genome analysis comparing induced and uninduced cells showed 
the occurrence of only few insignificant mutations which cannot account for the growth 
retardation. Scanning electron microscopy revealed that the cells are prone to dramatic 
morphological aberrations. Here we observed a high number of lobular appendages. High 
resolution TEM images indicated that these appendages are released from the membrane, 
which suggests an expelling mechanism possibly to liberate the cells from a disadvantageous 
membrane composition. Furthermore, in this chapter it is demonstrated that although GGGP- 
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and DGGGP-synthases from Methanococcus maripaludis can synthesize DGGGP in G3P 
configuration, this production is absent in E.coli or only present in trace amounts. Remarkably, 
the deletion of a functional araM gene for G1P synthesis was shown to be redundant because 
E.coli can generate G1P naturally, or as a side-effect of cultivation on OPT1 medium. When 
testing the physicochemical robustness we observed a beneficial effect under cryogenic 
conditions and butanol exposures but not to heat shock, as anticipated. As discussed in 
Chapter 2, the main characteristic that contribute to thermal robustness of archaea is the 
ability to form membrane spanning bipolar lipids. Because the enzyme(s) responsible for the 
putative tail-to-tail condensation are currently unknown we set out to identify this system in 
Thermococcus kodakarensis in Chapter 7. Here we constructed a series of strains with 
deletions or overexpression from a selection of high-probability candidate genes. Although 
the biochemical nature and the responsible gene was not included, we identified four genes 
that highly influenced the ultimate level of tetraether lipids. By total ion monitoring MS of the 
isolated lipids we found that the level of tetraethers highly correlates with the amount of 
unsaturated diether lipids. This makes a substrate-product relationship between unsaturated 
diether lipids and tetraethers very likely, and ultimately increases the odds of encountering 
the true responsible gene.
General Discussion 
1. Introduction 
The global demand for chemicals and energy is increasing steadily and unfortunately 
accompanied by a detrimental impact on the environment. These developments, but also 
the depletion of the natural resources necessitates a transition from fossil fuels to biomass. 
Clean technologies are thus required for industry to comply with the ever growing demand for 
energy and chemicals. One of the promising approaches that attracted widespread attention 
for quite some time is microbial green chemical productions by engineered micro-organisms 
through ‘synthetic biology’. This scientific field combines different disciplines and aims to 
create, control and programme cellular behaviour, leading to improved so-called microbial 
cell factories. Here, the focus lies mainly on the design and optimization of biochemical 
pathways in microbes to enable or increase the production of interesting compounds. One of 
the limitations however, is that these metabolic modifications may cause an enormous stress 
on the micro-organisms. Because of this, applied research also focusses on developing new 
methods for survival or alleviation of the demanding production conditions. One example is 
to enhance product export by the engineering of transporters that specifically transport a 
product of interest like amino acids and alkanes [396-399]. The most interesting compounds 
contributing to a green economy, however, are alcohols and fatty acids. This is mainly because 
of their high energy storage, easy production and potential to cut CO
2
 emissions [400]. For 
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microbial production of these compounds, however, it has long been recognized that the 
toxicodynamic site of interaction is usually focussed on the membrane [401-403]. Especially 
long chain alcohols are known to fluidize the membrane by intercalating between the 
phospholipids. This ultimately leads to lysis of the production host. To deal with this problem, 
complementing traits are generally focussed on stabilizing the cytoplasmic membranes to 
increase solvent tolerance. Such fortification strategies through membrane engineering are 
usually done by computational or rational design. One can model or predict the outcome of 
membrane dynamics in silico and apply this knowledge to the host. Rational design on the 
other hand can be done by reproducing promising homeoviscous adaptation mechanisms to 
the host. Beneficial membrane modifications can be identified by exposure of compounds to 
multiple micro-organisms or copying membrane modifications from naturally adapted micro-
organisms. In this study, we intended to produce a membrane composed partially of archaeal 
lipids as a fortification strategy. This endeavour is based on the observation that some archaea 
can withstand high levels of solvents, low pH and high temperatures.
Are archaeal membranes truly more robust?
Because many archaea thrive in extreme habitats, it is generally believed that their membranes, 
composed of diether or tetrether lipids, are more stable than their bacterial counterparts. 
However, are archaeal membranes truly more robust? To address this question, a couple of 
biophysical studies on liposomes have been done to compare archaeal lipids with bacterial 
lipids [28, 156, 404, 405]. These studies consistently concluded that archaeal lipids have a higher 
thermal stability and lower permeability to protons and carboxyfluorescein. With the exception 
of one study [121], these reports did not involve lipids from extreme hyperthermophilic 
bacteria, nor was the question ever addressed in vivo. In Chapter 2, we therefore listed the 
growth boundaries of archaea and bacteria and the corresponding membrane adaptation 
mechanisms. To come to an unbiased answer to the question on archaeal membrane 
stability, an unambiguous perspective of robustness is required. To address this, we listed 
all published data on the growth range boundaries, instead of just the growth optimum. A 
comparison of archaeal and bacterial robustness however also requires a precise specification 
of one particular physicochemical challenge. This is mainly because adaptability of the barrier 
function is found to be flexible but not universal. Different physicochemical perturbations elicit 
different adaptation mechanisms in the cytoplasmic membrane which is especially illustrated 
in the following example. It is generally known that some archaea, like methanogens, can 
tolerate high levels of organic solvents in deep sea oil reservoirs at high temperatures [406]. 
However, when comparing the hyperthermophilic archaeon Thermococcus kodakarensis 
(also tetraether lipids) with a mesophilic bacterium like Escherichia coli, they seem to have 
nearly comparable NOAEL (no observed adverse effect level) and LD50 (median lethal dose) 
to butanol exposure (Fig. S1). This specific comparison shows that robustness cannot be 
generalized nor attributed to membrane composition alone. Neither T. kodakarensis, nor E. 
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coli are commonly exposed to butanol. Consequently, one cannot exclude the possibility that 
e.g. maintaining the functionality of membrane proteins poses a bigger challenge than the 
membrane itself. To come to a justified conclusion about archaeal and bacterial membrane 
robustness, we thus only compared the membrane adaptations of various extremophiles 
to heat, cold, acidity, alkalinity and pressure in Chapter 2. In this case, variables other than 
membrane robustness are assumed to be equal and eliminated from the comparison. 
Besides the (pseudo)peptidoglycan cell wall, the phospholipid composition is only one of 
few true chemical differences between archaea and bacteria. The comparative analysis from 
Chapter 2 thus provides the most legitimate answer to the question whether the membrane 
is accountable for a difference between survival boundaries. Our findings confirmed that 
the archaeal domain is relatively abundant in environments with the highest temperatures 
and lowest pH. Bacterial lipids were not observed above 100oC or below pH 1 in contrast to 
archaeal lipids. The bacteria, on the other hand, seem to dominate the coldest environments 
and to a lower extent also to alkalinity. Archaea were not observed growing below -2oC or 
above pH 11 in contrast to bacteria. On the basis of the encountered lipid compositions we 
postulate that phosphatidic acid-based lipids are superior in inflicting membrane fluidization, 
whereas archaetidic acid-based lipids are generally better accommodated for rigidifying 
modifications. A mechanistic foundation that supports this is the fact that fluidization is 
generally aimed at providing more space between hydrocarbon chains at the hydrophobic 
centre of the bilayer. This adjustment is most efficiently done by introduction of double 
bonds in fatty acids to generate cone-shaped lipids. Conversely, this may be less efficiently 
accomplished in archaeal lipids which retain a cylinder shaped lipid despite the presence of 
double bonds. On the other hand, rigidifying modifications are generally aimed at providing 
less space and motion at the interface of the bilayer, with membrane spanning lipids forming 
a monolayer as extreme example. A consequence of this is a denser packing which culminates 
in an extremely low permeability to solutes in archaeal membranes. One minor flaw of the 
extremophile comparison is the fact that we cannot exclude that measurement errors are 
included in the analysis by selection of studies. It e.g. cannot be ruled out that in the future, 
bacteria with higher growth temperatures or archaea with much lower growth temperatures 
will be isolated. However, due to the fact that classical sampling and cultivation methods do 
not favour archaea over bacteria, or vice versa, it seems unlikely that the observed boundaries 
have been prone to a major selection bias. Support for this is found in a recent meta-genomics 
and transcriptomics sequence analysis study of the subglacial lake Vostok (Antarctica)[407] 
which confirms one of the conclusions drawn. Here, the metagenome showed a distribution 
of 94% bacterial sequences, 6% eukaryal and only a trace amount of archaeal sequences. 
This study on a highly confined environment supports the bacterial dominance of cryogenic 
habitats as was also concluded from our comparative analysis.
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2. Contemplations on the mixed membrane hypothesis
In Chapter 6, we introduced an entire archaeal lipid synthesis pathway in E.coli and 
attempted to simultaneously down-regulate the endogenous bacterial lipid pathway 
(S1). The main goal of the construction of a mixed membrane was to generate a robust 
membrane and meanwhile provide the possibility to study the proposed hypothesis about 
the archaeal and bacterial divergence. Wächtershauser postulated his mixed membrane 
hypothesis in 2003 [14] to account for some seemingly incompatible facts. Archaea and 
bacteria share a high number of orthologous genes, mainly for transcription and translation, 
and are therefore most certainly descendants from a primeval common ancestor cell 
[408]. A multi-component genetic machinery must therefore have existed and due to its 
heritable character also been confined within a cellular lipid membrane. Extant archaea 
and bacteria, however, have highly distinct membrane lipids, which raises questions 
about the composition of the pre-cell membrane. Wächtershäuser, proposed that this 
might have been a mixed heterochiral membrane. Through selective events, a less stable 
unfavourable mixed membrane segregated into membranes with a predominance of fatty-
acyl-ester-G3P lipids in a bacterial ancestor, and isoprenoid-ether-G1P lipids dominating in 
an archaeal ancestor. Alternatively, a homochiral bacterial or archaeal membrane evolved 
first in pre-cells. In this scenario, a subsequent membrane transformation in either one 
of the domains followed through an inevitable intermediary heterochiral membrane. 
This last event, however, is regarded as counter-selective and its occurrence thus highly 
questionable. In case it would not have been counter-selective, we would come across 
hybrid heterochiral membranes to this day as well. These deductions thus attribute 
the first scenario as the most plausible one, and inevitably leads to the question why a 
heterochiral membrane in pre-cells evolved in the first place. The answer to this equally 
important question should be sought in identifying the conditions that support stability 
of mixed membranes instead, rather than testing its stability at mesophilic circumstances. 
Despite the fact that some studies on heterochirality are available [17, 409-411], consensus 
about the stability of heterochiral membranes has not yet been reached. To our humble 
opinion, this is because it is dependent on what is considered to be a stable membrane. 
Whereas some authors put emphasis on low permeability, however, more importantly is 
probably only the ability of lipids to self-assemble into a closed bilayer system. Both the 
level of permeability and fluidity to modern-times mesophiles are subordinate because the 
conditions where pre-cells evolved are largely unknown, but was likely heterogeneous in 
all aspects. The conditions where initial life evolved are hypothesized to be from deep sea 
hydrothermal vents, mineral cavities or at the interface of natural proton and hydroxide ion 
laminar flows [13, 347]. At this stage in the evolution of LUCA, it has also been speculated 
that the proto-membrane self-assembled from lipids from non-enzymatic origin [14, 412]. 
Peretó et al. and Lombard et al., however both point at the phylogenomic observation that 
biosynthesis of fatty acids and isoprenoids and a member of the two superfamilies of G1P 
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and G3P synthesizing dehydrogenases were likely present in LUCA already. If true, this does 
not discard the ‘abiotic source of lipids’ hypothesis, but is difficult to reconcile with a LUCA 
having all pathways available at certain point in time. 
The reason why mixed membranes evolved in LUCA, may possibly not be due to selection 
pressures that favoured the characteristics of a mixed membrane. Instead, the solution 
may be that before emergence of fully developed LUCA cells, individual constituents 
relied on exogenous abiotic sources that were irregular and unreliable in their supply. 
The consequence may have been that mixing hydrocarbon chains provided higher chance 
of survival. Another consequence of this is that enzymatic pathways for the synthesis of 
hydrocarbon chains appeared in a later stage than the lipid assembly enzymes and as a 
result required broad substrate promiscuity. Until now, for many segments of the lipid 
assembly machinery, rudimentary substrate promiscuities indeed have been reported. In 
the proposed scenario: (i) early stage pre-LUCA-cells may have had non-stereoselective 
glycerol-phosphate dehydrogenases [413]. Our findings of substrate promiscuity of both 
GGGP-synthase and DGGGP-synthase from M. maripaludis towards G3P and the unusual 
bacterial G1P production in E.coli (Chapter 6) supports the possible coexistence of G1P 
and G3P in this pre-LUCA cell. In this stage fully developed enzymes for polar head group 
attachment were also already present. Koga specifically points at the fact that these 
enzymes have very broad specificity even to unnatural lipids like isoprenoid-esters [7]. In 
this stage, these cells had access to free fatty acids and perhaps also to isoprenoids from 
non-enzymatic origin. The abiotic source of fatty acids could have been, as indicated by 
Lombart et al.[13], through Fisher-Tropsch synthesis involving CO and H
2
 reactions in the 
presence of iron catalysts under the conditions of hydrothermal vents. Additionally, the 
organic carbon content in meteorites contains fatty acids and glycerol monoacyl derivates 
which are shown to readily self-assemble to primitive membranes [354]. The fact that 
both archaeal and bacterial species are capable of generating the uncommon fatty acyl 
ether lipids [5, 6] supports this hypothesis to some extent. (ii) In a subsequent stage, a too 
limited supply of fatty acids may have provoked the invention of the fatty acid synthesis 
pathway (FAS) and prenyl-synthases. This is further supported by the fact that both enzyme 
families are present in contemporary archaea and bacteria which were ultimately recruited 
for different purposes [413]. (iii) In the final stage before the divergence of the archaeal 
and bacterial domain, stereo-selective glycerol-phosphate dehydrogenases evolved which 
triggered the separation into two domains. 
3. MEP-DOXP up-regulation and subsequent improvements on flux
The success of engineering a mixed membrane in E.coli is for a great deal dependent on 
an enriched pool of the isoprenoid building blocks isopentenyl-diphosphate (IPP) and 
dimethylallyl-diphosphate (DMAPP). For this reason we first embarked on the engineering 
of a platform strain which could rely on two completely different strategies. The first option 
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was to introduce a complete heterologous HMG-CoA reductase (mevalonate) pathway. On 
this occasion, the desirable absence of innate flux regulation provides a major benefit as 
already indicated by Martin V.J.J. et al. [237]. The main challenge of this approach would 
have been the introduction of an imperatively high number of heterologous genes (8 in 
total) and the subsequent refactoring of that pathway. Furthermore, this strategy would 
have been burdened with difficulties when attempting to obtain stable integrations for 
such a high number of genes. The alternative was to up-regulate the innate MEP-DOXP 
pathway as described in Chapter 3, (Fig. S2A). The main advantage of the latter strategy is 
that only endogenous enzymes need to be manipulated and heterologous gene expression 
is not required. To our experience, however, the up-regulation of the MEP-DOXP pathway 
by overexpression of the idi, ispDF and dxs genes alone did not lead to very high yields. The 
main question that arose was whether innate regulatory inhibitions were counteracting 
the effect of overexpression. We thus had the choice to further elucidate the encountered 
flux limitation or systematically trying additional over-expressions on other MEP-DOXP 
genes. A few studies are available demonstrating that higher isoprenoid yields can be 
achieved by other strategies that mitigate subsequent limitations [210-212]. One example 
is by targeting the pool of (methylerythritol cyclodiphosphate) MEC that leaks into the 
extracellular environment. Zhou et al. show that this loss can be confined by overexpression 
of ispG and the knock-out of potential MEC efflux pumps [210]. Another option is given by 
Bitok et al. who demonstrated a feedback and feedforward inhibitory mechanism on IspF 
in vitro [211]. To study the role for the latter mechanism during up-regulations we tested 
the overexpression of idi and dxs with either ispD or ispD and ispF. These overexpressions 
were compared with a construct without the latter genes (idi-dxs). This idi-dxs construct 
could in potential have demonstrated a substantial isoprenoid decrease in case of such 
feedback mechanism was involved during in vivo up-regulation of the MEP-DOXP pathway. 
One could argue however that this setup did not allow us to draw firm conclusions about 
any regulatory event in vivo, given the fact that the inhibitory complex wasn’t measured 
nor the carbon flux. Secondly, the accumulation of farnesyldiphosphate (FPP) to complex 
with IspF and 2C-methyl-D-erythritol 4-phosphate (MEP) was rather disputable. On the 
other hand, this setup did allow the determination of the individual constraints of IspD and 
IspF on the up-regulation, and as such could have motivated us to perform metabolomics 
analysis to study the involvement of a potential feedback inhibition. In this set-up, however, 
we showed that IspF does not provide a major contribution nor limitation during MEP-DOXP 
up-regulations and that feedback inhibition on IspF is therefore unlikely to occur. When 
Zhang et al. reported the implications of genotype improvement and statistical medium 
optimization [213], their findings validated that physiological control elements at the level 
of the MEP-DOXP enzymes are unlikely to play a major role. 
On the basis of our archaeal lipid production assays (Chapter 6) we concluded that two other 
constraints may have limited further MEP-DOXP up-regulations as determined in Chapter 3. 
Firstly, we demonstrated that DGGGP-synthase from Methanococcus maripaludis, instead 
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of Archaeoglobus fulgidus, for a great deal improved the lipid (isoprenoid) production. This 
particular observation showed that isoprenoid flux may possibly be further restricted by 
the downstream isoprenoid pathway. It is conceivable that other lipid intermediates (GGPP 
or GGGP) were accumulating in the strain with the A. fulgidus gene besides the measured 
end-products. This finding also pointed at the risk of relying flux increase strategies on 
the detection of only one metabolite. Metabolomics analysis would have been desirable 
to adjust or pinpoint individual rate limitations. Retrospectively, the measured lycopene 
levels were therefore a bad representation of flux increase in Chapter 3 as well. In the 
case of DGGGP-synthases, the A. fulgidus gene appeared to be a major limitation to the 
production of the measured end-products archaetidylglycerol (AG) and DGGGP and 
supports the conclusions being drawn from (Chapter 3) that production levels can benefit 
from optimizing the expression of the downstream pathway of the isoprenoid variants. 
Secondly, another even higher constraint appeared when a substantial improvement was 
observed by changing LB medium to OPT1 defined medium [213]. Although the reported 
OPT1 medium was not provided with a rationale behind stimulating isoprenoid synthesis 
[213], the OPT1 recipe provides some insight. The most contributing constituents are 
glycerol and citric acid. The glycerol is a readily used carbon source that upon internalization 
becomes phosphorylated. The resulting glycerol-3-phosphate is than converted to 
dihydroxyacetone-phosphate which upon conversion to glyceraldehyde-3-phosphate is 
readily used as substrate for the MEP-DOXP pathway. The citric acid on the other hand, 
diminishes conversion of pyruvate to oxaloacetate for the TCA cycle. A consequence of 
citric acid uptake is thus a redistribution of pyruvate as second required substrate for the 
MEP-DOXP pathway. The effect of this medium, however, could possibly also be reached 
by a metabolic engineering approach targeting the pyruvate branch-point. A proposed 
strategy would be to co-express gluconeogenic phosphoenolpyruvate carboxykinase (pckA) 
which converts oxaloacetate back to phosphoenol-pyruvate (Fig. 1). This overexpression 
can be complemented with an overexpression of glycerol-phosphate synthase (gapB) that 
converts glycerate to glyceraldehyde-3-phosphate which increases the second required 
substrate of the MEP-DOXP pathway. This approach may possibly result in an increased 
MEP-DOXP flux that is comparable to the use of the OPT1 medium.
Initially we intended to compare the transcription levels of integrated operons between a 
set of strategically chosen loci dependent on extensive protein occupancy domains (EPODs). 
At the chosen heEPOD (highly expressed) position we expected to find higher transcription 
levels as compared to the EPOD-independent locus and the tsEPOD (transcriptionally silent) 
locus. The supposedly varyingtranscription initiation levels were also hypothesized to 
result in different levels of MEP-DOXP up-regulation as a consequence of varying degrees 
of expressions. Retrospectively, a successful integration at the initially favoured heEPOD 
was unlikely to significantly improve the MEP-DOXP up-regulation. When we tested the 
integrated operons, we observed that a lower expression level of idi, ispDF and dxs was
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Figure 1. Proposed strategy to increase MEP-DOXP flux and a complementing approach to obtain an auxotrophic 
conditional knock-down of phosphatidic acid synthesis Red arrows and markings indicate targets for overexpression 
or knock-out. Overproduction of GapB: glyceraldehyde-3-phosphate dehydrogenase; DXS: 1-deoxy-D-xylulose-5-
phosphate synthase; Pck: phosphoenol pyruvate carboxykinase are proposed to increase MEP-DOXP carbon flux. 
A conditional down-regulation of phosphatidic acid synthesis can be obtained by generating a gpsA (glycerol-3-
phosphate dehydrogenase) knock-out strain and providing inadequate glycerol levels. 
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causing a significantly increased production of lycopene compared to the plasmid-encoded 
variants. A higher transcription from the heEPOD would therefore not have contributed to 
higher isoprenoid yields as well. 
4. Down-regulation of the endogenous lipid synthesis,
To down-regulate E.coli’s endogenous lipid synthesis, we focussed on the first committed 
step of phospholipid synthesis, i.e. glycerol-3-phosphate acyl-transferase. This conversion 
requires two substrates, which are acyl-ACP and glycerol-3-phosphate. As the fatty acid 
component is also required for purposes other than phospholipids, targeting the fatty 
acid synthesis (FAS) cycle would have been a too risky endeavour. Especially, the necessity 
for many membrane proteins to become post-translationally modified by acylation and 
the precursor role in cofactors like biotin would have required an extensive tuning when 
targeting fatty acid synthesis. As an alternative to the FAS cycle, we attempted to silence 
lysophosphatidic acid synthesis being the first committed step of phospholipid synthesis. In 
bacteria, this catalysis is performed by the plsX-plsY pathway. In E.coli, this is by exception 
and for yet unknown reasons also performed by the alternative plsB pathway [270]. To 
conditionally knock-down lysophosphatidic acid synthesis we therefore exchanged the 
plsB promoter region with a tunable rhamnose promoter in a plsX knock-out strain (Fig. 
S2A and S2B). Because of insufficient repression of the rhamnose promoter, however, 
we had to complement the strain with an overexpression of acpP (acyl carrier protein). 
This overexpression leads to an excess of the inactive apo-ACP isoform, which is known 
to competitively inhibit the redundant PlsB [277]. Here we observed dramatic growth 
retardation when inducing both PlsB and ACP overexpression, which suggested that 
membrane synthesis was silenced. We looked into the mechanism of action by performing 
a proteome analysis of the induced strain compared to a wild-type plsB strain. This led 
us to conclude that expression of fatty acid synthesis was down-regulated and fatty acid 
degradation was up-regulated in the conditional knock-down strain. By exogenously adding 
fatty acids and lysophophatidic acids we concluded that a shortage of available acyl-ACP 
was likely the cause of the growth defect. Although all data supported this conclusion, a 
major limitation of the experimental setup was that the concentration of key metabolites 
was never measured directly (i.e. acyl-ACP and fluxes) but solely deduced from the growth 
performances, proteome data and fatty acid and LPA rescue assay. Secondly, one can argue 
that an overproduced PlsB and apo-ACP pool cannot represent a realistic physiological 
control mechanism to down-regulate membrane synthesis. Nevertheless, it is hard to 
believe that a competitive inhibition by a cofactor (apo-ACP) has no biological reason or 
significance. In addition, E.coli is also equipped with an ACP-phosphodiesterase (acpH) 
that converts holo-ACP back to inactive apo-ACP, for which the physiological role is largely 
unknown [414]. Taken also these factors into account, it is conceivable that the proposed 
silencing mechanism is implemented to abruptly silence lipid synthesis when needed. 
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As a follow up to this study we therefore suggest to repeat the proteomics analysis to 
statistically validate the observed effects and to complement this data with metabolomics 
data. Furthermore, this study can be extended with transcriptomics specifically targeting 
ACP-synthase (acpS) and ACP-phosphodiesterase (acpH), to determine the conditions or 
growth phases at which apo-ACP allows detection of physiological levels of apo-ACP. 
When we implemented the PlsB-ACP inhibitory system in combination with the archaeal 
lipid synthesis, we did not observe a significant decrease in the amount of endogenous 
lipids (not shown). One of the main determining factors was the fact that production of 
archaeal lipids was dependent on the presence of glycerol whereas the down-regulation 
of bacterial lipids was dependent on rhamnose. Because these inducers are both carbon 
sources and had to be combined with IPTG at the same time, it is unclear whether a 
combination of glycerol and rhamnose could elicit both desired effects, or catabolite 
repression was frustrating either one of the systems. In addition to this, we had to introduce 
the required acpP gene into the pMS148 plasmid which may have resulted in different 
expression levels as established during the proteome analysis (Fig. S2B). These factors, 
along with an incomplete characterization of induction of the down-regulatory system may 
have caused the inadequacy of our attempts to lower the fraction of bacterial lipids. An 
alternative that was more likely to cause significantly lower levels of endogenous lipids 
was the supplementation of glucose to elicit catabolite repression via the CAP domain 
on the rhamnose promoter of PlsB. However, also the archaeal lipid synthesis might be 
affected, as both the pMS148 and pAC029 plasmids and integrated MEP-DOXP operon 
are also controlled by a CRP or LacI repression. As an alternative to the down-regulation 
of endogenous lipid synthesis via plsB, we also attempted to generate a disruption of 
glycerol-3-phosphate dehydrogenase (gpsA). Despite having access to a G3P transporter 
(GlpT) [415], this mutant could not be isolated as glycerol-3P auxotroph when attempting 
to disrupt this essential gene (gpsA). As an alternative, one could try to obtain a ∆gpsA 
mutant by providing glycerol instead. E.coli is able to take up exogenous glycerol into the 
cytoplasm via the GlpF transporter and GlpK kinase system. The glycerol channel (GlpF) 
facilitates the uptake of glycerol upon which the kinase (GlpK) traps the glycerol inside 
the cell as glycerol-3-phosphate. A depletion of glycerol-3-phosphate in a gpsA–knockout 
strain can subsequently be obtained by providing insufficient or no glycerol as a means to 
conditionally knock-down phosphatidic acid synthesis (Fig. 1). This approach however, is 
presently hampered by the committed use of OPT1 medium. This is because glycerol is the 
foremost constituent of OPT1 because of its crucial role in MEP-DOXP upregulation in the 
current strain (WUR182). This detail can be solved by implementation of the previously 
discussed overexpression of pck and gapB to circumvent the as yet compulsory usage of the 
OPT1 medium to further increase isoprenoid flux.
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5. A hybrid heterochiral membrane and its implications
One of the prominent achievements of this study was the production of a membrane 
consisting of 28% archaeal lipids. Basically two observations support that the foreign lipids 
were incorporated in the membrane. Firstly, the archaeal head group attachments were 
almost completely dependent on enzymes endogenous to E. coli. As all of these enzymes 
are membrane embedded, the archaeal lipids must have been present at that location 
as well. Secondly, we observed that the endogenous lipid pool of phosphatidylglycerol 
(PG) decreased proportionally to the increase of archaetidylglycerol (AG). As discussed 
in Chapter 6 we postulate that this seemingly mutual exclusiveness was a result of the 
balanced regulation between anionic and zwitterionic lipids, and not by a lack of polar 
head group substrate glycerol-3-phosphate. The mechanism that keeps anionic and 
zwitterionic phospholipids in equilibrium is regulated via the acidic phospholipid content in 
the membrane. These levels elicit a compensatory synthesis of zwitterionic phosphatidyl-
ethanolamine (PE) lipids by activation of phosphatidyl serine synthase (PssA). It has been 
shown that an ionic interaction of acidic phospholipids (PG) with PssA activates the enzyme 
from its latent cytosolic form [416]. Because the PG levels that normally stimulate PssA were 
relatively low, this regulation thus must have occurred via anionic AG as well. Accordingly, 
this conclusion supports the incorporation of AG in the membrane. Despite a sustained 
balance between the anionic and zwitterionic lipids and a fairly normal growth behaviour, 
the EM pictures showed dramatic morphological malformations. Here we observed a high 
number of extraneous appendages and subsequent release of vesicles. Although the exact 
cause is not determined, this finding suggests that the E.coli cells attempt to expel the 
foreign lipids, instead of maintaining lipid homogeneity. Because of this, it may indicate 
that the mixed membrane situation is not sustainable in vivo, and that a homogeneously 
mixed lipid membrane was never obtained. Interestingly, the in vitro study of Shimada and 
Yamagishi disclosed a comparable mol/mol ratio in their mixed lipid systems [17]. In this 
study, the obtained liposomes were shown to increase in thermal robustness compared 
to homochiral bacterial liposomes. This can only be reached when stable homogeneous 
structures are being formed. Shortly after this study, Balleza et al. also confirmed the 
stability of mixed lipid vesicles using synthetic lipids [417]. In this study, archaeal lipids 
diphytanyl phosphatidylcholine (DPhPC ) were mixed at a 1:1 ratio with bacterial dipalmitoyl-
phosphatidylcholine (DPPC) or dihexadecylphosphatidylcholine (DHPC). These mixtures led 
to stable vesicles with solid or finely reticulated domains (Fig. 2A and B) depending on the 
presence of ester or ether bonds in the archaeal species respectively. Over time however, 
they also observed the formation of solid coalescent domains from the reticulated domains 
indicating low miscibility of the archaeal and bacterial lipids used (Fig. 2C). In our strain, 
however, the synthesized archaeal lipids were chemically different from the lipids used in 
these in vitro studies (unsaturated diethers versus saturated diether or bipolar tetraether 
lipids by Shimada and Yamagishi [17] or saturated diethers lipids using homochiral G3P 
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backbones with choline headgroups only by Balezza et al. [417]. Despite this, the mixed 
vesicles from Balleza et al. are supportive of low miscibility in the hybrid membrane 
constructed in vivo. 
A 
B 
C 
A 
B 
C 
Figure 2. Mixed lipid vesicles from 
A Ether-lipid DPhPC and ester-lipid 
DPPC showing formation of solid 
domains or B ether-lipid DPhPC and 
ether-lipid DHPC show reticulated 
and C solid coalescent domains 
respectively. Images adapted from 
Balleza et al [417].
There are however also in vivo findings that support miscibility of mixed lipids. Unsaturated 
isoprenoids like undecaprenyl-phosphate (UndP) are well known to function as sugar 
carriers in bacterial membranes. These compounds are known to readily incorporate 
between the bacterial fatty-acid lipids [418], but their quantities are very low. A few 
natural mixed membranes, which are likely homochiral, are shown in vivo. Gattinger et al. 
reported the existence of a membrane composed of 83.4% ether-linked, and 5.6% ester-
linked fatty acid hydrocarbon chains mixed with isoprenoid-ether lipids in the euryarchaeon 
Methanothermus fervidus [6]. Despite the indicated uncertainties concerning chemical 
disparity, our study confirms that heterochirality of the incorporated glycerol-phosphates 
lead to a viable situation which does not affect growth. We postulate that the unsaturated 
nature or the concentration of the foreign lipids may have had a significant influence on the 
observed phenotypical changes for which the outcome may completely change once the 
archaeal lipids become saturated or when the archaeal lipid content increases.
6. Hybrid membranes: a solution to solvents?
The most obvious reason why archaea are labelled as being naturally robust, is because 
most harsh conditions are counteracted by the efficient rigidifying ability of their lipids. 
Typical examples of membrane stability that may become useful in industry are those 
against high temperature, low pH, but also stability against high concentrations of solvents. 
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Because of this, we tested the WUR182 strain for its tolerance to heat, cold and butanol 
exposure (Chapter 6). With the exception of cold exposure, firm conclusions cannot be 
drawn yet because of the absence of a proper control strain. We deliberately neglected to 
include a wild-type strain. The inclusion of a strain with a comparable genotype but different 
phenotype seemed like a more suitable control. Therefore, we included a control strain that 
was expected not to contain archaeal lipids due to a dysfunctional araM gene for glycerol-1-
phosphate synthesis. However, from the LC-MS analysis it appeared that this control strain 
also had archaeal lipids albeit at lower quantities (10% vs. 28%). Alternatively, the mixed 
membrane strains are referenced to the included lycopene strain. Using this strain as a 
reference, however, should be approached with caution. This is because lycopene is known 
to intercalate in archaeal membranes. In bacteria, polar carotenoids are described to buffer 
the fluidizing effect of cis-unsaturated fatty acids, but the effect of the non-polar carotenoid 
lycopene on bacterial membranes is unknown. In the robustness assays, we were expecting 
to find a higher survival after high temperature exposures because of the rigidifying 
effect by the methyl branches of the archaeal lipids. The results, however, indicated a 
lower tolerance to heat shocks compared to the strain with low levels of ether-lipid and 
the lycopene control. Interestingly, we also observed an increased tolerance to butanol 
exposure and also to cryogenic conditions. The cryoprotectant effect is best explained by a 
reduced rupturing of membranes by ice crystals.
To explain the observation of a reduced heat shock survival, two possibilities come to 
mind. Firstly, the produced diether lipids are fully unsaturated. It is generally accepted 
that the unsaturated intermediate DGGGP, displays a level of stability to acidity and heat 
that is similar to ester-lipids because of the allylic ether bonds [419]. The consequence of 
unsaturated archaeal lipids on membrane fluidity however is ambiguous. The record-holder 
of hyperthermophilic growth, Methanopyrus kandleri contains high levels of unsaturated 
lipids including DGGGP and AG [66, 420], and were also detected in Thermococcus 
kodakarensis in Chapter 7. The psychrophilic archaeon Methanococcoides burtonii however 
is also highly enriched with unsaturated lipids [64]. One factor that substantially changes 
the stability of unsaturated lipids is the position of the double bonds. An ether-lipid is more 
labile when the unsaturation is positioned adjacent to the ether bond by forming an allylic 
ether [419]. This lability however is completely abolished in case the unsaturations are not 
positioned at the C1 or C2 relative to the ether bond. This situation leads to maximally 
6 unsaturations per diether lipid and possibly also occurs to some extent in both M. 
kandleri and M. burtonii. A comparison with the unsaturated lipids encountered in the 
hyperthermophile M. kandleri and psychrophiles M. burtonii may thus not be completely 
justified. On the other hand, as hydrolysis of the allylic ether bond was established 
complete at 80oC during HCL-methanolysis [419], the allylic lability may not be involved in 
the decreased heat shock survival which was performed below 58oC under non-acidified 
conditions for only 2 min. Instead, the membranes ability to maintain a closed and intact 
bilayer (stability) when mixed with ester-lipids may explain the observation. In this case 
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the trend that cells with 28% archaeal lipids are less tolerant to heat shocks than cells with 
10% archaeal lipids is an interesting observation. It suggests that higher archaeal lipid ratios 
lead to a lower ability to maintain temperature dependent stability. Conversely, a mixed 
membrane may not benefit from an archaeal lipid percentage of only 28%. Although, the 
28% ratio is the highest accomplished level of mixed lipids in vivo thus far, it may simply not 
be high enough to obtain beneficial effects on thermal stability. Despite this possibility, the 
trend we observed in the heat shock assay is not indicative of an improved survival when 
the ratio increases. However, it cannot be ruled out.
The set-up of the butanol exposure assay also did not allow us to draw firm conclusions 
about solvent robustness. Interestingly, a 1.5% butanol exposure led to a relatively 
higher level of recovered colonies compared to the lycopene control strain. This finding is 
indicative of a higher robustness. A likely explanation for this increased robustness might 
be the steric hindrance of methyl-groups preventing intercalation of the alcohols between 
the membrane lipids. One could argue that a 1-h exposure was simply not long enough to 
claim an increased butanol survival; however a 2.5% butanol exposure was high enough 
to lyse nearly 100% of the cells regardless of the strain being used. At a concentration of 
1.5% butanol, 100% of the cells with a mixed membrane survived the 1-h butanol exposure. 
Applying the mixed membrane may therefore seem like a promising strategy to process or 
produce alcohols. More research however, is required with the inclusion of a proper control 
strain to determine whether growth is also tolerated in presence of alcohols rather than 
measuring survival after a transient exposure. 
7. Perspectives
Future research should first focus on the issues of miscibility and saturation. We would like 
to address the miscibility issue by approaching it from two different angles. Determining 
miscibility can first be done by isolating the observed budding appendages or released 
vesicles from the strain with the hybrid membrane. This can be done either with or without 
a brief sonication treatment to accelerate the detachment of the appendages. The resulting 
vesicles can be analysed by LC-MS to determine whether enrichment of archaeal lipids in 
the vesicles has taken place. In case no enrichment took place, the archaeal lipids may 
become homogeneously divided over the plasma-membrane or perhaps aggregated in 
patches/rafts dispersed throughout the membrane. As a secondary approach to assess the 
miscibility, one could develop a fluorescent probe that specifically binds to ether-bonds, 
or use an unspecific probe like 1-(4-trimethylammoniumphenyl)-6-phenyl 1,3,5-hexatriene 
p-toluene-sulfonate (TMA-DPH)[417, 421] to visualize the dispersion of archaeal lipids. 
Ideally, these experiments are also done with cells which are equipped with a functional 
geranylgeranyl reductase to compare saturated with unsaturated archaeal lipids. As already 
emphasized by Koga and Morii [419], unsaturated core lipids, DGGGP and thus also the 
obtained unsaturated AG, may contain relatively labile allyl ether bonds. These bonds have 
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an equal stability in terms of heat and acid tolerance as bacterial acyl-ester lipids. Besides 
this difference by the level of saturation, a difference in miscibility between unsaturated and 
saturated diether lipids is also likely to occur. Unfortunately, packing efficiency or dynamics 
of both saturated and unsaturated archaeal lipids have never been modelled in molecular 
dynamics studies. Therefore it is thus not possible to predict their different behaviour. In 
contrast, for bipolar tetraether lipids with its molecular variants several studies are available 
[123, 422, 423].
This brings us back to the discussion on the mixed membrane hypothesis of the common 
ancestor of archaea and bacteria. What are the implications of our findings for this 
hypothesis? Two main findings described in Chapter 6 support the primordial existence of a 
mixed membrane in LUCA: (i) the viability of a membrane containing 28% archaeal lipids and 
(ii) the promiscuous specificity of bacterial enzymes for archaeal lipid substrates and vice 
versa. Several key questions, however, remain unanswered. In this respect, the question 
whether archaeal and bacterial lipids result in homogeneous mixtures has currently the most 
important implication for the mixed membrane hypothesis. In case the archaeal lipids are 
not miscible but expelled trough budding, it is interesting to study whether this is an active 
budding process like formation of outer membrane vesicles (OMV’s)[424], or accelerated by 
spontaneous lipid segregation. To come to a proper biophysical characterization of a mixed 
membrane, the viscosity of the membrane can be measured by performing fluorescence 
anisotropy. A temperature dependent proton permeability of the mixed membrane can be 
determined by preparing liposomes loaded with a pH buffer. Proton permeability can be 
assessed by monitoring the pH from a fluorescent pH indicator dye (pyranine) and pulsing 
the liposome mixtures with acid according to Nichols and Deamer [425]. 
Besides the key questions concerning miscibility, viscosity and permeability of the membrane, 
many more minor issues remain unsolved. Firstly, the question remains whether higher 
levels of archaeal lipids are also tolerated and whether these lipids are sustainable over an 
extended period of time or ultimately counter-selected. This issue can be solved once the 
proposed engineering has been accomplished to make the use of OPT1 medium redundant. 
Growing a strain with the proposed modifications (Fig. 1) and provided with limiting glycerol 
concentrations might then result in even higher archaeal lipid levels than detected thus far. 
Another issue that is interesting to study is the composition of the peptidoglycan cell wall. 
Here one might expect to observe some dramatic effects. The endogenous pool of farnesyl-
diphosphate is natively converted to undecaprenyl-diphopshate (UndP) which functions as 
a carrier to transport LPS constituents from the inner membrane to the periplasmic space 
via the lpt translocase system. Due to an up-regulated synthesis of GGGP, the level of 
available UndP might become limiting with dramatic consequences to the peptidoglycan 
layer. Another interesting issue is the location of the archaeal lipids, i.e. do they end up 
in the inner or outer membrane, or both? Lipids from the outer-membrane are usually 
transported by flippases and therefore the novel archaeal lipids might only accumulate 
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in the inner membrane. This question can be addressed by separating the inner from the 
outer membrane by making use of a sucrose density gradient ultra-centrifugation [426]. As 
a final prospect to an application of the mixed membrane, the strain is a highly interesting 
tool for the identification of the missing link in glycerol dialkyl glycerol tetraether (GDGT) 
lipid synthesis. Here the envisioned enzyme system attaches two diether lipids to form a 
single membrane spanning tetraether lipid via a tail-to-tail condensation reaction [9]. Both 
the enzyme(s) and the involved substrates remain unidentified to this day. The mixed 
membrane strain can provide a powerful tool for the identification of the responsible 
enzyme, because all of the obviously anticipated substrates are present within the strain. 
The genes identified in Chapter 7, or a series of heterologously expressed genes from a 
mesophilic archaeon like Methanospirillum hungatei (Topt=37oC, 59%TE’s) with confirmed 
tetraether lipids can be used in the mixed membrane model to screen for GDGT synthase 
activity.
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Figure S2A. Schematic representation of the initial setup of the mixed membrane engineering. With the 
exception of the geranylgeranyl reductase gene (ggr), all genes and modifications were implemented as indicated 
in Fig. S2B Abbreviations: acpP: acyl carrier protein; araM: glycerol-1-phosphate dehydrogenase; carS: CDP-
archaeol synthase; crtE: geranylgeranyl-diphosphate synthase; DGGGPs: di-O-geranylgeranyl-glycerylphosphate 
synthase; dxs: 1-deoxy-D-xylulose-5-phosphate synthase; GGGPs: geranylgeranylglyceryl-phosphate synthase; ggr: 
geranylgeranyl reductase; idi: isopentenyl-diphosphate isomerase; ispDF: 2C-methyl-D-erythritol-4-phosphate 
cytidylyltransferase and 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase resp.; pgpA: phosphatidylglycerol 
phosphatase; pgsA: phosphatidylglycero-phosphatesynthase; plsB: glycerol-3-phosphate acyltransferase; 
plsX: phosphate-acyltransferase; plsY: glycerol-3-phosphate acyltransferase; psdA: phosphatidylserine 
decarboxylase;pssA: phosphatidylserine synthase; 
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